From f6f66f351cc9cfb7ddfae1fd096f5795310dd654 Mon Sep 17 00:00:00 2001 From: Praveen Kumar Date: Mon, 18 May 2026 08:54:57 +0000 Subject: [PATCH 01/21] WHO Tuberculosis Rifampicin Resistant Data Import --- .../README.md | 54 ++ .../manifest.json | 26 + .../Tuberculosis_rr_mdr_tb_outcomes.csv | 500 ++++++++++++++++++ .../Tuberculosis_rr_mdr_tb_output.csv | 500 ++++++++++++++++++ .../Tuberculosis_rr_mdr_tb_output.tmcf | 8 + ...rculosis_rifampicin_resistant_metadata.csv | 14 + ...uberculosis_rifampicin_resistant_pvmap.csv | 9 + ...nload_tuberculosis_rifampicin_resistant.py | 66 +++ 8 files changed, 1177 insertions(+) create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/README.md create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/manifest.json create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.csv create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.tmcf create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/README.md b/statvar_imports/tuberculosis_rifampicin_resistant/README.md new file mode 100644 index 0000000000..1c742a0100 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/README.md @@ -0,0 +1,54 @@ +# WHO Tuberculosis: Tuberculosis: Treatment outcomes of people with RR/MDR-TB + +## Overview +This dataset provides the percentage of TB patients who started rifampicin-resistant TB treatment and whose treatment outcome was recorded as treatment success (cured or treatment completed), treatment failed, died, lost to follow-up, or not evaluated, within the reporting period. + +## Data Source + +**Source URL:** +https://data.who.int/indicators/i/39E4281/F1912F6 + +The data comes from the official WHO reporting database and includes comprehensive, country-level health metrics detailing annual Tuberculosis notifications and case classifications. + +## How To Download Input Data +To download the data, you'll need to run the provided download script `who_data_download_tuberculosis_rifampicin_resistant.py`. This script automatically queries the WHO API for the indicator, merges it with the WHO geographical master list to append standard `iso3` country codes, and saves the cleaned `Tuberculosis_rr_mdr_tb_outcomes.csv` file inside an "input_files" folder. + +type of place: Country. + +statvars: Health / Tuberculosis. + +years: 2010 to 2022 + +place_resolution: manually. + +release_frequency: P1Y + +## Processing Instructions +To process the WHO Tuberculosis data and generate statistical variables, use the following commands from your root `data` directory: + +**Download input file** +```bash +python3 statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py +``` + +**For Test Data Run** +```bash + python3 tools/statvar_importer/stat_var_processor.py \ + --input_data="statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv" \ + --pv_map="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv" \ + --output_path="statvar_imports/tuberculosis_rifampicin_resistant/output_files/tuberculosis_rifampicin_resistant" \ + --config_file="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv" \ + --existing_statvar_mcf="gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" +``` + +**For Main data run** +```bash + python3 tools/statvar_importer/stat_var_processor.py \ + --input_data="statvar_imports/tuberculosis_rifampicin_resistant/input_files/Tuberculosis_rr_mdr_tb_outcomes.csv" \ + --pv_map="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv" \ + --output_path="statvar_imports/tuberculosis_rifampicin_resistant/output_files/tuberculosis_rifampicin_resistant" \ + --config_file="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv" \ + --existing_statvar_mcf="gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" +``` + +#### Refresh type: Fully Autorefresh \ No newline at end of file diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json new file mode 100644 index 0000000000..6d22e7efda --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json @@ -0,0 +1,26 @@ +{ + "import_specifications": [ + { + "import_name": "WHO_TuberculosisTreatmentOutcomes_RR_MDR_TB", + "curator_emails": [ + "support@datacommons.org" + ], + "provenance_url": "", + "provenance_description": "Treatment outcomes among those who started rifampicin-resistant TB treatment during a specified reporting period.", + "scripts": [ + "who_data_download_tuberculosis_rifampicin_resistant.py", + "../../../tools/statvar_importer/stat_var_processor.py --input_data=input_files/Tuberculosis_rr_mdr_tb_outcomes.csv --pv_map=tuberculosis_rr_mdr_tb_outcomes_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rr_mdr_tb_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" + ], + "import_inputs": [ + { + "template_mcf": "output/tuberculosis_rr_mdr_tb_output.tmcf", + "cleaned_csv": "output/tuberculosis_rr_mdr_tb_output.csv" + } + ], + "source_files": [ + "input_files/Tuberculosis_rr_mdr_tb_outcomes.csv" + ], + "cron_schedule": "0 10 10,21 * *" + } + ] +} \ No newline at end of file diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv new file mode 100644 index 0000000000..0edca6e2b6 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv @@ -0,0 +1,500 @@ +IND_ID,INDICATOR_NAME,YEAR,COUNTRY,iso3,DISAGGR_1,VALUE +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Not evaluated,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Successfully treated,71.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Died,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Lost to follow-up,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Successfully treated,63.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Treatment failed,2.17391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Died,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Lost to follow-up,19.5652173913043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Not evaluated,2.17391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Successfully treated,65.1162790697675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Died,11.6279069767442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Lost to follow-up,23.2558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Successfully treated,63.855421686747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Died,16.8674698795181 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Lost to follow-up,19.2771084337349 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Successfully treated,62.0915032679739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Treatment failed,2.61437908496732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Died,13.7254901960784 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Lost to follow-up,20.9150326797386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Not evaluated,0.65359477124183 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Successfully treated,63.9175257731959 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Treatment failed,1.03092783505155 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Died,12.3711340206186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Lost to follow-up,22.1649484536082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Not evaluated,0.515463917525773 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Successfully treated,68.8073394495413 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Treatment failed,2.75229357798165 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Died,10.0917431192661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Lost to follow-up,16.8195718654434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Not evaluated,1.52905198776758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Successfully treated,71.2121212121212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Treatment failed,2.02020202020202 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Died,8.58585858585859 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Lost to follow-up,14.3939393939394 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Not evaluated,3.78787878787879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Successfully treated,74.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Treatment failed,0.952380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Died,9.84126984126984 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Lost to follow-up,13.015873015873 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Not evaluated,1.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Successfully treated,68.4478371501272 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Treatment failed,2.79898218829517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Died,11.1959287531807 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Lost to follow-up,16.793893129771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Not evaluated,0.763358778625954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Successfully treated,72.3154362416107 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Treatment failed,2.18120805369128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Died,11.0738255033557 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Lost to follow-up,13.4228187919463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Not evaluated,1.00671140939597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Successfully treated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Treatment failed,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Albania,ALB,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Successfully treated,75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Died,25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Died,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Died,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Albania,ALB,Successfully treated,60 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Albania,ALB,Died,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Albania,ALB,Not evaluated,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,American Samoa,ASM,Lost to follow-up,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,American Samoa,ASM,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Successfully treated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Not evaluated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Successfully treated,77.3480662983426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Treatment failed,0.552486187845304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Died,8.28729281767956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Lost to follow-up,13.8121546961326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Successfully treated,72.4279835390947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Treatment failed,0.411522633744856 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Died,8.23045267489712 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Lost to follow-up,18.9300411522634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Successfully treated,72.2466960352423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Died,6.75675675675676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Lost to follow-up,12.1621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Not evaluated,18.9189189189189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Successfully treated,80.4347826086957 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Died,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Lost to follow-up,9.78260869565217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Not evaluated,5.43478260869565 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Successfully treated,69 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Died,14 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Lost to follow-up,17 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Successfully treated,56 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Died,8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Lost to follow-up,12 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Not evaluated,24 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Lost to follow-up,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Not evaluated,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Successfully treated,48.7804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Died,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Lost to follow-up,9.75609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Not evaluated,24.390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Treatment failed,2.08333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Died,14.5833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Lost to follow-up,22.9166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Not evaluated,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Successfully treated,66 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Treatment failed,2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Died,22 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Lost to follow-up,10 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Successfully treated,26.7857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Treatment failed,1.78571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Died,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Lost to follow-up,16.0714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Not evaluated,44.6428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Successfully treated,61.71875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Lost to follow-up,24.21875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Not evaluated,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Successfully treated,61.71875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Lost to follow-up,24.21875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Not evaluated,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Successfully treated,72.8070175438597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Died,11.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Lost to follow-up,14.0350877192982 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Not evaluated,1.75438596491228 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Died,40 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Lost to follow-up,10 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Not evaluated,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Successfully treated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Not evaluated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Successfully treated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Successfully treated,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Lost to follow-up,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Not evaluated,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Lost to follow-up,25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Died,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Lost to follow-up,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Not evaluated,10 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Successfully treated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Lost to follow-up,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Successfully treated,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Died,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Not evaluated,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Successfully treated,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Lost to follow-up,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Not evaluated,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Lost to follow-up,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Successfully treated,48 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Died,12 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Lost to follow-up,36 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Not evaluated,4 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Successfully treated,46.031746031746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Treatment failed,1.58730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Lost to follow-up,34.9206349206349 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Not evaluated,3.17460317460317 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Treatment failed,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Lost to follow-up,28.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Not evaluated,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Successfully treated,59.4594594594595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Treatment failed,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Died,13.5135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Lost to follow-up,21.6216216216216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Successfully treated,54.3859649122807 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Died,19.2982456140351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Lost to follow-up,22.8070175438597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Not evaluated,3.50877192982456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Died,14.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Lost to follow-up,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Treatment failed,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Treatment failed,24.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Died,8.46153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Not evaluated,13.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Successfully treated,41.8166939443535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Treatment failed,16.4484451718494 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Died,7.28314238952537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Lost to follow-up,8.34697217675941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Not evaluated,26.1047463175123 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Successfully treated,49.9065420560748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Treatment failed,20.4672897196262 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Died,8.41121495327103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Lost to follow-up,8.22429906542056 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Not evaluated,12.9906542056075 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Successfully treated,42.2350472193074 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Treatment failed,7.71248688352571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Died,5.40398740818468 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Lost to follow-up,4.45960125918153 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Not evaluated,40.1888772298006 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Successfully treated,55.4945054945055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Treatment failed,8.97435897435897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Lost to follow-up,7.37179487179487 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Not evaluated,21.0164835164835 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Successfully treated,40.9697821503865 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Treatment failed,6.39494026704146 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Died,5.86788475052706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Lost to follow-up,8.9599437807449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Not evaluated,37.8074490513001 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Successfully treated,40.9945528026709 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Treatment failed,9.7873835881216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Died,4.09418379898085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Lost to follow-up,13.1259884027412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Not evaluated,31.9978914074855 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Successfully treated,52.2664199814986 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Treatment failed,6.91951896392229 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Died,5.64292321924144 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Lost to follow-up,25.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Successfully treated,60.1208459214502 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Died,23.5649546827795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Lost to follow-up,16.3141993957704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Successfully treated,69.8198198198198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Treatment failed,1.8018018018018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Died,19.8198198198198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Lost to follow-up,8.55855855855856 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Successfully treated,67.5409836065574 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Treatment failed,1.9672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Died,22.9508196721311 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Lost to follow-up,4.26229508196721 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Not evaluated,3.27868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Successfully treated,71.864406779661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Treatment failed,4.74576271186441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Died,18.6440677966102 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Lost to follow-up,2.71186440677966 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Not evaluated,2.03389830508475 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Successfully treated,73.4513274336283 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Treatment failed,3.53982300884956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Died,19.4690265486726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Lost to follow-up,3.09734513274336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Not evaluated,0.442477876106195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Successfully treated,76.2237762237762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Treatment failed,2.0979020979021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Died,12.5874125874126 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Lost to follow-up,2.7972027972028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Not evaluated,6.29370629370629 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Successfully treated,81.6793893129771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Treatment failed,0.763358778625954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Died,15.2671755725191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Lost to follow-up,2.29007633587786 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Successfully treated,77.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Treatment failed,2.35294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Lost to follow-up,8.23529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Successfully treated,84.4155844155844 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Treatment failed,2.5974025974026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Died,7.79220779220779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Lost to follow-up,5.1948051948052 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Treatment failed,1.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Died,8.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Lost to follow-up,4.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Successfully treated,90.4109589041096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Died,8.21917808219178 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Lost to follow-up,1.36986301369863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Successfully treated,84.2105263157895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Treatment failed,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Died,13.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Lost to follow-up,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Not evaluated,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Successfully treated,72.4137931034483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Died,18.1034482758621 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Lost to follow-up,7.75862068965517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Not evaluated,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Successfully treated,82.6568265682657 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Treatment failed,3.690036900369 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Died,11.8081180811808 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Lost to follow-up,1.8450184501845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Successfully treated,68.0100755667506 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Treatment failed,2.51889168765743 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Died,12.3425692695214 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Lost to follow-up,8.06045340050378 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Not evaluated,9.06801007556675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Successfully treated,69.6588868940754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Treatment failed,0.538599640933573 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Died,15.2603231597846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Lost to follow-up,8.79712746858169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Not evaluated,5.74506283662478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Successfully treated,75.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Treatment failed,0.757575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Died,11.969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Lost to follow-up,10.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Not evaluated,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Successfully treated,72.4039829302987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Treatment failed,2.13371266002845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Died,12.0910384068279 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Lost to follow-up,7.96586059743955 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Not evaluated,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Successfully treated,75.2824858757062 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Treatment failed,1.69491525423729 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Died,10.7344632768362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Lost to follow-up,7.20338983050848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Not evaluated,5.08474576271186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Successfully treated,70.1388888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Treatment failed,1.52777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Died,10.4166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Lost to follow-up,6.80555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Successfully treated,68.266253869969 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Treatment failed,3.09597523219814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Died,8.97832817337461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Lost to follow-up,5.57275541795666 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Not evaluated,14.0866873065015 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Successfully treated,60.6164383561644 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Treatment failed,1.1986301369863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Died,5.82191780821918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Lost to follow-up,2.73972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Not evaluated,29.6232876712329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Successfully treated,78.0155642023346 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Treatment failed,2.91828793774319 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Died,8.94941634241245 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Lost to follow-up,4.08560311284047 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Not evaluated,6.03112840466926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Successfully treated,81.9178082191781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Treatment failed,0.273972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Died,6.84931506849315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Lost to follow-up,6.71232876712329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Not evaluated,4.24657534246575 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Successfully treated,100 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Successfully treated,75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Died,25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Successfully treated,60 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Treatment failed,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Died,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Successfully treated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Not evaluated,50 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Successfully treated,80 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Lost to follow-up,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Not evaluated,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Successfully treated,40 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Died,20 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Not evaluated,40 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Died,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Lost to follow-up,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Successfully treated,4.05405405405405 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Treatment failed,0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Died,1.35135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Lost to follow-up,1.35135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Not evaluated,93.2432432432432 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Successfully treated,8.13953488372093 diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.csv b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.csv new file mode 100644 index 0000000000..9ee1054e0e --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.csv @@ -0,0 +1,500 @@ +observationDate,observationAbout,value,variableMeasured +2011,country/AFG,66.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2011,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2011,country/AFG,9.52381,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2011,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2011,country/AFG,23.80952,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2012,country/AFG,71.05263,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2012,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2012,country/AFG,15.78947,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2012,country/AFG,7.89474,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2012,country/AFG,5.26316,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2013,country/AFG,63.04348,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2013,country/AFG,2.17391,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2013,country/AFG,13.04348,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2013,country/AFG,19.56522,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2013,country/AFG,2.17391,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/AFG,65.11628,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/AFG,11.62791,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/AFG,23.25581,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/AFG,63.85542,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/AFG,16.86747,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/AFG,19.27711,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/AFG,62.0915,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/AFG,2.61438,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/AFG,13.72549,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/AFG,20.91503,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/AFG,0.65359,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/AFG,63.91753,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/AFG,1.03093,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/AFG,12.37113,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/AFG,22.16495,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/AFG,0.51546,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/AFG,68.80734,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/AFG,2.75229,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/AFG,10.09174,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/AFG,16.81957,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/AFG,1.52905,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/AFG,71.21212,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/AFG,2.0202,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/AFG,8.58586,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/AFG,14.39394,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/AFG,3.78788,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/AFG,74.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/AFG,0.95238,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/AFG,9.84127,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/AFG,13.01587,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/AFG,1.90476,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/AFG,68.44784,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/AFG,2.79898,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/AFG,11.19593,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/AFG,16.79389,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/AFG,0.76336,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/AFG,72.31544,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/AFG,2.18121,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/AFG,11.07383,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/AFG,13.42282,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/AFG,1.00671,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2006,country/ALB,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/ALB,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/ALB,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/ALB,75,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/ALB,25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/ALB,60,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/ALB,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/ALB,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/ALB,66.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/ALB,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/ASM,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/ASM,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2009,country/AGO,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2011,country/AGO,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2013,country/AGO,77.34807,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2013,country/AGO,0.55249,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2013,country/AGO,8.28729,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2013,country/AGO,13.81215,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2013,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/AGO,72.42798,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/AGO,0.41152,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/AGO,8.23045,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/AGO,18.93004,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/AGO,72.2467,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/CAF,6.75676,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/CAF,12.16216,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/CAF,18.91892,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/CAF,80.43478,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/CAF,4.34783,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/CAF,9.78261,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/CAF,5.43478,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/CAF,69,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/CAF,14,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/CAF,17,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/TCD,56,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/TCD,8,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/TCD,12,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/TCD,24,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/TCD,72.72727,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/TCD,9.09091,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/TCD,12.12121,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/TCD,6.06061,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/TCD,48.78049,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/TCD,2.43902,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/TCD,14.63415,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/TCD,9.7561,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/TCD,24.39024,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/TCD,56.25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/TCD,2.08333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/TCD,14.58333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/TCD,22.91667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/TCD,4.16667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/TCD,66,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/TCD,2,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/TCD,22,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/TCD,10,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/TCD,26.78571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/TCD,1.78571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/TCD,10.71429,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/TCD,16.07143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/TCD,44.64286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/TCD,61.71875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/TCD,12.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/TCD,24.21875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/TCD,1.5625,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/TCD,61.71875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/TCD,12.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/TCD,24.21875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/TCD,1.5625,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/TCD,72.80702,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/TCD,11.40351,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/TCD,14.03509,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/TCD,1.75439,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2002,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2002,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2002,country/CHL,40,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2002,country/CHL,10,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2002,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2004,country/CHL,42.85714,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2004,country/CHL,28.57143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2004,country/CHL,14.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2004,country/CHL,14.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2006,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2006,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2006,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2006,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2006,country/CHL,35.71429,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2007,country/CHL,36.36364,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2007,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2007,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2007,country/CHL,18.18182,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2007,country/CHL,45.45455,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2008,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2008,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2008,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2008,country/CHL,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2008,country/CHL,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2009,country/CHL,21.05263,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2009,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2009,country/CHL,26.31579,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2009,country/CHL,15.78947,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2009,country/CHL,36.84211,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2010,country/CHL,41.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2010,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2010,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2010,country/CHL,25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2010,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2011,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2011,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2011,country/CHL,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2011,country/CHL,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2011,country/CHL,10,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2012,country/CHL,55.55556,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2012,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2012,country/CHL,22.22222,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2012,country/CHL,11.11111,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2012,country/CHL,11.11111,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2013,country/CHL,21.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2013,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2013,country/CHL,28.57143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2013,country/CHL,42.85714,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2013,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/CHL,30.76923,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/CHL,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/CHL,30.76923,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/CHL,15.38462,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/CHL,15.38462,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/CHL,36.84211,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/CHL,10.52632,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/CHL,26.31579,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/CHL,26.31579,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/CHL,71.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/CHL,21.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/CHL,48,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/CHL,12,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/CHL,36,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/CHL,4,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/CHL,46.03175,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/CHL,1.5873,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/CHL,14.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/CHL,34.92063,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/CHL,3.1746,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/CHL,1.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/CHL,13.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/CHL,28.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/CHL,6.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/CHL,59.45946,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/CHL,5.40541,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/CHL,13.51351,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/CHL,21.62162,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/CHL,54.38596,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/CHL,19.29825,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/CHL,22.80702,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/CHL,3.50877,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/CHL,63.63636,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/CHL,1.81818,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/CHL,14.54545,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/CHL,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2008,country/CHN,46.15385,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2008,country/CHN,38.46154,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2008,country/CHN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2008,country/CHN,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2008,country/CHN,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2009,country/CHN,46.15385,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2009,country/CHN,24.61538,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2009,country/CHN,8.46154,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2009,country/CHN,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2009,country/CHN,13.07692,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2010,country/CHN,41.81669,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2010,country/CHN,16.44845,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2010,country/CHN,7.28314,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2010,country/CHN,8.34697,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2010,country/CHN,26.10475,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2011,country/CHN,49.90654,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2011,country/CHN,20.46729,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2011,country/CHN,8.41121,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2011,country/CHN,8.2243,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2011,country/CHN,12.99065,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2012,country/CHN,42.23505,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2012,country/CHN,7.71249,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2012,country/CHN,5.40399,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2012,country/CHN,4.4596,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2012,country/CHN,40.18888,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2013,country/CHN,55.49451,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2013,country/CHN,8.97436,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2013,country/CHN,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2013,country/CHN,7.37179,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2013,country/CHN,21.01648,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/CHN,40.96978,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/CHN,6.39494,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/CHN,5.86788,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/CHN,8.95994,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/CHN,37.80745,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/CHN,40.99455,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/CHN,9.78738,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/CHN,4.09418,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/CHN,13.12599,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/CHN,31.99789,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/CHN,52.26642,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/CHN,6.91952,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/CHN,5.64292,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2011,country/SWZ,25.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2011,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2013,country/SWZ,60.12085,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2013,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2013,country/SWZ,23.56495,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2013,country/SWZ,16.3142,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2013,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/SWZ,69.81982,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/SWZ,1.8018,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/SWZ,19.81982,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/SWZ,8.55856,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/SWZ,67.54098,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/SWZ,1.96721,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/SWZ,22.95082,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/SWZ,4.2623,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/SWZ,3.27869,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/SWZ,71.86441,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/SWZ,4.74576,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/SWZ,18.64407,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/SWZ,2.71186,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/SWZ,2.0339,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/SWZ,73.45133,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/SWZ,3.53982,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/SWZ,19.46903,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/SWZ,3.09735,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/SWZ,0.44248,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/SWZ,76.22378,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/SWZ,2.0979,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/SWZ,12.58741,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/SWZ,2.7972,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/SWZ,6.29371,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/SWZ,81.67939,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/SWZ,0.76336,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/SWZ,15.26718,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/SWZ,2.29008,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/SWZ,77.64706,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/SWZ,2.35294,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/SWZ,11.76471,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/SWZ,8.23529,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/SWZ,84.41558,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/SWZ,2.5974,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/SWZ,7.79221,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/SWZ,5.19481,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/SWZ,85.71429,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/SWZ,1.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/SWZ,8.57143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/SWZ,4.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2009,country/ETH,90.41096,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2009,country/ETH,8.21918,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2009,country/ETH,1.36986,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2009,country/ETH,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2010,country/ETH,84.21053,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2010,country/ETH,0.87719,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2010,country/ETH,13.15789,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2010,country/ETH,0.87719,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2010,country/ETH,0.87719,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2011,country/ETH,72.41379,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2011,country/ETH,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2011,country/ETH,18.10345,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2011,country/ETH,7.75862,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2011,country/ETH,1.72414,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2012,country/ETH,82.65683,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2012,country/ETH,3.69004,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2012,country/ETH,11.80812,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2012,country/ETH,1.84502,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2012,country/ETH,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2013,country/ETH,68.01008,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2013,country/ETH,2.51889,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2013,country/ETH,12.34257,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2013,country/ETH,8.06045,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2013,country/ETH,9.06801,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/ETH,69.65889,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/ETH,0.5386,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/ETH,15.26032,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/ETH,8.79713,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/ETH,5.74506,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/ETH,75.15152,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/ETH,0.75758,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/ETH,11.9697,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/ETH,10.45455,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/ETH,1.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/ETH,72.40398,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/ETH,2.13371,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/ETH,12.09104,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/ETH,7.96586,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/ETH,5.40541,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/ETH,75.28249,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/ETH,1.69492,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/ETH,10.73446,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/ETH,7.20339,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/ETH,5.08475,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/ETH,70.13889,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/ETH,1.52778,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/ETH,10.41667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/ETH,6.80556,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/ETH,11.11111,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/ETH,68.26625,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/ETH,3.09598,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/ETH,8.97833,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/ETH,5.57276,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/ETH,14.08669,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2020,country/ETH,60.61644,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2020,country/ETH,1.19863,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2020,country/ETH,5.82192,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2020,country/ETH,2.73973,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2020,country/ETH,29.62329,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/ETH,78.01556,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/ETH,2.91829,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/ETH,8.94942,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/ETH,4.0856,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/ETH,6.03113,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/ETH,81.91781,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/ETH,0.27397,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/ETH,6.84932,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/ETH,6.71233,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/ETH,4.24658,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2014,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2021,country/FJI,75,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2021,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2021,country/FJI,25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2021,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2021,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/FJI,60,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/FJI,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/FJI,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2015,country/FIN,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2015,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2015,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2015,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2015,country/FIN,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2016,country/FIN,80,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2016,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2016,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2016,country/FIN,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2016,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2017,country/FIN,40,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2017,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2017,country/FIN,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2017,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2017,country/FIN,40,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/FIN,66.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2019,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2019,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2019,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2019,country/FIN,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2022,country/FIN,62.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2022,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2022,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2022,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2022,country/FIN,37.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2018,country/FRA,4.05405,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +2018,country/FRA,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +2018,country/FRA,1.35135,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +2018,country/FRA,1.35135,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +2018,country/FRA,93.24324,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +2019,country/FRA,8.13953,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.tmcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.tmcf new file mode 100644 index 0000000000..f3640586bf --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.tmcf @@ -0,0 +1,8 @@ +Node: E:TB_output->E0 +observationDate: C:TB_output->observationDate +observationAbout: C:TB_output->observationAbout +value: C:TB_output->value +variableMeasured: C:TB_output->variableMeasured +scalingFactor: 100 +typeOf: dcs:StatVarObservation +unit: dcs:Percent diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv new file mode 100644 index 0000000000..b56a8d7547 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv @@ -0,0 +1,14 @@ +config,value +provenance_url,https://data.who.int/indicators/i/39E4281/F1912F6 +output_columns,"observationDate,observationAbout,variableMeasured,value,unit,scalingFactor" +#places_within,country/POL +#place_types,"AdministrativeArea,AdministrativeArea1,AdministrativeArea2,State" +#debug,1 +#input_rows,100 +#word_delimiter,'' +#skip_rows,1 +populationType,Person +measuredProperty,count +header_rows,1 +mapped_columns,6 +dc_api_root,https://api.datacommons.org \ No newline at end of file diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv new file mode 100644 index 0000000000..7a483d0c5e --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv @@ -0,0 +1,9 @@ +key,p1,v1,p2,v2,p3,v3,p4,v4,p5,v5,p6,v6,p7,v7 +iso3,observationAbout,country/{Data},,,,,, +YEAR,observationDate,{Data},,,,,, +DISAGGR_1:Died,treatmentOutcome,dcs:DiedDuringTreatment,,,,,, +DISAGGR_1:Lost to follow-up,treatmentOutcome,dcs:LostToFollowUp,,,,,, +DISAGGR_1:Not evaluated,treatmentOutcome,dcs:TreatmentNotEvaluated,,,,,, +DISAGGR_1:Successfully treated,treatmentOutcome,dcs:SuccessfullyTreated,,,,,, +DISAGGR_1:Treatment failed,treatmentOutcome,dcs:TreatmentFailed,,,,,, +VALUE,value,{Number},populationType,dcs:Person,measuredProperty,dcs:count,medicalCondition,dcs:MultidrugOrRifampicinResistantTuberculosis,unit,dcs:Percent,scalingFactor,100,, \ No newline at end of file diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py b/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py new file mode 100644 index 0000000000..35a040cb57 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py @@ -0,0 +1,66 @@ +import os +import requests +import io +import pandas as pd +import logging + +# Configure logging +logging.basicConfig(level=logging.INFO, format='%(asctime)s - %(levelname)s - %(message)s') + +def download_tb_rr_mdr_data(): + # 1. Get the Clean Data from the API using the new Indicator ID + api_url = "https://xmart-api-public.who.int/DATA_/RELAY_TB_DATA" + params = { + "$filter": "IND_ID eq '39E4281F1912F6'", + "$select": "IND_ID,INDICATOR_NAME,YEAR,COUNTRY,DISAGGR_1,VALUE", + "$format": "csv" + } + + logging.info("1. Fetching clean percentage data from WHO API...") + api_response = requests.get(api_url, params=params) + + if api_response.status_code != 200: + logging.error(f"Failed to fetch API data. HTTP {api_response.status_code}") + return + + # Load the clean API data into a pandas table + api_df = pd.read_csv(io.StringIO(api_response.text)) + + # 2. Get ONLY the iso3 code from the master database + logging.info("2. Fetching country iso3 codes from WHO master database...") + master_url = "https://extranet.who.int/tme/generateCSV.asp?ds=notifications" + master_response = requests.get(master_url) + if master_response.status_code != 200: + logging.error(f"Failed to fetch master data. HTTP {master_response.status_code}") + return + + # We only pull the 'country' (for matching) and 'iso3' columns + geo_columns = ['country', 'iso3'] + master_df = pd.read_csv(io.StringIO(master_response.text), usecols=geo_columns).drop_duplicates() + + # 3. Merge the two datasets together based on the country name + logging.info("3. Merging data and formatting...") + # The API uses uppercase 'COUNTRY', the master uses lowercase 'country' + merged_df = pd.merge(api_df, master_df, left_on='COUNTRY', right_on='country', how='left') + + # Drop the duplicate lowercase 'country' column used for joining + merged_df = merged_df.drop(columns=['country']) + + # Reorder columns so the iso3 code sits right next to the Country name + final_columns = [ + 'IND_ID', 'INDICATOR_NAME', 'YEAR', 'COUNTRY', 'iso3','DISAGGR_1', 'VALUE' + ] + merged_df = merged_df[final_columns] + + # 4. Save to CSV in a new folder + output_dir = "input_files" + filename = os.path.join(output_dir, "Tuberculosis_rr_mdr_tb_outcomes.csv") + + os.makedirs(output_dir, exist_ok=True) + + # Save without the pandas index column + merged_df.to_csv(filename, index=False) + logging.info(f"Success! Data saved locally as '{filename}'") + +if __name__ == "__main__": + download_tb_rr_mdr_data() \ No newline at end of file From 61205f3f73f1a3acee9dbba2f9e90fafee7150d5 Mon Sep 17 00:00:00 2001 From: Praveen Kumar Date: Mon, 18 May 2026 09:05:36 +0000 Subject: [PATCH 02/21] WHO Tuberculosis Rifampicin Resistant Data Import --- .../who_data_download_tuberculosis_rifampicin_resistant.py | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py b/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py index 35a040cb57..eedb85ea59 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py +++ b/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py @@ -53,7 +53,7 @@ def download_tb_rr_mdr_data(): merged_df = merged_df[final_columns] # 4. Save to CSV in a new folder - output_dir = "input_files" + output_dir = "statvar_imports/tuberculosis_rifampicin_resistant/input_files" filename = os.path.join(output_dir, "Tuberculosis_rr_mdr_tb_outcomes.csv") os.makedirs(output_dir, exist_ok=True) From dbbc953794c9546de929c45aa4c17a23f319f1fb Mon Sep 17 00:00:00 2001 From: Praveen Kumar Date: Mon, 18 May 2026 09:31:07 +0000 Subject: [PATCH 03/21] WHO Tuberculosis Rifampicin Resistant Data Import --- .../manifest.json | 2 +- ...uberculosis_rr_mdr_tb_output_stat_vars.mcf | 42 ++++++++++++++++++ ...osis_rr_mdr_tb_output_stat_vars_schema.mcf | 43 +++++++++++++++++++ ...nload_tuberculosis_rifampicin_resistant.py | 4 +- 4 files changed, 88 insertions(+), 3 deletions(-) create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json index 6d22e7efda..ce050ffb1c 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json +++ b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json @@ -9,7 +9,7 @@ "provenance_description": "Treatment outcomes among those who started rifampicin-resistant TB treatment during a specified reporting period.", "scripts": [ "who_data_download_tuberculosis_rifampicin_resistant.py", - "../../../tools/statvar_importer/stat_var_processor.py --input_data=input_files/Tuberculosis_rr_mdr_tb_outcomes.csv --pv_map=tuberculosis_rr_mdr_tb_outcomes_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rr_mdr_tb_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" + "../../../tools/statvar_importer/stat_var_processor.py --input_data=input_files/Tuberculosis_rr_mdr_tb_outcomes.csv --pv_map=tuberculosis_rifampicin_resistant_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rr_mdr_tb_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" ], "import_inputs": [ { diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf new file mode 100644 index 0000000000..6ae55d8c0f --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf @@ -0,0 +1,42 @@ +# Auto generated using command: "data/tools/statvar_importer/stat_var_processor.py --input_data=data/statvar_imports/TB For RR_MDR-TB/input_files/Tuberculosis_rr_mdr_tb_outcomes.csv --pv_map=data/statvar_imports/TB For RR_MDR-TB/tuberculosis_rifampicin_resistant_pv_mapping.csv --output_path=data/statvar_imports/TB For RR_MDR-TB/output/TB_output" on 2026-05-11 09:48:02.453639 + +Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment +typeOf: dcid:StatisticalVariable +populationType: dcid:Person +measuredProperty: dcid:count +statType: dcid:measuredValue +medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis +treatmentOutcome: dcid:DiedDuringTreatment + +Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp +typeOf: dcid:StatisticalVariable +populationType: dcid:Person +measuredProperty: dcid:count +statType: dcid:measuredValue +medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis +treatmentOutcome: dcid:LostToFollowUp + +Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +typeOf: dcid:StatisticalVariable +populationType: dcid:Person +measuredProperty: dcid:count +statType: dcid:measuredValue +medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis +treatmentOutcome: dcid:SuccessfullyTreated + +Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed +typeOf: dcid:StatisticalVariable +populationType: dcid:Person +measuredProperty: dcid:count +statType: dcid:measuredValue +medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis +treatmentOutcome: dcid:TreatmentFailed + +Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated +typeOf: dcid:StatisticalVariable +populationType: dcid:Person +measuredProperty: dcid:count +statType: dcid:measuredValue +medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis +treatmentOutcome: dcid:TreatmentNotEvaluated + diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf new file mode 100644 index 0000000000..727785df91 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf @@ -0,0 +1,43 @@ +Node: dcid:MultidrugOrRifampicinResistantTuberculosis +typeOf: dcid:Disease +name: "Multidrug Or Rifampicin Resistant Tuberculosis" +isProvisional: dcs:True + +Node: dcid:treatmentOutcome +typeOf: dcs:Property +name: "treatmentOutcome" +domainIncludes: dcid:Person +rangeIncludes: dcid:TreatmentOutcomeEnum +isProvisional: dcs:True + +Node: dcid:TreatmentOutcomeEnum +typeOf: schema:Class +subClassOf: dcs:Enumeration +name: "TreatmentOutcomeEnum" +isProvisional: dcs:True + +Node: dcid:SuccessfullyTreated +typeOf: dcid:TreatmentOutcomeEnum +name: "Successfully Treated" +isProvisional: dcs:True + +Node: dcid:TreatmentFailed +typeOf: dcid:TreatmentOutcomeEnum +name: "Treatment Failed" +isProvisional: dcs:True + +Node: dcid:DiedDuringTreatment +typeOf: dcid:TreatmentOutcomeEnum +name: "Died During Treatment" +isProvisional: dcs:True + +Node: dcid:LostToFollowUp +typeOf: dcid:TreatmentOutcomeEnum +name: "Lost To Follow Up" +isProvisional: dcs:True + +Node: dcid:TreatmentNotEvaluated +typeOf: dcid:TreatmentOutcomeEnum +name: "Treatment Not Evaluated" +isProvisional: dcs:True + diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py b/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py index eedb85ea59..1d2fb62b52 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py +++ b/statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py @@ -17,7 +17,7 @@ def download_tb_rr_mdr_data(): } logging.info("1. Fetching clean percentage data from WHO API...") - api_response = requests.get(api_url, params=params) + api_response = requests.get(api_url, params=params, timeout=30) if api_response.status_code != 200: logging.error(f"Failed to fetch API data. HTTP {api_response.status_code}") @@ -29,7 +29,7 @@ def download_tb_rr_mdr_data(): # 2. Get ONLY the iso3 code from the master database logging.info("2. Fetching country iso3 codes from WHO master database...") master_url = "https://extranet.who.int/tme/generateCSV.asp?ds=notifications" - master_response = requests.get(master_url) + master_response = requests.get(master_url, timeout=60) if master_response.status_code != 200: logging.error(f"Failed to fetch master data. HTTP {master_response.status_code}") return From 25f03f407ad86202c05b2f98cd4e2e93700ed980 Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 17:57:16 +0530 Subject: [PATCH 04/21] Delete statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf Deleting the .mcf file --- ...osis_rr_mdr_tb_output_stat_vars_schema.mcf | 43 ------------------- 1 file changed, 43 deletions(-) delete mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf deleted file mode 100644 index 727785df91..0000000000 --- a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars_schema.mcf +++ /dev/null @@ -1,43 +0,0 @@ -Node: dcid:MultidrugOrRifampicinResistantTuberculosis -typeOf: dcid:Disease -name: "Multidrug Or Rifampicin Resistant Tuberculosis" -isProvisional: dcs:True - -Node: dcid:treatmentOutcome -typeOf: dcs:Property -name: "treatmentOutcome" -domainIncludes: dcid:Person -rangeIncludes: dcid:TreatmentOutcomeEnum -isProvisional: dcs:True - -Node: dcid:TreatmentOutcomeEnum -typeOf: schema:Class -subClassOf: dcs:Enumeration -name: "TreatmentOutcomeEnum" -isProvisional: dcs:True - -Node: dcid:SuccessfullyTreated -typeOf: dcid:TreatmentOutcomeEnum -name: "Successfully Treated" -isProvisional: dcs:True - -Node: dcid:TreatmentFailed -typeOf: dcid:TreatmentOutcomeEnum -name: "Treatment Failed" -isProvisional: dcs:True - -Node: dcid:DiedDuringTreatment -typeOf: dcid:TreatmentOutcomeEnum -name: "Died During Treatment" -isProvisional: dcs:True - -Node: dcid:LostToFollowUp -typeOf: dcid:TreatmentOutcomeEnum -name: "Lost To Follow Up" -isProvisional: dcs:True - -Node: dcid:TreatmentNotEvaluated -typeOf: dcid:TreatmentOutcomeEnum -name: "Treatment Not Evaluated" -isProvisional: dcs:True - From 711f99b05b7159e29f94684fd4c4e8c1509f0089 Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 17:57:28 +0530 Subject: [PATCH 05/21] Delete statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf Deleting the .mcf file --- ...uberculosis_rr_mdr_tb_output_stat_vars.mcf | 42 ------------------- 1 file changed, 42 deletions(-) delete mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf deleted file mode 100644 index 6ae55d8c0f..0000000000 --- a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output_stat_vars.mcf +++ /dev/null @@ -1,42 +0,0 @@ -# Auto generated using command: "data/tools/statvar_importer/stat_var_processor.py --input_data=data/statvar_imports/TB For RR_MDR-TB/input_files/Tuberculosis_rr_mdr_tb_outcomes.csv --pv_map=data/statvar_imports/TB For RR_MDR-TB/tuberculosis_rifampicin_resistant_pv_mapping.csv --output_path=data/statvar_imports/TB For RR_MDR-TB/output/TB_output" on 2026-05-11 09:48:02.453639 - -Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -typeOf: dcid:StatisticalVariable -populationType: dcid:Person -measuredProperty: dcid:count -statType: dcid:measuredValue -medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis -treatmentOutcome: dcid:DiedDuringTreatment - -Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -typeOf: dcid:StatisticalVariable -populationType: dcid:Person -measuredProperty: dcid:count -statType: dcid:measuredValue -medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis -treatmentOutcome: dcid:LostToFollowUp - -Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -typeOf: dcid:StatisticalVariable -populationType: dcid:Person -measuredProperty: dcid:count -statType: dcid:measuredValue -medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis -treatmentOutcome: dcid:SuccessfullyTreated - -Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -typeOf: dcid:StatisticalVariable -populationType: dcid:Person -measuredProperty: dcid:count -statType: dcid:measuredValue -medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis -treatmentOutcome: dcid:TreatmentFailed - -Node: dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -typeOf: dcid:StatisticalVariable -populationType: dcid:Person -measuredProperty: dcid:count -statType: dcid:measuredValue -medicalCondition: dcid:MultidrugOrRifampicinResistantTuberculosis -treatmentOutcome: dcid:TreatmentNotEvaluated - From e48170a13de261e65cdbe26efcae37d95d024199 Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 17:59:27 +0530 Subject: [PATCH 06/21] Changing the test data file name --- ...b_outcomes.csv => tuberculosis_rifampicin_resistant_input.csv} | 0 1 file changed, 0 insertions(+), 0 deletions(-) rename statvar_imports/tuberculosis_rifampicin_resistant/testdata/{Tuberculosis_rr_mdr_tb_outcomes.csv => tuberculosis_rifampicin_resistant_input.csv} (100%) diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv similarity index 100% rename from statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv rename to statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv From e803c4f976fbdf88acec0c82d9c171c46be2c9ef Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 18:02:16 +0530 Subject: [PATCH 07/21] Changing the test data file name --- ...tb_output.csv => tuberculosis_rifampicin_resistant_output.csv} | 0 1 file changed, 0 insertions(+), 0 deletions(-) rename statvar_imports/tuberculosis_rifampicin_resistant/testdata/{Tuberculosis_rr_mdr_tb_output.csv => tuberculosis_rifampicin_resistant_output.csv} (100%) diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.csv b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.csv similarity index 100% rename from statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.csv rename to statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.csv From 2927229facd97a9aa71959c64f97ffd4965ccc4c Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 18:03:21 +0530 Subject: [PATCH 08/21] Changing the test data file name --- ..._output.tmcf => tuberculosis_rifampicin_resistant_output.tmcf} | 0 1 file changed, 0 insertions(+), 0 deletions(-) rename statvar_imports/tuberculosis_rifampicin_resistant/testdata/{Tuberculosis_rr_mdr_tb_output.tmcf => tuberculosis_rifampicin_resistant_output.tmcf} (100%) diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.tmcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.tmcf similarity index 100% rename from statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_output.tmcf rename to statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.tmcf From 830c5ca43c48e032a06f1d1eadb741b40910a54d Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 18:13:48 +0530 Subject: [PATCH 09/21] Changing the manifest file --- .../tuberculosis_rifampicin_resistant/manifest.json | 12 ++++++------ 1 file changed, 6 insertions(+), 6 deletions(-) diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json index ce050ffb1c..139de66619 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json +++ b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json @@ -1,7 +1,7 @@ { "import_specifications": [ { - "import_name": "WHO_TuberculosisTreatmentOutcomes_RR_MDR_TB", + "import_name": "WHO_TuberculosisRifampicinResistant", "curator_emails": [ "support@datacommons.org" ], @@ -9,18 +9,18 @@ "provenance_description": "Treatment outcomes among those who started rifampicin-resistant TB treatment during a specified reporting period.", "scripts": [ "who_data_download_tuberculosis_rifampicin_resistant.py", - "../../../tools/statvar_importer/stat_var_processor.py --input_data=input_files/Tuberculosis_rr_mdr_tb_outcomes.csv --pv_map=tuberculosis_rifampicin_resistant_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rr_mdr_tb_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" + "../../../tools/statvar_importer/stat_var_processor.py --input_data=test_data/tuberculosis_rifampicin_resistant_input.csv --pv_map=tuberculosis_rifampicin_resistant_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rifampicin_resistant_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" ], "import_inputs": [ { - "template_mcf": "output/tuberculosis_rr_mdr_tb_output.tmcf", - "cleaned_csv": "output/tuberculosis_rr_mdr_tb_output.csv" + "template_mcf": "output/tuberculosis_rifampicin_resistant_output.tmcf", + "cleaned_csv": "output/tuberculosis_rifampicin_resistant_output.csv" } ], "source_files": [ - "input_files/Tuberculosis_rr_mdr_tb_outcomes.csv" + "test_files/tuberculosis_rifampicin_resistant_input.csv" ], "cron_schedule": "0 10 10,21 * *" } ] -} \ No newline at end of file +} From 7ffb9aabbea6ebbe105316b3b353be43bb3b2982 Mon Sep 17 00:00:00 2001 From: pravnkumar-cloudsufi Date: Thu, 21 May 2026 18:18:28 +0530 Subject: [PATCH 10/21] Changing the manifest file --- .../tuberculosis_rifampicin_resistant/manifest.json | 4 ++-- 1 file changed, 2 insertions(+), 2 deletions(-) diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json index 139de66619..f8a42e0d42 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json +++ b/statvar_imports/tuberculosis_rifampicin_resistant/manifest.json @@ -5,11 +5,11 @@ "curator_emails": [ "support@datacommons.org" ], - "provenance_url": "", + "provenance_url": "https://data.who.int/indicators/i/39E4281/F1912F6", "provenance_description": "Treatment outcomes among those who started rifampicin-resistant TB treatment during a specified reporting period.", "scripts": [ "who_data_download_tuberculosis_rifampicin_resistant.py", - "../../../tools/statvar_importer/stat_var_processor.py --input_data=test_data/tuberculosis_rifampicin_resistant_input.csv --pv_map=tuberculosis_rifampicin_resistant_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rifampicin_resistant_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" + "../../../tools/statvar_importer/stat_var_processor.py --input_data=source_files/tuberculosis_rifampicin_resistant_input.csv --pv_map=tuberculosis_rifampicin_resistant_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rifampicin_resistant_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" ], "import_inputs": [ { From 6fbd602948e874c813b61d0d083134d2f9f9a9e8 Mon Sep 17 00:00:00 2001 From: smarthg-gi Date: Mon, 18 May 2026 12:40:59 +0000 Subject: [PATCH 11/21] adding who indicator import - adolescent birth rate (#1935) * adding files * Adding readme files * updates * updated files * Update manifest.json * Update README.md * Updating after suggested changes * Update manifest.json * Update manifest.json --- .../who/adolescent_birth_rate/README.md | 71 ++++++ .../adolescent_birth_rate_metadata.csv | 2 + .../adolescent_birth_rate_pvmap.csv | 230 ++++++++++++++++++ .../adolescent_birth_rate/data_download.py | 50 ++++ .../who/adolescent_birth_rate/manifest.json | 35 +++ .../test_data/adolescent_birth_rate_input.csv | 100 ++++++++ .../adolescent_birth_rate_output.csv | 100 ++++++++ .../adolescent_birth_rate_output.tmcf | 7 + 8 files changed, 595 insertions(+) create mode 100644 statvar_imports/who/adolescent_birth_rate/README.md create mode 100644 statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_metadata.csv create mode 100644 statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_pvmap.csv create mode 100644 statvar_imports/who/adolescent_birth_rate/data_download.py create mode 100644 statvar_imports/who/adolescent_birth_rate/manifest.json create mode 100644 statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_input.csv create mode 100644 statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.csv create mode 100644 statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.tmcf diff --git a/statvar_imports/who/adolescent_birth_rate/README.md b/statvar_imports/who/adolescent_birth_rate/README.md new file mode 100644 index 0000000000..05eeeca0c7 --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/README.md @@ -0,0 +1,71 @@ +# WHO Adolescent Birth Rate Import + +## Overview +This dataset contains national and regional-level statistics for the Adolescent Birth Rate (per 1,000 women). +Specifically, it provides data for two distinct age groups: +- 10-14 years (Y10T14) +- 15-19 years (Y15T19) + +**type of place:** Country, Region (M49 codes), WHO Regions, Overseas Territory, Special Administrative Regions +**years:** 2000 to 2024 +**place_resolution:** Resolved to DCIDs (e.g., dcid:country/FRA, dcid:europe, dcid:LatinAmericaAndCaribbean) + +## Data Source +**Source URL:** +https://data.who.int/indicators/i/24C65FE/27D371A + +**Provenance Description:** +The data comes from the World Health Organization (WHO). It specifically tracks Sustainable Development Goal (SDG) Indicator 3.7.2, measuring the adolescent birth rate (per 1,000 women aged 10–14 and 15–19) globally across different geographic classifications. + +## Refresh Type +Automatic Refresh + +For refresh of the data, the import includes a Python script (`data_download.py`) to automatically download the complete historical dataset directly from the WHO's backend Azure Blob storage endpoint. + +## Data Publish Frequency +Release Frequency = Annual + +## How To Download Input Data +To download the data, run the provided script: +```bash +python3 data_download.py +``` + +This will fetch the latest full dataset and save it locally as `input_files/adolescent_birth_rate_data.csv`, making it available for processing. + +## Processing Instructions +To process the WHO Adolescent Birth Rate data and generate statistical variables, use the following command from the `adolescent_birth_rate` directory: + +**For Data Run** +```bash +python3 ../../../tools/statvar_importer/stat_var_processor.py \ + --input_data=input_files/* \ + --pv_map=adolescent_birth_rate_pvmap.csv \ + --output_path=adolescent_birth_rate_output \ + --config_file=adolescent_birth_rate_metadata.csv +``` + +This generates the following output files: +- adolescent_birth_rate_output.csv +- adolescent_birth_rate_output_stat_vars_schema.mcf +- adolescent_birth_rate_output_stat_vars.mcf +- adolescent_birth_rate_output.tmcf + +**For Data Quality Checks and validation** +Validation of the data is done using the lint flag in the DataCommons import tool +```bash +java -jar datacommons-import-tool-0.1-jar-with-dependencies.jar lint adolescent_birth_rate_output_stat_vars_schema.mcf adolescent_birth_rate_output.csv adolescent_birth_rate_output.tmcf adolescent_birth_rate_output_stat_vars.mcf +``` + +This generates the following output files: +- report.json +- summary_report.csv +- summary_report.html + +The report files can be analyzed to check for errors and warnings. Further, linting is performed on the generated output files using the DataCommons import tool. + +## Testing +Testing is performed using the provided `test_data` directory: +- Input: `test_data/adolescent_birth_rate_input.csv` +- Output (expected): `test_data/adolescent_birth_rate_output.csv` +- MCF (expected): `test_data/adolescent_birth_rate_output.tmcf` diff --git a/statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_metadata.csv b/statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_metadata.csv new file mode 100644 index 0000000000..a432351995 --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_metadata.csv @@ -0,0 +1,2 @@ +parameter,value +output_columns,"observationDate,value,observationAbout,variableMeasured" \ No newline at end of file diff --git a/statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_pvmap.csv b/statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_pvmap.csv new file mode 100644 index 0000000000..cfd9b4b7f7 --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/adolescent_birth_rate_pvmap.csv @@ -0,0 +1,230 @@ +key,p1,v1,p2,v2,p3,v3,p4,v4,p5,v5 +RATE_PER_1000_N,value,{Number},populationType,Person,measuredProperty,fertilityRate,scalingFactor,1000,measurementDenominator,-measuredProperty +DIM_TIME,observationDate,{Number},,,,,,,, +Y10T14,age,[10 14 Years],,,,,,,, +Y15T19,age,[15 19 Years],,,,,,,, +FEMALE,gender,Female,,,,,,,, +DIM_GEO_CODE_M49: 956,#ignore,ignore,,,,,,,, +DIM_GEO_CODE_M49: 955,#ignore,ignore,,,,,,,, +France,observationAbout,dcid:country/FRA,,,,,,,, +Gabon,observationAbout,dcid:country/GAB,,,,,,,, +Georgia,observationAbout,dcid:country/GEO,,,,,,,, +Gambia,observationAbout,dcid:country/GMB,,,,,,,, +Germany,observationAbout,dcid:country/DEU,,,,,,,, +Greece,observationAbout,dcid:country/GRC,,,,,,,, +Guatemala,observationAbout,dcid:country/GTM,,,,,,,, +Guinea,observationAbout,dcid:country/GIN,,,,,,,, +Guyana,observationAbout,dcid:country/GUY,,,,,,,, +Haiti,observationAbout,dcid:country/HTI,,,,,,,, +Honduras,observationAbout,dcid:country/HND,,,,,,,, +"China, Hong Kong SAR",observationAbout,dcid:country/HKG,,,,,,,, +Hungary,observationAbout,dcid:country/HUN,,,,,,,, +Iceland,observationAbout,dcid:country/ISL,,,,,,,, +India,observationAbout,dcid:country/IND,,,,,,,, +Iraq,observationAbout,dcid:country/IRQ,,,,,,,, +Ireland,observationAbout,dcid:country/IRL,,,,,,,, +Israel,observationAbout,dcid:country/ISR,,,,,,,, +Italy,observationAbout,dcid:country/ITA,,,,,,,, +Côte d'Ivoire,observationAbout,dcid:country/CIV,,,,,,,, +Jamaica,observationAbout,dcid:country/JAM,,,,,,,, +Japan,observationAbout,dcid:country/JPN,,,,,,,, +Kazakhstan,observationAbout,dcid:country/KAZ,,,,,,,, +Kenya,observationAbout,dcid:country/KEN,,,,,,,, +Republic of Korea,observationAbout,dcid:country/KOR,,,,,,,, +Kyrgyzstan,observationAbout,dcid:country/KGZ,,,,,,,, +Latin America and the Caribbean,observationAbout,dcid:LatinAmericaAndCaribbean,,,,,,,, +Latvia,observationAbout,dcid:country/LVA,,,,,,,, +Liberia,observationAbout,dcid:country/LBR,,,,,,,, +Landlocked developing countries,observationAbout,dcid:undata-geo/G00403000,,,,,,,, +Lithuania,observationAbout,dcid:country/LTU,,,,,,,, +Luxembourg,observationAbout,dcid:country/LUX,,,,,,,, +"China, Macao SAR",observationAbout,dcid:country/MAC,,,,,,,, +Madagascar,observationAbout,dcid:country/MDG,,,,,,,, +Malaysia,observationAbout,dcid:country/MYS,,,,,,,, +Maldives,observationAbout,dcid:country/MDV,,,,,,,, +Malta,observationAbout,dcid:country/MLT,,,,,,,, +Mauritius,observationAbout,dcid:country/MUS,,,,,,,, +Mexico,observationAbout,dcid:country/MEX,,,,,,,, +Chile,observationAbout,dcid:country/CHL,,,,,,,, +Colombia,observationAbout,dcid:country/COL,,,,,,,, +Congo,observationAbout,dcid:country/COG,,,,,,,, +Democratic Republic of the Congo,observationAbout,dcid:country/COD,,,,,,,, +Costa Rica,observationAbout,dcid:country/CRI,,,,,,,, +Croatia,observationAbout,dcid:country/HRV,,,,,,,, +Cuba,observationAbout,dcid:country/CUB,,,,,,,, +Cyprus,observationAbout,dcid:country/CYP,,,,,,,, +Least developed countries,observationAbout,dcid:undata-geo/G00404000,,,,,,,, +Sub-Saharan Africa,observationAbout,dcid:SubSaharanAfrica,,,,,,,, +Czechia,observationAbout,dcid:country/CZE,,,,,,,, +Benin,observationAbout,dcid:country/BEN,,,,,,,, +Denmark,observationAbout,dcid:country/DNK,,,,,,,, +Dominica,observationAbout,dcid:country/DMA,,,,,,,, +Dominican Republic,observationAbout,dcid:country/DOM,,,,,,,, +Ecuador,observationAbout,dcid:country/ECU,,,,,,,, +El Salvador,observationAbout,dcid:country/SLV,,,,,,,, +Ethiopia,observationAbout,dcid:country/ETH,,,,,,,, +Estonia,observationAbout,dcid:country/EST,,,,,,,, +Fiji,observationAbout,dcid:country/FJI,,,,,,,, +Finland,observationAbout,dcid:country/FIN,,,,,,,, +"occupied Palestinian territory, including east Jerusalem",observationAbout,dcid:country/PSE,,,,,,,, +Ghana,observationAbout,dcid:country/GHA,,,,,,,, +Indonesia,observationAbout,dcid:country/IDN,,,,,,,, +Afghanistan,observationAbout,dcid:country/AFG,,,,,,,, +Albania,observationAbout,dcid:country/ALB,,,,,,,, +Oceania,observationAbout,dcid:oceania,,,,,,,, +Algeria,observationAbout,dcid:country/DZA,,,,,,,, +Northern Africa,observationAbout,dcid:NorthernAfrica,,,,,,,, +Andorra,observationAbout,dcid:country/AND,,,,,,,, +Northern America,observationAbout,dcid:undata-geo/G00136000,,,,,,,, +Angola,observationAbout,dcid:country/AGO,,,,,,,, +Eastern Asia,observationAbout,dcid:EasternAsia,,,,,,,, +Argentina,observationAbout,dcid:country/ARG,,,,,,,, +Southern Asia,observationAbout,dcid:SouthernAsia,,,,,,,, +South-eastern Asia,observationAbout,dcid:SouthEasternAsia,,,,,,,, +Australia,observationAbout,dcid:country/AUS,,,,,,,, +Austria,observationAbout,dcid:country/AUT,,,,,,,, +Bahamas,observationAbout,dcid:country/BHS,,,,,,,, +Bahrain,observationAbout,dcid:country/BHR,,,,,,,, +Bangladesh,observationAbout,dcid:country/BGD,,,,,,,, +Barbados,observationAbout,dcid:country/BRB,,,,,,,, +Australia and New Zealand,observationAbout,dcid:AustraliaAndNewZealand,,,,,,,, +Belgium,observationAbout,dcid:country/BEL,,,,,,,, +Central and Southern Asia,observationAbout,dcid:undata-geo/G00116000,,,,,,,, +Bolivia (Plurinational State of),observationAbout,dcid:country/BOL,,,,,,,, +Bosnia and Herzegovina,observationAbout,dcid:country/BIH,,,,,,,, +Brazil,observationAbout,dcid:country/BRA,,,,,,,, +Belize,observationAbout,dcid:country/BLZ,,,,,,,, +Bulgaria,observationAbout,dcid:country/BGR,,,,,,,, +Myanmar,observationAbout,dcid:country/MMR,,,,,,,, +Belarus,observationAbout,dcid:country/BLR,,,,,,,, +Cambodia,observationAbout,dcid:country/KHM,,,,,,,, +Cameroon,observationAbout,dcid:country/CMR,,,,,,,, +Canada,observationAbout,dcid:country/CAN,,,,,,,, +Central Asia,observationAbout,dcid:CentralAsia,,,,,,,, +Sri Lanka,observationAbout,dcid:country/LKA,,,,,,,, +Europe,observationAbout,dcid:europe,,,,,,,, +Comoros,observationAbout,dcid:country/COM,,,,,,,, +Seychelles,observationAbout,dcid:country/SYC,,,,,,,, +Sierra Leone,observationAbout,dcid:country/SLE,,,,,,,, +Singapore,observationAbout,dcid:country/SGP,,,,,,,, +Slovakia,observationAbout,dcid:country/SVK,,,,,,,, +Viet Nam,observationAbout,dcid:country/VNM,,,,,,,, +Slovenia,observationAbout,dcid:country/SVN,,,,,,,, +Somalia,observationAbout,dcid:country/SOM,,,,,,,, +South Africa,observationAbout,dcid:country/ZAF,,,,,,,, +Zimbabwe,observationAbout,dcid:country/ZWE,,,,,,,, +Small Island Developing States,observationAbout,dcid:undata-geo/G00405000,,,,,,,, +Spain,observationAbout,dcid:country/ESP,,,,,,,, +Sudan,observationAbout,dcid:country/SDN,,,,,,,, +Suriname,observationAbout,dcid:country/SUR,,,,,,,, +Northern Africa and Western Asia,observationAbout,dcid:undata-geo/G00103000,,,,,,,, +Eswatini,observationAbout,dcid:country/SWZ,,,,,,,, +Sweden,observationAbout,dcid:country/SWE,,,,,,,, +Eastern and South-Eastern Asia,observationAbout,dcid:undata-geo/G00122000,,,,,,,, +Switzerland,observationAbout,dcid:country/CHE,,,,,,,, +Thailand,observationAbout,dcid:country/THA,,,,,,,, +Togo,observationAbout,dcid:country/TGO,,,,,,,, +Trinidad and Tobago,observationAbout,dcid:country/TTO,,,,,,,, +Tunisia,observationAbout,dcid:country/TUN,,,,,,,, +Turkmenistan,observationAbout,dcid:country/TKM,,,,,,,, +Turks and Caicos Islands,observationAbout,dcid:country/TCA,,,,,,,, +Tuvalu,observationAbout,dcid:country/TUV,,,,,,,, +Uganda,observationAbout,dcid:country/UGA,,,,,,,, +Ukraine,observationAbout,dcid:country/UKR,,,,,,,, +North Macedonia,observationAbout,dcid:country/MKD,,,,,,,, +Egypt,observationAbout,dcid:country/EGY,,,,,,,, +United Kingdom of Great Britain and Northern Ireland,observationAbout,dcid:country/GBR,,,,,,,, +United Republic of Tanzania,observationAbout,dcid:country/TZA,,,,,,,, +United States of America,observationAbout,dcid:country/USA,,,,,,,, +Burkina Faso,observationAbout,dcid:country/BFA,,,,,,,, +Uruguay,observationAbout,dcid:country/URY,,,,,,,, +Uzbekistan,observationAbout,dcid:country/UZB,,,,,,,, +Venezuela (Bolivarian Republic of),observationAbout,dcid:country/VEN,,,,,,,, +Samoa,observationAbout,dcid:country/WSM,,,,,,,, +Yemen,observationAbout,dcid:country/YEM,,,,,,,, +Montenegro,observationAbout,dcid:country/MNE,,,,,,,, +Morocco,observationAbout,dcid:country/MAR,,,,,,,, +Oman,observationAbout,dcid:country/OMN,,,,,,,, +Europe and Northern America,observationAbout,dcid:undata-geo/G00126000,,,,,,,, +Nepal,observationAbout,dcid:country/NPL,,,,,,,, +Netherlands (Kingdom of the),observationAbout,dcid:country/NLD,,,,,,,, +Oceania (exc. Australia and New Zealand),observationAbout,dcid:undata-geo/G00145000,,,,,,,, +New Zealand,observationAbout,dcid:country/NZL,,,,,,,, +Nicaragua,observationAbout,dcid:country/NIC,,,,,,,, +Nigeria,observationAbout,dcid:country/NGA,,,,,,,, +Norway,observationAbout,dcid:country/NOR,,,,,,,, +Pakistan,observationAbout,dcid:country/PAK,,,,,,,, +Panama,observationAbout,dcid:country/PAN,,,,,,,, +Peru,observationAbout,dcid:country/PER,,,,,,,, +Poland,observationAbout,dcid:country/POL,,,,,,,, +Portugal,observationAbout,dcid:country/PRT,,,,,,,, +Guinea-Bissau,observationAbout,dcid:country/GNB,,,,,,,, +Timor-Leste,observationAbout,dcid:country/TLS,,,,,,,, +Puerto Rico,observationAbout,dcid:country/PRI,,,,,,,, +Qatar,observationAbout,dcid:country/QAT,,,,,,,, +Romania,observationAbout,dcid:country/ROU,,,,,,,, +Russian Federation,observationAbout,dcid:country/RUS,,,,,,,, +Rwanda,observationAbout,dcid:country/RWA,,,,,,,, +Saint Lucia,observationAbout,dcid:country/LCA,,,,,,,, +Saint Vincent and the Grenadines,observationAbout,dcid:country/VCT,,,,,,,, +Senegal,observationAbout,dcid:country/SEN,,,,,,,, +Serbia,observationAbout,dcid:country/SRB,,,,,,,, +South Sudan,observationAbout,dcid:country/SSD,,,,,,,, +Jordan,observationAbout,dcid:country/JOR,,,,,,,, +Kuwait,observationAbout,dcid:country/KWT,,,,,,,, +Lao People's Democratic Republic,observationAbout,dcid:country/LAO,,,,,,,, +Lesotho,observationAbout,dcid:country/LSO,,,,,,,, +Malawi,observationAbout,dcid:country/MWI,,,,,,,, +Mali,observationAbout,dcid:country/MLI,,,,,,,, +Mauritania,observationAbout,dcid:country/MRT,,,,,,,, +Mongolia,observationAbout,dcid:country/MNG,,,,,,,, +Republic of Moldova,observationAbout,dcid:country/MDA,,,,,,,, +Mozambique,observationAbout,dcid:country/MOZ,,,,,,,, +Nauru,observationAbout,dcid:country/NRU,,,,,,,, +Niger,observationAbout,dcid:country/NER,,,,,,,, +Niue,observationAbout,dcid:country/NIU,,,,,,,, +Brunei Darussalam,observationAbout,dcid:country/BRN,,,,,,,, +Chad,observationAbout,dcid:country/TCD,,,,,,,, +Zambia,observationAbout,dcid:country/ZMB,,,,,,,, +Azerbaijan,observationAbout,dcid:country/AZE,,,,,,,, +Armenia,observationAbout,dcid:country/ARM,,,,,,,, +Burundi,observationAbout,dcid:country/BDI,,,,,,,, +Central African Republic,observationAbout,dcid:country/CAF,,,,,,,, +San Marino,observationAbout,dcid:country/SMR,,,,,,,, +Sao Tome and Principe,observationAbout,dcid:country/STP,,,,,,,, +Tajikistan,observationAbout,dcid:country/TJK,,,,,,,, +Namibia,observationAbout,dcid:country/NAM,,,,,,,, +Micronesia (Federated States of),observationAbout,dcid:country/FSM,,,,,,,, +Paraguay,observationAbout,dcid:country/PRY,,,,,,,, +Philippines,observationAbout,dcid:country/PHL,,,,,,,, +Kiribati,observationAbout,dcid:country/KIR,,,,,,,, +Democratic People's Republic of Korea,observationAbout,dcid:country/PRK,,,,,,,, +Djibouti,observationAbout,dcid:country/DJI,,,,,,,, +Cabo Verde,observationAbout,dcid:country/CPV,,,,,,,, +Cook Islands,observationAbout,dcid:country/COK,,,,,,,, +Saint Kitts and Nevis,observationAbout,dcid:country/KNA,,,,,,,, +Saudi Arabia,observationAbout,dcid:country/SAU,,,,,,,, +Tonga,observationAbout,dcid:country/TON,,,,,,,, +United Arab Emirates,observationAbout,dcid:country/ARE,,,,,,,, +Marshall Islands,observationAbout,dcid:country/MHL,,,,,,,, +Palau,observationAbout,dcid:country/PLW,,,,,,,, +Papua New Guinea,observationAbout,dcid:country/PNG,,,,,,,, +Eritrea,observationAbout,dcid:country/ERI,,,,,,,, +Botswana,observationAbout,dcid:country/BWA,,,,,,,, +Libya,observationAbout,dcid:country/LBY,,,,,,,, +Türkiye,observationAbout,dcid:country/TUR,,,,,,,, +Grenada,observationAbout,dcid:country/GRD,,,,,,,, +Iran (Islamic Republic of),observationAbout,dcid:country/IRN,,,,,,,, +Antigua and Barbuda,observationAbout,dcid:country/ATG,,,,,,,, +Lebanon,observationAbout,dcid:country/LBN,,,,,,,, +Africa,observationAbout,dcid:africa,,,,,,,, +Americas,observationAbout,dcid:undata-geo/G00134000,,,,,,,, +Eastern Mediterranean,observationAbout,dcid:undata-geo/G00121000,,,,,,,, +Western Pacific,observationAbout,dcid:undata-geo/G00160000,,,,,,,, +World,observationAbout,dcid:Earth,,,,,,,, +Bhutan,observationAbout,dcid:country/BTN,,,,,,,, +China,observationAbout,dcid:country/CHN,,,,,,,, +Solomon Islands,observationAbout,dcid:country/SLB,,,,,,,, +Equatorial Guinea,observationAbout,dcid:country/GNQ,,,,,,,, +Syrian Arab Republic,observationAbout,dcid:country/SYR,,,,,,,, +Vanuatu,observationAbout,dcid:country/VUT,,,,,,,, \ No newline at end of file diff --git a/statvar_imports/who/adolescent_birth_rate/data_download.py b/statvar_imports/who/adolescent_birth_rate/data_download.py new file mode 100644 index 0000000000..00d2888a4c --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/data_download.py @@ -0,0 +1,50 @@ +import requests +import os + +output_dir = "input_files" + +def download_full_who_data(indicator_id="27D371A"): + """ + Downloads the complete historical dataset for a WHO indicator + directly from the WHDH Azure Blob Storage. + """ + # 1. Create the output directory if it doesn't exist + os.makedirs(output_dir, exist_ok=True) + + # 2. Construct the filename inside the output directory + # Using indicator_id ensures the file has a unique name + filename = os.path.join(output_dir, "adolescent_birth_rate_input.csv") + + # Root URL for the WHDH raw data dumps + base_url = f"https://srhdpeuwpubsa.blob.core.windows.net/whdh/DATADOT/INDICATOR/{indicator_id}_ALL_LATEST.csv" + + print(f"Requesting full historical CSV for {indicator_id}...") + + try: + # We use stream=True to handle potentially large files efficiently + with requests.get(base_url, stream=True, timeout=300) as r: + r.raise_for_status() + with open(filename, 'wb') as f: + for chunk in r.iter_content(chunk_size=8192): + f.write(chunk) + + # Verify the file has data beyond the header + if os.path.exists(filename): + with open(filename, 'r', encoding='utf-8', errors='ignore') as f: + line_count = sum(1 for _ in f) + + if line_count <= 1: + os.remove(filename) + print("No data fetched (empty file or header only)") + return "no data fetched" + + print(f"Successfully saved to: {filename} ({line_count} lines found)") + return filename + + except requests.exceptions.HTTPError as err: + print(f"Error fetching data: {err}") + return "error" + +if __name__ == "__main__": + WHO_INDICATOR_ID = "27D371A" + download_full_who_data(WHO_INDICATOR_ID) \ No newline at end of file diff --git a/statvar_imports/who/adolescent_birth_rate/manifest.json b/statvar_imports/who/adolescent_birth_rate/manifest.json new file mode 100644 index 0000000000..d044f29c3e --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/manifest.json @@ -0,0 +1,35 @@ +{ + "import_specifications": [ + { + "import_name": "Adolescent_Birth_Rate", + "curator_emails": [ + "support@datacommons.org" + ], + "provenance_url": "https://data.who.int/indicators/i/24C65FE/27D371A", + "provenance_description": "The annual number of births to females aged 10-14 or 15-19 years per 1,000 females in the respective age group.", + "scripts": [ + "data_download.py", + "../../../tools/statvar_importer/stat_var_processor.py --input_data=./input_files/* --pv_map=adolescent_birth_rate_pvmap.csv --config_file=adolescent_birth_rate_metadata.csv --output_path=./adolescent_birth_rate_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" + ], + "import_inputs": [ + { + "template_mcf": "adolescent_birth_rate_output.tmcf", + "cleaned_csv": "adolescent_birth_rate_output.csv" + } + ], + "source_files": [ + "input_files/*.csv" + ], + "cron_schedule": "0 0 20 6 *", + "resource_limits": {"cpu": 4, "memory": 8, "disk":100} + } + ], + "config_override": { + "invoke_import_validation": true, + "invoke_import_tool": true, + "invoke_differ_tool": true, + "skip_input_upload": false, + "skip_gcs_upload": false, + "cleanup_gcs_volume_mount": false + } +} diff --git a/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_input.csv b/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_input.csv new file mode 100644 index 0000000000..737875caf1 --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_input.csv @@ -0,0 +1,100 @@ +IND_ID,IND_CODE,IND_UUID,IND_PER_CODE,DIM_TIME,DIM_TIME_TYPE,DIM_GEO_CODE_M49,DIM_GEO_CODE_TYPE,DIM_PUBLISH_STATE_CODE,IND_NAME,GEO_NAME_SHORT,DIM_SEX,DIM_AGE,RATE_PER_1000_N +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,250,COUNTRY,PUBLISHED,Adolescent birth rate,France,FEMALE,Y10T14,0.109999999 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,266,COUNTRY,PUBLISHED,Adolescent birth rate,Gabon,FEMALE,Y10T14,9.714962959 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,268,COUNTRY,PUBLISHED,Adolescent birth rate,Georgia,FEMALE,Y10T14,0.465688169 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,270,COUNTRY,PUBLISHED,Adolescent birth rate,Gambia,FEMALE,Y10T14,13.78736305 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,276,COUNTRY,PUBLISHED,Adolescent birth rate,Germany,FEMALE,Y10T14,0.090000004 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,300,COUNTRY,PUBLISHED,Adolescent birth rate,Greece,FEMALE,Y10T14,0.25999999 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,320,COUNTRY,PUBLISHED,Adolescent birth rate,Guatemala,FEMALE,Y10T14,4.293919563 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,324,COUNTRY,PUBLISHED,Adolescent birth rate,Guinea,FEMALE,Y10T14,17.8015728 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,328,COUNTRY,PUBLISHED,Adolescent birth rate,Guyana,FEMALE,Y10T14,5.07000351 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,332,COUNTRY,PUBLISHED,Adolescent birth rate,Haiti,FEMALE,Y10T14,1.961849213 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,340,COUNTRY,PUBLISHED,Adolescent birth rate,Honduras,FEMALE,Y10T14,5.760355473 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,344,SPECIAL ADMINISTRATIVE REGION (SAR),PUBLISHED,Adolescent birth rate,"China, Hong Kong SAR",FEMALE,Y10T14,0.06552276 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,348,COUNTRY,PUBLISHED,Adolescent birth rate,Hungary,FEMALE,Y10T14,0.340000004 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,352,COUNTRY,PUBLISHED,Adolescent birth rate,Iceland,FEMALE,Y10T14,0.090000004 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,356,COUNTRY,PUBLISHED,Adolescent birth rate,India,FEMALE,Y10T14,3.565319538 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,368,COUNTRY,PUBLISHED,Adolescent birth rate,Iraq,FEMALE,Y10T14,1.079672217 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,372,COUNTRY,PUBLISHED,Adolescent birth rate,Ireland,FEMALE,Y10T14,0.059999999 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,376,COUNTRY,PUBLISHED,Adolescent birth rate,Israel,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,380,COUNTRY,PUBLISHED,Adolescent birth rate,Italy,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,384,COUNTRY,PUBLISHED,Adolescent birth rate,Côte d'Ivoire,FEMALE,Y10T14,16.80167198 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,388,COUNTRY,PUBLISHED,Adolescent birth rate,Jamaica,FEMALE,Y10T14,2.398034334 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,392,COUNTRY,PUBLISHED,Adolescent birth rate,Japan,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,398,COUNTRY,PUBLISHED,Adolescent birth rate,Kazakhstan,FEMALE,Y10T14,0.045684028 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,404,COUNTRY,PUBLISHED,Adolescent birth rate,Kenya,FEMALE,Y10T14,8.109374046 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,410,COUNTRY,PUBLISHED,Adolescent birth rate,Republic of Korea,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,417,COUNTRY,PUBLISHED,Adolescent birth rate,Kyrgyzstan,FEMALE,Y10T14,0.012746891 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,419,REGION,PUBLISHED,Adolescent birth rate,Latin America and the Caribbean,FEMALE,Y10T14,3.19 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,428,COUNTRY,PUBLISHED,Adolescent birth rate,Latvia,FEMALE,Y10T14,0.059999999 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,430,COUNTRY,PUBLISHED,Adolescent birth rate,Liberia,FEMALE,Y10T14,11.0688448 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,432,CLASSIFICATION,PUBLISHED,Adolescent birth rate,Landlocked developing countries,FEMALE,Y10T14,6.421 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,440,COUNTRY,PUBLISHED,Adolescent birth rate,Lithuania,FEMALE,Y10T14,0.079999998 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,442,COUNTRY,PUBLISHED,Adolescent birth rate,Luxembourg,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,446,SPECIAL ADMINISTRATIVE REGION (SAR),PUBLISHED,Adolescent birth rate,"China, Macao SAR",FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,450,COUNTRY,PUBLISHED,Adolescent birth rate,Madagascar,FEMALE,Y10T14,17.35933113 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,458,COUNTRY,PUBLISHED,Adolescent birth rate,Malaysia,FEMALE,Y10T14,0.168421507 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,462,COUNTRY,PUBLISHED,Adolescent birth rate,Maldives,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,470,COUNTRY,PUBLISHED,Adolescent birth rate,Malta,FEMALE,Y10T14,1.159999967 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,480,COUNTRY,PUBLISHED,Adolescent birth rate,Mauritius,FEMALE,Y10T14,0.614789665 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2001,YEAR,484,COUNTRY,PUBLISHED,Adolescent birth rate,Mexico,FEMALE,Y10T14,1.713469267 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,152,COUNTRY,PUBLISHED,Adolescent birth rate,Chile,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,170,COUNTRY,PUBLISHED,Adolescent birth rate,Colombia,FEMALE,Y10T14,5.061411858 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,178,COUNTRY,PUBLISHED,Adolescent birth rate,Congo,FEMALE,Y10T14,3.457941055 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,180,COUNTRY,PUBLISHED,Adolescent birth rate,Democratic Republic of the Congo,FEMALE,Y10T14,9.702086449 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,188,COUNTRY,PUBLISHED,Adolescent birth rate,Costa Rica,FEMALE,Y10T14,2.383807659 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,191,COUNTRY,PUBLISHED,Adolescent birth rate,Croatia,FEMALE,Y10T14,0.039999999 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,192,COUNTRY,PUBLISHED,Adolescent birth rate,Cuba,FEMALE,Y10T14,1.209337473 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,196,COUNTRY,PUBLISHED,Adolescent birth rate,Cyprus,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,199,CLASSIFICATION,PUBLISHED,Adolescent birth rate,Least developed countries,FEMALE,Y10T14,8.821 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,202,REGION,PUBLISHED,Adolescent birth rate,Sub-Saharan Africa,FEMALE,Y10T14,8.656 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,203,COUNTRY,PUBLISHED,Adolescent birth rate,Czechia,FEMALE,Y10T14,0.079999998 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,204,COUNTRY,PUBLISHED,Adolescent birth rate,Benin,FEMALE,Y10T14,10.78123951 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,208,COUNTRY,PUBLISHED,Adolescent birth rate,Denmark,FEMALE,Y10T14,0.02 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,212,COUNTRY,PUBLISHED,Adolescent birth rate,Dominica,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,214,COUNTRY,PUBLISHED,Adolescent birth rate,Dominican Republic,FEMALE,Y10T14,9.384902 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,218,COUNTRY,PUBLISHED,Adolescent birth rate,Ecuador,FEMALE,Y10T14,2.016113043 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,222,COUNTRY,PUBLISHED,Adolescent birth rate,El Salvador,FEMALE,Y10T14,3.322462559 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,231,COUNTRY,PUBLISHED,Adolescent birth rate,Ethiopia,FEMALE,Y10T14,5.653252602 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,233,COUNTRY,PUBLISHED,Adolescent birth rate,Estonia,FEMALE,Y10T14,0.090000004 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,242,COUNTRY,PUBLISHED,Adolescent birth rate,Fiji,FEMALE,Y10T14,0.218264386 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,246,COUNTRY,PUBLISHED,Adolescent birth rate,Finland,FEMALE,Y10T14,0.02 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,250,COUNTRY,PUBLISHED,Adolescent birth rate,France,FEMALE,Y10T14,0.109999999 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,266,COUNTRY,PUBLISHED,Adolescent birth rate,Gabon,FEMALE,Y10T14,9.180970192 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,268,COUNTRY,PUBLISHED,Adolescent birth rate,Georgia,FEMALE,Y10T14,0.385228693 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,270,COUNTRY,PUBLISHED,Adolescent birth rate,Gambia,FEMALE,Y10T14,6.315164089 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,275,NATIONAL LIBERATION MOVEMENT,PUBLISHED,Adolescent birth rate,"occupied Palestinian territory, including east Jerusalem",FEMALE,Y10T14,1.021056533 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,276,COUNTRY,PUBLISHED,Adolescent birth rate,Germany,FEMALE,Y10T14,0.079999998 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,288,COUNTRY,PUBLISHED,Adolescent birth rate,Ghana,FEMALE,Y10T14,2.192457676 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,300,COUNTRY,PUBLISHED,Adolescent birth rate,Greece,FEMALE,Y10T14,0.310000002 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,324,COUNTRY,PUBLISHED,Adolescent birth rate,Guinea,FEMALE,Y10T14,20.33905029 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,328,COUNTRY,PUBLISHED,Adolescent birth rate,Guyana,FEMALE,Y10T14,0.708357751 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,332,COUNTRY,PUBLISHED,Adolescent birth rate,Haiti,FEMALE,Y10T14,1.555833101 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,340,COUNTRY,PUBLISHED,Adolescent birth rate,Honduras,FEMALE,Y10T14,4.923030853 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,344,SPECIAL ADMINISTRATIVE REGION (SAR),PUBLISHED,Adolescent birth rate,"China, Hong Kong SAR",FEMALE,Y10T14,0.066062517 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,348,COUNTRY,PUBLISHED,Adolescent birth rate,Hungary,FEMALE,Y10T14,0.389999986 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,352,COUNTRY,PUBLISHED,Adolescent birth rate,Iceland,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,356,COUNTRY,PUBLISHED,Adolescent birth rate,India,FEMALE,Y10T14,2.382202387 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2003,YEAR,360,COUNTRY,PUBLISHED,Adolescent birth rate,Indonesia,FEMALE,Y10T14,1.404004693 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,4,COUNTRY,PUBLISHED,Adolescent birth rate,Afghanistan,FEMALE,Y10T14,8.190049171 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,8,COUNTRY,PUBLISHED,Adolescent birth rate,Albania,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,9,REGION,PUBLISHED,Adolescent birth rate,Oceania,FEMALE,Y10T14,1.956 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,12,COUNTRY,PUBLISHED,Adolescent birth rate,Algeria,FEMALE,Y10T14,0.201883197 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,15,REGION,PUBLISHED,Adolescent birth rate,Northern Africa,FEMALE,Y10T14,1.874 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,20,COUNTRY,PUBLISHED,Adolescent birth rate,Andorra,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,21,REGION,PUBLISHED,Adolescent birth rate,Northern America,FEMALE,Y10T14,0.766 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,24,COUNTRY,PUBLISHED,Adolescent birth rate,Angola,FEMALE,Y10T14,6.913015842 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,30,REGION,PUBLISHED,Adolescent birth rate,Eastern Asia,FEMALE,Y10T14,0.007 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,32,COUNTRY,PUBLISHED,Adolescent birth rate,Argentina,FEMALE,Y10T14,1.570291042 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,34,REGION,PUBLISHED,Adolescent birth rate,Southern Asia,FEMALE,Y10T14,3.715 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,35,REGION,PUBLISHED,Adolescent birth rate,South-eastern Asia,FEMALE,Y10T14,0.821 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,36,COUNTRY,PUBLISHED,Adolescent birth rate,Australia,FEMALE,Y10T14,0.125714064 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,40,COUNTRY,PUBLISHED,Adolescent birth rate,Austria,FEMALE,Y10T14,0.01 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,44,COUNTRY,PUBLISHED,Adolescent birth rate,Bahamas,FEMALE,Y10T14,0 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,48,COUNTRY,PUBLISHED,Adolescent birth rate,Bahrain,FEMALE,Y10T14,0.115234859 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,50,COUNTRY,PUBLISHED,Adolescent birth rate,Bangladesh,FEMALE,Y10T14,9.777834892 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,52,COUNTRY,PUBLISHED,Adolescent birth rate,Barbados,FEMALE,Y10T14,0.52405411 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,53,REGION,PUBLISHED,Adolescent birth rate,Australia and New Zealand,FEMALE,Y10T14,0.143 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,56,COUNTRY,PUBLISHED,Adolescent birth rate,Belgium,FEMALE,Y10T14,0.090000004 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,62,REGION,PUBLISHED,Adolescent birth rate,Central and Southern Asia,FEMALE,Y10T14,3.577 +27D371AMDG_0000000003,MDG_0000000003,27D371A,MDG_0000000003,2005,YEAR,68,COUNTRY,PUBLISHED,Adolescent birth rate,Bolivia (Plurinational State of),FEMALE,Y10T14,2.777525187 diff --git a/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.csv b/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.csv new file mode 100644 index 0000000000..d38ca3b38d --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.csv @@ -0,0 +1,100 @@ +observationDate,value,observationAbout,variableMeasured +2001,0.11,dcid:country/FRA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,9.71496,dcid:country/GAB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.46569,dcid:country/GEO,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,13.78736,dcid:country/GMB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.09,dcid:country/DEU,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.26,dcid:country/GRC,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,4.29392,dcid:country/GTM,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,17.80157,dcid:country/GIN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,5.07,dcid:country/GUY,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,1.96185,dcid:country/HTI,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,5.76036,dcid:country/HND,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.06552,dcid:country/HKG,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.34,dcid:country/HUN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.09,dcid:country/ISL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,3.56532,dcid:country/IND,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,1.07967,dcid:country/IRQ,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.06,dcid:country/IRL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/ISR,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/ITA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,16.80167,dcid:country/CIV,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,2.39803,dcid:country/JAM,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/JPN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.04568,dcid:country/KAZ,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,8.10937,dcid:country/KEN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/KOR,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.01275,dcid:country/KGZ,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,3.19,dcid:LatinAmericaAndCaribbean,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.06,dcid:country/LVA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,11.06884,dcid:country/LBR,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,6.421,dcid:undata-geo/G00403000,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.08,dcid:country/LTU,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/LUX,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/MAC,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,17.35933,dcid:country/MDG,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.16842,dcid:country/MYS,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0,dcid:country/MDV,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,1.16,dcid:country/MLT,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,0.61479,dcid:country/MUS,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2001,1.71347,dcid:country/MEX,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0,dcid:country/CHL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,5.06141,dcid:country/COL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,3.45794,dcid:country/COG,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,9.70209,dcid:country/COD,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,2.38381,dcid:country/CRI,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.04,dcid:country/HRV,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,1.20934,dcid:country/CUB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0,dcid:country/CYP,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,8.821,dcid:undata-geo/G00404000,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,8.656,dcid:SubSaharanAfrica,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.08,dcid:country/CZE,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,10.78124,dcid:country/BEN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.02,dcid:country/DNK,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0,dcid:country/DMA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,9.3849,dcid:country/DOM,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,2.01611,dcid:country/ECU,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,3.32246,dcid:country/SLV,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,5.65325,dcid:country/ETH,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.09,dcid:country/EST,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.21826,dcid:country/FJI,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.02,dcid:country/FIN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.11,dcid:country/FRA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,9.18097,dcid:country/GAB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.38523,dcid:country/GEO,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,6.31516,dcid:country/GMB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,1.02106,dcid:country/PSE,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.08,dcid:country/DEU,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,2.19246,dcid:country/GHA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.31,dcid:country/GRC,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,20.33905,dcid:country/GIN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.70836,dcid:country/GUY,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,1.55583,dcid:country/HTI,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,4.92303,dcid:country/HND,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.06606,dcid:country/HKG,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0.39,dcid:country/HUN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,0,dcid:country/ISL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,2.3822,dcid:country/IND,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2003,1.404,dcid:country/IDN,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,8.19005,dcid:country/AFG,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0,dcid:country/ALB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,1.956,dcid:oceania,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.20188,dcid:country/DZA,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,1.874,dcid:NorthernAfrica,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0,dcid:country/AND,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.766,dcid:undata-geo/G00136000,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,6.91302,dcid:country/AGO,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.007,dcid:EasternAsia,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,1.57029,dcid:country/ARG,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,3.715,dcid:SouthernAsia,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.821,dcid:SouthEasternAsia,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.12571,dcid:country/AUS,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.01,dcid:country/AUT,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0,dcid:country/BHS,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.11523,dcid:country/BHR,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,9.77783,dcid:country/BGD,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.52405,dcid:country/BRB,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.143,dcid:AustraliaAndNewZealand,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,0.09,dcid:country/BEL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,3.577,dcid:undata-geo/G00116000,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female +2005,2.77753,dcid:country/BOL,dcid:FertilityRate_Person_10To14Years_Female_AsAFractionOf_Count_Person_10To14Years_Female diff --git a/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.tmcf b/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.tmcf new file mode 100644 index 0000000000..85ff9bc094 --- /dev/null +++ b/statvar_imports/who/adolescent_birth_rate/test_data/adolescent_birth_rate_output.tmcf @@ -0,0 +1,7 @@ +Node: E:adolescent_birth_rate_output->E0 +observationDate: C:adolescent_birth_rate_output->observationDate +value: C:adolescent_birth_rate_output->value +observationAbout: C:adolescent_birth_rate_output->observationAbout +variableMeasured: C:adolescent_birth_rate_output->variableMeasured +scalingFactor: 1000 +typeOf: dcs:StatVarObservation From c621f6255e6a67bb33d6b8b8a8c29895e1864be4 Mon Sep 17 00:00:00 2001 From: Sandeep Tuniki <7530864+SandeepTuniki@users.noreply.github.com> Date: Wed, 20 May 2026 15:42:11 +0530 Subject: [PATCH 12/21] feat: Add queries to pre-compute derived edges and Cache table (#2015) --- import-automation/workflow/cloudbuild.yaml | 3 +- .../workflow/cloudbuild_main.yaml | 3 +- .../ingestion-helper/aggregation_utils.py | 585 +++++++++++++++++- .../workflow/ingestion-helper/main.py | 27 +- 4 files changed, 585 insertions(+), 33 deletions(-) diff --git a/import-automation/workflow/cloudbuild.yaml b/import-automation/workflow/cloudbuild.yaml index ed1f872036..c61170ad75 100644 --- a/import-automation/workflow/cloudbuild.yaml +++ b/import-automation/workflow/cloudbuild.yaml @@ -28,11 +28,12 @@ substitutions: _BQ_DATASET_ID: 'datacommons' _PROJECT_NUMBER: '965988403328' _AR_REPO_URL: 'us-docker.pkg.dev/datcom-ci/gcr.io' + _BQ_SPANNER_CONN_ID: 'projects/datcom-import-automation-prod/locations/us/connections/bq_spanner_conn' steps: - id: 'ingestion-helper-service' name: 'gcr.io/cloud-builders/gcloud' - args: ['run', 'deploy', 'ingestion-helper-service', '--image', '${_AR_REPO_URL}/datacommons-ingestion-helper:latest', '--region', '${_LOCATION}', '--project', '${_PROJECT_ID}', '--no-allow-unauthenticated', '--set-env-vars', 'PROJECT_ID=${_PROJECT_ID},LOCATION=${_LOCATION},SPANNER_PROJECT_ID=${_SPANNER_PROJECT_ID},SPANNER_INSTANCE_ID=${_SPANNER_INSTANCE_ID},SPANNER_DATABASE_ID=${_SPANNER_DATABASE_ID},SPANNER_GRAPH_DATABASE_ID=${_SPANNER_GRAPH_DATABASE_ID},GCS_BUCKET_ID=${_GCS_BUCKET_ID},BQ_DATASET_ID=${_BQ_DATASET_ID}'] + args: ['run', 'deploy', 'ingestion-helper-service', '--image', '${_AR_REPO_URL}/datacommons-ingestion-helper:latest', '--region', '${_LOCATION}', '--project', '${_PROJECT_ID}', '--no-allow-unauthenticated', '--set-env-vars', 'PROJECT_ID=${_PROJECT_ID},LOCATION=${_LOCATION},SPANNER_PROJECT_ID=${_SPANNER_PROJECT_ID},SPANNER_INSTANCE_ID=${_SPANNER_INSTANCE_ID},SPANNER_DATABASE_ID=${_SPANNER_DATABASE_ID},SPANNER_GRAPH_DATABASE_ID=${_SPANNER_GRAPH_DATABASE_ID},GCS_BUCKET_ID=${_GCS_BUCKET_ID},BQ_DATASET_ID=${_BQ_DATASET_ID},BQ_SPANNER_CONN_ID=${_BQ_SPANNER_CONN_ID}'] - id: 'import-helper-service' name: 'gcr.io/cloud-builders/gcloud' diff --git a/import-automation/workflow/cloudbuild_main.yaml b/import-automation/workflow/cloudbuild_main.yaml index 8f7343a404..6102647d92 100644 --- a/import-automation/workflow/cloudbuild_main.yaml +++ b/import-automation/workflow/cloudbuild_main.yaml @@ -28,6 +28,7 @@ substitutions: _LOCATION: 'us-central1' _PROJECT_NUMBER: '879489846695' _AR_REPO_URL: 'us-docker.pkg.dev/datcom-ci/gcr.io' + _BQ_SPANNER_CONN_ID: 'projects/datcom-ci/locations/us-central1/connections/bq_spanner_conn_test' steps: @@ -52,7 +53,7 @@ steps: - '.' - '--config=cloudbuild.yaml' - '--project=${_PROJECT_ID}' - - '--substitutions=_PROJECT_ID=${_PROJECT_ID},_SPANNER_PROJECT_ID=${_SPANNER_PROJECT_ID},_SPANNER_INSTANCE_ID=${_SPANNER_INSTANCE_ID},_SPANNER_DATABASE_ID=${_SPANNER_DATABASE_ID},_SPANNER_GRAPH_DATABASE_ID=${_SPANNER_GRAPH_DATABASE_ID},_GCS_BUCKET_ID=${_GCS_BUCKET_ID},_LOCATION=${_LOCATION},_GCS_MOUNT_BUCKET=${_GCS_MOUNT_BUCKET},_BQ_DATASET_ID=${_BQ_DATASET_ID},_PROJECT_NUMBER=${_PROJECT_NUMBER}' + - '--substitutions=_PROJECT_ID=${_PROJECT_ID},_SPANNER_PROJECT_ID=${_SPANNER_PROJECT_ID},_SPANNER_INSTANCE_ID=${_SPANNER_INSTANCE_ID},_SPANNER_DATABASE_ID=${_SPANNER_DATABASE_ID},_SPANNER_GRAPH_DATABASE_ID=${_SPANNER_GRAPH_DATABASE_ID},_GCS_BUCKET_ID=${_GCS_BUCKET_ID},_LOCATION=${_LOCATION},_GCS_MOUNT_BUCKET=${_GCS_MOUNT_BUCKET},_BQ_DATASET_ID=${_BQ_DATASET_ID},_PROJECT_NUMBER=${_PROJECT_NUMBER},_BQ_SPANNER_CONN_ID=${_BQ_SPANNER_CONN_ID}' dir: 'import-automation/workflow' # 2. Run E2E Tests on Staging diff --git a/import-automation/workflow/ingestion-helper/aggregation_utils.py b/import-automation/workflow/ingestion-helper/aggregation_utils.py index 16fe06c77f..df79a02bbf 100644 --- a/import-automation/workflow/ingestion-helper/aggregation_utils.py +++ b/import-automation/workflow/ingestion-helper/aggregation_utils.py @@ -14,56 +14,581 @@ import logging import os +import time +from typing import Any, Dict, List, Optional + from google.cloud import bigquery logging.getLogger().setLevel(logging.INFO) -class AggregationUtils: - def __init__(self): - # Initialize BigQuery Client +class BigQueryExecutor: + """Handles BigQuery client initialization and query execution.""" + def __init__(self, + connection_id: str, + project_id: str, + instance_id: str, + database_id: str) -> None: + self.connection_id = connection_id + self.project_id = project_id + self.instance_id = instance_id + self.database_id = database_id try: - self.bq_client = bigquery.Client() + self.client = bigquery.Client(project=self.project_id) except Exception as e: logging.warning(f"Failed to initialize BigQuery client: {e}") - self.bq_client = None + self.client = None + + def get_spanner_destination_uri(self) -> str: + """Returns the Spanner destination URI for EXPORT DATA.""" + return f"https://spanner.googleapis.com/projects/{self.project_id}/instances/{self.instance_id}/databases/{self.database_id}" + + def execute(self, query: str, job_config: Optional[bigquery.QueryJobConfig] = None) -> bigquery.table.RowIterator: + """Executes a query and returns the result.""" + if not self.client: + logging.error("BigQuery client not initialized") + raise RuntimeError("BigQuery client not initialized") + + start_time = time.time() + logging.info(f"Executing query (first 100 chars): {query.strip()[:100]}...") + + try: + query_job = self.client.query(query, job_config=job_config) + result = query_job.result() + duration = time.time() - start_time + logging.info(f"Query completed in {duration:.2f}s. Job ID: {query_job.job_id}") + return result + except Exception as e: + logging.error(f"Query execution failed after {time.time() - start_time:.2f}s: {e}") + raise + + +class LinkedEdgeGenerator: + """Generates and ingests linked relationship edges (e.g., transitive closures) into Spanner for faster lookup.""" + def __init__(self, executor: BigQueryExecutor) -> None: + self.executor = executor + + def run_all(self, import_names: List[str] = None) -> None: + """Runs all global aggregations in sequence.""" + if not import_names: + logging.info("No imports specified. Skipping global aggregations.") + return + + logging.info(f"Running global aggregations for imports: {import_names}") + + # TODO: Run these methods in parallel to speed up execution since they are independent. + self.run_linked_contained_in_place(import_names) + self.run_linked_member_of(import_names) + self.run_linked_member(import_names) + + + def run_linked_contained_in_place(self, import_names: List[str] = None) -> None: + """Expands place containment hierarchies.""" + if not import_names: + return + + dest = self.executor.get_spanner_destination_uri() + provenances = [f"'dc/base/{name}'" for name in import_names] + provenance_filter = f" AND provenance IN ({', '.join(provenances)})" + + query = f""" + -- Pull base edges needed for containedInPlace aggregation + CREATE OR REPLACE TEMPORARY TABLE `temp_base_contained_in_place` AS + SELECT * FROM EXTERNAL_QUERY("{self.executor.connection_id}", + "SELECT subject_id, predicate, object_id FROM Edge WHERE predicate = 'containedInPlace'{provenance_filter}"); + + -- Pull existing generated edges to filter them out later + CREATE OR REPLACE TEMPORARY TABLE `temp_existing_linked_contained_in_place` AS + SELECT * FROM EXTERNAL_QUERY("{self.executor.connection_id}", + "SELECT subject_id, predicate, object_id, provenance FROM Edge WHERE predicate = 'linkedContainedInPlace'"); + + CREATE OR REPLACE TEMPORARY TABLE `temp_contained_in_place` AS + SELECT subject_id, object_id + FROM `temp_base_contained_in_place`; + + EXPORT DATA + OPTIONS( uri="{dest}", + format='CLOUD_SPANNER', + spanner_options = '{{"table": "Edge"}}' ) AS + with RECURSIVE Ancestors AS ( + SELECT + subject_id, + object_id AS ancestor_place, + 1 AS level + FROM + temp_contained_in_place + UNION ALL + + SELECT + a.subject_id, + t.object_id AS ancestor_place, + a.level + 1 + FROM + Ancestors AS a + JOIN + temp_contained_in_place AS t + ON a.ancestor_place = t.subject_id + WHERE + a.level <= 10 -- Limit to 10 levels + ), + NewEdges AS ( + SELECT DISTINCT + subject_id, + 'linkedContainedInPlace' as predicate, + ancestor_place as object_id, + 'dc/base/GeneratedGraphs' as provenance + FROM + Ancestors + ), + FilteredEdges AS ( + SELECT + subject_id, + predicate, + object_id, + provenance + FROM + NewEdges n + WHERE NOT EXISTS ( + SELECT 1 + FROM `temp_existing_linked_contained_in_place` e + WHERE n.subject_id = e.subject_id + AND n.predicate = e.predicate + AND n.object_id = e.object_id + AND n.provenance = e.provenance + ) + ) + SELECT + subject_id, + predicate, + object_id, + provenance + FROM + FilteredEdges + """ + self.executor.execute(query) + + def run_linked_member_of(self, import_names: List[str] = None) -> None: + """Expands membership hierarchies using memberOf and specializationOf.""" + if not import_names: + return + + dest = self.executor.get_spanner_destination_uri() + provenances = [f"'dc/base/{name}'" for name in import_names] + provenance_filter = f" AND provenance IN ({', '.join(provenances)})" + + query = f""" + -- Pull base edges needed for memberOf aggregation + CREATE OR REPLACE TEMPORARY TABLE `temp_base_member_of` AS + SELECT * FROM EXTERNAL_QUERY("{self.executor.connection_id}", + "SELECT subject_id, predicate, object_id FROM Edge WHERE predicate IN ('memberOf', 'specializationOf'){provenance_filter}"); + + -- Pull existing generated edges to filter them out later + CREATE OR REPLACE TEMPORARY TABLE `temp_existing_linked_member_of` AS + SELECT * FROM EXTERNAL_QUERY("{self.executor.connection_id}", + "SELECT subject_id, predicate, object_id, provenance FROM Edge WHERE predicate = 'linkedMemberOf'"); + + CREATE OR REPLACE TEMPORARY TABLE `temp_hierarchy` AS + SELECT DISTINCT subject_id, predicate, object_id + FROM `temp_base_member_of`; + + EXPORT DATA + OPTIONS( uri="{dest}", + format='CLOUD_SPANNER', + spanner_options = '{{"table": "Edge"}}' ) AS + WITH RECURSIVE Ancestors AS ( + SELECT + subject_id, + object_id AS ancestor, + 1 AS level + FROM + temp_hierarchy + WHERE + predicate = 'memberOf' + UNION ALL + + SELECT + a.subject_id, + t.object_id AS ancestor, + a.level + 1 + FROM + Ancestors AS a + JOIN + temp_hierarchy AS t + ON a.ancestor = t.subject_id + WHERE + a.level <= 20 -- Limit to 20 levels + AND t.predicate = 'specializationOf' + ), + NewEdges AS ( + SELECT DISTINCT + subject_id, + 'linkedMemberOf' as predicate, + ancestor as object_id, + 'dc/base/GeneratedGraphs' as provenance + FROM + Ancestors + ), + FilteredEdges AS ( + SELECT + subject_id, + predicate, + object_id, + provenance + FROM + NewEdges n + WHERE NOT EXISTS ( + SELECT 1 + FROM `temp_existing_linked_member_of` e + WHERE n.subject_id = e.subject_id + AND n.predicate = e.predicate + AND n.object_id = e.object_id + AND n.provenance = e.provenance + ) + ) + SELECT + subject_id, + predicate, + object_id, + provenance + FROM + FilteredEdges + """ + self.executor.execute(query) + + def run_linked_member(self, import_names: List[str] = None) -> None: + """Expands topic/SVGP descendants to identify leaf members.""" + if not import_names: + return - self.bq_dataset_id = os.environ.get('BQ_DATASET_ID') + dest = self.executor.get_spanner_destination_uri() + provenances = [f"'dc/base/{name}'" for name in import_names] + provenance_filter = f" AND provenance IN ({', '.join(provenances)})" - def run_aggregation(self, import_list): + query = f""" + -- Pull base edges needed for member aggregation + CREATE OR REPLACE TEMPORARY TABLE `temp_base_member` AS + SELECT * FROM EXTERNAL_QUERY("{self.executor.connection_id}", + "SELECT subject_id, predicate, object_id FROM Edge WHERE predicate IN ('relevantVariable', 'member'){provenance_filter}"); + + -- Pull existing generated edges to filter them out later + CREATE OR REPLACE TEMPORARY TABLE `temp_existing_linked_member` AS + SELECT * FROM EXTERNAL_QUERY("{self.executor.connection_id}", + "SELECT subject_id, predicate, object_id, provenance FROM Edge WHERE predicate = 'linkedMember'"); + + CREATE OR REPLACE TEMPORARY TABLE `temp_topic_hierarchy` AS + SELECT DISTINCT subject_id, object_id + FROM `temp_base_member` + WHERE (subject_id LIKE 'dc/topic%' OR subject_id LIKE 'dc/svpg%'); + + EXPORT DATA + OPTIONS( uri="{dest}", + format='CLOUD_SPANNER', + spanner_options = '{{"table": "Edge"}}' ) AS + WITH RECURSIVE Descendants AS ( + SELECT + subject_id, + object_id AS descendant, + 1 AS level + FROM + temp_topic_hierarchy + UNION ALL + + SELECT + d.subject_id, + t.object_id AS descendant, + d.level + 1 + FROM + Descendants AS d + JOIN + temp_topic_hierarchy AS t + ON d.descendant = t.subject_id + WHERE + d.level <= 20 -- Limit to 20 levels + ), + NewEdges AS ( + SELECT DISTINCT + descendant as subject_id, + 'linkedMember' as predicate, + subject_id as object_id, + 'dc/base/GeneratedGraphs' as provenance + FROM + Descendants + WHERE subject_id LIKE 'dc/topic%' + AND descendant NOT LIKE 'dc/topic%' + AND descendant NOT LIKE 'dc/svpg%' + ), + FilteredEdges AS ( + SELECT + subject_id, + predicate, + object_id, + provenance + FROM + NewEdges n + WHERE NOT EXISTS ( + SELECT 1 + FROM `temp_existing_linked_member` e + WHERE n.subject_id = e.subject_id + AND n.predicate = e.predicate + AND n.object_id = e.object_id + AND n.provenance = e.provenance + ) + ) + SELECT + subject_id, + predicate, + object_id, + provenance + FROM + FilteredEdges """ - Runs a BQ query for each import in the import_list. + self.executor.execute(query) + + +class ProvenanceSummaryGenerator: + """Contains the SQL queries to generate ProvenanceSummary in the Cache table.""" + def __init__(self, executor: BigQueryExecutor) -> None: + self.executor = executor + + def run_all(self, import_names: List[str]) -> None: + """Runs all provenance summary generation in sequence.""" + if not import_names: + logging.info("No imports specified. Skipping cache aggregations.") + return + + logging.info(f"Running provenance summary generation for imports: {import_names}") + self.run_provenance_summary_aggregation(import_names) + + def run_provenance_summary_aggregation(self, import_names: List[str]) -> None: + """Calculates ProvenanceSummary for all variables and populates the Cache table.""" + if not import_names: + return + + dest = self.executor.get_spanner_destination_uri() + connection_id = self.executor.connection_id + + # Format import names for the SQL IN clause + imports_str = ", ".join([f"'{name}'" for name in import_names]) + + query = f""" + -- Step 1: Fetch Observation rows for the specific import + -- We cast 'observations' to STRING to avoid the PROTO error. + CREATE OR REPLACE TEMPORARY TABLE `temp_obs_raw` AS + SELECT + variable_measured, + observation_about, + facet_id, + import_name, + observation_period, + measurement_method, + unit, + scaling_factor, + is_dc_aggregate, + observations_json + FROM EXTERNAL_QUERY("{connection_id}", + '''SELECT + variable_measured, + observation_about, + facet_id, + import_name, + observation_period, + measurement_method, + unit, + scaling_factor, + is_dc_aggregate, + CAST(observations AS STRING) as observations_json + FROM Observation + WHERE import_name IN ({imports_str}) '''); + + -- Step 2: Fetch ALL Node names (Narrow selection to reduce data transfer) + CREATE OR REPLACE TEMPORARY TABLE `temp_node_names` AS + SELECT subject_id, name + FROM EXTERNAL_QUERY("{connection_id}", + "SELECT subject_id, name FROM Node WHERE name IS NOT NULL"); + + -- Step 3: Fetch ALL typeOf edges (Narrow selection) + CREATE OR REPLACE TEMPORARY TABLE `temp_type_edges` AS + SELECT subject_id, object_id as place_type + FROM EXTERNAL_QUERY("{connection_id}", + "SELECT subject_id, object_id FROM Edge WHERE predicate = 'typeOf'"); + + -- Step 4: Join and Flatten in BigQuery + CREATE OR REPLACE TEMPORARY TABLE `temp_prepared` AS + SELECT + raw.variable_measured, + raw.observation_about, + raw.facet_id, + raw.import_name, + raw.observation_period, + raw.measurement_method, + raw.unit, + raw.scaling_factor, + raw.is_dc_aggregate, + JSON_VALUE(v, '$.key') as date_val, + SAFE_CAST(JSON_VALUE(v, '$.value') AS FLOAT64) as value_num, + CONCAT('dc/base/', raw.import_name) as provenance_dcid, + nodes.name as place_name, + edges.place_type + FROM `temp_obs_raw` raw + CROSS JOIN UNNEST(JSON_EXTRACT_ARRAY(SAFE.PARSE_JSON(observations_json), '$.values')) as v + LEFT JOIN `temp_node_names` nodes ON raw.observation_about = nodes.subject_id + LEFT JOIN `temp_type_edges` edges ON raw.observation_about = edges.subject_id; + + -- Step 5: Aggregate Place Type Summaries + CREATE OR REPLACE TEMPORARY TABLE `temp_place_type_summary` AS + SELECT + variable_measured, + provenance_dcid, + facet_id, + place_type, + COUNT(DISTINCT observation_about) as place_count, + MIN(value_num) as min_val, + MAX(value_num) as max_val, + ARRAY_AGG( + STRUCT(observation_about as dcid, place_name as name) + ORDER BY observation_about LIMIT 3 + ) as top_places + FROM `temp_prepared` + WHERE place_type IS NOT NULL + GROUP BY variable_measured, provenance_dcid, facet_id, place_type; + + -- Step 6: Final aggregation and export to Cache + EXPORT DATA + OPTIONS( uri="{dest}", + format='CLOUD_SPANNER', + spanner_options = '{{"table": "Cache"}}' ) AS + WITH facet_base AS ( + SELECT + variable_measured, provenance_dcid, facet_id, + ANY_VALUE(import_name) as import_name, + ANY_VALUE(measurement_method) as measurement_method, + ANY_VALUE(observation_period) as observation_period, + ANY_VALUE(unit) as unit, + ANY_VALUE(scaling_factor) as scaling_factor, + ANY_VALUE(is_dc_aggregate) as is_dc_aggregate, + MIN(date_val) as min_date, + MAX(date_val) as max_date, + MIN(value_num) as facet_min, + MAX(value_num) as facet_max, + COUNT(*) as facet_obs_count, + COUNT(DISTINCT observation_about) as facet_ts_count + FROM `temp_prepared` + GROUP BY variable_measured, provenance_dcid, facet_id + ), + facet_summaries AS ( + SELECT + fb.variable_measured, + fb.provenance_dcid, + fb.facet_id, + fb.import_name, + fb.measurement_method, + fb.observation_period, + fb.unit, + fb.scaling_factor, + fb.is_dc_aggregate, + fb.min_date, + fb.max_date, + fb.facet_min, + fb.facet_max, + fb.facet_obs_count, + fb.facet_ts_count, + ARRAY_AGG(STRUCT(pts.place_type, pts.place_count, pts.min_val, pts.max_val, pts.top_places)) as pt_summaries + FROM facet_base fb + LEFT JOIN `temp_place_type_summary` pts USING (variable_measured, provenance_dcid, facet_id) + GROUP BY + variable_measured, provenance_dcid, facet_id, import_name, measurement_method, + observation_period, unit, scaling_factor, is_dc_aggregate, min_date, max_date, + facet_min, facet_max, facet_obs_count, facet_ts_count + ) + SELECT + 'ProvenanceSummary' as type, + variable_measured as key, + provenance_dcid as provenance, + JSON_OBJECT( + 'import_name', ANY_VALUE(import_name), + 'observation_count', CAST(SUM(facet_obs_count) AS FLOAT64), + 'time_series_count', CAST(SUM(facet_ts_count) AS FLOAT64), + 'series_summary', ARRAY_AGG( + JSON_OBJECT( + 'series_key', JSON_OBJECT( + 'measurement_method', measurement_method, + 'observation_period', observation_period, + 'unit', unit, + 'scaling_factor', scaling_factor, + 'is_dc_aggregate', COALESCE(is_dc_aggregate, false) + ), + 'earliest_date', min_date, + 'latest_date', max_date, + 'min_value', facet_min, + 'max_value', facet_max, + 'observation_count', CAST(facet_obs_count AS FLOAT64), + 'time_series_count', CAST(facet_ts_count AS FLOAT64), + 'place_type_summary', ( + SELECT JSON_OBJECT( + ARRAY_AGG(place_type), + ARRAY_AGG(JSON_OBJECT( + 'place_count', place_count, + 'min_value', min_val, + 'max_value', max_val, + 'top_places', ( + SELECT ARRAY_AGG(JSON_OBJECT('dcid', tp.dcid, 'name', tp.name)) + FROM UNNEST(top_places) tp + ) + )) + ) + FROM UNNEST(pt_summaries) + WHERE place_type IS NOT NULL + ) + ) + ) + ) as value + FROM facet_summaries + GROUP BY variable_measured, provenance_dcid; + """ + self.executor.execute(query) + + +class AggregationUtils: + """Orchestrates the overall aggregation workflow.""" + def __init__(self, + connection_id: str, + project_id: str, + instance_id: str, + database_id: str) -> None: + self.executor = BigQueryExecutor( + connection_id=connection_id, + project_id=project_id, + instance_id=instance_id, + database_id=database_id + ) + self.linked_edge_generator = LinkedEdgeGenerator(self.executor) + self.provenance_summary_generator = ProvenanceSummaryGenerator(self.executor) + + def run_aggregation(self, import_list: List[Dict[str, Any]]) -> bool: + """ + Orchestrates standard per-import aggregations and global aggregations. """ logging.info(f"Received request for importList: {import_list}") - results = [] - if not self.bq_client: - logging.error("BigQuery client not initialized") - return False try: + import_names = [] + # 1. Run standard per-import aggregations for import_item in import_list: import_name = import_item.get('importName') - - query = None - # Define specific queries based on importName if import_name: - query = """ - SELECT @import_name as import_name, CURRENT_TIMESTAMP() as execution_time - """ - else: - logging.info('Skipping aggregation logic') - continue - - if query: + import_names.append(import_name) + query = "SELECT @import_name as import_name, CURRENT_TIMESTAMP() as execution_time" job_config = bigquery.QueryJobConfig(query_parameters=[ - bigquery.ScalarQueryParameter("import_name", "STRING", - import_name), + bigquery.ScalarQueryParameter("import_name", "STRING", import_name), ]) - query_job = self.bq_client.query(query, job_config=job_config) - query_results = query_job.result() - for row in query_results: - results.append(dict(row)) - return True + self.executor.execute(query, job_config=job_config) + else: + logging.info('Skipping aggregation logic for empty importName') + # 2. Run global aggregations + self.linked_edge_generator.run_all(import_names) + self.provenance_summary_generator.run_all(import_names) + + return True except Exception as e: logging.error(f"Aggregation failed: {e}") raise e diff --git a/import-automation/workflow/ingestion-helper/main.py b/import-automation/workflow/ingestion-helper/main.py index ce2e57accb..4f45186d04 100644 --- a/import-automation/workflow/ingestion-helper/main.py +++ b/import-automation/workflow/ingestion-helper/main.py @@ -28,6 +28,9 @@ flags.DEFINE_string('spanner_graph_database_id', os.environ.get('SPANNER_GRAPH_DATABASE_ID'), 'Spanner Graph Database ID') +flags.DEFINE_string('spanner_connection_id', + os.environ.get('BQ_SPANNER_CONN_ID'), + 'BigQuery Connection ID to access Cloud Spanner') flags.DEFINE_string('gcs_bucket_id', os.environ.get('GCS_BUCKET_ID'), 'GCS Bucket ID') flags.DEFINE_string('location', os.environ.get('LOCATION'), 'Location') @@ -249,7 +252,29 @@ def ingestion_helper(request): # Input: # importList: list of imports to aggregate import_list = request_json.get('importList', []) - aggregation = AggregationUtils() + + # Validate required flags are not empty or None + missing_flags = [] + if not FLAGS.spanner_connection_id: + missing_flags.append('spanner_connection_id (BQ_SPANNER_CONN_ID)') + if not FLAGS.spanner_project_id: + missing_flags.append('spanner_project_id (SPANNER_PROJECT_ID)') + if not FLAGS.spanner_instance_id: + missing_flags.append('spanner_instance_id (SPANNER_INSTANCE_ID)') + if not FLAGS.spanner_graph_database_id: + missing_flags.append('spanner_graph_database_id (SPANNER_GRAPH_DATABASE_ID)') + + if missing_flags: + error_msg = f"Missing required configuration flags/env-vars: {', '.join(missing_flags)}" + logging.error(error_msg) + return (error_msg, 400) + + aggregation = AggregationUtils( + connection_id=FLAGS.spanner_connection_id, + project_id=FLAGS.spanner_project_id, + instance_id=FLAGS.spanner_instance_id, + database_id=FLAGS.spanner_graph_database_id, + ) try: if aggregation.run_aggregation(import_list): return ('OK', 200) From 5b95e398daed5d3c21680b28eef74bca44edef82 Mon Sep 17 00:00:00 2001 From: Gabriel Mechali Date: Wed, 20 May 2026 15:04:18 -0400 Subject: [PATCH 13/21] [DCP Ingestion] Replace c/g/Root by dc/g/Root in Seeding. (#2021) * Replace c/g/Root by d/c/g/Root in Seeding. * New tests for spanner seed --- .../workflow/ingestion-helper/spanner_client.py | 2 +- .../workflow/ingestion-helper/spanner_client_test.py | 9 +++++---- 2 files changed, 6 insertions(+), 5 deletions(-) diff --git a/import-automation/workflow/ingestion-helper/spanner_client.py b/import-automation/workflow/ingestion-helper/spanner_client.py index 50e8aeb166..6871f8bed7 100644 --- a/import-automation/workflow/ingestion-helper/spanner_client.py +++ b/import-automation/workflow/ingestion-helper/spanner_client.py @@ -569,7 +569,7 @@ def _seed(transaction: Transaction): "StatVarGroup": ["StatVarGroup", "StatVarGroup", "StatVarGroup", ["Class"], spanner.COMMIT_TIMESTAMP], "StatVarObservation": ["StatVarObservation", "StatVarObservation", "StatVarObservation", ["Class"], spanner.COMMIT_TIMESTAMP], "Topic": ["Topic", "Topic", "Topic", ["Class"], spanner.COMMIT_TIMESTAMP], - "c/g/Root": ["c/g/Root", "c/g/Root", "c/g/Root", ["StatVarGroup"], spanner.COMMIT_TIMESTAMP], + "dc/g/Root": ["dc/g/Root", "Data Commons Variables", "Data Commons Variables", ["StatVarGroup"], spanner.COMMIT_TIMESTAMP], } subjects = list(candidates.keys()) sql = "SELECT subject_id FROM Node WHERE subject_id IN UNNEST(@subjects)" diff --git a/import-automation/workflow/ingestion-helper/spanner_client_test.py b/import-automation/workflow/ingestion-helper/spanner_client_test.py index 4eeb6e920a..5725474730 100644 --- a/import-automation/workflow/ingestion-helper/spanner_client_test.py +++ b/import-automation/workflow/ingestion-helper/spanner_client_test.py @@ -248,13 +248,14 @@ def run_in_transaction_side_effect(callback, *args, **kwargs): self.assertEqual(kwargs['table'], 'Node') self.assertEqual(kwargs['columns'], ["subject_id", "name", "value", "types", "last_update_timestamp"]) self.assertEqual(len(kwargs['values']), 5) - expected_subjects = ["StatisticalVariable", "StatVarGroup", "StatVarObservation", "Topic", "c/g/Root"] + expected_subjects = ["StatisticalVariable", "StatVarGroup", "StatVarObservation", "Topic", "dc/g/Root"] + expected_names = ["StatisticalVariable", "StatVarGroup", "StatVarObservation", "Topic", "Data Commons Variables"] actual_subjects = [val[0] for val in kwargs['values']] actual_names = [val[1] for val in kwargs['values']] actual_values = [val[2] for val in kwargs['values']] self.assertEqual(actual_subjects, expected_subjects) - self.assertEqual(actual_names, expected_subjects) - self.assertEqual(actual_values, expected_subjects) + self.assertEqual(actual_names, expected_names) + self.assertEqual(actual_values, expected_names) @patch('google.cloud.spanner.Client') def test_seed_database_already_exists(self, mock_spanner_client): @@ -265,7 +266,7 @@ def test_seed_database_already_exists(self, mock_spanner_client): mock_instance.database.return_value = mock_db mock_transaction = MagicMock() - mock_transaction.execute_sql.return_value = [["StatisticalVariable"], ["StatVarGroup"], ["StatVarObservation"], ["Topic"], ["c/g/Root"]] + mock_transaction.execute_sql.return_value = [["StatisticalVariable"], ["StatVarGroup"], ["StatVarObservation"], ["Topic"], ["dc/g/Root"]] def run_in_transaction_side_effect(callback, *args, **kwargs): return callback(mock_transaction, *args, **kwargs) mock_db.run_in_transaction.side_effect = run_in_transaction_side_effect From 62449d3f9d625ad8981a90e9bb1f869f578f9f30 Mon Sep 17 00:00:00 2001 From: Gabriel Mechali Date: Wed, 20 May 2026 18:15:58 -0400 Subject: [PATCH 14/21] [DCP - BQ Federation] Propagate location in to the BQ connection (#2022) * Pass in the location all the way through the BQ Connection. allow either LOCATION or REGION flag because base DC one uses location, but DCP already uses REGIOn. * Update import-automation/workflow/ingestion-helper/aggregation_utils.py Co-authored-by: gemini-code-assist[bot] <176961590+gemini-code-assist[bot]@users.noreply.github.com> * Update import-automation/workflow/ingestion-helper/aggregation_utils.py Co-authored-by: gemini-code-assist[bot] <176961590+gemini-code-assist[bot]@users.noreply.github.com> --------- Co-authored-by: gemini-code-assist[bot] <176961590+gemini-code-assist[bot]@users.noreply.github.com> --- .../workflow/ingestion-helper/aggregation_utils.py | 12 ++++++++---- import-automation/workflow/ingestion-helper/main.py | 3 ++- 2 files changed, 10 insertions(+), 5 deletions(-) diff --git a/import-automation/workflow/ingestion-helper/aggregation_utils.py b/import-automation/workflow/ingestion-helper/aggregation_utils.py index df79a02bbf..2320850195 100644 --- a/import-automation/workflow/ingestion-helper/aggregation_utils.py +++ b/import-automation/workflow/ingestion-helper/aggregation_utils.py @@ -27,13 +27,15 @@ def __init__(self, connection_id: str, project_id: str, instance_id: str, - database_id: str) -> None: + database_id: str, + location: Optional[str] = None) -> None: self.connection_id = connection_id self.project_id = project_id self.instance_id = instance_id self.database_id = database_id + self.location = location try: - self.client = bigquery.Client(project=self.project_id) + self.client = bigquery.Client(project=self.project_id, location=self.location) except Exception as e: logging.warning(f"Failed to initialize BigQuery client: {e}") self.client = None @@ -553,12 +555,14 @@ def __init__(self, connection_id: str, project_id: str, instance_id: str, - database_id: str) -> None: + database_id: str, + location: Optional[str] = None) -> None: self.executor = BigQueryExecutor( connection_id=connection_id, project_id=project_id, instance_id=instance_id, - database_id=database_id + database_id=database_id, + location=location ) self.linked_edge_generator = LinkedEdgeGenerator(self.executor) self.provenance_summary_generator = ProvenanceSummaryGenerator(self.executor) diff --git a/import-automation/workflow/ingestion-helper/main.py b/import-automation/workflow/ingestion-helper/main.py index 4f45186d04..51a986f2cd 100644 --- a/import-automation/workflow/ingestion-helper/main.py +++ b/import-automation/workflow/ingestion-helper/main.py @@ -33,7 +33,7 @@ 'BigQuery Connection ID to access Cloud Spanner') flags.DEFINE_string('gcs_bucket_id', os.environ.get('GCS_BUCKET_ID'), 'GCS Bucket ID') -flags.DEFINE_string('location', os.environ.get('LOCATION'), 'Location') +flags.DEFINE_string('location', os.environ.get('LOCATION') or os.environ.get('REGION'), 'Location') flags.DEFINE_bool( 'enable_embeddings', os.environ.get('ENABLE_EMBEDDINGS', 'false').lower() == 'true', @@ -274,6 +274,7 @@ def ingestion_helper(request): project_id=FLAGS.spanner_project_id, instance_id=FLAGS.spanner_instance_id, database_id=FLAGS.spanner_graph_database_id, + location=FLAGS.location, ) try: if aggregation.run_aggregation(import_list): From d3ac93c89b396e235c4bccf71c935d26ce2024a1 Mon Sep 17 00:00:00 2001 From: Sandeep Tuniki <7530864+SandeepTuniki@users.noreply.github.com> Date: Thu, 21 May 2026 10:51:56 +0530 Subject: [PATCH 15/21] fix: Register ValuesEntry helper in Observations PROTO BUNDLE (#2023) --- import-automation/workflow/ingestion-helper/schema.sql | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) diff --git a/import-automation/workflow/ingestion-helper/schema.sql b/import-automation/workflow/ingestion-helper/schema.sql index 45ddd4f748..84b9a5153b 100644 --- a/import-automation/workflow/ingestion-helper/schema.sql +++ b/import-automation/workflow/ingestion-helper/schema.sql @@ -13,7 +13,8 @@ -- limitations under the License. CREATE PROTO BUNDLE ( - `org.datacommons.Observations` + `org.datacommons.Observations`, + `org.datacommons.Observations.ValuesEntry` ); CREATE TABLE Node ( From 04263a0e2165deb107d7cd0673d11d7fb1d81e7b Mon Sep 17 00:00:00 2001 From: Vishal Gupta Date: Thu, 21 May 2026 06:55:51 +0000 Subject: [PATCH 16/21] Remove VariableMetadata table (#2020) --- .../workflow/ingestion-helper/schema.sql | 16 ---------------- .../workflow/ingestion-helper/spanner_client.py | 2 +- 2 files changed, 1 insertion(+), 17 deletions(-) diff --git a/import-automation/workflow/ingestion-helper/schema.sql b/import-automation/workflow/ingestion-helper/schema.sql index 84b9a5153b..cb7231901b 100644 --- a/import-automation/workflow/ingestion-helper/schema.sql +++ b/import-automation/workflow/ingestion-helper/schema.sql @@ -118,22 +118,6 @@ CREATE TABLE Cache ( value JSON, ) PRIMARY KEY(type, key, provenance); -CREATE TABLE VariableMetadata ( - variable_measured STRING(1024) NOT NULL, - import_name STRING(1024) NOT NULL, - facet_id STRING(1024) NOT NULL, - observation_period STRING(1024), - measurement_method STRING(1024), - unit STRING(1024), - scaling_factor STRING(1024), - is_dc_aggregate BOOL, - total_observations INT64, - observed_places INT64, - min_date STRING(1024), - max_date STRING(1024), - place_types ARRAY, -) PRIMARY KEY(variable_measured, import_name); - CREATE INDEX InEdge ON Edge(object_id, predicate, subject_id, provenance) OPTIONS ( columnar_policy = 'enabled' ); diff --git a/import-automation/workflow/ingestion-helper/spanner_client.py b/import-automation/workflow/ingestion-helper/spanner_client.py index 6871f8bed7..8443ff4c96 100644 --- a/import-automation/workflow/ingestion-helper/spanner_client.py +++ b/import-automation/workflow/ingestion-helper/spanner_client.py @@ -467,7 +467,7 @@ def initialize_database(self, enable_embeddings=False): required_tables = [ "Node", "Edge", "Observation", "ImportStatus", "IngestionHistory", - "ImportVersionHistory", "IngestionLock", "Cache", "VariableMetadata" + "ImportVersionHistory", "IngestionLock", "Cache" ] required_indexes = ["InEdge", "VariableMeasuredObservationAbout"] required_models = [] From f260a8a4ffc87670ec75adfb6178949e40799be0 Mon Sep 17 00:00:00 2001 From: Sandeep Tuniki <7530864+SandeepTuniki@users.noreply.github.com> Date: Thu, 21 May 2026 17:15:49 +0530 Subject: [PATCH 17/21] Fix the provenance summary generation query (#2024) --- .../ingestion-helper/aggregation_utils.py | 36 +++++++++++-------- 1 file changed, 22 insertions(+), 14 deletions(-) diff --git a/import-automation/workflow/ingestion-helper/aggregation_utils.py b/import-automation/workflow/ingestion-helper/aggregation_utils.py index 2320850195..c26a280125 100644 --- a/import-automation/workflow/ingestion-helper/aggregation_utils.py +++ b/import-automation/workflow/ingestion-helper/aggregation_utils.py @@ -397,7 +397,13 @@ def run_provenance_summary_aggregation(self, import_names: List[str]) -> None: unit, scaling_factor, is_dc_aggregate, - CAST(observations AS STRING) as observations_json + IF(ARRAY_LENGTH(observations.values) > 0, + ( + SELECT CONCAT('{{"values":[', STRING_AGG(FORMAT('{{"key":"%s","value":"%s"}}', entry.key, entry.value), ','), ']}}') + FROM UNNEST(observations.values) as entry + ), + NULL + ) as observations_json FROM Observation WHERE import_name IN ({imports_str}) '''); @@ -525,20 +531,22 @@ def run_provenance_summary_aggregation(self, import_names: List[str]) -> None: 'observation_count', CAST(facet_obs_count AS FLOAT64), 'time_series_count', CAST(facet_ts_count AS FLOAT64), 'place_type_summary', ( - SELECT JSON_OBJECT( - ARRAY_AGG(place_type), - ARRAY_AGG(JSON_OBJECT( - 'place_count', place_count, - 'min_value', min_val, - 'max_value', max_val, - 'top_places', ( - SELECT ARRAY_AGG(JSON_OBJECT('dcid', tp.dcid, 'name', tp.name)) - FROM UNNEST(top_places) tp - ) - )) + SELECT IF(ARRAY_LENGTH(keys) > 0, JSON_OBJECT(keys, vals), NULL) + FROM ( + SELECT + ARRAY_AGG(place_type) as keys, + ARRAY_AGG(JSON_OBJECT( + 'place_count', place_count, + 'min_value', min_val, + 'max_value', max_val, + 'top_places', ( + SELECT ARRAY_AGG(JSON_OBJECT('dcid', tp.dcid, 'name', tp.name)) + FROM UNNEST(top_places) tp + ) + )) as vals + FROM UNNEST(pt_summaries) + WHERE place_type IS NOT NULL ) - FROM UNNEST(pt_summaries) - WHERE place_type IS NOT NULL ) ) ) From ecaf82c8214a087bc5448db8c4cd52fb3882ca04 Mon Sep 17 00:00:00 2001 From: TarunBali Date: Thu, 21 May 2026 12:43:33 +0000 Subject: [PATCH 18/21] NASA_VIIRSActiveFiresEvents_Fixes_corrected config path as well as added skip_validation_config (#2013) * corrected config path as well as added skip_validation_config * fixed config * added invoke_import_tool false --- scripts/fires/firms/fire_events_pipeline_config.py | 2 +- scripts/fires/firms/manifest.json | 9 +++++++-- 2 files changed, 8 insertions(+), 3 deletions(-) diff --git a/scripts/fires/firms/fire_events_pipeline_config.py b/scripts/fires/firms/fire_events_pipeline_config.py index 6eb6ce1be7..a5cdc2c382 100644 --- a/scripts/fires/firms/fire_events_pipeline_config.py +++ b/scripts/fires/firms/fire_events_pipeline_config.py @@ -88,7 +88,7 @@ # Output events csv into a common folder with a year in filename, # as the import automation can copy all files in a single folder. "output_dir": - "gs://{gcs_bucket}/{gcs_folder}/{stage}/{import_name}-{stage}-{year}-without-usa-", + "gs://{gcs_bucket}/{gcs_folder}/{import_name}-{stage}-{year}-without-usa-", "event_type": "FireEvent", diff --git a/scripts/fires/firms/manifest.json b/scripts/fires/firms/manifest.json index 8d62460d64..bda7e317ea 100644 --- a/scripts/fires/firms/manifest.json +++ b/scripts/fires/firms/manifest.json @@ -16,8 +16,13 @@ "cleaned_csv": "" } ], - "user_script_timeout": 86400, - "cron_schedule": "0 5 1 * *" + "cron_schedule": "0 5 1 * *", + "config_override": { + "skip_gcs_upload": true, + "invoke_differ_tool": false, + "invoke_import_validation": false, + "invoke_import_tool": false + } } ] } \ No newline at end of file From c33de552cd4ecd9c46b7a66e7aba49f7cdb8ac0f Mon Sep 17 00:00:00 2001 From: Sandeep Tuniki <7530864+SandeepTuniki@users.noreply.github.com> Date: Fri, 22 May 2026 10:44:20 +0530 Subject: [PATCH 19/21] fix: Skip "dc/base/" prefix for custom data instances (#2025) --- .../ingestion-helper/aggregation_utils.py | 44 +++++++++++++------ .../workflow/ingestion-helper/main.py | 5 +++ 2 files changed, 36 insertions(+), 13 deletions(-) diff --git a/import-automation/workflow/ingestion-helper/aggregation_utils.py b/import-automation/workflow/ingestion-helper/aggregation_utils.py index c26a280125..0993ac32b8 100644 --- a/import-automation/workflow/ingestion-helper/aggregation_utils.py +++ b/import-automation/workflow/ingestion-helper/aggregation_utils.py @@ -66,8 +66,9 @@ def execute(self, query: str, job_config: Optional[bigquery.QueryJobConfig] = No class LinkedEdgeGenerator: """Generates and ingests linked relationship edges (e.g., transitive closures) into Spanner for faster lookup.""" - def __init__(self, executor: BigQueryExecutor) -> None: + def __init__(self, executor: BigQueryExecutor, is_base_dc: bool = True) -> None: self.executor = executor + self.is_base_dc = is_base_dc def run_all(self, import_names: List[str] = None) -> None: """Runs all global aggregations in sequence.""" @@ -89,8 +90,12 @@ def run_linked_contained_in_place(self, import_names: List[str] = None) -> None: return dest = self.executor.get_spanner_destination_uri() - provenances = [f"'dc/base/{name}'" for name in import_names] + # Escape single quotes to prevent SQL injection + safe_names = [name.replace("'", "''") for name in import_names] + prefix = "dc/base/" if self.is_base_dc else "" + provenances = [f"'{prefix}{name}'" for name in safe_names] provenance_filter = f" AND provenance IN ({', '.join(provenances)})" + gen_graphs_prov = 'dc/base/GeneratedGraphs' if self.is_base_dc else 'GeneratedGraphs' query = f""" -- Pull base edges needed for containedInPlace aggregation @@ -137,7 +142,7 @@ def run_linked_contained_in_place(self, import_names: List[str] = None) -> None: subject_id, 'linkedContainedInPlace' as predicate, ancestor_place as object_id, - 'dc/base/GeneratedGraphs' as provenance + '{gen_graphs_prov}' as provenance FROM Ancestors ), @@ -174,8 +179,12 @@ def run_linked_member_of(self, import_names: List[str] = None) -> None: return dest = self.executor.get_spanner_destination_uri() - provenances = [f"'dc/base/{name}'" for name in import_names] + # Escape single quotes to prevent SQL injection + safe_names = [name.replace("'", "''") for name in import_names] + prefix = "dc/base/" if self.is_base_dc else "" + provenances = [f"'{prefix}{name}'" for name in safe_names] provenance_filter = f" AND provenance IN ({', '.join(provenances)})" + gen_graphs_prov = 'dc/base/GeneratedGraphs' if self.is_base_dc else 'GeneratedGraphs' query = f""" -- Pull base edges needed for memberOf aggregation @@ -225,7 +234,7 @@ def run_linked_member_of(self, import_names: List[str] = None) -> None: subject_id, 'linkedMemberOf' as predicate, ancestor as object_id, - 'dc/base/GeneratedGraphs' as provenance + '{gen_graphs_prov}' as provenance FROM Ancestors ), @@ -262,8 +271,12 @@ def run_linked_member(self, import_names: List[str] = None) -> None: return dest = self.executor.get_spanner_destination_uri() - provenances = [f"'dc/base/{name}'" for name in import_names] + # Escape single quotes to prevent SQL injection + safe_names = [name.replace("'", "''") for name in import_names] + prefix = "dc/base/" if self.is_base_dc else "" + provenances = [f"'{prefix}{name}'" for name in safe_names] provenance_filter = f" AND provenance IN ({', '.join(provenances)})" + gen_graphs_prov = 'dc/base/GeneratedGraphs' if self.is_base_dc else 'GeneratedGraphs' query = f""" -- Pull base edges needed for member aggregation @@ -311,7 +324,7 @@ def run_linked_member(self, import_names: List[str] = None) -> None: descendant as subject_id, 'linkedMember' as predicate, subject_id as object_id, - 'dc/base/GeneratedGraphs' as provenance + '{gen_graphs_prov}' as provenance FROM Descendants WHERE subject_id LIKE 'dc/topic%' @@ -348,8 +361,9 @@ def run_linked_member(self, import_names: List[str] = None) -> None: class ProvenanceSummaryGenerator: """Contains the SQL queries to generate ProvenanceSummary in the Cache table.""" - def __init__(self, executor: BigQueryExecutor) -> None: + def __init__(self, executor: BigQueryExecutor, is_base_dc: bool = True) -> None: self.executor = executor + self.is_base_dc = is_base_dc def run_all(self, import_names: List[str]) -> None: """Runs all provenance summary generation in sequence.""" @@ -368,8 +382,11 @@ def run_provenance_summary_aggregation(self, import_names: List[str]) -> None: dest = self.executor.get_spanner_destination_uri() connection_id = self.executor.connection_id + # Escape single quotes to prevent SQL injection + safe_names = [name.replace("'", "''") for name in import_names] # Format import names for the SQL IN clause - imports_str = ", ".join([f"'{name}'" for name in import_names]) + imports_str = ", ".join([f"'{name}'" for name in safe_names]) + provenance_dcid_expr = "CONCAT('dc/base/', raw.import_name)" if self.is_base_dc else "raw.import_name" query = f""" -- Step 1: Fetch Observation rows for the specific import @@ -433,7 +450,7 @@ def run_provenance_summary_aggregation(self, import_names: List[str]) -> None: raw.is_dc_aggregate, JSON_VALUE(v, '$.key') as date_val, SAFE_CAST(JSON_VALUE(v, '$.value') AS FLOAT64) as value_num, - CONCAT('dc/base/', raw.import_name) as provenance_dcid, + {provenance_dcid_expr} as provenance_dcid, nodes.name as place_name, edges.place_type FROM `temp_obs_raw` raw @@ -564,7 +581,8 @@ def __init__(self, project_id: str, instance_id: str, database_id: str, - location: Optional[str] = None) -> None: + location: Optional[str] = None, + is_base_dc: bool = True) -> None: self.executor = BigQueryExecutor( connection_id=connection_id, project_id=project_id, @@ -572,8 +590,8 @@ def __init__(self, database_id=database_id, location=location ) - self.linked_edge_generator = LinkedEdgeGenerator(self.executor) - self.provenance_summary_generator = ProvenanceSummaryGenerator(self.executor) + self.linked_edge_generator = LinkedEdgeGenerator(self.executor, is_base_dc) + self.provenance_summary_generator = ProvenanceSummaryGenerator(self.executor, is_base_dc) def run_aggregation(self, import_list: List[Dict[str, Any]]) -> bool: """ diff --git a/import-automation/workflow/ingestion-helper/main.py b/import-automation/workflow/ingestion-helper/main.py index 51a986f2cd..b452788875 100644 --- a/import-automation/workflow/ingestion-helper/main.py +++ b/import-automation/workflow/ingestion-helper/main.py @@ -41,6 +41,10 @@ flags.DEFINE_list( 'node_types', ['StatisticalVariable', 'Topic'], 'Node types to generate embeddings for') +flags.DEFINE_bool( + 'is_base_dc', + os.environ.get('IS_BASE_DC', 'true').lower() == 'true', + 'Is base DC') if not FLAGS.is_parsed(): FLAGS(['ingestion_helper']) @@ -275,6 +279,7 @@ def ingestion_helper(request): instance_id=FLAGS.spanner_instance_id, database_id=FLAGS.spanner_graph_database_id, location=FLAGS.location, + is_base_dc=FLAGS.is_base_dc, ) try: if aggregation.run_aggregation(import_list): From 766cfe92fe79700a2ec9700c152b753453b92130 Mon Sep 17 00:00:00 2001 From: Vishal Gupta Date: Fri, 22 May 2026 07:15:02 +0000 Subject: [PATCH 20/21] Add timeout for aggregations (#2026) --- import-automation/workflow/cloudbuild.yaml | 2 +- import-automation/workflow/spanner-ingestion-workflow.yaml | 1 + 2 files changed, 2 insertions(+), 1 deletion(-) diff --git a/import-automation/workflow/cloudbuild.yaml b/import-automation/workflow/cloudbuild.yaml index c61170ad75..a725e346e5 100644 --- a/import-automation/workflow/cloudbuild.yaml +++ b/import-automation/workflow/cloudbuild.yaml @@ -33,7 +33,7 @@ substitutions: steps: - id: 'ingestion-helper-service' name: 'gcr.io/cloud-builders/gcloud' - args: ['run', 'deploy', 'ingestion-helper-service', '--image', '${_AR_REPO_URL}/datacommons-ingestion-helper:latest', '--region', '${_LOCATION}', '--project', '${_PROJECT_ID}', '--no-allow-unauthenticated', '--set-env-vars', 'PROJECT_ID=${_PROJECT_ID},LOCATION=${_LOCATION},SPANNER_PROJECT_ID=${_SPANNER_PROJECT_ID},SPANNER_INSTANCE_ID=${_SPANNER_INSTANCE_ID},SPANNER_DATABASE_ID=${_SPANNER_DATABASE_ID},SPANNER_GRAPH_DATABASE_ID=${_SPANNER_GRAPH_DATABASE_ID},GCS_BUCKET_ID=${_GCS_BUCKET_ID},BQ_DATASET_ID=${_BQ_DATASET_ID},BQ_SPANNER_CONN_ID=${_BQ_SPANNER_CONN_ID}'] + args: ['run', 'deploy', 'ingestion-helper-service', '--image', '${_AR_REPO_URL}/datacommons-ingestion-helper:latest', '--region', '${_LOCATION}', '--project', '${_PROJECT_ID}', '--no-allow-unauthenticated', '--timeout', '60m', '--set-env-vars', 'PROJECT_ID=${_PROJECT_ID},LOCATION=${_LOCATION},SPANNER_PROJECT_ID=${_SPANNER_PROJECT_ID},SPANNER_INSTANCE_ID=${_SPANNER_INSTANCE_ID},SPANNER_DATABASE_ID=${_SPANNER_DATABASE_ID},SPANNER_GRAPH_DATABASE_ID=${_SPANNER_GRAPH_DATABASE_ID},GCS_BUCKET_ID=${_GCS_BUCKET_ID},BQ_DATASET_ID=${_BQ_DATASET_ID},BQ_SPANNER_CONN_ID=${_BQ_SPANNER_CONN_ID}'] - id: 'import-helper-service' name: 'gcr.io/cloud-builders/gcloud' diff --git a/import-automation/workflow/spanner-ingestion-workflow.yaml b/import-automation/workflow/spanner-ingestion-workflow.yaml index 01f2976d26..1f18d1feda 100644 --- a/import-automation/workflow/spanner-ingestion-workflow.yaml +++ b/import-automation/workflow/spanner-ingestion-workflow.yaml @@ -66,6 +66,7 @@ main: call: http.post args: url: ${helper_url} + timeout: 1800 auth: type: OIDC body: From 7e2b7bf765307919e45a05f0d999616f6e1f8e84 Mon Sep 17 00:00:00 2001 From: Praveen Kumar Date: Tue, 26 May 2026 12:57:46 +0000 Subject: [PATCH 21/21] Tuberculosis Rifampicin Resistant Import --- ...uberculosis_rifampicin_resistant_input.csv | 11391 ++++++++++++++++ .../README.md | 12 +- .../mainfest.json | 26 + ...uberculosis_rifampicin_resistant_input.csv | 390 - ...berculosis_rifampicin_resistant_output.csv | 600 +- ...erculosis_rifampicin_resistant_output.tmcf | 14 +- ...osis_rifampicin_resistant_data_download.py | 66 + ...rculosis_rifampicin_resistant_metadata.csv | 2 +- ...uberculosis_rifampicin_resistant_pvmap.csv | 2 +- temp.csv | 0 10 files changed, 11598 insertions(+), 905 deletions(-) create mode 100644 input_files/tuberculosis_rifampicin_resistant_input.csv create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/mainfest.json create mode 100644 statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_data_download.py create mode 100644 temp.csv diff --git a/input_files/tuberculosis_rifampicin_resistant_input.csv b/input_files/tuberculosis_rifampicin_resistant_input.csv new file mode 100644 index 0000000000..5cbad4590a --- /dev/null +++ b/input_files/tuberculosis_rifampicin_resistant_input.csv @@ -0,0 +1,11391 @@ +IND_ID,INDICATOR_NAME,YEAR,COUNTRY,iso3,DISAGGR_1,VALUE +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Afghanistan,AFG,Not evaluated,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Successfully treated,71.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Died,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Lost to follow-up,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Afghanistan,AFG,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Successfully treated,63.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Treatment failed,2.17391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Died,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Lost to follow-up,19.5652173913043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Afghanistan,AFG,Not evaluated,2.17391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Successfully treated,65.1162790697675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Died,11.6279069767442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Lost to follow-up,23.2558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Afghanistan,AFG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Successfully treated,63.855421686747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Died,16.8674698795181 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Lost to follow-up,19.2771084337349 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Afghanistan,AFG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Successfully treated,62.0915032679739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Treatment failed,2.61437908496732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Died,13.7254901960784 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Lost to follow-up,20.9150326797386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Afghanistan,AFG,Not evaluated,0.65359477124183 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Successfully treated,63.9175257731959 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Treatment failed,1.03092783505155 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Died,12.3711340206186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Lost to follow-up,22.1649484536082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Afghanistan,AFG,Not evaluated,0.515463917525773 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Successfully treated,68.8073394495413 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Treatment failed,2.75229357798165 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Died,10.0917431192661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Lost to follow-up,16.8195718654434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Afghanistan,AFG,Not evaluated,1.52905198776758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Successfully treated,71.2121212121212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Treatment failed,2.02020202020202 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Died,8.58585858585859 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Lost to follow-up,14.3939393939394 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Afghanistan,AFG,Not evaluated,3.78787878787879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Successfully treated,74.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Treatment failed,0.952380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Died,9.84126984126984 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Lost to follow-up,13.015873015873 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Afghanistan,AFG,Not evaluated,1.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Successfully treated,68.4478371501272 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Treatment failed,2.79898218829517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Died,11.1959287531807 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Lost to follow-up,16.793893129771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Afghanistan,AFG,Not evaluated,0.763358778625954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Successfully treated,72.3154362416107 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Treatment failed,2.18120805369128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Died,11.0738255033557 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Lost to follow-up,13.4228187919463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Afghanistan,AFG,Not evaluated,1.00671140939597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Treatment failed,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Albania,ALB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Albania,ALB,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Albania,ALB,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Albania,ALB,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Albania,ALB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,American Samoa,ASM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,American Samoa,ASM,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,American Samoa,ASM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Angola,AGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Successfully treated,77.3480662983426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Treatment failed,0.552486187845304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Died,8.28729281767956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Lost to follow-up,13.8121546961326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Successfully treated,72.4279835390947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Treatment failed,0.411522633744856 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Died,8.23045267489712 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Lost to follow-up,18.9300411522634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Successfully treated,72.2466960352423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Died,6.75675675675676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Lost to follow-up,12.1621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Not evaluated,18.9189189189189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Successfully treated,80.4347826086957 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Died,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Lost to follow-up,9.78260869565217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Not evaluated,5.43478260869565 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Successfully treated,69.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Died,14.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Lost to follow-up,17.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Successfully treated,56.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Lost to follow-up,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Not evaluated,24.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Lost to follow-up,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Not evaluated,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Successfully treated,48.7804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Died,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Lost to follow-up,9.75609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Not evaluated,24.390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Treatment failed,2.08333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Died,14.5833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Lost to follow-up,22.9166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Not evaluated,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Successfully treated,66.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Treatment failed,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Died,22.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Successfully treated,26.7857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Treatment failed,1.78571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Died,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Lost to follow-up,16.0714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Not evaluated,44.6428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Successfully treated,61.71875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Lost to follow-up,24.21875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Not evaluated,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Successfully treated,61.71875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Lost to follow-up,24.21875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Not evaluated,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Successfully treated,72.8070175438597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Died,11.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Lost to follow-up,14.0350877192982 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Not evaluated,1.75438596491228 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Not evaluated,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Successfully treated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Not evaluated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Successfully treated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Successfully treated,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Lost to follow-up,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Not evaluated,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Successfully treated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Lost to follow-up,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Successfully treated,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Died,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Not evaluated,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Successfully treated,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Lost to follow-up,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Not evaluated,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Lost to follow-up,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Successfully treated,48.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Died,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Lost to follow-up,36.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Not evaluated,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Successfully treated,46.031746031746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Treatment failed,1.58730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Lost to follow-up,34.9206349206349 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Not evaluated,3.17460317460317 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Treatment failed,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Lost to follow-up,28.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Not evaluated,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Successfully treated,59.4594594594595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Treatment failed,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Died,13.5135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Lost to follow-up,21.6216216216216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Successfully treated,54.3859649122807 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Died,19.2982456140351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Lost to follow-up,22.8070175438597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Not evaluated,3.50877192982456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Died,14.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Treatment failed,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Treatment failed,24.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Died,8.46153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Not evaluated,13.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Successfully treated,41.8166939443535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Treatment failed,16.4484451718494 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Died,7.28314238952537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Lost to follow-up,8.34697217675941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Not evaluated,26.1047463175123 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Successfully treated,49.9065420560748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Treatment failed,20.4672897196262 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Died,8.41121495327103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Lost to follow-up,8.22429906542056 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Not evaluated,12.9906542056075 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Successfully treated,42.2350472193074 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Treatment failed,7.71248688352571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Died,5.40398740818468 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Lost to follow-up,4.45960125918153 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Not evaluated,40.1888772298006 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Successfully treated,55.4945054945055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Treatment failed,8.97435897435897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Lost to follow-up,7.37179487179487 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Not evaluated,21.0164835164835 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Successfully treated,40.9697821503865 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Treatment failed,6.39494026704146 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Died,5.86788475052706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Lost to follow-up,8.9599437807449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Not evaluated,37.8074490513001 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Successfully treated,40.9945528026709 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Treatment failed,9.7873835881216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Died,4.09418379898085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Lost to follow-up,13.1259884027412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Not evaluated,31.9978914074855 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Successfully treated,52.2664199814986 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Treatment failed,6.91951896392229 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Died,5.64292321924144 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Lost to follow-up,25.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Successfully treated,60.1208459214502 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Died,23.5649546827795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Lost to follow-up,16.3141993957704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Successfully treated,69.8198198198198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Treatment failed,1.8018018018018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Died,19.8198198198198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Lost to follow-up,8.55855855855856 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Successfully treated,67.5409836065574 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Treatment failed,1.9672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Died,22.9508196721311 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Lost to follow-up,4.26229508196721 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Not evaluated,3.27868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Successfully treated,71.864406779661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Treatment failed,4.74576271186441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Died,18.6440677966102 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Lost to follow-up,2.71186440677966 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Not evaluated,2.03389830508475 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Successfully treated,73.4513274336283 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Treatment failed,3.53982300884956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Died,19.4690265486726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Lost to follow-up,3.09734513274336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Not evaluated,0.442477876106195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Successfully treated,76.2237762237762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Treatment failed,2.0979020979021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Died,12.5874125874126 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Lost to follow-up,2.7972027972028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Not evaluated,6.29370629370629 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Successfully treated,81.6793893129771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Treatment failed,0.763358778625954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Died,15.2671755725191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Lost to follow-up,2.29007633587786 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Successfully treated,77.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Treatment failed,2.35294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Lost to follow-up,8.23529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Successfully treated,84.4155844155844 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Treatment failed,2.5974025974026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Died,7.79220779220779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Lost to follow-up,5.1948051948052 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Treatment failed,1.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Died,8.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Lost to follow-up,4.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Successfully treated,90.4109589041096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Died,8.21917808219178 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Lost to follow-up,1.36986301369863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Successfully treated,84.2105263157895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Treatment failed,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Died,13.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Lost to follow-up,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Not evaluated,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Successfully treated,72.4137931034483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Died,18.1034482758621 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Lost to follow-up,7.75862068965517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Not evaluated,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Successfully treated,82.6568265682657 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Treatment failed,3.690036900369 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Died,11.8081180811808 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Lost to follow-up,1.8450184501845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Successfully treated,68.0100755667506 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Treatment failed,2.51889168765743 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Died,12.3425692695214 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Lost to follow-up,8.06045340050378 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Not evaluated,9.06801007556675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Successfully treated,69.6588868940754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Treatment failed,0.538599640933573 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Died,15.2603231597846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Lost to follow-up,8.79712746858169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Not evaluated,5.74506283662478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Successfully treated,75.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Treatment failed,0.757575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Died,11.969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Lost to follow-up,10.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Not evaluated,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Successfully treated,72.4039829302987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Treatment failed,2.13371266002845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Died,12.0910384068279 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Lost to follow-up,7.96586059743955 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Not evaluated,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Successfully treated,75.2824858757062 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Treatment failed,1.69491525423729 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Died,10.7344632768362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Lost to follow-up,7.20338983050848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Not evaluated,5.08474576271186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Successfully treated,70.1388888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Treatment failed,1.52777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Died,10.4166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Lost to follow-up,6.80555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Successfully treated,68.266253869969 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Treatment failed,3.09597523219814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Died,8.97832817337461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Lost to follow-up,5.57275541795666 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Not evaluated,14.0866873065015 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Successfully treated,60.6164383561644 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Treatment failed,1.1986301369863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Died,5.82191780821918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Lost to follow-up,2.73972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Not evaluated,29.6232876712329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Successfully treated,78.0155642023346 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Treatment failed,2.91828793774319 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Died,8.94941634241245 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Lost to follow-up,4.08560311284047 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Not evaluated,6.03112840466926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Successfully treated,81.9178082191781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Treatment failed,0.273972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Died,6.84931506849315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Lost to follow-up,6.71232876712329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Not evaluated,4.24657534246575 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Successfully treated,4.05405405405405 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Died,1.35135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Lost to follow-up,1.35135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Not evaluated,93.2432432432432 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Successfully treated,8.13953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Lost to follow-up,3.48837209302326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Not evaluated,88.3720930232558 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,France,FRA,Successfully treated,1.61290322580645 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,France,FRA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,France,FRA,Died,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,France,FRA,Lost to follow-up,4.83870967741936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,France,FRA,Not evaluated,90.3225806451613 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,France,FRA,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,France,FRA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,France,FRA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,France,FRA,Lost to follow-up,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,France,FRA,Not evaluated,97.6744186046512 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Honduras,HND,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Honduras,HND,Lost to follow-up,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Honduras,HND,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Honduras,HND,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Honduras,HND,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Honduras,HND,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Honduras,HND,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Honduras,HND,Died,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Honduras,HND,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Honduras,HND,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Honduras,HND,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Honduras,HND,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Honduras,HND,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Honduras,HND,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Honduras,HND,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Honduras,HND,Successfully treated,47.6190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Honduras,HND,Died,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Honduras,HND,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Honduras,HND,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Honduras,HND,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Honduras,HND,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Honduras,HND,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Honduras,HND,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Honduras,HND,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Honduras,HND,Successfully treated,77.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Honduras,HND,Died,22.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Honduras,HND,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Honduras,HND,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Honduras,HND,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Honduras,HND,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Honduras,HND,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Honduras,HND,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Honduras,HND,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Honduras,HND,Not evaluated,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Hungary,HUN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Hungary,HUN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Hungary,HUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Hungary,HUN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Hungary,HUN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Hungary,HUN,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Hungary,HUN,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Hungary,HUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Hungary,HUN,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Hungary,HUN,Successfully treated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Hungary,HUN,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Hungary,HUN,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Hungary,HUN,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Hungary,HUN,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Hungary,HUN,Successfully treated,42.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Hungary,HUN,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Hungary,HUN,Lost to follow-up,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Hungary,HUN,Not evaluated,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Hungary,HUN,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Hungary,HUN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Hungary,HUN,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Hungary,HUN,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Hungary,HUN,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Hungary,HUN,Died,44.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Hungary,HUN,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Hungary,HUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Hungary,HUN,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Hungary,HUN,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Hungary,HUN,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Hungary,HUN,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Hungary,HUN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Hungary,HUN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Hungary,HUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Hungary,HUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Hungary,HUN,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Hungary,HUN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Hungary,HUN,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Hungary,HUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Hungary,HUN,Successfully treated,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Hungary,HUN,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Hungary,HUN,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Hungary,HUN,Not evaluated,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Hungary,HUN,Successfully treated,44.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Hungary,HUN,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Hungary,HUN,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Hungary,HUN,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Hungary,HUN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Hungary,HUN,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Hungary,HUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Hungary,HUN,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Hungary,HUN,Successfully treated,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Hungary,HUN,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Hungary,HUN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Hungary,HUN,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Hungary,HUN,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Hungary,HUN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Hungary,HUN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Hungary,HUN,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Hungary,HUN,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Hungary,HUN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Hungary,HUN,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Hungary,HUN,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Hungary,HUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Hungary,HUN,Successfully treated,78.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Hungary,HUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Hungary,HUN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Hungary,HUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Hungary,HUN,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,India,IND,Successfully treated,51.6129032258065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,India,IND,Treatment failed,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,India,IND,Died,19.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,India,IND,Lost to follow-up,19.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,India,IND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,India,IND,Successfully treated,43.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,India,IND,Treatment failed,13.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,India,IND,Died,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,India,IND,Lost to follow-up,22.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,India,IND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,India,IND,Successfully treated,49.6587030716724 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,India,IND,Treatment failed,6.91126279863481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,India,IND,Died,20.3071672354949 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,India,IND,Lost to follow-up,21.6723549488055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,India,IND,Not evaluated,1.45051194539249 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,India,IND,Successfully treated,47.7085242896425 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,India,IND,Treatment failed,9.16590284142988 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,India,IND,Died,22.1356553620532 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,India,IND,Lost to follow-up,18.7442713107241 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,India,IND,Not evaluated,2.24564619615032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,India,IND,Successfully treated,49.7039668442866 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,India,IND,Treatment failed,7.22320899940793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,India,IND,Died,22.6465364120782 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,India,IND,Lost to follow-up,16.9923031379515 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,India,IND,Not evaluated,3.4339846062759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,India,IND,Successfully treated,45.7832182762793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,India,IND,Treatment failed,7.50836239413565 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,India,IND,Died,21.5571845420255 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,India,IND,Lost to follow-up,20.4184755533414 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,India,IND,Not evaluated,4.73275923421821 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,India,IND,Successfully treated,46.1859384629972 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,India,IND,Treatment failed,7.14455032475229 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,India,IND,Died,21.4810600673209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,India,IND,Lost to follow-up,19.6937372588062 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,India,IND,Not evaluated,5.49471388612336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,India,IND,Successfully treated,45.7023619250577 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,India,IND,Treatment failed,8.34665245959865 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,India,IND,Died,20.9554253240987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,India,IND,Lost to follow-up,19.8410584265672 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,India,IND,Not evaluated,5.15450186467768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,India,IND,Successfully treated,46.3732107097827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,India,IND,Treatment failed,7.88771045019654 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,India,IND,Died,19.691463324186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,India,IND,Lost to follow-up,19.10554031002 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,India,IND,Not evaluated,6.94207520581473 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,India,IND,Successfully treated,47.8115492363768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,India,IND,Treatment failed,8.56101454950749 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,India,IND,Died,18.5076964785975 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,India,IND,Lost to follow-up,19.0499141488689 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,India,IND,Not evaluated,6.0698255866494 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,India,IND,Successfully treated,49.0025802513664 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,India,IND,Treatment failed,9.11133923369309 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,India,IND,Died,17.8980661987071 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,India,IND,Lost to follow-up,18.5667119829093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,India,IND,Not evaluated,5.42130233332409 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,India,IND,Successfully treated,56.0422130107436 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,India,IND,Treatment failed,12.3551306996024 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,India,IND,Died,13.8503510701294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,India,IND,Lost to follow-up,14.3917604263599 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,India,IND,Not evaluated,3.36054479316471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,India,IND,Successfully treated,57.3318216175359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Madagascar,MDG,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Madagascar,MDG,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Madagascar,MDG,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Madagascar,MDG,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Madagascar,MDG,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Madagascar,MDG,Died,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Madagascar,MDG,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Madagascar,MDG,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Madagascar,MDG,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Madagascar,MDG,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Madagascar,MDG,Successfully treated,84.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Madagascar,MDG,Died,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Madagascar,MDG,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Madagascar,MDG,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Madagascar,MDG,Treatment failed,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Madagascar,MDG,Died,20.4081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Madagascar,MDG,Lost to follow-up,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Madagascar,MDG,Successfully treated,75.609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Madagascar,MDG,Died,17.0731707317073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Madagascar,MDG,Lost to follow-up,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Madagascar,MDG,Successfully treated,78.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Madagascar,MDG,Died,10.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Madagascar,MDG,Lost to follow-up,10.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Madagascar,MDG,Successfully treated,81.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Madagascar,MDG,Treatment failed,2.35294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Madagascar,MDG,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Madagascar,MDG,Lost to follow-up,4.70588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malawi,MWI,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malawi,MWI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malawi,MWI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malawi,MWI,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malawi,MWI,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malawi,MWI,Died,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malawi,MWI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malawi,MWI,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malawi,MWI,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malawi,MWI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malawi,MWI,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malawi,MWI,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malawi,MWI,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malawi,MWI,Lost to follow-up,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malawi,MWI,Successfully treated,68.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malawi,MWI,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malawi,MWI,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malawi,MWI,Successfully treated,63.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malawi,MWI,Died,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malawi,MWI,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malawi,MWI,Successfully treated,52.6315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malawi,MWI,Died,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malawi,MWI,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malawi,MWI,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malawi,MWI,Successfully treated,58.4905660377359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malawi,MWI,Died,33.9622641509434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malawi,MWI,Lost to follow-up,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malawi,MWI,Not evaluated,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malawi,MWI,Successfully treated,60.9375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malawi,MWI,Died,32.8125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malawi,MWI,Lost to follow-up,4.6875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malawi,MWI,Not evaluated,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malawi,MWI,Successfully treated,58.6206896551724 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malawi,MWI,Treatment failed,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malawi,MWI,Died,29.3103448275862 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malawi,MWI,Lost to follow-up,8.62068965517242 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malawi,MWI,Not evaluated,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malawi,MWI,Successfully treated,55.1724137931035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malawi,MWI,Treatment failed,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malawi,MWI,Died,34.4827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malawi,MWI,Lost to follow-up,6.89655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malawi,MWI,Not evaluated,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malawi,MWI,Successfully treated,72.5663716814159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malawi,MWI,Treatment failed,4.42477876106195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malawi,MWI,Died,16.8141592920354 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malawi,MWI,Lost to follow-up,5.30973451327434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malawi,MWI,Not evaluated,0.88495575221239 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malawi,MWI,Successfully treated,73.5632183908046 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malawi,MWI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malawi,MWI,Died,17.2413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malawi,MWI,Lost to follow-up,9.19540229885057 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malawi,MWI,Successfully treated,76.4150943396226 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malawi,MWI,Treatment failed,1.88679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malawi,MWI,Died,16.0377358490566 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malawi,MWI,Lost to follow-up,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malawi,MWI,Not evaluated,1.88679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malawi,MWI,Successfully treated,66.2650602409639 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malawi,MWI,Treatment failed,2.40963855421687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malawi,MWI,Died,24.0963855421687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malawi,MWI,Lost to follow-up,3.6144578313253 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malawi,MWI,Not evaluated,3.6144578313253 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malawi,MWI,Successfully treated,74.2268041237114 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malawi,MWI,Treatment failed,1.03092783505155 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malawi,MWI,Died,21.6494845360825 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malawi,MWI,Lost to follow-up,3.09278350515464 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malawi,MWI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Malaysia,MYS,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Malaysia,MYS,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Malaysia,MYS,Not evaluated,58.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malaysia,MYS,Successfully treated,47.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malaysia,MYS,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malaysia,MYS,Lost to follow-up,2.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malaysia,MYS,Not evaluated,35.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malaysia,MYS,Successfully treated,58.9285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malaysia,MYS,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malaysia,MYS,Lost to follow-up,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Malaysia,MYS,Not evaluated,23.2142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malaysia,MYS,Successfully treated,47.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malaysia,MYS,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malaysia,MYS,Lost to follow-up,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Malaysia,MYS,Not evaluated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malaysia,MYS,Successfully treated,31.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malaysia,MYS,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malaysia,MYS,Lost to follow-up,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Malaysia,MYS,Not evaluated,53.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malaysia,MYS,Successfully treated,27.6595744680851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malaysia,MYS,Died,12.0567375886525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malaysia,MYS,Lost to follow-up,5.67375886524823 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Malaysia,MYS,Not evaluated,54.6099290780142 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malaysia,MYS,Successfully treated,29.7297297297297 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malaysia,MYS,Treatment failed,10.8108108108108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malaysia,MYS,Died,13.5135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malaysia,MYS,Lost to follow-up,2.7027027027027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Malaysia,MYS,Not evaluated,43.2432432432432 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malaysia,MYS,Successfully treated,61.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malaysia,MYS,Treatment failed,1.47058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malaysia,MYS,Died,17.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malaysia,MYS,Lost to follow-up,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malaysia,MYS,Not evaluated,4.41176470588235 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malaysia,MYS,Successfully treated,31.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malaysia,MYS,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malaysia,MYS,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Malaysia,MYS,Not evaluated,38.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malaysia,MYS,Successfully treated,41.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malaysia,MYS,Died,22.3529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malaysia,MYS,Lost to follow-up,21.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Malaysia,MYS,Not evaluated,15.2941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malaysia,MYS,Successfully treated,49.2957746478873 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malaysia,MYS,Died,28.169014084507 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malaysia,MYS,Lost to follow-up,2.8169014084507 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Malaysia,MYS,Not evaluated,19.7183098591549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malaysia,MYS,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malaysia,MYS,Treatment failed,1.53846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malaysia,MYS,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malaysia,MYS,Lost to follow-up,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Malaysia,MYS,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malaysia,MYS,Successfully treated,63.5036496350365 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malaysia,MYS,Died,13.8686131386861 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malaysia,MYS,Lost to follow-up,10.2189781021898 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Malaysia,MYS,Not evaluated,12.4087591240876 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malaysia,MYS,Successfully treated,55.0295857988166 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malaysia,MYS,Treatment failed,3.55029585798817 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malaysia,MYS,Died,24.2603550295858 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malaysia,MYS,Lost to follow-up,7.10059171597633 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Malaysia,MYS,Not evaluated,10.0591715976331 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malaysia,MYS,Successfully treated,56.7741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malaysia,MYS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malaysia,MYS,Died,16.1290322580645 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malaysia,MYS,Lost to follow-up,18.0645161290323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Qatar,QAT,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Qatar,QAT,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Qatar,QAT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Qatar,QAT,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Qatar,QAT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Qatar,QAT,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Qatar,QAT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Qatar,QAT,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Qatar,QAT,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Qatar,QAT,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Qatar,QAT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Qatar,QAT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Qatar,QAT,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Qatar,QAT,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Qatar,QAT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Qatar,QAT,Successfully treated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Qatar,QAT,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Qatar,QAT,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Qatar,QAT,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Qatar,QAT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Qatar,QAT,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Qatar,QAT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Qatar,QAT,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Qatar,QAT,Not evaluated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Qatar,QAT,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Qatar,QAT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Qatar,QAT,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Qatar,QAT,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Qatar,QAT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Qatar,QAT,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Qatar,QAT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Qatar,QAT,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Korea,KOR,Successfully treated,59.4627594627595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Korea,KOR,Treatment failed,0.244200244200244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Korea,KOR,Died,8.91330891330891 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Korea,KOR,Lost to follow-up,23.5653235653236 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Korea,KOR,Not evaluated,7.81440781440781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Korea,KOR,Successfully treated,59.5709570957096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Korea,KOR,Treatment failed,1.23762376237624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Korea,KOR,Died,7.92079207920792 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Korea,KOR,Lost to follow-up,17.5742574257426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Korea,KOR,Not evaluated,13.6963696369637 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Korea,KOR,Successfully treated,59.2008412197687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Korea,KOR,Died,8.51735015772871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Korea,KOR,Lost to follow-up,9.67402733964248 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Korea,KOR,Not evaluated,22.6077812828602 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Korea,KOR,Successfully treated,62.6477541371158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Korea,KOR,Died,9.57446808510638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Korea,KOR,Lost to follow-up,5.20094562647754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Korea,KOR,Not evaluated,22.5768321513002 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Korea,KOR,Successfully treated,63.8352638352638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Korea,KOR,Died,9.00900900900901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Korea,KOR,Lost to follow-up,4.89060489060489 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Korea,KOR,Not evaluated,22.2651222651223 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Korea,KOR,Successfully treated,71.8870346598203 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Korea,KOR,Treatment failed,0.128369704749679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Korea,KOR,Died,13.7355584082157 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Korea,KOR,Lost to follow-up,7.18870346598203 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Korea,KOR,Not evaluated,7.06033376123235 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Korea,KOR,Successfully treated,72.6247987117552 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Korea,KOR,Died,16.5861513687601 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Korea,KOR,Lost to follow-up,4.99194847020934 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Korea,KOR,Not evaluated,5.79710144927536 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Korea,KOR,Successfully treated,75.7215619694397 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Korea,KOR,Treatment failed,0.509337860780985 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Korea,KOR,Died,12.3938879456706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Korea,KOR,Lost to follow-up,4.24448217317487 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Korea,KOR,Not evaluated,7.13073005093379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Korea,KOR,Successfully treated,72.2935779816514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Korea,KOR,Died,15.7798165137615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Korea,KOR,Lost to follow-up,5.87155963302752 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Korea,KOR,Not evaluated,6.05504587155963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Korea,KOR,Successfully treated,75.5434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Korea,KOR,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Korea,KOR,Lost to follow-up,2.44565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Korea,KOR,Not evaluated,3.26086956521739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Korea,KOR,Successfully treated,77.3743016759777 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Korea,KOR,Died,16.7597765363129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Korea,KOR,Lost to follow-up,3.63128491620112 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Korea,KOR,Not evaluated,2.23463687150838 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Korea,KOR,Successfully treated,73.9583333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Korea,KOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Korea,KOR,Died,17.2916666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Korea,KOR,Lost to follow-up,4.79166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Korea,KOR,Not evaluated,3.95833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Republic of Moldova,MDA,Successfully treated,52.3622047244095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Republic of Moldova,MDA,Treatment failed,8.26771653543307 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Republic of Moldova,MDA,Died,8.26771653543307 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Republic of Moldova,MDA,Lost to follow-up,29.5275590551181 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Republic of Moldova,MDA,Not evaluated,1.5748031496063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Republic of Moldova,MDA,Successfully treated,48.4674329501916 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Republic of Moldova,MDA,Treatment failed,15.1340996168582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Republic of Moldova,MDA,Died,9.96168582375479 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Republic of Moldova,MDA,Lost to follow-up,26.2452107279694 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Republic of Moldova,MDA,Not evaluated,0.191570881226054 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Republic of Moldova,MDA,Successfully treated,49.3046776232617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Republic of Moldova,MDA,Treatment failed,10.3666245259166 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Republic of Moldova,MDA,Died,12.7686472819216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Republic of Moldova,MDA,Lost to follow-up,27.307206068268 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Republic of Moldova,MDA,Not evaluated,0.252844500632111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Moldova,MDA,Successfully treated,54.2706964520368 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Moldova,MDA,Treatment failed,9.46123521681997 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Moldova,MDA,Died,13.1406044678055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Moldova,MDA,Lost to follow-up,23.1274638633377 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Republic of Moldova,MDA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Moldova,MDA,Successfully treated,58.8785046728972 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Moldova,MDA,Treatment failed,10.1635514018692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Moldova,MDA,Died,10.6308411214953 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Moldova,MDA,Lost to follow-up,19.9766355140187 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Republic of Moldova,MDA,Not evaluated,0.350467289719626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Moldova,MDA,Successfully treated,57.0519618239661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Moldova,MDA,Treatment failed,9.86214209968187 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Moldova,MDA,Died,11.8769883351007 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Moldova,MDA,Lost to follow-up,20.5726405090138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Republic of Moldova,MDA,Not evaluated,0.63626723223754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Moldova,MDA,Successfully treated,49.727965179543 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Moldova,MDA,Treatment failed,15.4515778019587 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Moldova,MDA,Died,14.0369967355822 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Moldova,MDA,Lost to follow-up,20.4570184983678 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Republic of Moldova,MDA,Not evaluated,0.326441784548422 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Moldova,MDA,Successfully treated,48.8955823293173 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Moldova,MDA,Treatment failed,17.7710843373494 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Moldova,MDA,Died,12.0481927710843 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Moldova,MDA,Lost to follow-up,20.281124497992 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Republic of Moldova,MDA,Not evaluated,1.00401606425703 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Moldova,MDA,Successfully treated,52.9111338100102 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Moldova,MDA,Treatment failed,13.4831460674157 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Moldova,MDA,Died,12.7681307456588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Moldova,MDA,Lost to follow-up,20.2247191011236 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Republic of Moldova,MDA,Not evaluated,0.612870275791624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Moldova,MDA,Successfully treated,55.8212058212058 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Moldova,MDA,Treatment failed,12.8898128898129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Moldova,MDA,Died,12.1621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Moldova,MDA,Lost to follow-up,19.022869022869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Republic of Moldova,MDA,Not evaluated,0.103950103950104 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Moldova,MDA,Successfully treated,58.7404994571118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Moldova,MDA,Treatment failed,12.0521172638437 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Moldova,MDA,Died,10.6406080347448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Moldova,MDA,Lost to follow-up,18.3496199782845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Republic of Moldova,MDA,Not evaluated,0.217155266015201 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Moldova,MDA,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Moldova,MDA,Treatment failed,6.26118067978533 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Moldova,MDA,Died,13.5957066189624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Moldova,MDA,Lost to follow-up,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Republic of Moldova,MDA,Not evaluated,8.58676207513417 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Moldova,MDA,Successfully treated,61.8025751072961 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Moldova,MDA,Treatment failed,5.15021459227468 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Moldova,MDA,Died,13.9484978540773 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Moldova,MDA,Lost to follow-up,16.9527896995708 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Republic of Moldova,MDA,Not evaluated,2.14592274678112 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Moldova,MDA,Successfully treated,69.9774266365689 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Moldova,MDA,Treatment failed,2.25733634311512 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Moldova,MDA,Died,14.6726862302483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Moldova,MDA,Lost to follow-up,13.0925507900677 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Republic of Moldova,MDA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tajikistan,TJK,Died,10.3932584269663 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tajikistan,TJK,Lost to follow-up,8.14606741573034 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tajikistan,TJK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tajikistan,TJK,Successfully treated,85.0282485875706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tajikistan,TJK,Treatment failed,1.12994350282486 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tajikistan,TJK,Died,6.77966101694915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tajikistan,TJK,Lost to follow-up,6.77966101694915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tajikistan,TJK,Not evaluated,0.282485875706215 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Tajikistan,TJK,Successfully treated,86.084142394822 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Tajikistan,TJK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Tajikistan,TJK,Died,7.11974110032362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Tajikistan,TJK,Lost to follow-up,6.79611650485437 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Tajikistan,TJK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Thailand,THA,Successfully treated,57.9710144927536 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Thailand,THA,Treatment failed,0.966183574879227 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Thailand,THA,Died,16.9082125603865 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Thailand,THA,Lost to follow-up,12.0772946859903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Thailand,THA,Not evaluated,12.0772946859903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Thailand,THA,Successfully treated,60.2272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Thailand,THA,Treatment failed,1.13636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Thailand,THA,Died,21.0227272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Thailand,THA,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Thailand,THA,Not evaluated,5.11363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Thailand,THA,Successfully treated,60.9243697478992 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Thailand,THA,Treatment failed,3.2563025210084 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Thailand,THA,Died,16.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Thailand,THA,Lost to follow-up,8.71848739495798 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Thailand,THA,Not evaluated,10.9243697478992 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Thailand,THA,Successfully treated,53.9365452408931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Thailand,THA,Treatment failed,3.29024676850764 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Thailand,THA,Died,18.448883666275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Thailand,THA,Lost to follow-up,11.7508813160987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Thailand,THA,Not evaluated,12.5734430082256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Thailand,THA,Successfully treated,62.967032967033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Thailand,THA,Treatment failed,2.1978021978022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Thailand,THA,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Thailand,THA,Lost to follow-up,10.5494505494506 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Thailand,THA,Not evaluated,5.05494505494506 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Thailand,THA,Successfully treated,69.7716894977169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Thailand,THA,Treatment failed,3.37899543378995 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Thailand,THA,Died,11.324200913242 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Thailand,THA,Lost to follow-up,10.3196347031963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Thailand,THA,Not evaluated,5.2054794520548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Thailand,THA,Successfully treated,72.0665499124343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Thailand,THA,Treatment failed,1.66374781085814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Thailand,THA,Died,16.9877408056042 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Thailand,THA,Lost to follow-up,6.91768826619965 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Thailand,THA,Not evaluated,2.36427320490368 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Thailand,THA,Successfully treated,70.0251889168766 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Thailand,THA,Treatment failed,1.63727959697733 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Thailand,THA,Died,15.7430730478589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Thailand,THA,Lost to follow-up,9.94962216624685 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Thailand,THA,Not evaluated,2.6448362720403 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Thailand,THA,Successfully treated,69.6796338672769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Thailand,THA,Treatment failed,2.74599542334096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Thailand,THA,Died,14.6453089244851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Thailand,THA,Lost to follow-up,11.7848970251716 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Thailand,THA,Not evaluated,1.1441647597254 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Timor-Leste,TLS,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Timor-Leste,TLS,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Timor-Leste,TLS,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Timor-Leste,TLS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Timor-Leste,TLS,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Timor-Leste,TLS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Timor-Leste,TLS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Timor-Leste,TLS,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Timor-Leste,TLS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Timor-Leste,TLS,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Timor-Leste,TLS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Timor-Leste,TLS,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Timor-Leste,TLS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Timor-Leste,TLS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Timor-Leste,TLS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Timor-Leste,TLS,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Timor-Leste,TLS,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Timor-Leste,TLS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Timor-Leste,TLS,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Timor-Leste,TLS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Timor-Leste,TLS,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Timor-Leste,TLS,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Timor-Leste,TLS,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Timor-Leste,TLS,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Timor-Leste,TLS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Timor-Leste,TLS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Timor-Leste,TLS,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Timor-Leste,TLS,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Timor-Leste,TLS,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Timor-Leste,TLS,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Timor-Leste,TLS,Died,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Timor-Leste,TLS,Lost to follow-up,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Timor-Leste,TLS,Successfully treated,94.7368421052632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Timor-Leste,TLS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Timor-Leste,TLS,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Timor-Leste,TLS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Timor-Leste,TLS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Togo,TGO,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Togo,TGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Togo,TGO,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Togo,TGO,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Togo,TGO,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Togo,TGO,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Togo,TGO,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Togo,TGO,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Togo,TGO,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Togo,TGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Togo,TGO,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Togo,TGO,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Togo,TGO,Lost to follow-up,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Togo,TGO,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Togo,TGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Togo,TGO,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Togo,TGO,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Togo,TGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Togo,TGO,Successfully treated,93.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Togo,TGO,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Togo,TGO,Successfully treated,46.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Togo,TGO,Died,32.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Togo,TGO,Not evaluated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Togo,TGO,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Togo,TGO,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Togo,TGO,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Togo,TGO,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Togo,TGO,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Togo,TGO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Togo,TGO,Successfully treated,57.8947368421053 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Togo,TGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Togo,TGO,Died,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Togo,TGO,Lost to follow-up,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Togo,TGO,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Togo,TGO,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Togo,TGO,Died,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Togo,TGO,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Togo,TGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Trinidad and Tobago,TTO,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Trinidad and Tobago,TTO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Trinidad and Tobago,TTO,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Trinidad and Tobago,TTO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Australia,AUS,Not evaluated,53.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Australia,AUS,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Australia,AUS,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Australia,AUS,Not evaluated,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Australia,AUS,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Australia,AUS,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Australia,AUS,Successfully treated,61.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Australia,AUS,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Australia,AUS,Not evaluated,27.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Australia,AUS,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Australia,AUS,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Australia,AUS,Not evaluated,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Australia,AUS,Successfully treated,80.952380952381 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Australia,AUS,Not evaluated,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Australia,AUS,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Australia,AUS,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Australia,AUS,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Australia,AUS,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Australia,AUS,Successfully treated,86.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Australia,AUS,Not evaluated,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Australia,AUS,Successfully treated,88.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Australia,AUS,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Australia,AUS,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Australia,AUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Australia,AUS,Successfully treated,55.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Australia,AUS,Not evaluated,45.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Australia,AUS,Successfully treated,84.2105263157895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Australia,AUS,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Australia,AUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Australia,AUS,Not evaluated,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Austria,AUT,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Austria,AUT,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Austria,AUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Austria,AUT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Austria,AUT,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Austria,AUT,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Austria,AUT,Not evaluated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Austria,AUT,Successfully treated,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Austria,AUT,Lost to follow-up,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Austria,AUT,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Austria,AUT,Successfully treated,43.4782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Austria,AUT,Lost to follow-up,34.7826086956522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Austria,AUT,Not evaluated,21.7391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Austria,AUT,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Austria,AUT,Lost to follow-up,31.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Austria,AUT,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Austria,AUT,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Austria,AUT,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Austria,AUT,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Austria,AUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Austria,AUT,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Austria,AUT,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Austria,AUT,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Austria,AUT,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Austria,AUT,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Austria,AUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Austria,AUT,Not evaluated,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Austria,AUT,Successfully treated,63.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Austria,AUT,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Austria,AUT,Not evaluated,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Austria,AUT,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Austria,AUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Austria,AUT,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Austria,AUT,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Austria,AUT,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Austria,AUT,Not evaluated,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Austria,AUT,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Austria,AUT,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Austria,AUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Austria,AUT,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Austria,AUT,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Austria,AUT,Died,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Austria,AUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Austria,AUT,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Austria,AUT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Austria,AUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Austria,AUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Austria,AUT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Austria,AUT,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Austria,AUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Austria,AUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Austria,AUT,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Austria,AUT,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Austria,AUT,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Austria,AUT,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Austria,AUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Austria,AUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Austria,AUT,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Austria,AUT,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Azerbaijan,AZE,Successfully treated,56.5217391304348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Azerbaijan,AZE,Treatment failed,34.7826086956522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Azerbaijan,AZE,Died,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Azerbaijan,AZE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Azerbaijan,AZE,Successfully treated,74.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Azerbaijan,AZE,Treatment failed,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Azerbaijan,AZE,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Azerbaijan,AZE,Lost to follow-up,6.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Azerbaijan,AZE,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Azerbaijan,AZE,Treatment failed,20.6293706293706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Azerbaijan,AZE,Died,21.3286713286713 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Azerbaijan,AZE,Lost to follow-up,3.4965034965035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Azerbaijan,AZE,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Azerbaijan,AZE,Treatment failed,16.6371681415929 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Azerbaijan,AZE,Died,17.3451327433628 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Azerbaijan,AZE,Lost to follow-up,6.01769911504425 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Azerbaijan,AZE,Successfully treated,60.3217158176944 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Azerbaijan,AZE,Treatment failed,17.6943699731904 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Azerbaijan,AZE,Died,15.8176943699732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Azerbaijan,AZE,Lost to follow-up,6.16621983914209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Azerbaijan,AZE,Successfully treated,59.0417310664606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Azerbaijan,AZE,Treatment failed,18.2380216383308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Azerbaijan,AZE,Died,17.1561051004637 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Azerbaijan,AZE,Lost to follow-up,5.56414219474498 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Azerbaijan,AZE,Successfully treated,59.1946308724832 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Azerbaijan,AZE,Treatment failed,18.1208053691275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Azerbaijan,AZE,Died,17.0469798657718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Azerbaijan,AZE,Lost to follow-up,5.63758389261745 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Azerbaijan,AZE,Successfully treated,59.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Azerbaijan,AZE,Treatment failed,17.875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Azerbaijan,AZE,Died,15.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Azerbaijan,AZE,Lost to follow-up,7.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Azerbaijan,AZE,Successfully treated,60.1503759398496 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Azerbaijan,AZE,Treatment failed,16.7919799498747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Azerbaijan,AZE,Died,14.0350877192982 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Azerbaijan,AZE,Lost to follow-up,9.02255639097744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Azerbaijan,AZE,Successfully treated,59.3240093240093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Azerbaijan,AZE,Treatment failed,15.8508158508159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Azerbaijan,AZE,Died,12.004662004662 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Azerbaijan,AZE,Lost to follow-up,12.8205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Azerbaijan,AZE,Successfully treated,57.3690621193666 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Azerbaijan,AZE,Treatment failed,17.2959805115713 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Azerbaijan,AZE,Died,11.4494518879415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Azerbaijan,AZE,Lost to follow-up,13.8855054811206 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Azerbaijan,AZE,Successfully treated,59.6319018404908 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Azerbaijan,AZE,Treatment failed,12.1472392638037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Azerbaijan,AZE,Died,10.6748466257669 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Azerbaijan,AZE,Lost to follow-up,17.5460122699387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Macao SAR",MAC,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Macao SAR",MAC,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Macao SAR",MAC,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Macao SAR",MAC,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Macao SAR",MAC,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Macao SAR",MAC,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Macao SAR",MAC,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Macao SAR",MAC,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Macao SAR",MAC,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Macao SAR",MAC,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Macao SAR",MAC,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Macao SAR",MAC,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Macao SAR",MAC,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Colombia,COL,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Colombia,COL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Colombia,COL,Died,5.76923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Colombia,COL,Lost to follow-up,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Colombia,COL,Not evaluated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Colombia,COL,Successfully treated,13.953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Colombia,COL,Treatment failed,1.55038759689923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Colombia,COL,Died,10.8527131782946 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Colombia,COL,Lost to follow-up,10.077519379845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Colombia,COL,Not evaluated,63.5658914728682 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Colombia,COL,Successfully treated,49.21875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Colombia,COL,Treatment failed,2.34375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Colombia,COL,Died,21.09375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Colombia,COL,Lost to follow-up,24.21875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Colombia,COL,Not evaluated,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Colombia,COL,Successfully treated,48.4848484848485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Colombia,COL,Treatment failed,1.01010101010101 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Colombia,COL,Died,7.07070707070707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Colombia,COL,Lost to follow-up,28.2828282828283 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Colombia,COL,Not evaluated,15.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Colombia,COL,Successfully treated,62.1621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Colombia,COL,Treatment failed,0.675675675675676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Colombia,COL,Died,12.8378378378378 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Colombia,COL,Lost to follow-up,20.9459459459459 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Colombia,COL,Not evaluated,3.37837837837838 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Colombia,COL,Successfully treated,49.7237569060774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Colombia,COL,Treatment failed,1.65745856353591 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Colombia,COL,Died,22.0994475138122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Colombia,COL,Lost to follow-up,23.7569060773481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Colombia,COL,Not evaluated,2.76243093922652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Colombia,COL,Successfully treated,39.5348837209302 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Colombia,COL,Treatment failed,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Colombia,COL,Died,15.1162790697674 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Colombia,COL,Lost to follow-up,26.7441860465116 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Colombia,COL,Not evaluated,16.2790697674419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Colombia,COL,Successfully treated,50.561797752809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Colombia,COL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Colombia,COL,Died,15.7303370786517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Colombia,COL,Lost to follow-up,24.1573033707865 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Colombia,COL,Not evaluated,9.55056179775281 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Colombia,COL,Successfully treated,43.979057591623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Colombia,COL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Colombia,COL,Died,17.2774869109948 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Colombia,COL,Lost to follow-up,29.3193717277487 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Colombia,COL,Not evaluated,9.42408376963351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Colombia,COL,Successfully treated,44.6236559139785 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Colombia,COL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Colombia,COL,Died,21.505376344086 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Colombia,COL,Lost to follow-up,20.4301075268817 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Colombia,COL,Not evaluated,13.4408602150538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Colombia,COL,Successfully treated,56.3451776649746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Colombia,COL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Colombia,COL,Died,13.1979695431472 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Colombia,COL,Lost to follow-up,16.243654822335 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Colombia,COL,Not evaluated,14.2131979695431 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Colombia,COL,Successfully treated,51.8248175182482 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Colombia,COL,Treatment failed,0.72992700729927 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Colombia,COL,Died,27.007299270073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Colombia,COL,Lost to follow-up,13.8686131386861 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Colombia,COL,Not evaluated,6.56934306569343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Colombia,COL,Successfully treated,57.4358974358975 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Colombia,COL,Treatment failed,0.512820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Colombia,COL,Died,23.5897435897436 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Colombia,COL,Lost to follow-up,15.8974358974359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Colombia,COL,Not evaluated,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Colombia,COL,Successfully treated,54.8117154811716 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Colombia,COL,Treatment failed,1.67364016736402 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Colombia,COL,Died,15.8995815899582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Colombia,COL,Lost to follow-up,27.6150627615063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Colombia,COL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Comoros,COM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Comoros,COM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Comoros,COM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Comoros,COM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Comoros,COM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Comoros,COM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Comoros,COM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Comoros,COM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Comoros,COM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Comoros,COM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Congo,COG,Successfully treated,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Congo,COG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Congo,COG,Died,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Congo,COG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Congo,COG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Congo,COG,Successfully treated,88.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Congo,COG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Congo,COG,Died,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Congo,COG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Congo,COG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Congo,COG,Successfully treated,81.203007518797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Congo,COG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Congo,COG,Died,9.02255639097744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Congo,COG,Lost to follow-up,4.51127819548872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Congo,COG,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Congo,COG,Successfully treated,81.203007518797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Congo,COG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Congo,COG,Died,9.02255639097744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Congo,COG,Lost to follow-up,4.51127819548872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Congo,COG,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Congo,COG,Successfully treated,65.6488549618321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Congo,COG,Treatment failed,9.16030534351145 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Congo,COG,Died,19.8473282442748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Congo,COG,Lost to follow-up,5.34351145038168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Congo,COG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Congo,COG,Successfully treated,66.1654135338346 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Congo,COG,Treatment failed,9.02255639097744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Congo,COG,Died,19.5488721804511 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Congo,COG,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Congo,COG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Congo,COG,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Congo,COG,Treatment failed,2.31481481481482 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Congo,COG,Died,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Congo,COG,Lost to follow-up,8.7962962962963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Congo,COG,Not evaluated,1.38888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cook Islands,COK,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cook Islands,COK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cook Islands,COK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cook Islands,COK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cook Islands,COK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Costa Rica,CRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Costa Rica,CRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Costa Rica,CRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Costa Rica,CRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Costa Rica,CRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Costa Rica,CRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Costa Rica,CRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Costa Rica,CRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Costa Rica,CRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Costa Rica,CRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Costa Rica,CRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Costa Rica,CRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Costa Rica,CRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Costa Rica,CRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Costa Rica,CRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Costa Rica,CRI,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Costa Rica,CRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Costa Rica,CRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Costa Rica,CRI,Lost to follow-up,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Costa Rica,CRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Costa Rica,CRI,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Costa Rica,CRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Costa Rica,CRI,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Costa Rica,CRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Costa Rica,CRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Costa Rica,CRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Costa Rica,CRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Costa Rica,CRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Costa Rica,CRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Costa Rica,CRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Côte d'Ivoire,CIV,Successfully treated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Côte d'Ivoire,CIV,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Côte d'Ivoire,CIV,Died,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Côte d'Ivoire,CIV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Côte d'Ivoire,CIV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Côte d'Ivoire,CIV,Successfully treated,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Côte d'Ivoire,CIV,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Côte d'Ivoire,CIV,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Côte d'Ivoire,CIV,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Côte d'Ivoire,CIV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Côte d'Ivoire,CIV,Successfully treated,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Germany,DEU,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Germany,DEU,Not evaluated,9.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Germany,DEU,Successfully treated,62.7659574468085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Germany,DEU,Treatment failed,11.7021276595745 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Germany,DEU,Died,9.57446808510638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Germany,DEU,Lost to follow-up,2.12765957446809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Germany,DEU,Not evaluated,13.8297872340426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Germany,DEU,Successfully treated,54.2168674698795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Germany,DEU,Treatment failed,2.40963855421687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Germany,DEU,Died,4.81927710843374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Germany,DEU,Lost to follow-up,10.8433734939759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Germany,DEU,Not evaluated,27.710843373494 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Germany,DEU,Successfully treated,64.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Germany,DEU,Treatment failed,3.07692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Germany,DEU,Died,4.61538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Germany,DEU,Lost to follow-up,3.07692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Germany,DEU,Not evaluated,24.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Germany,DEU,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Germany,DEU,Died,2.04081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Germany,DEU,Lost to follow-up,12.2448979591837 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Germany,DEU,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Germany,DEU,Successfully treated,61.2903225806452 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Germany,DEU,Treatment failed,1.61290322580645 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Germany,DEU,Died,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Germany,DEU,Lost to follow-up,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Germany,DEU,Not evaluated,24.1935483870968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Germany,DEU,Successfully treated,54.9019607843137 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Germany,DEU,Died,9.80392156862745 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Germany,DEU,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Germany,DEU,Not evaluated,29.4117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Germany,DEU,Successfully treated,52.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Germany,DEU,Died,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Germany,DEU,Lost to follow-up,3.63636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Germany,DEU,Not evaluated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Germany,DEU,Successfully treated,46.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Germany,DEU,Treatment failed,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Germany,DEU,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Germany,DEU,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Germany,DEU,Not evaluated,36.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Germany,DEU,Successfully treated,39.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Germany,DEU,Treatment failed,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Germany,DEU,Died,7.61904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Germany,DEU,Lost to follow-up,8.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Germany,DEU,Not evaluated,41.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Germany,DEU,Successfully treated,35.4838709677419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Germany,DEU,Treatment failed,1.0752688172043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Germany,DEU,Died,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Germany,DEU,Lost to follow-up,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Germany,DEU,Not evaluated,50.5376344086022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Germany,DEU,Successfully treated,43.2203389830509 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Germany,DEU,Died,3.38983050847458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Germany,DEU,Lost to follow-up,5.93220338983051 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Germany,DEU,Not evaluated,47.4576271186441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Germany,DEU,Successfully treated,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Germany,DEU,Treatment failed,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Germany,DEU,Died,6.14035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Germany,DEU,Lost to follow-up,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Germany,DEU,Not evaluated,48.2456140350877 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Germany,DEU,Successfully treated,57.03125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Germany,DEU,Died,2.34375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Germany,DEU,Lost to follow-up,2.34375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Germany,DEU,Not evaluated,38.28125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Germany,DEU,Successfully treated,54.8387096774194 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Germany,DEU,Died,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Germany,DEU,Lost to follow-up,2.41935483870968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Germany,DEU,Not evaluated,39.5161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Germany,DEU,Successfully treated,56.7010309278351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Germany,DEU,Died,4.12371134020619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Germany,DEU,Lost to follow-up,2.06185567010309 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Germany,DEU,Not evaluated,37.1134020618557 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Germany,DEU,Successfully treated,45.2631578947368 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Germany,DEU,Died,3.15789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Germany,DEU,Lost to follow-up,4.21052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Germany,DEU,Not evaluated,47.3684210526316 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Germany,DEU,Successfully treated,49.4505494505495 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Germany,DEU,Treatment failed,1.0989010989011 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Germany,DEU,Died,8.79120879120879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Germany,DEU,Lost to follow-up,4.3956043956044 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Germany,DEU,Not evaluated,36.2637362637363 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Germany,DEU,Successfully treated,44.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Germany,DEU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Germany,DEU,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Germany,DEU,Lost to follow-up,1.17647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Germany,DEU,Not evaluated,48.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ghana,GHA,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ghana,GHA,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ghana,GHA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ghana,GHA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ghana,GHA,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ghana,GHA,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ghana,GHA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ghana,GHA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ghana,GHA,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ghana,GHA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ghana,GHA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ghana,GHA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ghana,GHA,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ghana,GHA,Died,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ghana,GHA,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ghana,GHA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ghana,GHA,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ghana,GHA,Died,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ghana,GHA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ghana,GHA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ghana,GHA,Successfully treated,55.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ghana,GHA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ghana,GHA,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ghana,GHA,Not evaluated,11.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ghana,GHA,Successfully treated,62.3376623376623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ghana,GHA,Died,15.5844155844156 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ghana,GHA,Lost to follow-up,2.5974025974026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ghana,GHA,Not evaluated,19.4805194805195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ghana,GHA,Successfully treated,63.3928571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ghana,GHA,Treatment failed,2.67857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ghana,GHA,Died,19.6428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ghana,GHA,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ghana,GHA,Not evaluated,8.03571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ghana,GHA,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ghana,GHA,Treatment failed,3.08641975308642 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ghana,GHA,Died,24.6913580246914 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ghana,GHA,Lost to follow-up,11.7283950617284 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ghana,GHA,Not evaluated,4.93827160493827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ghana,GHA,Successfully treated,70.9677419354839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ghana,GHA,Treatment failed,17.5115207373272 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ghana,GHA,Died,1.84331797235023 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ghana,GHA,Lost to follow-up,7.83410138248848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ghana,GHA,Not evaluated,1.84331797235023 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ghana,GHA,Successfully treated,74.8743718592965 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ghana,GHA,Treatment failed,1.00502512562814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ghana,GHA,Died,15.5778894472362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ghana,GHA,Lost to follow-up,5.52763819095477 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ghana,GHA,Not evaluated,3.01507537688442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ghana,GHA,Successfully treated,72.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ghana,GHA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ghana,GHA,Died,17.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ghana,GHA,Lost to follow-up,4.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ghana,GHA,Not evaluated,5.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ghana,GHA,Successfully treated,66.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ghana,GHA,Treatment failed,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ghana,GHA,Died,17.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ghana,GHA,Lost to follow-up,5.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ghana,GHA,Not evaluated,9.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Guam,GUM,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guam,GUM,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guam,GUM,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guam,GUM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guam,GUM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guam,GUM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guam,GUM,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guam,GUM,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guam,GUM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guam,GUM,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guam,GUM,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guam,GUM,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guam,GUM,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iraq,IRQ,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iraq,IRQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iraq,IRQ,Died,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iraq,IRQ,Lost to follow-up,15.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iraq,IRQ,Not evaluated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iraq,IRQ,Successfully treated,8.06451612903226 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iraq,IRQ,Died,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iraq,IRQ,Lost to follow-up,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iraq,IRQ,Not evaluated,79.0322580645161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iraq,IRQ,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iraq,IRQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iraq,IRQ,Died,18.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iraq,IRQ,Lost to follow-up,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iraq,IRQ,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iraq,IRQ,Successfully treated,64.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iraq,IRQ,Treatment failed,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iraq,IRQ,Died,18.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iraq,IRQ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iraq,IRQ,Not evaluated,16.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iraq,IRQ,Successfully treated,46.969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iraq,IRQ,Treatment failed,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iraq,IRQ,Died,10.6060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iraq,IRQ,Lost to follow-up,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iraq,IRQ,Not evaluated,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iraq,IRQ,Successfully treated,58.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iraq,IRQ,Treatment failed,1.19047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iraq,IRQ,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iraq,IRQ,Lost to follow-up,22.6190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iraq,IRQ,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iraq,IRQ,Successfully treated,49.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iraq,IRQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iraq,IRQ,Died,14.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iraq,IRQ,Lost to follow-up,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iraq,IRQ,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iraq,IRQ,Successfully treated,56.1643835616438 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iraq,IRQ,Treatment failed,2.73972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iraq,IRQ,Died,17.8082191780822 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iraq,IRQ,Lost to follow-up,12.3287671232877 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iraq,IRQ,Not evaluated,10.958904109589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iraq,IRQ,Successfully treated,80.7228915662651 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iraq,IRQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iraq,IRQ,Died,2.40963855421687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iraq,IRQ,Lost to follow-up,16.8674698795181 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iraq,IRQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iraq,IRQ,Successfully treated,77.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iraq,IRQ,Treatment failed,1.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iraq,IRQ,Died,1.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iraq,IRQ,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iraq,IRQ,Not evaluated,1.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iraq,IRQ,Successfully treated,62.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iraq,IRQ,Treatment failed,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iraq,IRQ,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iraq,IRQ,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iraq,IRQ,Not evaluated,2.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iraq,IRQ,Successfully treated,68.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iraq,IRQ,Treatment failed,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iraq,IRQ,Died,8.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iraq,IRQ,Lost to follow-up,16.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iraq,IRQ,Not evaluated,0.952380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iraq,IRQ,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iraq,IRQ,Treatment failed,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iraq,IRQ,Died,11.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iraq,IRQ,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iraq,IRQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iraq,IRQ,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iraq,IRQ,Treatment failed,2.02020202020202 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iraq,IRQ,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iraq,IRQ,Lost to follow-up,5.05050505050505 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iraq,IRQ,Not evaluated,4.04040404040404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iraq,IRQ,Successfully treated,76.056338028169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iraq,IRQ,Treatment failed,0.704225352112676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iraq,IRQ,Died,12.6760563380282 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iraq,IRQ,Lost to follow-up,6.33802816901409 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iraq,IRQ,Not evaluated,4.22535211267606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Ireland,IRL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Ireland,IRL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ireland,IRL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ireland,IRL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ireland,IRL,Successfully treated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ireland,IRL,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ireland,IRL,Not evaluated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ireland,IRL,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ireland,IRL,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ireland,IRL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ireland,IRL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ireland,IRL,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ireland,IRL,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ireland,IRL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ireland,IRL,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ireland,IRL,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ireland,IRL,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ireland,IRL,Successfully treated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ireland,IRL,Not evaluated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ireland,IRL,Successfully treated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ireland,IRL,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ireland,IRL,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ireland,IRL,Not evaluated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ireland,IRL,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ireland,IRL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ireland,IRL,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ireland,IRL,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ireland,IRL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ireland,IRL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ireland,IRL,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ireland,IRL,Successfully treated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ireland,IRL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ireland,IRL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ireland,IRL,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ireland,IRL,Not evaluated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Israel,ISR,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Israel,ISR,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Israel,ISR,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Israel,ISR,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Israel,ISR,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Israel,ISR,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Israel,ISR,Died,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,Israel,ISR,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,Israel,ISR,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Israel,ISR,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Israel,ISR,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Israel,ISR,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Israel,ISR,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Israel,ISR,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Israel,ISR,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Israel,ISR,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Israel,ISR,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Israel,ISR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Israel,ISR,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Israel,ISR,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Israel,ISR,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Israel,ISR,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Israel,ISR,Not evaluated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Israel,ISR,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Israel,ISR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Israel,ISR,Not evaluated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Israel,ISR,Successfully treated,92.3076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Israel,ISR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Israel,ISR,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Israel,ISR,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Israel,ISR,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Israel,ISR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Israel,ISR,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Israel,ISR,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Israel,ISR,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Israel,ISR,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Israel,ISR,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Mauritania,MRT,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Mauritania,MRT,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritania,MRT,Successfully treated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritania,MRT,Died,23.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritania,MRT,Lost to follow-up,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritania,MRT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritania,MRT,Successfully treated,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritania,MRT,Treatment failed,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritania,MRT,Died,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritania,MRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritania,MRT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritania,MRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritania,MRT,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mauritania,MRT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mauritania,MRT,Treatment failed,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mauritania,MRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mauritania,MRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mauritania,MRT,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mauritania,MRT,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mauritania,MRT,Lost to follow-up,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritania,MRT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritania,MRT,Died,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritania,MRT,Lost to follow-up,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritania,MRT,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritania,MRT,Successfully treated,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritania,MRT,Died,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritania,MRT,Lost to follow-up,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritania,MRT,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritania,MRT,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritania,MRT,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritania,MRT,Lost to follow-up,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritania,MRT,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritania,MRT,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritania,MRT,Lost to follow-up,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritania,MRT,Successfully treated,43.4782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritania,MRT,Treatment failed,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritania,MRT,Died,34.7826086956522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritania,MRT,Lost to follow-up,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritania,MRT,Not evaluated,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritania,MRT,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritania,MRT,Treatment failed,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritania,MRT,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritania,MRT,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritania,MRT,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mauritania,MRT,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mauritania,MRT,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mauritania,MRT,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritania,MRT,Successfully treated,73.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritania,MRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritania,MRT,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritania,MRT,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritania,MRT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mauritius,MUS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mauritius,MUS,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritius,MUS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mauritius,MUS,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritius,MUS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mauritius,MUS,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritius,MUS,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mauritius,MUS,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritius,MUS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mauritius,MUS,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritius,MUS,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritius,MUS,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mauritius,MUS,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritius,MUS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritius,MUS,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mauritius,MUS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mauritius,MUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mauritius,MUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mauritius,MUS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mauritius,MUS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Mexico,MEX,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Mexico,MEX,Treatment failed,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Mexico,MEX,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Mexico,MEX,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mexico,MEX,Successfully treated,26.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mexico,MEX,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mexico,MEX,Died,16.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mexico,MEX,Lost to follow-up,22.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mexico,MEX,Not evaluated,26.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mexico,MEX,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mexico,MEX,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mexico,MEX,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mexico,MEX,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mexico,MEX,Successfully treated,72.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mexico,MEX,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mexico,MEX,Died,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mexico,MEX,Lost to follow-up,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mexico,MEX,Successfully treated,81.0810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mexico,MEX,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mexico,MEX,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mexico,MEX,Lost to follow-up,18.9189189189189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mexico,MEX,Successfully treated,71.7488789237668 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mexico,MEX,Treatment failed,4.48430493273543 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mexico,MEX,Died,11.2107623318386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mexico,MEX,Lost to follow-up,12.1076233183857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mexico,MEX,Not evaluated,0.448430493273543 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mexico,MEX,Successfully treated,69.0789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mexico,MEX,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mexico,MEX,Died,11.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mexico,MEX,Lost to follow-up,13.8157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mexico,MEX,Successfully treated,73.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mexico,MEX,Treatment failed,4.51127819548872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mexico,MEX,Died,9.77443609022556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mexico,MEX,Lost to follow-up,12.0300751879699 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mexico,MEX,Successfully treated,59.8802395209581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mexico,MEX,Treatment failed,4.79041916167665 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mexico,MEX,Died,15.5688622754491 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mexico,MEX,Lost to follow-up,19.7604790419162 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mexico,MEX,Successfully treated,55.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mexico,MEX,Treatment failed,4.32692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mexico,MEX,Died,11.0576923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mexico,MEX,Lost to follow-up,18.2692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mexico,MEX,Not evaluated,10.5769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mexico,MEX,Successfully treated,71.3414634146342 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mexico,MEX,Treatment failed,3.65853658536585 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mexico,MEX,Died,9.75609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mexico,MEX,Lost to follow-up,15.2439024390244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mexico,MEX,Successfully treated,67.5324675324675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mexico,MEX,Treatment failed,2.5974025974026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nicaragua,NIC,Died,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nicaragua,NIC,Lost to follow-up,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nicaragua,NIC,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nicaragua,NIC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nicaragua,NIC,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nicaragua,NIC,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nicaragua,NIC,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nicaragua,NIC,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nicaragua,NIC,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nicaragua,NIC,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nicaragua,NIC,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nicaragua,NIC,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nicaragua,NIC,Successfully treated,65.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nicaragua,NIC,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nicaragua,NIC,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nicaragua,NIC,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nicaragua,NIC,Died,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nicaragua,NIC,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nicaragua,NIC,Successfully treated,72.4137931034483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nicaragua,NIC,Died,10.3448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nicaragua,NIC,Lost to follow-up,17.2413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nicaragua,NIC,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nicaragua,NIC,Treatment failed,1.78571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nicaragua,NIC,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nicaragua,NIC,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nicaragua,NIC,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nicaragua,NIC,Treatment failed,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nicaragua,NIC,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nicaragua,NIC,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nicaragua,NIC,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nicaragua,NIC,Died,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nicaragua,NIC,Lost to follow-up,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Niger,NER,Successfully treated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Niger,NER,Treatment failed,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Niger,NER,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Niger,NER,Lost to follow-up,5.12820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Niger,NER,Successfully treated,87.1794871794872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Niger,NER,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Niger,NER,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Niger,NER,Lost to follow-up,5.12820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Niger,NER,Successfully treated,85.1851851851852 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Niger,NER,Treatment failed,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Niger,NER,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Niger,NER,Lost to follow-up,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Niger,NER,Successfully treated,86.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Niger,NER,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Niger,NER,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Niger,NER,Lost to follow-up,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Niger,NER,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Niger,NER,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Niger,NER,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Niger,NER,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Niger,NER,Successfully treated,86.046511627907 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Niger,NER,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Niger,NER,Died,9.30232558139535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Niger,NER,Lost to follow-up,4.65116279069768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Niger,NER,Successfully treated,80.6451612903226 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Niger,NER,Treatment failed,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Niger,NER,Died,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Niger,NER,Lost to follow-up,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Niger,NER,Successfully treated,78.2608695652174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Niger,NER,Treatment failed,6.52173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Niger,NER,Died,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Niger,NER,Lost to follow-up,2.17391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Niger,NER,Successfully treated,82.3529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Niger,NER,Treatment failed,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Niger,NER,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Niger,NER,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Niger,NER,Successfully treated,88.0952380952381 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Niger,NER,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Niger,NER,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Niger,NER,Lost to follow-up,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Niger,NER,Successfully treated,85.5072463768116 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Niger,NER,Treatment failed,2.89855072463768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Niger,NER,Died,10.1449275362319 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Niger,NER,Lost to follow-up,1.44927536231884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Niger,NER,Successfully treated,75.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Niger,NER,Treatment failed,6.15384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Niger,NER,Died,16.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Niger,NER,Lost to follow-up,1.53846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Niger,NER,Successfully treated,85.9375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Niger,NER,Treatment failed,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Niger,NER,Died,7.8125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Niger,NER,Lost to follow-up,4.6875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Niger,NER,Successfully treated,74.6268656716418 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Niger,NER,Treatment failed,4.47761194029851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Niger,NER,Died,17.910447761194 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Niger,NER,Lost to follow-up,2.98507462686567 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Niger,NER,Successfully treated,76.4705882352941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Niger,NER,Treatment failed,1.17647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Niger,NER,Died,14.1176470588235 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Niger,NER,Lost to follow-up,8.23529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Niger,NER,Successfully treated,72.3577235772358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Niger,NER,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Niger,NER,Died,19.5121951219512 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Niger,NER,Lost to follow-up,5.69105691056911 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Niger,NER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nigeria,NGA,Successfully treated,60.8695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nigeria,NGA,Treatment failed,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nigeria,NGA,Died,26.0869565217391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nigeria,NGA,Lost to follow-up,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nigeria,NGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nigeria,NGA,Successfully treated,63.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nigeria,NGA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nigeria,NGA,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nigeria,NGA,Lost to follow-up,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nigeria,NGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nigeria,NGA,Successfully treated,62.3376623376623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nigeria,NGA,Treatment failed,0.649350649350649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nigeria,NGA,Died,14.9350649350649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nigeria,NGA,Lost to follow-up,0.649350649350649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nigeria,NGA,Not evaluated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nigeria,NGA,Successfully treated,76.6961651917404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nigeria,NGA,Treatment failed,1.17994100294985 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nigeria,NGA,Died,13.2743362831858 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nigeria,NGA,Lost to follow-up,4.42477876106195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nigeria,NGA,Not evaluated,4.42477876106195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nigeria,NGA,Successfully treated,74.2316784869976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nigeria,NGA,Treatment failed,0.236406619385343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nigeria,NGA,Died,17.0212765957447 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nigeria,NGA,Lost to follow-up,4.9645390070922 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nigeria,NGA,Not evaluated,3.54609929078014 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nigeria,NGA,Successfully treated,77.8963414634146 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nigeria,NGA,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nigeria,NGA,Died,15.8536585365854 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nigeria,NGA,Lost to follow-up,2.28658536585366 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nigeria,NGA,Not evaluated,1.52439024390244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nigeria,NGA,Successfully treated,76.9784172661871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nigeria,NGA,Treatment failed,1.99840127897682 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nigeria,NGA,Died,12.7897681854516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nigeria,NGA,Lost to follow-up,2.15827338129496 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nigeria,NGA,Not evaluated,6.07513988808953 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nigeria,NGA,Successfully treated,76.9876819708847 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nigeria,NGA,Treatment failed,2.01567749160134 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nigeria,NGA,Died,11.9820828667413 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nigeria,NGA,Lost to follow-up,4.98320268756999 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nigeria,NGA,Not evaluated,4.03135498320269 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nigeria,NGA,Successfully treated,78.1530343007916 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nigeria,NGA,Treatment failed,1.58311345646438 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nigeria,NGA,Died,10.5013192612137 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nigeria,NGA,Lost to follow-up,6.27968337730871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nigeria,NGA,Not evaluated,3.48284960422164 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nigeria,NGA,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nigeria,NGA,Treatment failed,1.0126582278481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nigeria,NGA,Died,10.9873417721519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nigeria,NGA,Lost to follow-up,6.0253164556962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nigeria,NGA,Not evaluated,1.9746835443038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nigeria,NGA,Successfully treated,82.6428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nigeria,NGA,Treatment failed,2.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nigeria,NGA,Died,9.07142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nigeria,NGA,Lost to follow-up,4.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nigeria,NGA,Not evaluated,1.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nigeria,NGA,Successfully treated,84.3878015475649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nigeria,NGA,Treatment failed,0.773782430587164 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nigeria,NGA,Died,7.37369139736004 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nigeria,NGA,Lost to follow-up,5.68957669549386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nigeria,NGA,Not evaluated,1.77514792899408 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nigeria,NGA,Successfully treated,76.2637362637363 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nigeria,NGA,Treatment failed,0.879120879120879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nigeria,NGA,Died,6.62480376766091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nigeria,NGA,Lost to follow-up,8.41444270015699 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nigeria,NGA,Not evaluated,7.81789638932496 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,North Macedonia,MKD,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Rwanda,RWA,Not evaluated,1.38888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Rwanda,RWA,Successfully treated,88.5057471264368 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Rwanda,RWA,Died,10.3448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Rwanda,RWA,Lost to follow-up,1.14942528735632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Rwanda,RWA,Successfully treated,90.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Rwanda,RWA,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Rwanda,RWA,Lost to follow-up,1.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Rwanda,RWA,Successfully treated,98.2758620689655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Rwanda,RWA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Rwanda,RWA,Not evaluated,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Rwanda,RWA,Successfully treated,81.3953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Rwanda,RWA,Died,16.2790697674419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Rwanda,RWA,Lost to follow-up,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Rwanda,RWA,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Rwanda,RWA,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Rwanda,RWA,Successfully treated,90.1098901098901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Rwanda,RWA,Treatment failed,1.0989010989011 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Rwanda,RWA,Died,8.79120879120879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Rwanda,RWA,Successfully treated,91.1392405063291 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Rwanda,RWA,Died,8.86075949367089 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Rwanda,RWA,Successfully treated,80.5194805194805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Rwanda,RWA,Treatment failed,1.2987012987013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Rwanda,RWA,Died,16.8831168831169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Rwanda,RWA,Lost to follow-up,1.2987012987013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Rwanda,RWA,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Rwanda,RWA,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Rwanda,RWA,Lost to follow-up,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Rwanda,RWA,Successfully treated,94.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Rwanda,RWA,Died,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Rwanda,RWA,Lost to follow-up,1.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Rwanda,RWA,Successfully treated,95.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Rwanda,RWA,Died,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Rwanda,RWA,Successfully treated,96.969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Rwanda,RWA,Died,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Rwanda,RWA,Successfully treated,87.3015873015873 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Rwanda,RWA,Treatment failed,3.17460317460317 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Rwanda,RWA,Died,6.34920634920635 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Rwanda,RWA,Lost to follow-up,3.17460317460317 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saint Kitts and Nevis,KNA,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saint Kitts and Nevis,KNA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saint Kitts and Nevis,KNA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saint Kitts and Nevis,KNA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saint Kitts and Nevis,KNA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Samoa,WSM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Samoa,WSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Samoa,WSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Samoa,WSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Samoa,WSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Samoa,WSM,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Samoa,WSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Samoa,WSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Samoa,WSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Samoa,WSM,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Samoa,WSM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Samoa,WSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Samoa,WSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Samoa,WSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Samoa,WSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Samoa,WSM,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Samoa,WSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sao Tome and Principe,STP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sao Tome and Principe,STP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sao Tome and Principe,STP,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sao Tome and Principe,STP,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sao Tome and Principe,STP,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sao Tome and Principe,STP,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sao Tome and Principe,STP,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sao Tome and Principe,STP,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sao Tome and Principe,STP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sao Tome and Principe,STP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sao Tome and Principe,STP,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sao Tome and Principe,STP,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sao Tome and Principe,STP,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sao Tome and Principe,STP,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sao Tome and Principe,STP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sao Tome and Principe,STP,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sao Tome and Principe,STP,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sao Tome and Principe,STP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sao Tome and Principe,STP,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sao Tome and Principe,STP,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sao Tome and Principe,STP,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sao Tome and Principe,STP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sao Tome and Principe,STP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sao Tome and Principe,STP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sao Tome and Principe,STP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sao Tome and Principe,STP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Saudi Arabia,SAU,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Saudi Arabia,SAU,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Saudi Arabia,SAU,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Saudi Arabia,SAU,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Saudi Arabia,SAU,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Saudi Arabia,SAU,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Saudi Arabia,SAU,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Saudi Arabia,SAU,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Saudi Arabia,SAU,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Saudi Arabia,SAU,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Saudi Arabia,SAU,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Saudi Arabia,SAU,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Saudi Arabia,SAU,Lost to follow-up,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Saudi Arabia,SAU,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saudi Arabia,SAU,Successfully treated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saudi Arabia,SAU,Died,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saudi Arabia,SAU,Lost to follow-up,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Saudi Arabia,SAU,Not evaluated,38.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Saudi Arabia,SAU,Successfully treated,37.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Saudi Arabia,SAU,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Saudi Arabia,SAU,Lost to follow-up,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Saudi Arabia,SAU,Not evaluated,42.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Saudi Arabia,SAU,Successfully treated,91.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Saudi Arabia,SAU,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Saudi Arabia,SAU,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Saudi Arabia,SAU,Not evaluated,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Saudi Arabia,SAU,Successfully treated,86.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Saudi Arabia,SAU,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Saudi Arabia,SAU,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Saudi Arabia,SAU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Saudi Arabia,SAU,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Saudi Arabia,SAU,Died,25.9259259259259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Saudi Arabia,SAU,Lost to follow-up,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Saudi Arabia,SAU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Saudi Arabia,SAU,Successfully treated,81.4814814814815 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Saudi Arabia,SAU,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Saudi Arabia,SAU,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Saudi Arabia,SAU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Saudi Arabia,SAU,Successfully treated,63.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Saudi Arabia,SAU,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Saudi Arabia,SAU,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Saudi Arabia,SAU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Saudi Arabia,SAU,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Saudi Arabia,SAU,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Saudi Arabia,SAU,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Saudi Arabia,SAU,Not evaluated,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Saudi Arabia,SAU,Successfully treated,92.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Saudi Arabia,SAU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Saudi Arabia,SAU,Died,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Saudi Arabia,SAU,Lost to follow-up,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Saudi Arabia,SAU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Turkmenistan,TKM,Lost to follow-up,11.0787172011662 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Turkmenistan,TKM,Not evaluated,1.45772594752187 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Turkmenistan,TKM,Successfully treated,45.1730418943534 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Turkmenistan,TKM,Treatment failed,17.8506375227687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Turkmenistan,TKM,Died,16.7577413479053 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Turkmenistan,TKM,Lost to follow-up,16.7577413479053 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Turkmenistan,TKM,Not evaluated,3.4608378870674 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Turkmenistan,TKM,Successfully treated,55.1617873651772 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Turkmenistan,TKM,Treatment failed,16.3328197226502 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Turkmenistan,TKM,Died,16.3328197226502 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Turkmenistan,TKM,Lost to follow-up,10.939907550077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Turkmenistan,TKM,Not evaluated,1.2326656394453 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Turkmenistan,TKM,Successfully treated,59.9229287090559 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Turkmenistan,TKM,Treatment failed,12.1387283236994 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Turkmenistan,TKM,Died,17.1483622350674 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Turkmenistan,TKM,Lost to follow-up,8.67052023121387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Turkmenistan,TKM,Not evaluated,2.11946050096339 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Turkmenistan,TKM,Successfully treated,70.6333973128599 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Turkmenistan,TKM,Treatment failed,6.14203454894434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Turkmenistan,TKM,Died,14.2034548944338 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Turkmenistan,TKM,Lost to follow-up,8.06142034548944 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Turkmenistan,TKM,Not evaluated,0.959692898272553 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Turkmenistan,TKM,Successfully treated,71.011673151751 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Turkmenistan,TKM,Treatment failed,9.53307392996109 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Turkmenistan,TKM,Died,9.92217898832685 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Turkmenistan,TKM,Lost to follow-up,6.03112840466926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Turkmenistan,TKM,Not evaluated,3.50194552529183 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tuvalu,TUV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tuvalu,TUV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tuvalu,TUV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tuvalu,TUV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tuvalu,TUV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tuvalu,TUV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tuvalu,TUV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tuvalu,TUV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tuvalu,TUV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tuvalu,TUV,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tuvalu,TUV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tuvalu,TUV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tuvalu,TUV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tuvalu,TUV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tuvalu,TUV,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tuvalu,TUV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tuvalu,TUV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tuvalu,TUV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tuvalu,TUV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tuvalu,TUV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uganda,UGA,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uganda,UGA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uganda,UGA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uganda,UGA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uganda,UGA,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uganda,UGA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uganda,UGA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uganda,UGA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uganda,UGA,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uganda,UGA,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uganda,UGA,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uganda,UGA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uganda,UGA,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uganda,UGA,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uganda,UGA,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uganda,UGA,Successfully treated,80.4878048780488 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uganda,UGA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uganda,UGA,Died,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uganda,UGA,Lost to follow-up,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uganda,UGA,Not evaluated,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uganda,UGA,Successfully treated,73.3644859813084 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uganda,UGA,Treatment failed,0.934579439252336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uganda,UGA,Died,16.8224299065421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uganda,UGA,Lost to follow-up,4.20560747663551 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uganda,UGA,Not evaluated,4.67289719626168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uganda,UGA,Successfully treated,71.4953271028038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uganda,UGA,Treatment failed,0.467289719626168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uganda,UGA,Died,14.4859813084112 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uganda,UGA,Lost to follow-up,9.34579439252336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uganda,UGA,Not evaluated,4.20560747663551 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uganda,UGA,Successfully treated,74.4 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uganda,UGA,Treatment failed,0.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uganda,UGA,Died,13.6 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uganda,UGA,Lost to follow-up,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uganda,UGA,Not evaluated,3.2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uganda,UGA,Successfully treated,64.010989010989 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uganda,UGA,Treatment failed,1.0989010989011 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uganda,UGA,Died,19.7802197802198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uganda,UGA,Lost to follow-up,14.8351648351648 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uganda,UGA,Not evaluated,0.274725274725275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uganda,UGA,Successfully treated,73.9583333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uganda,UGA,Treatment failed,2.08333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uganda,UGA,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uganda,UGA,Lost to follow-up,7.29166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uganda,UGA,Successfully treated,77.5757575757576 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uganda,UGA,Treatment failed,3.43434343434343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uganda,UGA,Died,11.9191919191919 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uganda,UGA,Lost to follow-up,6.26262626262626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uganda,UGA,Not evaluated,0.808080808080808 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uganda,UGA,Successfully treated,79.8561151079137 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uganda,UGA,Treatment failed,2.87769784172662 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uganda,UGA,Died,12.589928057554 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uganda,UGA,Lost to follow-up,4.49640287769784 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uganda,UGA,Not evaluated,0.179856115107914 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uganda,UGA,Successfully treated,87.4396135265701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uganda,UGA,Treatment failed,1.20772946859903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uganda,UGA,Died,10.1449275362319 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uganda,UGA,Lost to follow-up,1.20772946859903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uganda,UGA,Successfully treated,88.0478087649403 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uganda,UGA,Treatment failed,0.99601593625498 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uganda,UGA,Died,9.16334661354582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uganda,UGA,Lost to follow-up,1.79282868525896 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uganda,UGA,Successfully treated,89.3899204244032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uganda,UGA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uganda,UGA,Died,7.29442970822281 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uganda,UGA,Lost to follow-up,3.31564986737401 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uganda,UGA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ukraine,UKR,Successfully treated,27.4628675356169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ukraine,UKR,Treatment failed,9.30585025765383 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ukraine,UKR,Died,31.221582297666 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ukraine,UKR,Lost to follow-up,13.8829948469233 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ukraine,UKR,Not evaluated,18.12670506214 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ukraine,UKR,Successfully treated,29.3182983085597 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ukraine,UKR,Treatment failed,9.50794464377242 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ukraine,UKR,Died,33.0855971296771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ukraine,UKR,Lost to follow-up,13.2752434648898 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ukraine,UKR,Not evaluated,14.812916453101 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ukraine,UKR,Successfully treated,34.0682414698163 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ukraine,UKR,Treatment failed,12.1259842519685 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ukraine,UKR,Died,29.5800524934383 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ukraine,UKR,Lost to follow-up,17.8740157480315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ukraine,UKR,Not evaluated,6.35170603674541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ukraine,UKR,Successfully treated,34.3592512598992 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ukraine,UKR,Treatment failed,16.4686825053996 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ukraine,UKR,Died,26.9078473722102 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ukraine,UKR,Lost to follow-up,18.5385169186465 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ukraine,UKR,Not evaluated,3.72570194384449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ukraine,UKR,Successfully treated,38.6217738765885 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ukraine,UKR,Treatment failed,17.018210402201 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ukraine,UKR,Died,21.6821695270536 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ukraine,UKR,Lost to follow-up,17.9614830341936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ukraine,UKR,Not evaluated,4.71636315996332 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ukraine,UKR,Successfully treated,45.9576247560636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ukraine,UKR,Treatment failed,17.8979648731531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ukraine,UKR,Died,16.8664622247003 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ukraine,UKR,Lost to follow-up,16.5319208252021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ukraine,UKR,Not evaluated,2.74602732088096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ukraine,UKR,Successfully treated,50.777133825079 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ukraine,UKR,Treatment failed,16.0695468914647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ukraine,UKR,Died,15.7139093782929 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ukraine,UKR,Lost to follow-up,16.5569020021075 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ukraine,UKR,Not evaluated,0.882507903055848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ukraine,UKR,Successfully treated,49.3335165590216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ukraine,UKR,Treatment failed,17.9744400164903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ukraine,UKR,Died,15.9406348770098 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ukraine,UKR,Lost to follow-up,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ukraine,UKR,Not evaluated,0.96193486326783 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ukraine,UKR,Successfully treated,50.964846671653 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ukraine,UKR,Treatment failed,17.8908002991773 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ukraine,UKR,Died,15.168287210172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ukraine,UKR,Lost to follow-up,15.5123410620793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ukraine,UKR,Not evaluated,0.463724756918474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ukraine,UKR,Successfully treated,50.4955484629599 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ukraine,UKR,Treatment failed,17.3525953300857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ukraine,UKR,Died,16.2943053922392 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ukraine,UKR,Lost to follow-up,15.5551822610449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ukraine,UKR,Not evaluated,0.302368553670418 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ukraine,UKR,Successfully treated,61.4409698305552 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ukraine,UKR,Treatment failed,12.4948339991734 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ukraine,UKR,Died,13.3489461358314 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ukraine,UKR,Lost to follow-up,12.6463700234192 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ukraine,UKR,Not evaluated,0.0688800110208018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ukraine,UKR,Successfully treated,65.1167554281032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ukraine,UKR,Treatment failed,8.48013109381401 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ukraine,UKR,Died,15.4854567800082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ukraine,UKR,Lost to follow-up,10.6308889799263 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ukraine,UKR,Not evaluated,0.2867677181483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ukraine,UKR,Successfully treated,65.5609167671894 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ukraine,UKR,Treatment failed,4.70446320868516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ukraine,UKR,Died,15.9227985524729 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ukraine,UKR,Lost to follow-up,13.2388419782871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ukraine,UKR,Not evaluated,0.572979493365501 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ukraine,UKR,Successfully treated,66.9662224976759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ukraine,UKR,Treatment failed,3.09885342423303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ukraine,UKR,Died,14.7505422993492 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ukraine,UKR,Lost to follow-up,13.975828943291 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ukraine,UKR,Not evaluated,1.20855283545088 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Arab Emirates,ARE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Arab Emirates,ARE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burkina Faso,BFA,Successfully treated,69.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burkina Faso,BFA,Treatment failed,4.83870967741936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burkina Faso,BFA,Died,19.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burkina Faso,BFA,Lost to follow-up,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burkina Faso,BFA,Successfully treated,74.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burkina Faso,BFA,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burkina Faso,BFA,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burkina Faso,BFA,Lost to follow-up,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burkina Faso,BFA,Successfully treated,60.2739726027397 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burkina Faso,BFA,Treatment failed,6.84931506849315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burkina Faso,BFA,Died,23.2876712328767 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burkina Faso,BFA,Lost to follow-up,9.58904109589041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burkina Faso,BFA,Successfully treated,69.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burkina Faso,BFA,Treatment failed,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burkina Faso,BFA,Died,16.1290322580645 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burkina Faso,BFA,Lost to follow-up,8.06451612903226 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Burundi,BDI,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Burundi,BDI,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Burundi,BDI,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Burundi,BDI,Successfully treated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Burundi,BDI,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Burundi,BDI,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Burundi,BDI,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Burundi,BDI,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Burundi,BDI,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Burundi,BDI,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Burundi,BDI,Not evaluated,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burundi,BDI,Successfully treated,65.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burundi,BDI,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burundi,BDI,Lost to follow-up,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burundi,BDI,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burundi,BDI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burundi,BDI,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burundi,BDI,Successfully treated,81.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burundi,BDI,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burundi,BDI,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burundi,BDI,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burundi,BDI,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burundi,BDI,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burundi,BDI,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burundi,BDI,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burundi,BDI,Successfully treated,89.4736842105263 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burundi,BDI,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burundi,BDI,Successfully treated,90.2439024390244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burundi,BDI,Died,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burundi,BDI,Lost to follow-up,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burundi,BDI,Successfully treated,96.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burundi,BDI,Died,3.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burundi,BDI,Successfully treated,96.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burundi,BDI,Died,3.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burundi,BDI,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burundi,BDI,Died,6.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burundi,BDI,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burundi,BDI,Successfully treated,92.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burundi,BDI,Died,6.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burundi,BDI,Lost to follow-up,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burundi,BDI,Successfully treated,93.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burundi,BDI,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burundi,BDI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burundi,BDI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burundi,BDI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burundi,BDI,Successfully treated,91.304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burundi,BDI,Died,6.52173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burundi,BDI,Lost to follow-up,2.17391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burundi,BDI,Successfully treated,91.4893617021277 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burundi,BDI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burundi,BDI,Died,6.38297872340426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burundi,BDI,Lost to follow-up,2.12765957446809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Burundi,BDI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cabo Verde,CPV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cabo Verde,CPV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cabo Verde,CPV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cabo Verde,CPV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cabo Verde,CPV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cabo Verde,CPV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cabo Verde,CPV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cabo Verde,CPV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cabo Verde,CPV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cabo Verde,CPV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cabo Verde,CPV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cabo Verde,CPV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cabo Verde,CPV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cabo Verde,CPV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cabo Verde,CPV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cabo Verde,CPV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cabo Verde,CPV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cabo Verde,CPV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cabo Verde,CPV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cabo Verde,CPV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cabo Verde,CPV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cabo Verde,CPV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cabo Verde,CPV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cabo Verde,CPV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cabo Verde,CPV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cabo Verde,CPV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cabo Verde,CPV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cabo Verde,CPV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cabo Verde,CPV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cabo Verde,CPV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cambodia,KHM,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cambodia,KHM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cambodia,KHM,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cambodia,KHM,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cambodia,KHM,Successfully treated,68.2926829268293 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cambodia,KHM,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cambodia,KHM,Died,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cambodia,KHM,Lost to follow-up,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cambodia,KHM,Successfully treated,78.2608695652174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cambodia,KHM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cambodia,KHM,Died,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cambodia,KHM,Lost to follow-up,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cambodia,KHM,Successfully treated,67.741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cambodia,KHM,Treatment failed,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cambodia,KHM,Died,29.0322580645161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cambodia,KHM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cambodia,KHM,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cambodia,KHM,Treatment failed,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cambodia,KHM,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cambodia,KHM,Lost to follow-up,1.78571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cambodia,KHM,Not evaluated,1.78571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cambodia,KHM,Successfully treated,79.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cambodia,KHM,Treatment failed,0.909090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cambodia,KHM,Died,11.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cambodia,KHM,Lost to follow-up,6.36363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cambodia,KHM,Not evaluated,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cambodia,KHM,Successfully treated,75.2066115702479 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cambodia,KHM,Treatment failed,1.65289256198347 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cambodia,KHM,Died,11.5702479338843 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cambodia,KHM,Lost to follow-up,5.78512396694215 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cambodia,KHM,Not evaluated,5.78512396694215 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cambodia,KHM,Successfully treated,76.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cambodia,KHM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cambodia,KHM,Died,17.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cambodia,KHM,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cambodia,KHM,Not evaluated,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cambodia,KHM,Successfully treated,70.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cambodia,KHM,Treatment failed,2.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cambodia,KHM,Died,16.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cambodia,KHM,Lost to follow-up,10.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cambodia,KHM,Successfully treated,64.3564356435644 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cambodia,KHM,Treatment failed,3.96039603960396 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cambodia,KHM,Died,24.7524752475248 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cambodia,KHM,Lost to follow-up,6.93069306930693 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cambodia,KHM,Successfully treated,70.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cambodia,KHM,Treatment failed,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cambodia,KHM,Died,20.7407407407407 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ecuador,ECU,Not evaluated,18.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ecuador,ECU,Successfully treated,48.0916030534351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ecuador,ECU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ecuador,ECU,Died,9.9236641221374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ecuador,ECU,Lost to follow-up,38.1679389312977 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ecuador,ECU,Not evaluated,3.81679389312977 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ecuador,ECU,Successfully treated,54.8387096774194 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ecuador,ECU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ecuador,ECU,Died,8.38709677419355 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ecuador,ECU,Lost to follow-up,34.1935483870968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ecuador,ECU,Not evaluated,2.58064516129032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ecuador,ECU,Successfully treated,39.9159663865546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ecuador,ECU,Treatment failed,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ecuador,ECU,Died,20.1680672268908 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ecuador,ECU,Lost to follow-up,29.8319327731092 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ecuador,ECU,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ecuador,ECU,Successfully treated,53.8745387453875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ecuador,ECU,Treatment failed,2.2140221402214 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ecuador,ECU,Died,10.7011070110701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ecuador,ECU,Lost to follow-up,32.4723247232472 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ecuador,ECU,Not evaluated,0.738007380073801 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ecuador,ECU,Successfully treated,64.9390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ecuador,ECU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ecuador,ECU,Died,10.6707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ecuador,ECU,Lost to follow-up,22.8658536585366 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ecuador,ECU,Not evaluated,1.52439024390244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Egypt,EGY,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Egypt,EGY,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Egypt,EGY,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Egypt,EGY,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Egypt,EGY,Successfully treated,72.093023255814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Egypt,EGY,Treatment failed,5.81395348837209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Egypt,EGY,Died,5.81395348837209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Egypt,EGY,Lost to follow-up,16.2790697674419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Egypt,EGY,Successfully treated,63.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Egypt,EGY,Treatment failed,1.38888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Egypt,EGY,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Egypt,EGY,Lost to follow-up,18.0555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Egypt,EGY,Successfully treated,81.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Egypt,EGY,Treatment failed,2.08333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Egypt,EGY,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Egypt,EGY,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Egypt,EGY,Successfully treated,67.6056338028169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Egypt,EGY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Egypt,EGY,Died,18.3098591549296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Egypt,EGY,Lost to follow-up,14.0845070422535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Egypt,EGY,Successfully treated,63.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Egypt,EGY,Treatment failed,1.92307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Egypt,EGY,Died,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Egypt,EGY,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Egypt,EGY,Successfully treated,56.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Egypt,EGY,Treatment failed,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Egypt,EGY,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Egypt,EGY,Lost to follow-up,21.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Egypt,EGY,Successfully treated,63.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Egypt,EGY,Treatment failed,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Egypt,EGY,Died,14.4736842105263 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Egypt,EGY,Lost to follow-up,19.7368421052632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Egypt,EGY,Successfully treated,65.4205607476636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Egypt,EGY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Egypt,EGY,Died,14.018691588785 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Egypt,EGY,Lost to follow-up,20.5607476635514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Egypt,EGY,Successfully treated,66.2790697674419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Egypt,EGY,Treatment failed,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Egypt,EGY,Died,8.13953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Egypt,EGY,Lost to follow-up,23.2558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Egypt,EGY,Successfully treated,67.2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Egypt,EGY,Treatment failed,0.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Egypt,EGY,Died,16.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Egypt,EGY,Lost to follow-up,15.2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Egypt,EGY,Successfully treated,61.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Egypt,EGY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Egypt,EGY,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Egypt,EGY,Lost to follow-up,28.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Egypt,EGY,Successfully treated,65.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Egypt,EGY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Egypt,EGY,Died,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Egypt,EGY,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Egypt,EGY,Successfully treated,65.0793650793651 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Egypt,EGY,Treatment failed,1.58730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Egypt,EGY,Died,17.4603174603175 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Egypt,EGY,Lost to follow-up,15.8730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Egypt,EGY,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Egypt,EGY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Egypt,EGY,Died,11.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Egypt,EGY,Lost to follow-up,13.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Egypt,EGY,Successfully treated,80.4123711340206 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Egypt,EGY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Egypt,EGY,Died,9.27835051546392 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Egypt,EGY,Lost to follow-up,10.3092783505155 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Egypt,EGY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,El Salvador,SLV,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,El Salvador,SLV,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,El Salvador,SLV,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,El Salvador,SLV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,El Salvador,SLV,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,El Salvador,SLV,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,El Salvador,SLV,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,El Salvador,SLV,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,El Salvador,SLV,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,El Salvador,SLV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,El Salvador,SLV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,El Salvador,SLV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,El Salvador,SLV,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,El Salvador,SLV,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,El Salvador,SLV,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,El Salvador,SLV,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,El Salvador,SLV,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,El Salvador,SLV,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,El Salvador,SLV,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,El Salvador,SLV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,El Salvador,SLV,Successfully treated,81.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,El Salvador,SLV,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,El Salvador,SLV,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,El Salvador,SLV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,El Salvador,SLV,Successfully treated,95.2380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,El Salvador,SLV,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,El Salvador,SLV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,El Salvador,SLV,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,El Salvador,SLV,Died,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,El Salvador,SLV,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,El Salvador,SLV,Successfully treated,90.4761904761905 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,El Salvador,SLV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,El Salvador,SLV,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,El Salvador,SLV,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,El Salvador,SLV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,El Salvador,SLV,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,El Salvador,SLV,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,El Salvador,SLV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Equatorial Guinea,GNQ,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Equatorial Guinea,GNQ,Treatment failed,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Equatorial Guinea,GNQ,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Equatorial Guinea,GNQ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Equatorial Guinea,GNQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Equatorial Guinea,GNQ,Successfully treated,95.4545454545454 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lao People's Democratic Republic,LAO,Died,20.5128205128205 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lao People's Democratic Republic,LAO,Lost to follow-up,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lao People's Democratic Republic,LAO,Successfully treated,73.1707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lao People's Democratic Republic,LAO,Died,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lao People's Democratic Republic,LAO,Lost to follow-up,12.1951219512195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lao People's Democratic Republic,LAO,Successfully treated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lao People's Democratic Republic,LAO,Died,12.8205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lao People's Democratic Republic,LAO,Lost to follow-up,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lao People's Democratic Republic,LAO,Successfully treated,75.609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lao People's Democratic Republic,LAO,Died,12.1951219512195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lao People's Democratic Republic,LAO,Lost to follow-up,12.1951219512195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Latvia,LVA,Successfully treated,61.2676056338028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Latvia,LVA,Treatment failed,4.22535211267606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Latvia,LVA,Died,1.40845070422535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Latvia,LVA,Lost to follow-up,10.5633802816901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Latvia,LVA,Not evaluated,22.5352112676056 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Latvia,LVA,Successfully treated,60.6060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Latvia,LVA,Treatment failed,5.05050505050505 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Latvia,LVA,Died,15.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Latvia,LVA,Lost to follow-up,14.1414141414141 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Latvia,LVA,Not evaluated,5.05050505050505 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Latvia,LVA,Successfully treated,61.71875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Latvia,LVA,Treatment failed,4.6875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Latvia,LVA,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Latvia,LVA,Lost to follow-up,10.15625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Latvia,LVA,Not evaluated,4.6875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Latvia,LVA,Successfully treated,58.7786259541985 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Latvia,LVA,Treatment failed,4.58015267175573 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Latvia,LVA,Died,15.2671755725191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Latvia,LVA,Lost to follow-up,14.5038167938931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Latvia,LVA,Not evaluated,6.87022900763359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Latvia,LVA,Successfully treated,65.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Latvia,LVA,Treatment failed,5.68181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Latvia,LVA,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Latvia,LVA,Lost to follow-up,11.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Latvia,LVA,Not evaluated,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Latvia,LVA,Successfully treated,55.421686746988 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Latvia,LVA,Treatment failed,4.81927710843374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Latvia,LVA,Died,15.6626506024096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Latvia,LVA,Lost to follow-up,13.2530120481928 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Latvia,LVA,Not evaluated,10.8433734939759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Latvia,LVA,Successfully treated,63.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Latvia,LVA,Treatment failed,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Latvia,LVA,Died,17.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Latvia,LVA,Lost to follow-up,14.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Latvia,LVA,Not evaluated,1.11111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Latvia,LVA,Successfully treated,67.1875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Latvia,LVA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Latvia,LVA,Died,14.0625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Latvia,LVA,Lost to follow-up,15.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Latvia,LVA,Not evaluated,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Latvia,LVA,Successfully treated,72.4137931034483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Latvia,LVA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Latvia,LVA,Died,5.17241379310345 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Latvia,LVA,Lost to follow-up,20.6896551724138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Latvia,LVA,Not evaluated,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Latvia,LVA,Successfully treated,65.9574468085106 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Latvia,LVA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Latvia,LVA,Died,10.6382978723404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Latvia,LVA,Lost to follow-up,21.2765957446809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Latvia,LVA,Not evaluated,2.12765957446809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Latvia,LVA,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Latvia,LVA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Latvia,LVA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Latvia,LVA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Latvia,LVA,Not evaluated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lebanon,LBN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lebanon,LBN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lebanon,LBN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lebanon,LBN,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lebanon,LBN,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lebanon,LBN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lebanon,LBN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lebanon,LBN,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lebanon,LBN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lebanon,LBN,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lebanon,LBN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lebanon,LBN,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lebanon,LBN,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lebanon,LBN,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lebanon,LBN,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lebanon,LBN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lebanon,LBN,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lebanon,LBN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lebanon,LBN,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lebanon,LBN,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lebanon,LBN,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lebanon,LBN,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lebanon,LBN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lebanon,LBN,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lebanon,LBN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lebanon,LBN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lebanon,LBN,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lebanon,LBN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lebanon,LBN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lebanon,LBN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lebanon,LBN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lebanon,LBN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lebanon,LBN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lebanon,LBN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lebanon,LBN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lebanon,LBN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lebanon,LBN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lebanon,LBN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lebanon,LBN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lesotho,LSO,Successfully treated,60.2409638554217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lesotho,LSO,Died,33.7349397590361 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lesotho,LSO,Lost to follow-up,1.20481927710843 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lesotho,LSO,Not evaluated,4.81927710843374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lesotho,LSO,Successfully treated,64.5833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lesotho,LSO,Treatment failed,0.694444444444445 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lesotho,LSO,Died,34.0277777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lesotho,LSO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lesotho,LSO,Not evaluated,0.694444444444445 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lesotho,LSO,Successfully treated,63.3928571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lesotho,LSO,Treatment failed,0.446428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lesotho,LSO,Died,32.5892857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lesotho,LSO,Lost to follow-up,0.892857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lesotho,LSO,Not evaluated,2.67857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lesotho,LSO,Successfully treated,67.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lesotho,LSO,Died,22.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lesotho,LSO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lesotho,LSO,Not evaluated,9.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lesotho,LSO,Successfully treated,60.6896551724138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lesotho,LSO,Treatment failed,0.689655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lesotho,LSO,Died,35.1724137931035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lesotho,LSO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lesotho,LSO,Not evaluated,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lesotho,LSO,Successfully treated,63.6986301369863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lesotho,LSO,Died,30.1369863013699 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lesotho,LSO,Lost to follow-up,0.684931506849315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lesotho,LSO,Not evaluated,5.47945205479452 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lesotho,LSO,Successfully treated,62.5766871165644 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lesotho,LSO,Treatment failed,1.84049079754601 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lesotho,LSO,Died,33.1288343558282 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lesotho,LSO,Lost to follow-up,0.613496932515337 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lesotho,LSO,Not evaluated,1.84049079754601 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lesotho,LSO,Successfully treated,64.4736842105263 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lesotho,LSO,Died,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lesotho,LSO,Lost to follow-up,1.31578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lesotho,LSO,Not evaluated,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lesotho,LSO,Successfully treated,66.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lesotho,LSO,Died,28.0952380952381 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lesotho,LSO,Lost to follow-up,0.476190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nepal,NPL,Lost to follow-up,4.98220640569395 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nepal,NPL,Not evaluated,3.20284697508897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nepal,NPL,Successfully treated,77.020202020202 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nepal,NPL,Treatment failed,3.78787878787879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nepal,NPL,Died,8.58585858585859 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nepal,NPL,Lost to follow-up,10.1010101010101 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Nepal,NPL,Not evaluated,0.505050505050505 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nepal,NPL,Successfully treated,77.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nepal,NPL,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nepal,NPL,Died,13.2113821138211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nepal,NPL,Lost to follow-up,5.89430894308943 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Nepal,NPL,Not evaluated,1.01626016260163 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Netherlands (Kingdom of the),NLD,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Netherlands (Kingdom of the),NLD,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Netherlands (Kingdom of the),NLD,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Netherlands (Kingdom of the),NLD,Not evaluated,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Netherlands (Kingdom of the),NLD,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Netherlands (Kingdom of the),NLD,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Netherlands (Kingdom of the),NLD,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Netherlands (Kingdom of the),NLD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Netherlands (Kingdom of the),NLD,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Netherlands (Kingdom of the),NLD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Netherlands (Kingdom of the),NLD,Successfully treated,93.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Netherlands (Kingdom of the),NLD,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Netherlands (Kingdom of the),NLD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Netherlands (Kingdom of the),NLD,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Netherlands (Kingdom of the),NLD,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Netherlands (Kingdom of the),NLD,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Netherlands (Kingdom of the),NLD,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Netherlands (Kingdom of the),NLD,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Netherlands (Kingdom of the),NLD,Not evaluated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Netherlands (Kingdom of the),NLD,Successfully treated,64.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Netherlands (Kingdom of the),NLD,Lost to follow-up,17.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Netherlands (Kingdom of the),NLD,Not evaluated,17.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Netherlands (Kingdom of the),NLD,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Netherlands (Kingdom of the),NLD,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Netherlands (Kingdom of the),NLD,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Netherlands (Kingdom of the),NLD,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Netherlands (Kingdom of the),NLD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Netherlands (Kingdom of the),NLD,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Netherlands (Kingdom of the),NLD,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Netherlands (Kingdom of the),NLD,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Netherlands (Kingdom of the),NLD,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Netherlands (Kingdom of the),NLD,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Netherlands (Kingdom of the),NLD,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Netherlands (Kingdom of the),NLD,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Netherlands (Kingdom of the),NLD,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Netherlands (Kingdom of the),NLD,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Netherlands (Kingdom of the),NLD,Not evaluated,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Netherlands (Kingdom of the),NLD,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Netherlands (Kingdom of the),NLD,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Netherlands (Kingdom of the),NLD,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Netherlands (Kingdom of the),NLD,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Netherlands (Kingdom of the),NLD,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Netherlands (Kingdom of the),NLD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Netherlands (Kingdom of the),NLD,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Netherlands (Kingdom of the),NLD,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Netherlands (Kingdom of the),NLD,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Netherlands (Kingdom of the),NLD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Netherlands (Kingdom of the),NLD,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Netherlands (Kingdom of the),NLD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Netherlands (Kingdom of the),NLD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Netherlands (Kingdom of the),NLD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Netherlands (Kingdom of the),NLD,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,New Zealand,NZL,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,New Zealand,NZL,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,New Zealand,NZL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,New Zealand,NZL,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,New Zealand,NZL,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,New Zealand,NZL,Not evaluated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,New Zealand,NZL,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,New Zealand,NZL,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,New Zealand,NZL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,New Zealand,NZL,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,New Zealand,NZL,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,New Zealand,NZL,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,New Zealand,NZL,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,New Zealand,NZL,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,New Zealand,NZL,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,New Zealand,NZL,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,New Zealand,NZL,Not evaluated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,New Zealand,NZL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,New Zealand,NZL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,New Zealand,NZL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,New Zealand,NZL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,New Zealand,NZL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nicaragua,NIC,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nicaragua,NIC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nicaragua,NIC,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nicaragua,NIC,Not evaluated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nicaragua,NIC,Successfully treated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nicaragua,NIC,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nicaragua,NIC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nicaragua,NIC,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nicaragua,NIC,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nicaragua,NIC,Successfully treated,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nicaragua,NIC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nicaragua,NIC,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nicaragua,NIC,Lost to follow-up,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nicaragua,NIC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nicaragua,NIC,Successfully treated,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Paraguay,PRY,Successfully treated,53.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Paraguay,PRY,Died,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Paraguay,PRY,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Paraguay,PRY,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Paraguay,PRY,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Paraguay,PRY,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Paraguay,PRY,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Paraguay,PRY,Treatment failed,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Paraguay,PRY,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Paraguay,PRY,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Paraguay,PRY,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Paraguay,PRY,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Paraguay,PRY,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Paraguay,PRY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Paraguay,PRY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Paraguay,PRY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Paraguay,PRY,Successfully treated,65.2173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Paraguay,PRY,Died,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Paraguay,PRY,Lost to follow-up,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Paraguay,PRY,Not evaluated,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Paraguay,PRY,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Paraguay,PRY,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Paraguay,PRY,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Peru,PER,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Peru,PER,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Peru,PER,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Peru,PER,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Peru,PER,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Peru,PER,Successfully treated,22.9850746268657 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Peru,PER,Treatment failed,3.43283582089552 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Peru,PER,Died,6.86567164179105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Peru,PER,Lost to follow-up,11.3432835820896 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Peru,PER,Not evaluated,55.3731343283582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Peru,PER,Successfully treated,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Peru,PER,Treatment failed,4.8951048951049 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Peru,PER,Died,5.73426573426573 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Peru,PER,Lost to follow-up,12.1678321678322 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Peru,PER,Not evaluated,38.7412587412587 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Peru,PER,Successfully treated,39.332748024583 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Peru,PER,Treatment failed,6.05794556628622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Peru,PER,Died,5.09218612818262 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Peru,PER,Lost to follow-up,14.0474100087796 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Peru,PER,Not evaluated,35.4697102721686 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Peru,PER,Successfully treated,60.0378787878788 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Peru,PER,Treatment failed,5.49242424242424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Peru,PER,Died,6.34469696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Peru,PER,Lost to follow-up,18.2765151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Peru,PER,Not evaluated,9.84848484848485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Peru,PER,Successfully treated,53.5405872193437 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Peru,PER,Treatment failed,4.14507772020725 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Peru,PER,Died,6.82210708117444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Peru,PER,Lost to follow-up,25.9067357512953 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Peru,PER,Not evaluated,9.58549222797927 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Peru,PER,Successfully treated,59.9821746880571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Peru,PER,Treatment failed,2.85204991087344 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Peru,PER,Died,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Peru,PER,Lost to follow-up,29.6791443850267 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Peru,PER,Not evaluated,1.42602495543672 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Peru,PER,Successfully treated,55.1149881046788 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Peru,PER,Treatment failed,4.59952418715305 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Peru,PER,Died,5.55114988104679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Peru,PER,Lost to follow-up,30.689928628073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Peru,PER,Not evaluated,4.04440919904837 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Peru,PER,Successfully treated,51.5937731653076 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Peru,PER,Treatment failed,4.4477390659748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Peru,PER,Died,3.48406226834692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Peru,PER,Lost to follow-up,32.468495181616 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Peru,PER,Not evaluated,8.00593031875463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Peru,PER,Successfully treated,55.0465282748747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Peru,PER,Treatment failed,4.86757337151038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Peru,PER,Died,5.72655690765927 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Peru,PER,Lost to follow-up,32.2834645669291 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Peru,PER,Not evaluated,2.07587687902649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Peru,PER,Successfully treated,59.4807238394965 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Peru,PER,Treatment failed,3.933910306845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Peru,PER,Died,4.56333595594021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Peru,PER,Lost to follow-up,30.7631785995279 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Peru,PER,Not evaluated,1.2588512981904 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Peru,PER,Successfully treated,61.6757176105508 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Peru,PER,Treatment failed,3.72381691233514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Peru,PER,Died,5.19782777346781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Peru,PER,Lost to follow-up,25.3685027152832 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Peru,PER,Not evaluated,4.03413498836307 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Peru,PER,Successfully treated,61.7597292724196 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Peru,PER,Treatment failed,1.29723632261703 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Peru,PER,Died,4.23011844331641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Peru,PER,Lost to follow-up,23.4066553863508 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Peru,PER,Not evaluated,9.30626057529611 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Peru,PER,Successfully treated,61.9666048237477 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Peru,PER,Treatment failed,1.91713048855906 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Peru,PER,Died,6.7408781694496 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Peru,PER,Lost to follow-up,26.4069264069264 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Peru,PER,Not evaluated,2.96846011131725 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Peru,PER,Successfully treated,65.4320987654321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Peru,PER,Treatment failed,1.81554103122731 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Peru,PER,Died,6.68119099491649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Peru,PER,Lost to follow-up,23.8198983297023 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Peru,PER,Not evaluated,2.25127087872186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Peru,PER,Successfully treated,64.0701754385965 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Peru,PER,Treatment failed,3.64912280701754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Peru,PER,Died,6.24561403508772 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Peru,PER,Lost to follow-up,25.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Peru,PER,Not evaluated,0.631578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Peru,PER,Successfully treated,56.5093803297328 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Peru,PER,Treatment failed,5.57134735645253 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Peru,PER,Died,8.07276861853326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Peru,PER,Lost to follow-up,28.3115406480955 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Peru,PER,Not evaluated,1.5349630471859 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Philippines,PHL,Successfully treated,63.1756756756757 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Philippines,PHL,Treatment failed,3.71621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Philippines,PHL,Died,10.8108108108108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Philippines,PHL,Lost to follow-up,20.9459459459459 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Philippines,PHL,Not evaluated,1.35135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Philippines,PHL,Successfully treated,53.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Philippines,PHL,Treatment failed,0.769230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Philippines,PHL,Died,11.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Philippines,PHL,Lost to follow-up,23.6538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Philippines,PHL,Not evaluated,10.1923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Philippines,PHL,Successfully treated,53.8071065989848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Philippines,PHL,Treatment failed,1.52284263959391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Philippines,PHL,Died,9.39086294416244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Philippines,PHL,Lost to follow-up,32.4873096446701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Philippines,PHL,Not evaluated,2.79187817258883 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Philippines,PHL,Successfully treated,41.6347381864623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Philippines,PHL,Treatment failed,1.53256704980843 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Philippines,PHL,Died,13.7931034482759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Philippines,PHL,Lost to follow-up,35.8876117496807 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Philippines,PHL,Not evaluated,7.15197956577267 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Philippines,PHL,Successfully treated,40.9298780487805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Philippines,PHL,Treatment failed,2.13414634146341 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Philippines,PHL,Died,11.6615853658537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Philippines,PHL,Lost to follow-up,39.4817073170732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Philippines,PHL,Not evaluated,5.79268292682927 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Philippines,PHL,Successfully treated,43.2703003337041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Philippines,PHL,Treatment failed,1.16796440489433 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Philippines,PHL,Died,13.4037819799778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Philippines,PHL,Lost to follow-up,34.6496106785317 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Philippines,PHL,Not evaluated,7.5083426028921 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Philippines,PHL,Successfully treated,49.0853658536585 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Philippines,PHL,Treatment failed,1.3719512195122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Philippines,PHL,Died,11.890243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Philippines,PHL,Lost to follow-up,29.1666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Philippines,PHL,Not evaluated,8.48577235772358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Philippines,PHL,Successfully treated,45.5421686746988 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Philippines,PHL,Treatment failed,1.32530120481928 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Philippines,PHL,Died,9.47791164658635 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Philippines,PHL,Lost to follow-up,32.6506024096386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Philippines,PHL,Not evaluated,11.004016064257 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Philippines,PHL,Successfully treated,54.4533887302 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Philippines,PHL,Treatment failed,1.3502986237341 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Philippines,PHL,Died,9.86756686574916 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Philippines,PHL,Lost to follow-up,30.4336535964685 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Philippines,PHL,Not evaluated,3.89509218384835 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Philippines,PHL,Successfully treated,58.351409978308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Philippines,PHL,Treatment failed,0.966278840465391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Philippines,PHL,Died,8.73594951686058 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Philippines,PHL,Lost to follow-up,31.8083218300138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Philippines,PHL,Not evaluated,0.138039834352199 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Philippines,PHL,Successfully treated,57.7015310828261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Philippines,PHL,Treatment failed,0.959232613908873 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Philippines,PHL,Died,8.24571112340897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Philippines,PHL,Lost to follow-up,32.7799299022321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Philippines,PHL,Not evaluated,0.313595277624055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Philippines,PHL,Successfully treated,67.3331074212132 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Philippines,PHL,Treatment failed,1.76211453744493 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Philippines,PHL,Died,9.65774313791935 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Philippines,PHL,Lost to follow-up,20.4676380887835 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Philippines,PHL,Not evaluated,0.779396814639105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Philippines,PHL,Successfully treated,73.4976068073037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Philippines,PHL,Treatment failed,2.62364828931041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Philippines,PHL,Died,11.3809608225492 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Philippines,PHL,Lost to follow-up,12.2673284878568 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Philippines,PHL,Not evaluated,0.230455592979968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Philippines,PHL,Successfully treated,79.0755777638976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Philippines,PHL,Treatment failed,3.08140745367479 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Philippines,PHL,Died,11.0139496148241 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Philippines,PHL,Lost to follow-up,6.72496356443889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Philippines,PHL,Not evaluated,0.104101603164689 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Philippines,PHL,Successfully treated,79.0954600379769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sri Lanka,LKA,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sri Lanka,LKA,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sri Lanka,LKA,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sri Lanka,LKA,Not evaluated,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sri Lanka,LKA,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sri Lanka,LKA,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sri Lanka,LKA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sri Lanka,LKA,Successfully treated,68.421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sri Lanka,LKA,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sri Lanka,LKA,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sri Lanka,LKA,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sri Lanka,LKA,Died,27.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sri Lanka,LKA,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sri Lanka,LKA,Not evaluated,27.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sri Lanka,LKA,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sri Lanka,LKA,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sri Lanka,LKA,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sri Lanka,LKA,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sri Lanka,LKA,Successfully treated,78.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sri Lanka,LKA,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sri Lanka,LKA,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sudan,SDN,Successfully treated,35.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sudan,SDN,Died,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sudan,SDN,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sudan,SDN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sudan,SDN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sudan,SDN,Died,22.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sudan,SDN,Lost to follow-up,14.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sudan,SDN,Not evaluated,14.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sudan,SDN,Successfully treated,53.448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sudan,SDN,Died,25.8620689655172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sudan,SDN,Lost to follow-up,20.6896551724138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sudan,SDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sudan,SDN,Successfully treated,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sudan,SDN,Died,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sudan,SDN,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sudan,SDN,Not evaluated,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sudan,SDN,Successfully treated,64.3835616438356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sudan,SDN,Treatment failed,2.73972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sudan,SDN,Died,21.9178082191781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sudan,SDN,Lost to follow-up,8.21917808219178 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sudan,SDN,Not evaluated,2.73972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sudan,SDN,Successfully treated,74.3243243243243 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sudan,SDN,Died,12.1621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sudan,SDN,Lost to follow-up,8.10810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sudan,SDN,Not evaluated,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sudan,SDN,Successfully treated,20.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sudan,SDN,Treatment failed,51.3888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sudan,SDN,Died,15.2777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sudan,SDN,Lost to follow-up,9.72222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sudan,SDN,Not evaluated,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sudan,SDN,Successfully treated,84.2105263157895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sudan,SDN,Died,8.27067669172932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sudan,SDN,Lost to follow-up,6.01503759398496 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sudan,SDN,Not evaluated,1.50375939849624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sudan,SDN,Successfully treated,84.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sudan,SDN,Died,10.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sudan,SDN,Lost to follow-up,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sudan,SDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sudan,SDN,Successfully treated,82.5471698113208 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sudan,SDN,Treatment failed,0.471698113207547 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sudan,SDN,Died,8.9622641509434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sudan,SDN,Lost to follow-up,7.07547169811321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sudan,SDN,Not evaluated,0.943396226415094 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sudan,SDN,Successfully treated,85.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sudan,SDN,Died,7.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sudan,SDN,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sudan,SDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sudan,SDN,Successfully treated,78.5046728971963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sudan,SDN,Died,12.6168224299065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sudan,SDN,Lost to follow-up,8.8785046728972 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sudan,SDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sudan,SDN,Successfully treated,48.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sudan,SDN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sudan,SDN,Died,17.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sudan,SDN,Lost to follow-up,32.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sudan,SDN,Not evaluated,1.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Suriname,SUR,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Suriname,SUR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Suriname,SUR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Suriname,SUR,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Suriname,SUR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Sweden,SWE,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Sweden,SWE,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Sweden,SWE,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Sweden,SWE,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sweden,SWE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sweden,SWE,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sweden,SWE,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sweden,SWE,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sweden,SWE,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sweden,SWE,Successfully treated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sweden,SWE,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sweden,SWE,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sweden,SWE,Successfully treated,94.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sweden,SWE,Died,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sweden,SWE,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sweden,SWE,Treatment failed,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sweden,SWE,Not evaluated,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sweden,SWE,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sweden,SWE,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sweden,SWE,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sweden,SWE,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sweden,SWE,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sweden,SWE,Successfully treated,93.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sweden,SWE,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sweden,SWE,Successfully treated,96.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sweden,SWE,Not evaluated,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sweden,SWE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sweden,SWE,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sweden,SWE,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sweden,SWE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sweden,SWE,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sweden,SWE,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sweden,SWE,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sweden,SWE,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sweden,SWE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Sweden,SWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sweden,SWE,Successfully treated,86.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sweden,SWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sweden,SWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sweden,SWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sweden,SWE,Not evaluated,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Switzerland,CHE,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Switzerland,CHE,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Switzerland,CHE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Switzerland,CHE,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Switzerland,CHE,Successfully treated,43.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Venezuela (Bolivarian Republic of),VEN,Successfully treated,68.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Venezuela (Bolivarian Republic of),VEN,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Venezuela (Bolivarian Republic of),VEN,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Venezuela (Bolivarian Republic of),VEN,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Viet Nam,VNM,Successfully treated,73.2673267326733 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Viet Nam,VNM,Treatment failed,6.93069306930693 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Viet Nam,VNM,Died,7.92079207920792 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Viet Nam,VNM,Lost to follow-up,8.91089108910891 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Viet Nam,VNM,Not evaluated,2.97029702970297 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Viet Nam,VNM,Successfully treated,78.3505154639175 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Viet Nam,VNM,Treatment failed,7.21649484536083 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Viet Nam,VNM,Died,8.24742268041237 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Viet Nam,VNM,Lost to follow-up,6.18556701030928 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Viet Nam,VNM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Viet Nam,VNM,Successfully treated,72.020725388601 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Viet Nam,VNM,Treatment failed,7.426597582038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Viet Nam,VNM,Died,6.90846286701209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Viet Nam,VNM,Lost to follow-up,12.7806563039724 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Viet Nam,VNM,Not evaluated,0.863557858376511 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Viet Nam,VNM,Successfully treated,70.54698457223 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Viet Nam,VNM,Treatment failed,5.61009817671809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Viet Nam,VNM,Died,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Viet Nam,VNM,Lost to follow-up,12.6227208976157 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Viet Nam,VNM,Not evaluated,1.54277699859748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Viet Nam,VNM,Successfully treated,68.9259645464025 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Viet Nam,VNM,Treatment failed,6.67361835245047 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Viet Nam,VNM,Died,9.07194994786236 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Viet Nam,VNM,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Viet Nam,VNM,Not evaluated,1.04275286757039 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Viet Nam,VNM,Successfully treated,75.130890052356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Viet Nam,VNM,Treatment failed,4.51570680628272 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Viet Nam,VNM,Died,10.8638743455497 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Viet Nam,VNM,Lost to follow-up,9.42408376963351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Viet Nam,VNM,Not evaluated,0.0654450261780105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Viet Nam,VNM,Successfully treated,74.4743276283619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Viet Nam,VNM,Treatment failed,4.05867970660147 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Viet Nam,VNM,Died,9.48655256723716 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Viet Nam,VNM,Lost to follow-up,10.5623471882641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Viet Nam,VNM,Not evaluated,1.41809290953545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Viet Nam,VNM,Successfully treated,67.8367346938776 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Viet Nam,VNM,Treatment failed,4.3265306122449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Viet Nam,VNM,Died,9.83673469387755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Viet Nam,VNM,Lost to follow-up,14.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Viet Nam,VNM,Not evaluated,3.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Viet Nam,VNM,Successfully treated,68.5233644859813 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Viet Nam,VNM,Treatment failed,3.96261682242991 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Viet Nam,VNM,Died,8.89719626168224 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Viet Nam,VNM,Lost to follow-up,14.9906542056075 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Viet Nam,VNM,Not evaluated,3.62616822429907 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Viet Nam,VNM,Successfully treated,71.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Viet Nam,VNM,Treatment failed,4.99145299145299 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Viet Nam,VNM,Died,7.00854700854701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Viet Nam,VNM,Lost to follow-up,12.8205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Viet Nam,VNM,Not evaluated,3.48717948717949 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Viet Nam,VNM,Successfully treated,74.4045622274405 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Viet Nam,VNM,Treatment failed,5.13250587051325 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Viet Nam,VNM,Died,6.10533378061053 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Viet Nam,VNM,Lost to follow-up,11.1707480711171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Viet Nam,VNM,Not evaluated,3.18685005031869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Viet Nam,VNM,Successfully treated,76.1936560934892 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Viet Nam,VNM,Treatment failed,4.10684474123539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Viet Nam,VNM,Died,6.54424040066778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Viet Nam,VNM,Lost to follow-up,9.61602671118531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Viet Nam,VNM,Not evaluated,3.53923205342237 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Viet Nam,VNM,Successfully treated,72.4299065420561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Viet Nam,VNM,Treatment failed,3.99320305862362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Viet Nam,VNM,Died,7.51911639762107 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Viet Nam,VNM,Lost to follow-up,11.5548003398471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Viet Nam,VNM,Not evaluated,4.50297366185217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Viet Nam,VNM,Successfully treated,71.3726884779516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Viet Nam,VNM,Treatment failed,2.77382645803698 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Viet Nam,VNM,Died,6.86344238975818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Viet Nam,VNM,Lost to follow-up,12.8022759601707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Viet Nam,VNM,Not evaluated,6.1877667140825 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Yemen,YEM,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Yemen,YEM,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Yemen,YEM,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Yemen,YEM,Successfully treated,70.7317073170732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Yemen,YEM,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Yemen,YEM,Died,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Yemen,YEM,Lost to follow-up,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Yemen,YEM,Not evaluated,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Yemen,YEM,Successfully treated,68.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Yemen,YEM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Yemen,YEM,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Yemen,YEM,Lost to follow-up,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Yemen,YEM,Successfully treated,84.8484848484848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Yemen,YEM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Yemen,YEM,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Yemen,YEM,Lost to follow-up,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Yemen,YEM,Successfully treated,76.7441860465116 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Yemen,YEM,Treatment failed,4.65116279069768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Yemen,YEM,Died,11.6279069767442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Yemen,YEM,Lost to follow-up,6.97674418604651 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Yemen,YEM,Successfully treated,67.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Yemen,YEM,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Yemen,YEM,Died,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Yemen,YEM,Lost to follow-up,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Yemen,YEM,Not evaluated,2.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Yemen,YEM,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Yemen,YEM,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Yemen,YEM,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Yemen,YEM,Lost to follow-up,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Yemen,YEM,Successfully treated,67.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Yemen,YEM,Treatment failed,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Yemen,YEM,Died,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Yemen,YEM,Lost to follow-up,14.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Yemen,YEM,Not evaluated,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Yemen,YEM,Successfully treated,77.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Yemen,YEM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Yemen,YEM,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Yemen,YEM,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Yemen,YEM,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Yemen,YEM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Yemen,YEM,Died,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Yemen,YEM,Lost to follow-up,16.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Yemen,YEM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zambia,ZMB,Successfully treated,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zambia,ZMB,Treatment failed,5.35714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zambia,ZMB,Died,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zambia,ZMB,Lost to follow-up,5.35714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zambia,ZMB,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zambia,ZMB,Successfully treated,29.1139240506329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zambia,ZMB,Treatment failed,2.53164556962025 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zambia,ZMB,Died,2.53164556962025 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zambia,ZMB,Lost to follow-up,3.79746835443038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zambia,ZMB,Not evaluated,62.0253164556962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zambia,ZMB,Successfully treated,27.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zambia,ZMB,Treatment failed,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zambia,ZMB,Died,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zambia,ZMB,Lost to follow-up,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zambia,ZMB,Not evaluated,64.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zambia,ZMB,Successfully treated,32.7586206896552 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zambia,ZMB,Treatment failed,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zambia,ZMB,Died,12.0689655172414 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zambia,ZMB,Lost to follow-up,46.551724137931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zambia,ZMB,Not evaluated,5.17241379310345 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zambia,ZMB,Successfully treated,51.4705882352941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zambia,ZMB,Treatment failed,1.47058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zambia,ZMB,Died,16.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zambia,ZMB,Lost to follow-up,29.4117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zambia,ZMB,Not evaluated,1.47058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zambia,ZMB,Successfully treated,59.5959595959596 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zambia,ZMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zambia,ZMB,Died,31.3131313131313 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zambia,ZMB,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zambia,ZMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zambia,ZMB,Successfully treated,70.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zambia,ZMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zambia,ZMB,Died,16.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zambia,ZMB,Lost to follow-up,9.55882352941176 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zambia,ZMB,Not evaluated,3.67647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zambia,ZMB,Successfully treated,75.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zambia,ZMB,Treatment failed,0.740740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zambia,ZMB,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zambia,ZMB,Lost to follow-up,10.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zambia,ZMB,Not evaluated,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zambia,ZMB,Successfully treated,77.755905511811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zambia,ZMB,Treatment failed,0.196850393700787 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zambia,ZMB,Died,10.8267716535433 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zambia,ZMB,Lost to follow-up,7.8740157480315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zambia,ZMB,Not evaluated,3.34645669291339 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zambia,ZMB,Successfully treated,74.8987854251012 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zambia,ZMB,Treatment failed,12.3481781376518 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zambia,ZMB,Died,1.01214574898785 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zambia,ZMB,Lost to follow-up,8.70445344129555 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zambia,ZMB,Not evaluated,3.03643724696356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zambia,ZMB,Successfully treated,78.9366053169734 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zambia,ZMB,Treatment failed,2.45398773006135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zambia,ZMB,Died,8.99795501022495 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zambia,ZMB,Lost to follow-up,6.74846625766871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zambia,ZMB,Not evaluated,2.86298568507157 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zambia,ZMB,Successfully treated,80.2816901408451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zambia,ZMB,Treatment failed,1.17370892018779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zambia,ZMB,Died,12.2065727699531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zambia,ZMB,Lost to follow-up,4.46009389671362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zambia,ZMB,Not evaluated,1.87793427230047 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zambia,ZMB,Successfully treated,80.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zambia,ZMB,Treatment failed,0.277777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zambia,ZMB,Died,11.9444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zambia,ZMB,Lost to follow-up,4.44444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Benin,BEN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Benin,BEN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Benin,BEN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Benin,BEN,Successfully treated,92.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Benin,BEN,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Benin,BEN,Successfully treated,84.2105263157895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Benin,BEN,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Benin,BEN,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Benin,BEN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Benin,BEN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Benin,BEN,Successfully treated,81.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Benin,BEN,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Benin,BEN,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Benin,BEN,Successfully treated,70.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Benin,BEN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Benin,BEN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Benin,BEN,Successfully treated,70.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Benin,BEN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Benin,BEN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Benin,BEN,Successfully treated,82.6086956521739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Benin,BEN,Treatment failed,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Benin,BEN,Died,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Benin,BEN,Lost to follow-up,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Benin,BEN,Successfully treated,82.6086956521739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Benin,BEN,Died,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Benin,BEN,Lost to follow-up,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Benin,BEN,Not evaluated,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Benin,BEN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Benin,BEN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Benin,BEN,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Benin,BEN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Benin,BEN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Benin,BEN,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bermuda,BMU,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bermuda,BMU,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bermuda,BMU,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bermuda,BMU,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bermuda,BMU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bhutan,BTN,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bhutan,BTN,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bhutan,BTN,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bhutan,BTN,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bhutan,BTN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bhutan,BTN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bhutan,BTN,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bhutan,BTN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bhutan,BTN,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bhutan,BTN,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bhutan,BTN,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bhutan,BTN,Successfully treated,82.3529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bhutan,BTN,Lost to follow-up,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bhutan,BTN,Not evaluated,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bhutan,BTN,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bhutan,BTN,Treatment failed,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bhutan,BTN,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bhutan,BTN,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bhutan,BTN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bhutan,BTN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bhutan,BTN,Successfully treated,91.8918918918919 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bhutan,BTN,Died,8.10810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bhutan,BTN,Successfully treated,90.1639344262295 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bhutan,BTN,Died,6.55737704918033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bhutan,BTN,Lost to follow-up,3.27868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bhutan,BTN,Successfully treated,91.4893617021277 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bhutan,BTN,Treatment failed,2.12765957446809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bhutan,BTN,Died,6.38297872340426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bhutan,BTN,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bhutan,BTN,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bhutan,BTN,Died,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bhutan,BTN,Lost to follow-up,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bhutan,BTN,Successfully treated,98.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bhutan,BTN,Died,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bhutan,BTN,Successfully treated,93.6507936507937 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bhutan,BTN,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bhutan,BTN,Lost to follow-up,1.58730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bhutan,BTN,Successfully treated,97.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bhutan,BTN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bhutan,BTN,Lost to follow-up,1.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bhutan,BTN,Not evaluated,1.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bhutan,BTN,Successfully treated,92.3076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bhutan,BTN,Died,4.61538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bhutan,BTN,Not evaluated,3.07692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bhutan,BTN,Successfully treated,96.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bhutan,BTN,Died,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bhutan,BTN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bhutan,BTN,Successfully treated,91.3793103448276 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bhutan,BTN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bhutan,BTN,Died,5.17241379310345 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bhutan,BTN,Lost to follow-up,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bhutan,BTN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bolivia (Plurinational State of),BOL,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bolivia (Plurinational State of),BOL,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bolivia (Plurinational State of),BOL,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bolivia (Plurinational State of),BOL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bolivia (Plurinational State of),BOL,Successfully treated,61.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bolivia (Plurinational State of),BOL,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bolivia (Plurinational State of),BOL,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bolivia (Plurinational State of),BOL,Lost to follow-up,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bolivia (Plurinational State of),BOL,Successfully treated,75.6756756756757 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bolivia (Plurinational State of),BOL,Treatment failed,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bolivia (Plurinational State of),BOL,Died,8.10810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bolivia (Plurinational State of),BOL,Lost to follow-up,10.8108108108108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bolivia (Plurinational State of),BOL,Successfully treated,53.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bolivia (Plurinational State of),BOL,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bolivia (Plurinational State of),BOL,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bolivia (Plurinational State of),BOL,Lost to follow-up,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bolivia (Plurinational State of),BOL,Successfully treated,63.4146341463415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bolivia (Plurinational State of),BOL,Treatment failed,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bolivia (Plurinational State of),BOL,Died,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bolivia (Plurinational State of),BOL,Lost to follow-up,24.390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bolivia (Plurinational State of),BOL,Successfully treated,67.4418604651163 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bolivia (Plurinational State of),BOL,Treatment failed,4.65116279069768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bolivia (Plurinational State of),BOL,Died,13.953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bolivia (Plurinational State of),BOL,Lost to follow-up,13.953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bolivia (Plurinational State of),BOL,Successfully treated,61.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bolivia (Plurinational State of),BOL,Treatment failed,6.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bolivia (Plurinational State of),BOL,Died,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bolivia (Plurinational State of),BOL,Lost to follow-up,15.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bolivia (Plurinational State of),BOL,Not evaluated,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bolivia (Plurinational State of),BOL,Successfully treated,74.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bolivia (Plurinational State of),BOL,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bolivia (Plurinational State of),BOL,Died,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bolivia (Plurinational State of),BOL,Lost to follow-up,14.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bolivia (Plurinational State of),BOL,Not evaluated,3.63636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bolivia (Plurinational State of),BOL,Successfully treated,65.8536585365854 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bolivia (Plurinational State of),BOL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bolivia (Plurinational State of),BOL,Died,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bolivia (Plurinational State of),BOL,Lost to follow-up,21.9512195121951 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bolivia (Plurinational State of),BOL,Not evaluated,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bolivia (Plurinational State of),BOL,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bolivia (Plurinational State of),BOL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bolivia (Plurinational State of),BOL,Died,16.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bolivia (Plurinational State of),BOL,Lost to follow-up,24.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bolivia (Plurinational State of),BOL,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Brazil,BRA,Not evaluated,7.51515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brazil,BRA,Successfully treated,51.6469038208169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brazil,BRA,Treatment failed,10.935441370224 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brazil,BRA,Died,9.22266139657444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brazil,BRA,Lost to follow-up,22.1343873517787 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brazil,BRA,Not evaluated,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Brazil,BRA,Successfully treated,52.4590163934426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Brazil,BRA,Treatment failed,10.2143757881463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Brazil,BRA,Died,10.4665825977301 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Brazil,BRA,Lost to follow-up,23.203026481715 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Brazil,BRA,Not evaluated,3.65699873896595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Brazil,BRA,Successfully treated,59.958071278826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Brazil,BRA,Treatment failed,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Brazil,BRA,Died,9.0146750524109 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Brazil,BRA,Lost to follow-up,24.0041928721174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Brazil,BRA,Not evaluated,1.46750524109015 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Brazil,BRA,Successfully treated,61.1721611721612 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Brazil,BRA,Treatment failed,5.31135531135531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Brazil,BRA,Died,11.1721611721612 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Brazil,BRA,Lost to follow-up,20.8791208791209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Brazil,BRA,Not evaluated,1.46520146520147 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Brazil,BRA,Successfully treated,57.2815533980583 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Brazil,BRA,Treatment failed,5.68654646324549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Brazil,BRA,Died,9.15395284327323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Brazil,BRA,Lost to follow-up,21.2205270457698 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Brazil,BRA,Not evaluated,6.65742024965326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Brazil,BRA,Successfully treated,60.0282485875706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Brazil,BRA,Treatment failed,4.37853107344633 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Brazil,BRA,Died,8.47457627118644 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Brazil,BRA,Lost to follow-up,22.7401129943503 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Brazil,BRA,Not evaluated,4.37853107344633 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Brazil,BRA,Successfully treated,55.2425665101722 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Brazil,BRA,Treatment failed,4.85133020344288 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Brazil,BRA,Died,8.92018779342723 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Brazil,BRA,Lost to follow-up,25.0391236306729 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Brazil,BRA,Not evaluated,5.94679186228482 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Brazil,BRA,Successfully treated,49.6610169491525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Brazil,BRA,Treatment failed,3.38983050847458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Brazil,BRA,Died,11.0169491525424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Brazil,BRA,Lost to follow-up,23.5593220338983 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Brazil,BRA,Not evaluated,12.3728813559322 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Brazil,BRA,Successfully treated,56.093489148581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Brazil,BRA,Treatment failed,2.67111853088481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Brazil,BRA,Died,9.18196994991653 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Brazil,BRA,Lost to follow-up,24.8747913188648 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Brazil,BRA,Not evaluated,7.17863105175292 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Brazil,BRA,Successfully treated,59.9195710455764 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Brazil,BRA,Treatment failed,1.07238605898123 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Brazil,BRA,Died,9.24932975871314 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Brazil,BRA,Lost to follow-up,26.6756032171582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Brazil,BRA,Not evaluated,3.08310991957105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brunei Darussalam,BRN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brunei Darussalam,BRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brunei Darussalam,BRN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brunei Darussalam,BRN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Brunei Darussalam,BRN,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Bulgaria,BGR,Successfully treated,25.9259259259259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Bulgaria,BGR,Treatment failed,25.9259259259259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Bulgaria,BGR,Died,1.23456790123457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Bulgaria,BGR,Lost to follow-up,12.3456790123457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Bulgaria,BGR,Not evaluated,34.5679012345679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bulgaria,BGR,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bulgaria,BGR,Treatment failed,11.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bulgaria,BGR,Died,38.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bulgaria,BGR,Lost to follow-up,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bulgaria,BGR,Not evaluated,17.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bulgaria,BGR,Successfully treated,22.5806451612903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bulgaria,BGR,Treatment failed,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bulgaria,BGR,Died,32.258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bulgaria,BGR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bulgaria,BGR,Not evaluated,35.4838709677419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bulgaria,BGR,Successfully treated,18.6046511627907 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bulgaria,BGR,Treatment failed,11.6279069767442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bulgaria,BGR,Died,34.8837209302326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bulgaria,BGR,Lost to follow-up,11.6279069767442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bulgaria,BGR,Not evaluated,23.2558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bulgaria,BGR,Successfully treated,16.0714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bulgaria,BGR,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bulgaria,BGR,Died,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bulgaria,BGR,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bulgaria,BGR,Not evaluated,26.7857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bulgaria,BGR,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bulgaria,BGR,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bulgaria,BGR,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bulgaria,BGR,Lost to follow-up,21.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bulgaria,BGR,Not evaluated,3.63636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bulgaria,BGR,Successfully treated,65.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bulgaria,BGR,Treatment failed,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bulgaria,BGR,Died,6.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bulgaria,BGR,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bulgaria,BGR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bulgaria,BGR,Successfully treated,51.5151515151515 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bulgaria,BGR,Treatment failed,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bulgaria,BGR,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bulgaria,BGR,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bulgaria,BGR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bulgaria,BGR,Successfully treated,53.6585365853659 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bulgaria,BGR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bulgaria,BGR,Died,26.8292682926829 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bulgaria,BGR,Lost to follow-up,17.0731707317073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bulgaria,BGR,Not evaluated,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bulgaria,BGR,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bulgaria,BGR,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bulgaria,BGR,Died,20.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bulgaria,BGR,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bulgaria,BGR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bulgaria,BGR,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bulgaria,BGR,Treatment failed,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bulgaria,BGR,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bulgaria,BGR,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bulgaria,BGR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bulgaria,BGR,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bulgaria,BGR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bulgaria,BGR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bulgaria,BGR,Lost to follow-up,17.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bulgaria,BGR,Not evaluated,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bulgaria,BGR,Successfully treated,60.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bulgaria,BGR,Treatment failed,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bulgaria,BGR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bulgaria,BGR,Lost to follow-up,17.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bulgaria,BGR,Not evaluated,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bulgaria,BGR,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bulgaria,BGR,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bulgaria,BGR,Died,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bulgaria,BGR,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bulgaria,BGR,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bulgaria,BGR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bulgaria,BGR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bulgaria,BGR,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bulgaria,BGR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bulgaria,BGR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burkina Faso,BFA,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burkina Faso,BFA,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burkina Faso,BFA,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burkina Faso,BFA,Lost to follow-up,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burkina Faso,BFA,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burkina Faso,BFA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burkina Faso,BFA,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burkina Faso,BFA,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burkina Faso,BFA,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burkina Faso,BFA,Treatment failed,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burkina Faso,BFA,Died,27.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burkina Faso,BFA,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burkina Faso,BFA,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burkina Faso,BFA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burkina Faso,BFA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burkina Faso,BFA,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burkina Faso,BFA,Successfully treated,73.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burkina Faso,BFA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burkina Faso,BFA,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burkina Faso,BFA,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burkina Faso,BFA,Successfully treated,57.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burkina Faso,BFA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burkina Faso,BFA,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burkina Faso,BFA,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burkina Faso,BFA,Successfully treated,61.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burkina Faso,BFA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burkina Faso,BFA,Died,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burkina Faso,BFA,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burkina Faso,BFA,Successfully treated,67.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burkina Faso,BFA,Treatment failed,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burkina Faso,BFA,Died,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burkina Faso,BFA,Lost to follow-up,23.5294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Burkina Faso,BFA,Not evaluated,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burkina Faso,BFA,Successfully treated,67.5675675675676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burkina Faso,BFA,Treatment failed,10.8108108108108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burkina Faso,BFA,Died,8.10810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burkina Faso,BFA,Lost to follow-up,13.5135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Burkina Faso,BFA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burkina Faso,BFA,Successfully treated,63.4146341463415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burkina Faso,BFA,Treatment failed,12.1951219512195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burkina Faso,BFA,Died,14.6341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burkina Faso,BFA,Lost to follow-up,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Burkina Faso,BFA,Not evaluated,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burkina Faso,BFA,Successfully treated,57.3529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burkina Faso,BFA,Treatment failed,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burkina Faso,BFA,Died,10.2941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burkina Faso,BFA,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Burkina Faso,BFA,Not evaluated,20.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burkina Faso,BFA,Successfully treated,71.5909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burkina Faso,BFA,Treatment failed,3.40909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burkina Faso,BFA,Died,20.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burkina Faso,BFA,Lost to follow-up,3.40909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Burkina Faso,BFA,Not evaluated,1.13636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Denmark,DNK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Denmark,DNK,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Denmark,DNK,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Denmark,DNK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Denmark,DNK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Denmark,DNK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Denmark,DNK,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Denmark,DNK,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Denmark,DNK,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Denmark,DNK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Denmark,DNK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Denmark,DNK,Not evaluated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Denmark,DNK,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Denmark,DNK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Denmark,DNK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Denmark,DNK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Denmark,DNK,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Djibouti,DJI,Successfully treated,51.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Djibouti,DJI,Treatment failed,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Djibouti,DJI,Died,28.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Djibouti,DJI,Lost to follow-up,15.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Djibouti,DJI,Not evaluated,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Djibouti,DJI,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Djibouti,DJI,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Djibouti,DJI,Died,19.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Djibouti,DJI,Lost to follow-up,30.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Djibouti,DJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Djibouti,DJI,Successfully treated,69.0140845070423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Djibouti,DJI,Treatment failed,9.85915492957746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Djibouti,DJI,Died,8.45070422535211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Djibouti,DJI,Lost to follow-up,9.85915492957746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Djibouti,DJI,Not evaluated,2.8169014084507 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Djibouti,DJI,Successfully treated,64.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Djibouti,DJI,Treatment failed,1.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Djibouti,DJI,Died,10.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Djibouti,DJI,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Djibouti,DJI,Not evaluated,10.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Djibouti,DJI,Successfully treated,71.875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Djibouti,DJI,Treatment failed,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Djibouti,DJI,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Djibouti,DJI,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Djibouti,DJI,Not evaluated,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Djibouti,DJI,Successfully treated,70.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Djibouti,DJI,Treatment failed,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Djibouti,DJI,Died,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Djibouti,DJI,Lost to follow-up,11.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Djibouti,DJI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominica,DMA,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominica,DMA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominica,DMA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominica,DMA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominica,DMA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Dominican Republic,DOM,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Dominican Republic,DOM,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Dominican Republic,DOM,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Dominican Republic,DOM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Dominican Republic,DOM,Successfully treated,70.1754385964912 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Dominican Republic,DOM,Treatment failed,12.280701754386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Dominican Republic,DOM,Died,8.7719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Dominican Republic,DOM,Lost to follow-up,8.7719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Dominican Republic,DOM,Successfully treated,69.0140845070423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Dominican Republic,DOM,Treatment failed,7.04225352112676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Dominican Republic,DOM,Died,14.0845070422535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Dominican Republic,DOM,Lost to follow-up,9.85915492957746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Dominican Republic,DOM,Successfully treated,55.9139784946237 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Dominican Republic,DOM,Treatment failed,10.752688172043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Dominican Republic,DOM,Died,13.9784946236559 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Dominican Republic,DOM,Lost to follow-up,19.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Dominican Republic,DOM,Successfully treated,68.3168316831683 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Dominican Republic,DOM,Treatment failed,3.96039603960396 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Dominican Republic,DOM,Died,5.94059405940594 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Dominican Republic,DOM,Lost to follow-up,20.7920792079208 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Dominican Republic,DOM,Not evaluated,0.99009900990099 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Dominican Republic,DOM,Successfully treated,60.7594936708861 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Dominican Republic,DOM,Treatment failed,5.06329113924051 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Dominican Republic,DOM,Died,12.6582278481013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Dominican Republic,DOM,Lost to follow-up,21.5189873417722 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominican Republic,DOM,Successfully treated,72.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominican Republic,DOM,Treatment failed,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominican Republic,DOM,Died,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominican Republic,DOM,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Dominican Republic,DOM,Successfully treated,73.4042553191489 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Dominican Republic,DOM,Treatment failed,3.19148936170213 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Dominican Republic,DOM,Died,4.25531914893617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Dominican Republic,DOM,Lost to follow-up,19.1489361702128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Dominican Republic,DOM,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Dominican Republic,DOM,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Dominican Republic,DOM,Died,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Dominican Republic,DOM,Lost to follow-up,28.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Dominican Republic,DOM,Successfully treated,62.0689655172414 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Dominican Republic,DOM,Treatment failed,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Dominican Republic,DOM,Died,11.4942528735632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Dominican Republic,DOM,Lost to follow-up,22.9885057471264 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Dominican Republic,DOM,Successfully treated,52.3364485981309 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Dominican Republic,DOM,Treatment failed,7.47663551401869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Dominican Republic,DOM,Died,5.60747663551402 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Dominican Republic,DOM,Lost to follow-up,34.5794392523365 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Dominican Republic,DOM,Successfully treated,57.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Dominican Republic,DOM,Treatment failed,4.80769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Dominican Republic,DOM,Died,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Dominican Republic,DOM,Lost to follow-up,27.8846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Dominican Republic,DOM,Successfully treated,51.8987341772152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Dominican Republic,DOM,Treatment failed,9.49367088607595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Dominican Republic,DOM,Died,8.86075949367089 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Dominican Republic,DOM,Lost to follow-up,29.746835443038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Dominican Republic,DOM,Successfully treated,71.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Dominican Republic,DOM,Treatment failed,3.94736842105263 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Dominican Republic,DOM,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Dominican Republic,DOM,Lost to follow-up,19.7368421052632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Dominican Republic,DOM,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Dominican Republic,DOM,Treatment failed,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Dominican Republic,DOM,Died,4.60526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Dominican Republic,DOM,Lost to follow-up,17.7631578947368 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Dominican Republic,DOM,Successfully treated,68.361581920904 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Dominican Republic,DOM,Treatment failed,2.25988700564972 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Dominican Republic,DOM,Died,5.08474576271186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Dominican Republic,DOM,Lost to follow-up,24.2937853107345 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Dominican Republic,DOM,Successfully treated,70.2247191011236 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Dominican Republic,DOM,Treatment failed,1.68539325842697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Dominican Republic,DOM,Died,9.55056179775281 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Dominican Republic,DOM,Lost to follow-up,18.5393258426966 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Dominican Republic,DOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Ecuador,ECU,Successfully treated,39.4495412844037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Ecuador,ECU,Treatment failed,7.3394495412844 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Ecuador,ECU,Died,20.1834862385321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Ecuador,ECU,Lost to follow-up,16.5137614678899 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Ecuador,ECU,Not evaluated,16.5137614678899 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ecuador,ECU,Successfully treated,74.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ecuador,ECU,Treatment failed,3.63636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ecuador,ECU,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ecuador,ECU,Lost to follow-up,10.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Ecuador,ECU,Not evaluated,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Ecuador,ECU,Successfully treated,51.1627906976744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Ecuador,ECU,Treatment failed,30.2325581395349 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Ecuador,ECU,Died,9.30232558139535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Ecuador,ECU,Lost to follow-up,9.30232558139535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Ecuador,ECU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ecuador,ECU,Successfully treated,62.0253164556962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ecuador,ECU,Treatment failed,3.79746835443038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ecuador,ECU,Died,6.32911392405063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ecuador,ECU,Lost to follow-up,26.5822784810127 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Ecuador,ECU,Not evaluated,1.26582278481013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Ecuador,ECU,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Ecuador,ECU,Treatment failed,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Ecuador,ECU,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Ecuador,ECU,Lost to follow-up,22.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Ecuador,ECU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ecuador,ECU,Successfully treated,53.5087719298246 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ecuador,ECU,Treatment failed,3.07017543859649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ecuador,ECU,Died,11.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ecuador,ECU,Lost to follow-up,31.140350877193 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ecuador,ECU,Not evaluated,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ecuador,ECU,Successfully treated,32.7868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ecuador,ECU,Treatment failed,4.0983606557377 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ecuador,ECU,Died,9.01639344262295 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ecuador,ECU,Lost to follow-up,31.9672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ecuador,ECU,Not evaluated,22.1311475409836 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ecuador,ECU,Successfully treated,55.9782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ecuador,ECU,Treatment failed,3.80434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ecuador,ECU,Died,11.4130434782609 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ecuador,ECU,Lost to follow-up,28.804347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ecuador,ECU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ecuador,ECU,Successfully treated,54.320987654321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ecuador,ECU,Treatment failed,2.88065843621399 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ecuador,ECU,Died,8.23045267489712 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ecuador,ECU,Lost to follow-up,34.5679012345679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ecuador,ECU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ecuador,ECU,Successfully treated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ecuador,ECU,Treatment failed,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ecuador,ECU,Died,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ecuador,ECU,Lost to follow-up,39.3939393939394 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ecuador,ECU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ecuador,ECU,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ecuador,ECU,Treatment failed,2.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ecuador,ECU,Died,5.83333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ecuador,ECU,Lost to follow-up,23.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kuwait,KWT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kuwait,KWT,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kuwait,KWT,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kuwait,KWT,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kuwait,KWT,Not evaluated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kuwait,KWT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kuwait,KWT,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kuwait,KWT,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kuwait,KWT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kuwait,KWT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kuwait,KWT,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kuwait,KWT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kuwait,KWT,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kuwait,KWT,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kuwait,KWT,Not evaluated,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kuwait,KWT,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kuwait,KWT,Not evaluated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kuwait,KWT,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kuwait,KWT,Lost to follow-up,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kuwait,KWT,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kuwait,KWT,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kuwait,KWT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kuwait,KWT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kuwait,KWT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kyrgyzstan,KGZ,Successfully treated,48.4848484848485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kyrgyzstan,KGZ,Treatment failed,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kyrgyzstan,KGZ,Died,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kyrgyzstan,KGZ,Lost to follow-up,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kyrgyzstan,KGZ,Not evaluated,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kyrgyzstan,KGZ,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kyrgyzstan,KGZ,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kyrgyzstan,KGZ,Died,5.3030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kyrgyzstan,KGZ,Lost to follow-up,35.6060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kyrgyzstan,KGZ,Not evaluated,0.757575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kyrgyzstan,KGZ,Successfully treated,49.618320610687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kyrgyzstan,KGZ,Treatment failed,14.5038167938931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kyrgyzstan,KGZ,Died,8.01526717557252 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kyrgyzstan,KGZ,Lost to follow-up,27.4809160305344 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kyrgyzstan,KGZ,Not evaluated,0.381679389312977 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kyrgyzstan,KGZ,Successfully treated,35.4128440366973 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kyrgyzstan,KGZ,Treatment failed,8.80733944954129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kyrgyzstan,KGZ,Died,9.72477064220183 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kyrgyzstan,KGZ,Lost to follow-up,38.1651376146789 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kyrgyzstan,KGZ,Not evaluated,7.88990825688073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kyrgyzstan,KGZ,Successfully treated,42.4460431654676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kyrgyzstan,KGZ,Treatment failed,6.29496402877698 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kyrgyzstan,KGZ,Died,11.6906474820144 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kyrgyzstan,KGZ,Lost to follow-up,18.3453237410072 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kyrgyzstan,KGZ,Not evaluated,21.2230215827338 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kyrgyzstan,KGZ,Successfully treated,56.9105691056911 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kyrgyzstan,KGZ,Treatment failed,7.11382113821138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kyrgyzstan,KGZ,Died,14.0243902439024 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kyrgyzstan,KGZ,Lost to follow-up,21.5447154471545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kyrgyzstan,KGZ,Not evaluated,0.40650406504065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kyrgyzstan,KGZ,Successfully treated,62.7096774193548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kyrgyzstan,KGZ,Treatment failed,8.64516129032258 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kyrgyzstan,KGZ,Died,12.258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kyrgyzstan,KGZ,Lost to follow-up,16.3870967741935 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kyrgyzstan,KGZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kyrgyzstan,KGZ,Successfully treated,57.4248120300752 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kyrgyzstan,KGZ,Treatment failed,6.8609022556391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kyrgyzstan,KGZ,Died,6.67293233082707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kyrgyzstan,KGZ,Lost to follow-up,19.3609022556391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kyrgyzstan,KGZ,Not evaluated,9.68045112781955 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kyrgyzstan,KGZ,Successfully treated,56.1797752808989 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kyrgyzstan,KGZ,Treatment failed,9.0751944684529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kyrgyzstan,KGZ,Died,12.2731201382887 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kyrgyzstan,KGZ,Lost to follow-up,22.4719101123596 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kyrgyzstan,KGZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kyrgyzstan,KGZ,Successfully treated,53.7005163511188 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kyrgyzstan,KGZ,Treatment failed,10.671256454389 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kyrgyzstan,KGZ,Died,12.4784853700516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kyrgyzstan,KGZ,Lost to follow-up,23.1497418244406 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kyrgyzstan,KGZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kyrgyzstan,KGZ,Successfully treated,53.1655844155844 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kyrgyzstan,KGZ,Treatment failed,11.9318181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kyrgyzstan,KGZ,Died,11.4448051948052 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kyrgyzstan,KGZ,Lost to follow-up,23.3766233766234 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kyrgyzstan,KGZ,Not evaluated,0.0811688311688312 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kyrgyzstan,KGZ,Successfully treated,55.1457975986278 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kyrgyzstan,KGZ,Treatment failed,10.377358490566 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kyrgyzstan,KGZ,Died,11.2349914236707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kyrgyzstan,KGZ,Lost to follow-up,23.0703259005146 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kyrgyzstan,KGZ,Not evaluated,0.171526586620926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kyrgyzstan,KGZ,Successfully treated,62.2990353697749 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kyrgyzstan,KGZ,Treatment failed,7.79742765273312 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kyrgyzstan,KGZ,Died,9.80707395498392 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kyrgyzstan,KGZ,Lost to follow-up,20.016077170418 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kyrgyzstan,KGZ,Not evaluated,0.0803858520900322 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kyrgyzstan,KGZ,Successfully treated,71.6965046888321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kyrgyzstan,KGZ,Treatment failed,3.58056265984655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kyrgyzstan,KGZ,Died,6.73486786018755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kyrgyzstan,KGZ,Lost to follow-up,17.7323103154305 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kyrgyzstan,KGZ,Not evaluated,0.255754475703325 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kyrgyzstan,KGZ,Successfully treated,71.7365269461078 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kyrgyzstan,KGZ,Treatment failed,3.95209580838323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kyrgyzstan,KGZ,Died,9.22155688622754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kyrgyzstan,KGZ,Lost to follow-up,14.9700598802395 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kyrgyzstan,KGZ,Not evaluated,0.119760479041916 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kyrgyzstan,KGZ,Successfully treated,74.8010610079576 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kyrgyzstan,KGZ,Treatment failed,2.91777188328912 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kyrgyzstan,KGZ,Died,6.36604774535809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kyrgyzstan,KGZ,Lost to follow-up,15.9151193633952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kyrgyzstan,KGZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kyrgyzstan,KGZ,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kyrgyzstan,KGZ,Treatment failed,3.98773006134969 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kyrgyzstan,KGZ,Died,5.67484662576687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kyrgyzstan,KGZ,Lost to follow-up,15.1840490797546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kyrgyzstan,KGZ,Not evaluated,0.153374233128834 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lao People's Democratic Republic,LAO,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lao People's Democratic Republic,LAO,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lao People's Democratic Republic,LAO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lao People's Democratic Republic,LAO,Successfully treated,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lao People's Democratic Republic,LAO,Died,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lao People's Democratic Republic,LAO,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lao People's Democratic Republic,LAO,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lao People's Democratic Republic,LAO,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lao People's Democratic Republic,LAO,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lao People's Democratic Republic,LAO,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lao People's Democratic Republic,LAO,Treatment failed,18.5185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lao People's Democratic Republic,LAO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lao People's Democratic Republic,LAO,Lost to follow-up,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lao People's Democratic Republic,LAO,Not evaluated,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lao People's Democratic Republic,LAO,Successfully treated,84.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lao People's Democratic Republic,LAO,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lao People's Democratic Republic,LAO,Lost to follow-up,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lao People's Democratic Republic,LAO,Successfully treated,81.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lao People's Democratic Republic,LAO,Died,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lao People's Democratic Republic,LAO,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lao People's Democratic Republic,LAO,Not evaluated,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lao People's Democratic Republic,LAO,Successfully treated,88.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lao People's Democratic Republic,LAO,Treatment failed,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lao People's Democratic Republic,LAO,Died,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lao People's Democratic Republic,LAO,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lao People's Democratic Republic,LAO,Successfully treated,84.4444444444445 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lao People's Democratic Republic,LAO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lao People's Democratic Republic,LAO,Died,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lao People's Democratic Republic,LAO,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lao People's Democratic Republic,LAO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lao People's Democratic Republic,LAO,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Myanmar,MMR,Treatment failed,1.0688042752171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Myanmar,MMR,Died,13.3600534402138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Myanmar,MMR,Lost to follow-up,5.21042084168337 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Myanmar,MMR,Not evaluated,0.133600534402138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Myanmar,MMR,Successfully treated,79.5871559633028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Myanmar,MMR,Treatment failed,1.23853211009174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Myanmar,MMR,Died,14.9082568807339 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Myanmar,MMR,Lost to follow-up,3.6697247706422 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Myanmar,MMR,Not evaluated,0.596330275229358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Myanmar,MMR,Successfully treated,79.3789808917198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Myanmar,MMR,Treatment failed,0.835987261146497 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Myanmar,MMR,Died,15.6847133757962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Myanmar,MMR,Lost to follow-up,3.98089171974522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Myanmar,MMR,Not evaluated,0.119426751592357 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Myanmar,MMR,Successfully treated,79.4484321873819 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Myanmar,MMR,Treatment failed,0.982244049867775 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Myanmar,MMR,Died,14.1292028711749 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Myanmar,MMR,Lost to follow-up,4.23120513789195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Myanmar,MMR,Not evaluated,1.20891575368342 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Myanmar,MMR,Successfully treated,78.1298299845441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Myanmar,MMR,Treatment failed,1.27511591962906 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Myanmar,MMR,Died,16.3446676970634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Myanmar,MMR,Lost to follow-up,4.25038639876352 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Myanmar,MMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Myanmar,MMR,Successfully treated,77.2680937818553 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Myanmar,MMR,Treatment failed,1.42711518858308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Myanmar,MMR,Died,13.506625891947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Myanmar,MMR,Lost to follow-up,4.07747196738022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Myanmar,MMR,Not evaluated,3.72069317023446 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Myanmar,MMR,Successfully treated,75.7900101936799 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Myanmar,MMR,Treatment failed,1.78389398572885 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Myanmar,MMR,Died,15.1376146788991 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Myanmar,MMR,Lost to follow-up,6.01427115188583 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Myanmar,MMR,Not evaluated,1.27420998980632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Myanmar,MMR,Successfully treated,75.3824756606398 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Myanmar,MMR,Treatment failed,2.50347705146036 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Myanmar,MMR,Died,14.4645340751043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Myanmar,MMR,Lost to follow-up,6.81502086230876 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Myanmar,MMR,Not evaluated,0.834492350486787 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Myanmar,MMR,Successfully treated,75.4536771728749 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Myanmar,MMR,Treatment failed,3.58166189111748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Myanmar,MMR,Died,13.7535816618911 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Myanmar,MMR,Lost to follow-up,6.78127984718243 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Myanmar,MMR,Not evaluated,0.429799426934097 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Namibia,NAM,Successfully treated,28.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Namibia,NAM,Treatment failed,9.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Namibia,NAM,Died,9.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Namibia,NAM,Lost to follow-up,20.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Namibia,NAM,Not evaluated,32.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Namibia,NAM,Successfully treated,51.131221719457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Namibia,NAM,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Namibia,NAM,Died,19.9095022624434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Namibia,NAM,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Namibia,NAM,Not evaluated,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Namibia,NAM,Successfully treated,41.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Namibia,NAM,Treatment failed,1.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Namibia,NAM,Died,18.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Namibia,NAM,Lost to follow-up,14.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Namibia,NAM,Not evaluated,23.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Namibia,NAM,Successfully treated,57.8703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Namibia,NAM,Treatment failed,4.62962962962963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Namibia,NAM,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Namibia,NAM,Lost to follow-up,19.9074074074074 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Namibia,NAM,Not evaluated,0.925925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Namibia,NAM,Successfully treated,59.2783505154639 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Namibia,NAM,Treatment failed,3.60824742268041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Namibia,NAM,Died,15.979381443299 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Namibia,NAM,Lost to follow-up,18.0412371134021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Namibia,NAM,Not evaluated,3.09278350515464 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Namibia,NAM,Successfully treated,68.2692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Namibia,NAM,Treatment failed,2.88461538461538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Namibia,NAM,Died,17.7884615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Namibia,NAM,Lost to follow-up,9.13461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Namibia,NAM,Not evaluated,1.92307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Namibia,NAM,Successfully treated,64.1304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Namibia,NAM,Treatment failed,1.6304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Namibia,NAM,Died,21.195652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Namibia,NAM,Lost to follow-up,10.3260869565217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Namibia,NAM,Not evaluated,2.71739130434783 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Namibia,NAM,Successfully treated,69.9248120300752 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Namibia,NAM,Treatment failed,1.50375939849624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Namibia,NAM,Died,18.421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Namibia,NAM,Lost to follow-up,9.77443609022556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Namibia,NAM,Not evaluated,0.37593984962406 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Namibia,NAM,Successfully treated,73.6111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Namibia,NAM,Treatment failed,1.38888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Namibia,NAM,Died,14.9305555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Namibia,NAM,Lost to follow-up,10.0694444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Namibia,NAM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Namibia,NAM,Successfully treated,71.264367816092 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Namibia,NAM,Treatment failed,3.16091954022989 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Namibia,NAM,Died,13.7931034482759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Namibia,NAM,Lost to follow-up,10.9195402298851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Namibia,NAM,Not evaluated,0.862068965517241 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Namibia,NAM,Successfully treated,66.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Namibia,NAM,Treatment failed,2.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Namibia,NAM,Died,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Namibia,NAM,Lost to follow-up,13.9473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Namibia,NAM,Not evaluated,0.526315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Namibia,NAM,Successfully treated,64.4518272425249 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Namibia,NAM,Treatment failed,4.31893687707641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Namibia,NAM,Died,15.6146179401993 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Namibia,NAM,Lost to follow-up,14.9501661129568 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Namibia,NAM,Not evaluated,0.664451827242525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Namibia,NAM,Successfully treated,75.1798561151079 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Namibia,NAM,Treatment failed,3.59712230215827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Namibia,NAM,Died,12.2302158273381 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Namibia,NAM,Lost to follow-up,8.27338129496403 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Namibia,NAM,Not evaluated,0.719424460431655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Namibia,NAM,Successfully treated,72.3076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Namibia,NAM,Treatment failed,1.53846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Namibia,NAM,Died,18.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Namibia,NAM,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Namibia,NAM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Namibia,NAM,Successfully treated,76.0162601626016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Namibia,NAM,Treatment failed,0.813008130081301 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Namibia,NAM,Died,11.3821138211382 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Namibia,NAM,Lost to follow-up,10.9756097560976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Namibia,NAM,Not evaluated,0.813008130081301 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Namibia,NAM,Successfully treated,74.0585774058578 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Namibia,NAM,Treatment failed,3.34728033472803 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Namibia,NAM,Died,14.6443514644351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Namibia,NAM,Lost to follow-up,7.94979079497908 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Namibia,NAM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nepal,NPL,Successfully treated,72.5190839694657 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nepal,NPL,Treatment failed,6.10687022900763 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nepal,NPL,Died,11.4503816793893 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nepal,NPL,Lost to follow-up,9.9236641221374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Nepal,NPL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nepal,NPL,Successfully treated,64.4295302013423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nepal,NPL,Treatment failed,6.71140939597315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nepal,NPL,Died,8.05369127516779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nepal,NPL,Lost to follow-up,20.8053691275168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Nepal,NPL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nepal,NPL,Successfully treated,71.5189873417722 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nepal,NPL,Treatment failed,8.22784810126582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nepal,NPL,Died,5.69620253164557 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nepal,NPL,Lost to follow-up,13.2911392405063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Nepal,NPL,Not evaluated,1.26582278481013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nepal,NPL,Successfully treated,74.5019920318725 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nepal,NPL,Treatment failed,9.9601593625498 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nepal,NPL,Died,3.18725099601594 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nepal,NPL,Lost to follow-up,11.9521912350598 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Nepal,NPL,Not evaluated,0.398406374501992 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nepal,NPL,Successfully treated,72.4890829694323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nepal,NPL,Treatment failed,9.60698689956332 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nepal,NPL,Died,6.11353711790393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nepal,NPL,Lost to follow-up,11.7903930131004 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Nepal,NPL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nepal,NPL,Successfully treated,76.4705882352941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nepal,NPL,Treatment failed,7.98319327731092 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nepal,NPL,Died,5.46218487394958 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nepal,NPL,Lost to follow-up,10.0840336134454 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Nepal,NPL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nepal,NPL,Successfully treated,71.2062256809339 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nepal,NPL,Treatment failed,7.39299610894942 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nepal,NPL,Died,13.2295719844358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nepal,NPL,Lost to follow-up,8.17120622568093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Nepal,NPL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nepal,NPL,Successfully treated,70.2797202797203 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nepal,NPL,Treatment failed,8.39160839160839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nepal,NPL,Died,9.79020979020979 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nepal,NPL,Lost to follow-up,9.44055944055944 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Nepal,NPL,Not evaluated,2.0979020979021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nepal,NPL,Successfully treated,69.6696696696697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nepal,NPL,Treatment failed,6.60660660660661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nepal,NPL,Died,10.5105105105105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nepal,NPL,Lost to follow-up,9.90990990990991 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Nepal,NPL,Not evaluated,3.3033033033033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nepal,NPL,Successfully treated,67.816091954023 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nepal,NPL,Treatment failed,2.01149425287356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nepal,NPL,Died,16.3793103448276 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nepal,NPL,Lost to follow-up,10.0574712643678 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Nepal,NPL,Not evaluated,3.73563218390805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nepal,NPL,Successfully treated,70.4268292682927 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nepal,NPL,Treatment failed,1.52439024390244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nepal,NPL,Died,14.3292682926829 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nepal,NPL,Lost to follow-up,9.14634146341463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Nepal,NPL,Not evaluated,4.57317073170732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nepal,NPL,Successfully treated,75.3048780487805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nepal,NPL,Treatment failed,5.79268292682927 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nepal,NPL,Died,9.45121951219512 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nepal,NPL,Lost to follow-up,3.96341463414634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Nepal,NPL,Not evaluated,5.48780487804878 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nepal,NPL,Successfully treated,72.6775956284153 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nepal,NPL,Treatment failed,0.546448087431694 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nepal,NPL,Died,12.0218579234973 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nepal,NPL,Lost to follow-up,8.19672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Nepal,NPL,Not evaluated,6.55737704918033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nepal,NPL,Successfully treated,75.0889679715303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nepal,NPL,Treatment failed,3.20284697508897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Nepal,NPL,Died,13.5231316725979 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Panama,PAN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Panama,PAN,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Panama,PAN,Successfully treated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Panama,PAN,Died,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Panama,PAN,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Panama,PAN,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Panama,PAN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Panama,PAN,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Panama,PAN,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Panama,PAN,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Panama,PAN,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Panama,PAN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Panama,PAN,Successfully treated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Panama,PAN,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Panama,PAN,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Panama,PAN,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Panama,PAN,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Panama,PAN,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Panama,PAN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Panama,PAN,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Panama,PAN,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Panama,PAN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Panama,PAN,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Panama,PAN,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Panama,PAN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Panama,PAN,Died,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Panama,PAN,Lost to follow-up,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Panama,PAN,Not evaluated,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Panama,PAN,Successfully treated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Panama,PAN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Panama,PAN,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Panama,PAN,Not evaluated,32.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Panama,PAN,Successfully treated,35.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Panama,PAN,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Panama,PAN,Lost to follow-up,32.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Panama,PAN,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Panama,PAN,Successfully treated,44.2622950819672 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Panama,PAN,Died,36.0655737704918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Panama,PAN,Lost to follow-up,19.672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Panama,PAN,Successfully treated,48.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Panama,PAN,Died,28.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Panama,PAN,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Panama,PAN,Successfully treated,58.974358974359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Panama,PAN,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Panama,PAN,Lost to follow-up,25.6410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Panama,PAN,Successfully treated,58.0645161290323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Panama,PAN,Died,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Panama,PAN,Lost to follow-up,29.0322580645161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Panama,PAN,Successfully treated,51.1627906976744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Panama,PAN,Died,27.906976744186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Panama,PAN,Lost to follow-up,20.9302325581395 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Panama,PAN,Successfully treated,48.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Panama,PAN,Died,34.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Panama,PAN,Lost to follow-up,17.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Papua New Guinea,PNG,Successfully treated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Papua New Guinea,PNG,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Papua New Guinea,PNG,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Papua New Guinea,PNG,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Papua New Guinea,PNG,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Papua New Guinea,PNG,Successfully treated,38.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Papua New Guinea,PNG,Treatment failed,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Papua New Guinea,PNG,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Papua New Guinea,PNG,Lost to follow-up,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Papua New Guinea,PNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Papua New Guinea,PNG,Successfully treated,13.7931034482759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Papua New Guinea,PNG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Papua New Guinea,PNG,Died,22.4137931034483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Papua New Guinea,PNG,Lost to follow-up,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Papua New Guinea,PNG,Not evaluated,60.3448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Papua New Guinea,PNG,Successfully treated,55.2941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Papua New Guinea,PNG,Treatment failed,1.17647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Papua New Guinea,PNG,Died,14.1176470588235 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Papua New Guinea,PNG,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Papua New Guinea,PNG,Not evaluated,9.41176470588235 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Papua New Guinea,PNG,Successfully treated,51.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Papua New Guinea,PNG,Treatment failed,0.555555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Papua New Guinea,PNG,Died,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Papua New Guinea,PNG,Lost to follow-up,31.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Papua New Guinea,PNG,Not evaluated,7.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Papua New Guinea,PNG,Successfully treated,68.4563758389262 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Papua New Guinea,PNG,Treatment failed,0.671140939597315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Papua New Guinea,PNG,Died,13.4228187919463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Papua New Guinea,PNG,Lost to follow-up,17.4496644295302 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Papua New Guinea,PNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Papua New Guinea,PNG,Successfully treated,74.5762711864407 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Papua New Guinea,PNG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Papua New Guinea,PNG,Died,12.2881355932203 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Papua New Guinea,PNG,Lost to follow-up,10.593220338983 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Papua New Guinea,PNG,Not evaluated,2.54237288135593 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Papua New Guinea,PNG,Successfully treated,74.5192307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Papua New Guinea,PNG,Treatment failed,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Papua New Guinea,PNG,Died,10.0961538461538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Papua New Guinea,PNG,Lost to follow-up,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Papua New Guinea,PNG,Not evaluated,1.92307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Papua New Guinea,PNG,Successfully treated,59.2797783933518 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Papua New Guinea,PNG,Treatment failed,1.93905817174515 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Papua New Guinea,PNG,Died,13.8504155124654 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Papua New Guinea,PNG,Lost to follow-up,11.0803324099723 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Papua New Guinea,PNG,Not evaluated,13.8504155124654 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Papua New Guinea,PNG,Successfully treated,70.0704225352113 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Papua New Guinea,PNG,Treatment failed,0.704225352112676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Papua New Guinea,PNG,Died,12.6760563380282 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Papua New Guinea,PNG,Lost to follow-up,14.0845070422535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Papua New Guinea,PNG,Not evaluated,2.46478873239437 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Papua New Guinea,PNG,Successfully treated,72.0524017467249 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Papua New Guinea,PNG,Treatment failed,0.436681222707424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Papua New Guinea,PNG,Died,8.73362445414847 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Papua New Guinea,PNG,Lost to follow-up,16.1572052401747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Papua New Guinea,PNG,Not evaluated,2.62008733624454 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Papua New Guinea,PNG,Successfully treated,52.9411764705882 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Papua New Guinea,PNG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Papua New Guinea,PNG,Died,12.5237191650854 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Papua New Guinea,PNG,Lost to follow-up,13.2827324478178 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Papua New Guinea,PNG,Not evaluated,21.2523719165085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Papua New Guinea,PNG,Successfully treated,32.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Papua New Guinea,PNG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Papua New Guinea,PNG,Died,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Papua New Guinea,PNG,Lost to follow-up,6.64335664335664 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Papua New Guinea,PNG,Not evaluated,56.1188811188811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Paraguay,PRY,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Paraguay,PRY,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Paraguay,PRY,Successfully treated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Paraguay,PRY,Treatment failed,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Paraguay,PRY,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Paraguay,PRY,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Paraguay,PRY,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Paraguay,PRY,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Paraguay,PRY,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Paraguay,PRY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Paraguay,PRY,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Paraguay,PRY,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Paraguay,PRY,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Paraguay,PRY,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Paraguay,PRY,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Paraguay,PRY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Paraguay,PRY,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Paraguay,PRY,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Paraguay,PRY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Paraguay,PRY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Paraguay,PRY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Paraguay,PRY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Paraguay,PRY,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Paraguay,PRY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Paraguay,PRY,Lost to follow-up,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Paraguay,PRY,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Paraguay,PRY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Paraguay,PRY,Lost to follow-up,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Paraguay,PRY,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Paraguay,PRY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Paraguay,PRY,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Paraguay,PRY,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Paraguay,PRY,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Paraguay,PRY,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Paraguay,PRY,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Paraguay,PRY,Died,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Paraguay,PRY,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Paraguay,PRY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belarus,BLR,Treatment failed,15.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belarus,BLR,Died,9.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belarus,BLR,Lost to follow-up,9.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belarus,BLR,Not evaluated,0.928571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belarus,BLR,Successfully treated,67.4576271186441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belarus,BLR,Treatment failed,13.3050847457627 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belarus,BLR,Died,8.13559322033898 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belarus,BLR,Lost to follow-up,9.74576271186441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belarus,BLR,Not evaluated,1.35593220338983 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belarus,BLR,Successfully treated,70.4779756326148 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belarus,BLR,Treatment failed,9.37207122774133 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belarus,BLR,Died,8.80974695407685 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belarus,BLR,Lost to follow-up,10.4967197750703 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belarus,BLR,Not evaluated,0.84348641049672 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belarus,BLR,Successfully treated,72.905331882481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belarus,BLR,Treatment failed,6.52883569096844 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belarus,BLR,Died,9.46681175190424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belarus,BLR,Lost to follow-up,10.3373231773667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belarus,BLR,Not evaluated,0.761697497279652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belarus,BLR,Successfully treated,82.9015544041451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belarus,BLR,Treatment failed,1.6839378238342 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belarus,BLR,Died,8.29015544041451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belarus,BLR,Lost to follow-up,6.0880829015544 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belarus,BLR,Not evaluated,1.03626943005181 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belarus,BLR,Successfully treated,79.8866855524079 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belarus,BLR,Treatment failed,1.41643059490085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belarus,BLR,Died,9.06515580736544 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belarus,BLR,Lost to follow-up,9.34844192634561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belarus,BLR,Not evaluated,0.28328611898017 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belarus,BLR,Successfully treated,81.0690423162584 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belarus,BLR,Treatment failed,2.00445434298441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belarus,BLR,Died,12.6948775055679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belarus,BLR,Lost to follow-up,2.89532293986637 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belarus,BLR,Not evaluated,1.33630289532294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belarus,BLR,Successfully treated,84.5665961945032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belarus,BLR,Treatment failed,1.26849894291755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belarus,BLR,Died,6.76532769556025 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belarus,BLR,Lost to follow-up,7.39957716701903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belarus,BLR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Belgium,BEL,Successfully treated,56.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Belgium,BEL,Died,28.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Belgium,BEL,Lost to follow-up,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Belgium,BEL,Not evaluated,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Belgium,BEL,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Belgium,BEL,Died,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Belgium,BEL,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Belgium,BEL,Successfully treated,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Belgium,BEL,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Belgium,BEL,Not evaluated,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Belgium,BEL,Successfully treated,68.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Belgium,BEL,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Belgium,BEL,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Belgium,BEL,Successfully treated,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Belgium,BEL,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Belgium,BEL,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Belgium,BEL,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Belgium,BEL,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Belgium,BEL,Treatment failed,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Belgium,BEL,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Belgium,BEL,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Belgium,BEL,Not evaluated,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belgium,BEL,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belgium,BEL,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belgium,BEL,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belgium,BEL,Not evaluated,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belgium,BEL,Successfully treated,57.8947368421053 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belgium,BEL,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belgium,BEL,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belgium,BEL,Not evaluated,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belgium,BEL,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belgium,BEL,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belgium,BEL,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belgium,BEL,Successfully treated,61.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belgium,BEL,Died,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belgium,BEL,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belgium,BEL,Successfully treated,78.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belgium,BEL,Not evaluated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belgium,BEL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belgium,BEL,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belgium,BEL,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belgium,BEL,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belgium,BEL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belgium,BEL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belgium,BEL,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belgium,BEL,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Belgium,BEL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belgium,BEL,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Belgium,BEL,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belgium,BEL,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belgium,BEL,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belgium,BEL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belgium,BEL,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belgium,BEL,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Belgium,BEL,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belgium,BEL,Successfully treated,64.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belgium,BEL,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belgium,BEL,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belgium,BEL,Not evaluated,23.5294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belgium,BEL,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belgium,BEL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belgium,BEL,Not evaluated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belgium,BEL,Successfully treated,46.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belgium,BEL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belgium,BEL,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belgium,BEL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belgium,BEL,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belize,BLZ,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belize,BLZ,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belize,BLZ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belize,BLZ,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belize,BLZ,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belize,BLZ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belize,BLZ,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belize,BLZ,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belize,BLZ,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belize,BLZ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belize,BLZ,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belize,BLZ,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belize,BLZ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belize,BLZ,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belize,BLZ,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belize,BLZ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belize,BLZ,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belize,BLZ,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belize,BLZ,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belize,BLZ,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belize,BLZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belize,BLZ,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belize,BLZ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Belize,BLZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Benin,BEN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Benin,BEN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Benin,BEN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Benin,BEN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Benin,BEN,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Benin,BEN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Benin,BEN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Benin,BEN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Benin,BEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Benin,BEN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Benin,BEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Benin,BEN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Benin,BEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bolivia (Plurinational State of),BOL,Treatment failed,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bolivia (Plurinational State of),BOL,Died,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bolivia (Plurinational State of),BOL,Lost to follow-up,29.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bolivia (Plurinational State of),BOL,Successfully treated,70.1149425287356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bolivia (Plurinational State of),BOL,Treatment failed,1.14942528735632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bolivia (Plurinational State of),BOL,Died,10.3448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bolivia (Plurinational State of),BOL,Lost to follow-up,18.3908045977012 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bolivia (Plurinational State of),BOL,Successfully treated,52.212389380531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bolivia (Plurinational State of),BOL,Treatment failed,0.88495575221239 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bolivia (Plurinational State of),BOL,Died,15.929203539823 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bolivia (Plurinational State of),BOL,Lost to follow-up,30.9734513274336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bolivia (Plurinational State of),BOL,Successfully treated,57.6086956521739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bolivia (Plurinational State of),BOL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bolivia (Plurinational State of),BOL,Died,16.304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bolivia (Plurinational State of),BOL,Lost to follow-up,26.0869565217391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bolivia (Plurinational State of),BOL,Successfully treated,56.3829787234043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bolivia (Plurinational State of),BOL,Treatment failed,1.06382978723404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bolivia (Plurinational State of),BOL,Died,19.1489361702128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bolivia (Plurinational State of),BOL,Lost to follow-up,23.4042553191489 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bolivia (Plurinational State of),BOL,Successfully treated,41.5841584158416 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bolivia (Plurinational State of),BOL,Treatment failed,0.99009900990099 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bolivia (Plurinational State of),BOL,Died,24.7524752475248 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bolivia (Plurinational State of),BOL,Lost to follow-up,32.6732673267327 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bolivia (Plurinational State of),BOL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bosnia and Herzegovina,BIH,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bosnia and Herzegovina,BIH,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bosnia and Herzegovina,BIH,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bosnia and Herzegovina,BIH,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bosnia and Herzegovina,BIH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bosnia and Herzegovina,BIH,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bosnia and Herzegovina,BIH,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bosnia and Herzegovina,BIH,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bosnia and Herzegovina,BIH,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bosnia and Herzegovina,BIH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bosnia and Herzegovina,BIH,Successfully treated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bosnia and Herzegovina,BIH,Treatment failed,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bosnia and Herzegovina,BIH,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bosnia and Herzegovina,BIH,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bosnia and Herzegovina,BIH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bosnia and Herzegovina,BIH,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bosnia and Herzegovina,BIH,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bosnia and Herzegovina,BIH,Died,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bosnia and Herzegovina,BIH,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bosnia and Herzegovina,BIH,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bosnia and Herzegovina,BIH,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bosnia and Herzegovina,BIH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bosnia and Herzegovina,BIH,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bosnia and Herzegovina,BIH,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bosnia and Herzegovina,BIH,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bosnia and Herzegovina,BIH,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bosnia and Herzegovina,BIH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bosnia and Herzegovina,BIH,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bosnia and Herzegovina,BIH,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bosnia and Herzegovina,BIH,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bosnia and Herzegovina,BIH,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Botswana,BWA,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Botswana,BWA,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Botswana,BWA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Botswana,BWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Botswana,BWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Botswana,BWA,Successfully treated,53.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Botswana,BWA,Died,15.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Botswana,BWA,Lost to follow-up,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Botswana,BWA,Not evaluated,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Botswana,BWA,Successfully treated,48.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Botswana,BWA,Died,15.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Botswana,BWA,Lost to follow-up,17.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Botswana,BWA,Not evaluated,18.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Botswana,BWA,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Botswana,BWA,Died,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Botswana,BWA,Lost to follow-up,1.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Botswana,BWA,Not evaluated,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Botswana,BWA,Successfully treated,63.013698630137 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Botswana,BWA,Died,17.8082191780822 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Botswana,BWA,Lost to follow-up,2.05479452054795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Botswana,BWA,Not evaluated,17.1232876712329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Botswana,BWA,Successfully treated,70.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Botswana,BWA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Botswana,BWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Botswana,BWA,Not evaluated,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Botswana,BWA,Successfully treated,69.8412698412698 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Botswana,BWA,Treatment failed,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Botswana,BWA,Died,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Botswana,BWA,Lost to follow-up,1.58730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Botswana,BWA,Not evaluated,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Botswana,BWA,Successfully treated,70.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Botswana,BWA,Treatment failed,1.96078431372549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Botswana,BWA,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Botswana,BWA,Lost to follow-up,1.96078431372549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Botswana,BWA,Not evaluated,13.7254901960784 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Botswana,BWA,Successfully treated,73.2558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Botswana,BWA,Died,17.4418604651163 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Botswana,BWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Botswana,BWA,Not evaluated,9.30232558139535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Botswana,BWA,Successfully treated,69.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Botswana,BWA,Treatment failed,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Botswana,BWA,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Botswana,BWA,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Botswana,BWA,Not evaluated,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Botswana,BWA,Successfully treated,77.9816513761468 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Botswana,BWA,Treatment failed,3.6697247706422 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Botswana,BWA,Died,11.9266055045872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Botswana,BWA,Lost to follow-up,3.6697247706422 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Botswana,BWA,Not evaluated,2.75229357798165 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Botswana,BWA,Successfully treated,68.9655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Botswana,BWA,Treatment failed,5.74712643678161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Botswana,BWA,Died,21.8390804597701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Botswana,BWA,Lost to follow-up,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Botswana,BWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Botswana,BWA,Successfully treated,70.3296703296703 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Botswana,BWA,Treatment failed,2.1978021978022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Botswana,BWA,Died,21.978021978022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Botswana,BWA,Lost to follow-up,2.1978021978022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Botswana,BWA,Not evaluated,3.2967032967033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Botswana,BWA,Successfully treated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Botswana,BWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Botswana,BWA,Died,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Botswana,BWA,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Botswana,BWA,Not evaluated,42.4242424242424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Botswana,BWA,Successfully treated,65.3061224489796 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Botswana,BWA,Treatment failed,2.04081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Botswana,BWA,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Botswana,BWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Botswana,BWA,Not evaluated,18.3673469387755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Botswana,BWA,Successfully treated,79.6296296296296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Botswana,BWA,Treatment failed,1.85185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Botswana,BWA,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Botswana,BWA,Lost to follow-up,1.85185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Botswana,BWA,Not evaluated,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Brazil,BRA,Successfully treated,57.3134328358209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Brazil,BRA,Treatment failed,8.95522388059701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Brazil,BRA,Died,23.2835820895522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Brazil,BRA,Lost to follow-up,10.4477611940299 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Brazil,BRA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Brazil,BRA,Successfully treated,60.126582278481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Brazil,BRA,Treatment failed,9.81012658227848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Brazil,BRA,Died,12.6582278481013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Brazil,BRA,Lost to follow-up,14.5569620253165 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Brazil,BRA,Not evaluated,2.84810126582279 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Brazil,BRA,Successfully treated,58.2554517133956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Brazil,BRA,Treatment failed,18.380062305296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Brazil,BRA,Died,10.2803738317757 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Brazil,BRA,Lost to follow-up,7.78816199376947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Brazil,BRA,Not evaluated,5.29595015576324 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Brazil,BRA,Successfully treated,58.7131367292225 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Brazil,BRA,Treatment failed,15.5495978552279 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Brazil,BRA,Died,8.57908847184987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Brazil,BRA,Lost to follow-up,14.2091152815013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Brazil,BRA,Not evaluated,2.94906166219839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Brazil,BRA,Successfully treated,43.8423645320197 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Brazil,BRA,Treatment failed,13.7931034482759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Brazil,BRA,Died,11.576354679803 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Brazil,BRA,Lost to follow-up,14.0394088669951 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Brazil,BRA,Not evaluated,16.7487684729064 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Brazil,BRA,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Brazil,BRA,Treatment failed,13.0630630630631 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Brazil,BRA,Died,11.2612612612613 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Brazil,BRA,Lost to follow-up,12.6126126126126 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Brazil,BRA,Not evaluated,13.0630630630631 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Brazil,BRA,Successfully treated,49.003984063745 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Brazil,BRA,Treatment failed,15.5378486055777 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Brazil,BRA,Died,10.9561752988048 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Brazil,BRA,Lost to follow-up,12.9482071713147 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Brazil,BRA,Not evaluated,11.5537848605578 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Brazil,BRA,Successfully treated,64.4359464627151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Brazil,BRA,Treatment failed,4.97131931166348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Brazil,BRA,Died,9.56022944550669 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Brazil,BRA,Lost to follow-up,14.7227533460803 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Brazil,BRA,Not evaluated,6.30975143403442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Brazil,BRA,Successfully treated,55.9096945551129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Brazil,BRA,Treatment failed,7.03851261620186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Brazil,BRA,Died,10.2257636122178 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Brazil,BRA,Lost to follow-up,17.9282868525896 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Brazil,BRA,Not evaluated,8.89774236387782 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Brazil,BRA,Successfully treated,50.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Brazil,BRA,Treatment failed,9.21212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Brazil,BRA,Died,11.3939393939394 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Brazil,BRA,Lost to follow-up,21.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Czechia,CZE,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Czechia,CZE,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Czechia,CZE,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Czechia,CZE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Czechia,CZE,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Czechia,CZE,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Czechia,CZE,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Czechia,CZE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Czechia,CZE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Czechia,CZE,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Czechia,CZE,Successfully treated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Czechia,CZE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Czechia,CZE,Lost to follow-up,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Czechia,CZE,Not evaluated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Czechia,CZE,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Czechia,CZE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Czechia,CZE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Czechia,CZE,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Czechia,CZE,Successfully treated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Czechia,CZE,Died,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Czechia,CZE,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Czechia,CZE,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Czechia,CZE,Successfully treated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Czechia,CZE,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Czechia,CZE,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Czechia,CZE,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Czechia,CZE,Successfully treated,58.8235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Czechia,CZE,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Czechia,CZE,Lost to follow-up,23.5294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Czechia,CZE,Not evaluated,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic People's Republic of Korea,PRK,Successfully treated,86.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic People's Republic of Korea,PRK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic People's Republic of Korea,PRK,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic People's Republic of Korea,PRK,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic People's Republic of Korea,PRK,Successfully treated,83.5294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic People's Republic of Korea,PRK,Treatment failed,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic People's Republic of Korea,PRK,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic People's Republic of Korea,PRK,Lost to follow-up,3.52941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic People's Republic of Korea,PRK,Successfully treated,91.0377358490566 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic People's Republic of Korea,PRK,Treatment failed,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic People's Republic of Korea,PRK,Died,1.41509433962264 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic People's Republic of Korea,PRK,Lost to follow-up,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic People's Republic of Korea,PRK,Successfully treated,72.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic People's Republic of Korea,PRK,Treatment failed,12.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic People's Republic of Korea,PRK,Died,9.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic People's Republic of Korea,PRK,Lost to follow-up,4.92307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic People's Republic of Korea,PRK,Successfully treated,79.8525798525799 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic People's Republic of Korea,PRK,Treatment failed,6.87960687960688 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic People's Republic of Korea,PRK,Died,7.86240786240786 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic People's Republic of Korea,PRK,Lost to follow-up,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic People's Republic of Korea,PRK,Successfully treated,77.5981524249423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic People's Republic of Korea,PRK,Treatment failed,8.1986143187067 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic People's Republic of Korea,PRK,Died,6.63972286374134 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic People's Republic of Korea,PRK,Lost to follow-up,7.5635103926097 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic People's Republic of Korea,PRK,Successfully treated,74.5124411566913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic People's Republic of Korea,PRK,Treatment failed,9.95292535305985 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic People's Republic of Korea,PRK,Died,6.45595158036315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic People's Republic of Korea,PRK,Lost to follow-up,9.07868190988568 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic People's Republic of Korea,PRK,Successfully treated,71.8858131487889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic People's Republic of Korea,PRK,Treatment failed,18.4256055363322 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic People's Republic of Korea,PRK,Died,5.36332179930796 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic People's Republic of Korea,PRK,Lost to follow-up,4.32525951557093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic People's Republic of Korea,PRK,Successfully treated,70.46875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic People's Republic of Korea,PRK,Treatment failed,17.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic People's Republic of Korea,PRK,Died,6.40625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic People's Republic of Korea,PRK,Lost to follow-up,5.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic People's Republic of Korea,PRK,Successfully treated,79.5092024539877 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic People's Republic of Korea,PRK,Treatment failed,10.1840490797546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic People's Republic of Korea,PRK,Died,4.9079754601227 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic People's Republic of Korea,PRK,Lost to follow-up,5.39877300613497 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic People's Republic of Korea,PRK,Successfully treated,80.3571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic People's Republic of Korea,PRK,Treatment failed,10.1190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic People's Republic of Korea,PRK,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic People's Republic of Korea,PRK,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic People's Republic of Korea,PRK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Democratic Republic of the Congo,COD,Successfully treated,53.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Democratic Republic of the Congo,COD,Treatment failed,0.571428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Democratic Republic of the Congo,COD,Died,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Democratic Republic of the Congo,COD,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Democratic Republic of the Congo,COD,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Democratic Republic of the Congo,COD,Successfully treated,60.5442176870748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Democratic Republic of the Congo,COD,Treatment failed,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Democratic Republic of the Congo,COD,Died,13.6054421768707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Democratic Republic of the Congo,COD,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Democratic Republic of the Congo,COD,Not evaluated,7.48299319727891 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Democratic Republic of the Congo,COD,Successfully treated,55.940594059406 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Democratic Republic of the Congo,COD,Treatment failed,2.47524752475248 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Democratic Republic of the Congo,COD,Died,13.3663366336634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Democratic Republic of the Congo,COD,Lost to follow-up,19.3069306930693 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Democratic Republic of the Congo,COD,Not evaluated,8.91089108910891 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Democratic Republic of the Congo,COD,Successfully treated,32.7683615819209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Democratic Republic of the Congo,COD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Democratic Republic of the Congo,COD,Died,15.819209039548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Democratic Republic of the Congo,COD,Lost to follow-up,5.64971751412429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Democratic Republic of the Congo,COD,Not evaluated,45.7627118644068 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Democratic Republic of the Congo,COD,Successfully treated,36.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Democratic Republic of the Congo,COD,Treatment failed,1.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Democratic Republic of the Congo,COD,Died,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Democratic Republic of the Congo,COD,Lost to follow-up,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Democratic Republic of the Congo,COD,Not evaluated,37.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Democratic Republic of the Congo,COD,Successfully treated,59.4202898550725 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Democratic Republic of the Congo,COD,Treatment failed,1.44927536231884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Democratic Republic of the Congo,COD,Died,21.7391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Democratic Republic of the Congo,COD,Lost to follow-up,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Democratic Republic of the Congo,COD,Not evaluated,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic Republic of the Congo,COD,Successfully treated,64.1791044776119 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic Republic of the Congo,COD,Treatment failed,4.47761194029851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic Republic of the Congo,COD,Died,14.1791044776119 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic Republic of the Congo,COD,Lost to follow-up,12.6865671641791 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Democratic Republic of the Congo,COD,Not evaluated,4.47761194029851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic Republic of the Congo,COD,Successfully treated,63.0597014925373 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic Republic of the Congo,COD,Treatment failed,1.86567164179104 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic Republic of the Congo,COD,Died,14.1791044776119 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic Republic of the Congo,COD,Lost to follow-up,14.1791044776119 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Democratic Republic of the Congo,COD,Not evaluated,6.71641791044776 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic Republic of the Congo,COD,Successfully treated,74.5535714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic Republic of the Congo,COD,Treatment failed,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic Republic of the Congo,COD,Died,11.3839285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic Republic of the Congo,COD,Lost to follow-up,10.2678571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Democratic Republic of the Congo,COD,Not evaluated,0.223214285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic Republic of the Congo,COD,Successfully treated,90.280777537797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic Republic of the Congo,COD,Treatment failed,0.215982721382289 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic Republic of the Congo,COD,Died,6.26349892008639 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic Republic of the Congo,COD,Lost to follow-up,2.37580993520518 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Democratic Republic of the Congo,COD,Not evaluated,0.863930885529158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic Republic of the Congo,COD,Successfully treated,86.4353312302839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic Republic of the Congo,COD,Treatment failed,3.15457413249211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic Republic of the Congo,COD,Died,8.2018927444795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic Republic of the Congo,COD,Lost to follow-up,2.20820189274448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Democratic Republic of the Congo,COD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic Republic of the Congo,COD,Successfully treated,81.7422434367542 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic Republic of the Congo,COD,Treatment failed,2.74463007159905 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic Republic of the Congo,COD,Died,7.99522673031026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic Republic of the Congo,COD,Lost to follow-up,7.39856801909308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Democratic Republic of the Congo,COD,Not evaluated,0.119331742243437 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic Republic of the Congo,COD,Successfully treated,84.1201716738197 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic Republic of the Congo,COD,Treatment failed,3.14735336194564 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic Republic of the Congo,COD,Died,9.01287553648069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic Republic of the Congo,COD,Lost to follow-up,3.71959942775393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Democratic Republic of the Congo,COD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic Republic of the Congo,COD,Successfully treated,77.3722627737226 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic Republic of the Congo,COD,Treatment failed,2.79805352798054 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic Republic of the Congo,COD,Died,10.9489051094891 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic Republic of the Congo,COD,Lost to follow-up,8.88077858880779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Democratic Republic of the Congo,COD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic Republic of the Congo,COD,Successfully treated,91.4346895074947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic Republic of the Congo,COD,Treatment failed,2.24839400428266 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic Republic of the Congo,COD,Died,5.0321199143469 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic Republic of the Congo,COD,Lost to follow-up,1.2847965738758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Democratic Republic of the Congo,COD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic Republic of the Congo,COD,Successfully treated,95.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic Republic of the Congo,COD,Treatment failed,0.533333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic Republic of the Congo,COD,Died,3.11111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic Republic of the Congo,COD,Lost to follow-up,0.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Democratic Republic of the Congo,COD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic Republic of the Congo,COD,Successfully treated,96.07982893799 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic Republic of the Congo,COD,Treatment failed,0.498930862437634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic Republic of the Congo,COD,Died,2.70848182466144 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic Republic of the Congo,COD,Lost to follow-up,0.427655024946543 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Democratic Republic of the Congo,COD,Not evaluated,0.285103349964362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Denmark,DNK,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Denmark,DNK,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Denmark,DNK,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Denmark,DNK,Treatment failed,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Denmark,DNK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kazakhstan,KAZ,Died,6.40470832612082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kazakhstan,KAZ,Lost to follow-up,6.87207893370261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kazakhstan,KAZ,Not evaluated,6.9240090012117 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kazakhstan,KAZ,Successfully treated,74.3204713932713 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kazakhstan,KAZ,Treatment failed,7.08990686181334 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kazakhstan,KAZ,Died,7.92624976240259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kazakhstan,KAZ,Lost to follow-up,7.81220300323133 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kazakhstan,KAZ,Not evaluated,2.85116897928151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kazakhstan,KAZ,Successfully treated,72.9932067101068 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kazakhstan,KAZ,Treatment failed,7.1953417440732 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kazakhstan,KAZ,Died,8.8035491473728 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kazakhstan,KAZ,Lost to follow-up,7.30625259947317 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kazakhstan,KAZ,Not evaluated,3.70164979897407 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kazakhstan,KAZ,Successfully treated,72.468208978091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kazakhstan,KAZ,Treatment failed,6.52673510035238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kazakhstan,KAZ,Died,10.5101884479853 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kazakhstan,KAZ,Lost to follow-up,7.53791941167458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kazakhstan,KAZ,Not evaluated,2.95694806189674 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kazakhstan,KAZ,Successfully treated,76.1550632911392 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kazakhstan,KAZ,Treatment failed,5.87025316455696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kazakhstan,KAZ,Died,9.55696202531646 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kazakhstan,KAZ,Lost to follow-up,7.40506329113924 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kazakhstan,KAZ,Not evaluated,1.0126582278481 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kazakhstan,KAZ,Successfully treated,78.1086084541808 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kazakhstan,KAZ,Treatment failed,6.09379821042888 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kazakhstan,KAZ,Died,9.39524838012959 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kazakhstan,KAZ,Lost to follow-up,4.39679111385375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kazakhstan,KAZ,Not evaluated,2.00555384140697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kazakhstan,KAZ,Successfully treated,79.5367412140575 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kazakhstan,KAZ,Treatment failed,5.09584664536741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kazakhstan,KAZ,Died,8.91373801916933 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kazakhstan,KAZ,Lost to follow-up,4.10543130990415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kazakhstan,KAZ,Not evaluated,2.3482428115016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kazakhstan,KAZ,Successfully treated,81.3038591232671 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kazakhstan,KAZ,Treatment failed,4.19632821281379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kazakhstan,KAZ,Died,8.89846384413638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kazakhstan,KAZ,Lost to follow-up,4.92693892843762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kazakhstan,KAZ,Not evaluated,0.674409891345073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kazakhstan,KAZ,Successfully treated,80.6964944649447 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kazakhstan,KAZ,Treatment failed,4.19741697416974 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kazakhstan,KAZ,Died,9.40959409594096 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kazakhstan,KAZ,Lost to follow-up,4.98154981549816 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kazakhstan,KAZ,Not evaluated,0.714944649446495 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kazakhstan,KAZ,Successfully treated,76.1371350984386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kazakhstan,KAZ,Treatment failed,3.326544467074 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kazakhstan,KAZ,Died,10.183299389002 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kazakhstan,KAZ,Lost to follow-up,4.90495587236932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kazakhstan,KAZ,Not evaluated,5.44806517311609 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kazakhstan,KAZ,Successfully treated,75.8823529411765 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kazakhstan,KAZ,Treatment failed,2.38235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kazakhstan,KAZ,Died,13.3235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kazakhstan,KAZ,Lost to follow-up,3.52941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kazakhstan,KAZ,Not evaluated,4.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kazakhstan,KAZ,Successfully treated,81.6238289694932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kazakhstan,KAZ,Treatment failed,1.75354311794379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kazakhstan,KAZ,Died,12.2267595484026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kazakhstan,KAZ,Lost to follow-up,3.33893826567379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kazakhstan,KAZ,Not evaluated,1.05693009848667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kazakhstan,KAZ,Successfully treated,84.0502978160159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kazakhstan,KAZ,Treatment failed,1.4559894109861 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kazakhstan,KAZ,Died,9.86101919258769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kazakhstan,KAZ,Lost to follow-up,3.44142951687624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kazakhstan,KAZ,Not evaluated,1.19126406353408 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kenya,KEN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kenya,KEN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kenya,KEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kenya,KEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kenya,KEN,Successfully treated,68.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kenya,KEN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kenya,KEN,Lost to follow-up,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kenya,KEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kenya,KEN,Successfully treated,61.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kenya,KEN,Died,20.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kenya,KEN,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kenya,KEN,Not evaluated,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kenya,KEN,Successfully treated,68.5393258426966 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kenya,KEN,Died,21.3483146067416 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kenya,KEN,Lost to follow-up,10.1123595505618 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kenya,KEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kenya,KEN,Successfully treated,82.2916666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kenya,KEN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kenya,KEN,Lost to follow-up,5.20833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kenya,KEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kenya,KEN,Successfully treated,70.4918032786885 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kenya,KEN,Died,9.01639344262295 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kenya,KEN,Lost to follow-up,3.27868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Kenya,KEN,Not evaluated,17.2131147540984 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kenya,KEN,Successfully treated,83.248730964467 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kenya,KEN,Died,7.61421319796954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kenya,KEN,Lost to follow-up,8.62944162436548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Kenya,KEN,Not evaluated,0.50761421319797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kenya,KEN,Successfully treated,82.3308270676692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kenya,KEN,Treatment failed,0.37593984962406 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kenya,KEN,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kenya,KEN,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Kenya,KEN,Not evaluated,1.50375939849624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kenya,KEN,Successfully treated,71.7131474103586 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kenya,KEN,Treatment failed,0.398406374501992 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kenya,KEN,Died,17.1314741035857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kenya,KEN,Lost to follow-up,5.1792828685259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Kenya,KEN,Not evaluated,5.57768924302789 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kenya,KEN,Successfully treated,73.030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kenya,KEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kenya,KEN,Died,15.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kenya,KEN,Lost to follow-up,4.24242424242424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kenya,KEN,Not evaluated,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kenya,KEN,Successfully treated,67.5324675324675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kenya,KEN,Treatment failed,0.974025974025974 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kenya,KEN,Died,17.5324675324675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kenya,KEN,Lost to follow-up,7.79220779220779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Kenya,KEN,Not evaluated,6.16883116883117 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kenya,KEN,Successfully treated,70.2564102564103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kenya,KEN,Treatment failed,0.769230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kenya,KEN,Died,17.948717948718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kenya,KEN,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kenya,KEN,Not evaluated,4.35897435897436 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kenya,KEN,Successfully treated,74.4086021505376 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kenya,KEN,Treatment failed,0.645161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kenya,KEN,Died,15.2688172043011 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kenya,KEN,Lost to follow-up,5.37634408602151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kenya,KEN,Not evaluated,4.3010752688172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kenya,KEN,Successfully treated,73.1075697211155 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kenya,KEN,Treatment failed,0.99601593625498 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kenya,KEN,Died,15.5378486055777 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kenya,KEN,Lost to follow-up,6.17529880478088 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kenya,KEN,Not evaluated,4.18326693227092 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kenya,KEN,Successfully treated,76.7676767676768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kenya,KEN,Treatment failed,0.505050505050505 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kenya,KEN,Died,16.3299663299663 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kenya,KEN,Lost to follow-up,3.87205387205387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kenya,KEN,Not evaluated,2.52525252525253 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kenya,KEN,Successfully treated,78.0645161290323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kenya,KEN,Treatment failed,0.645161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kenya,KEN,Died,15.9139784946237 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kenya,KEN,Lost to follow-up,4.3010752688172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Kenya,KEN,Not evaluated,1.0752688172043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kenya,KEN,Successfully treated,78.5932721712538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kenya,KEN,Treatment failed,0.305810397553517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kenya,KEN,Died,16.8195718654434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kenya,KEN,Lost to follow-up,2.75229357798165 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kenya,KEN,Not evaluated,1.52905198776758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kiribati,KIR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kiribati,KIR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kiribati,KIR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kiribati,KIR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Kiribati,KIR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kiribati,KIR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kiribati,KIR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kiribati,KIR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kiribati,KIR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Kiribati,KIR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kiribati,KIR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kiribati,KIR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kiribati,KIR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kiribati,KIR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Kiribati,KIR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kiribati,KIR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kiribati,KIR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kiribati,KIR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kiribati,KIR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Kiribati,KIR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kiribati,KIR,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kiribati,KIR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kiribati,KIR,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kiribati,KIR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Kiribati,KIR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kiribati,KIR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kiribati,KIR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kiribati,KIR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kiribati,KIR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Kiribati,KIR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Kuwait,KWT,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Kuwait,KWT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Kuwait,KWT,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Kuwait,KWT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Kuwait,KWT,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Kuwait,KWT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Kuwait,KWT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Kuwait,KWT,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kuwait,KWT,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kuwait,KWT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Morocco,MAR,Not evaluated,45.0292397660819 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Morocco,MAR,Successfully treated,39.3162393162393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Morocco,MAR,Treatment failed,5.98290598290598 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Morocco,MAR,Died,8.54700854700855 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Morocco,MAR,Lost to follow-up,23.9316239316239 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Morocco,MAR,Not evaluated,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Morocco,MAR,Successfully treated,47.6190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Morocco,MAR,Treatment failed,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Morocco,MAR,Died,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Morocco,MAR,Lost to follow-up,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Morocco,MAR,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Morocco,MAR,Successfully treated,39.622641509434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Morocco,MAR,Treatment failed,3.14465408805031 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Morocco,MAR,Died,18.2389937106918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Morocco,MAR,Lost to follow-up,13.8364779874214 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Morocco,MAR,Not evaluated,25.1572327044025 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Morocco,MAR,Successfully treated,38.2165605095541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Morocco,MAR,Treatment failed,3.18471337579618 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Morocco,MAR,Died,17.1974522292994 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Morocco,MAR,Lost to follow-up,14.6496815286624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Morocco,MAR,Not evaluated,26.7515923566879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Morocco,MAR,Successfully treated,30.188679245283 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Morocco,MAR,Treatment failed,7.54716981132076 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Morocco,MAR,Died,16.9811320754717 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Morocco,MAR,Lost to follow-up,18.8679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Morocco,MAR,Not evaluated,26.4150943396226 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Morocco,MAR,Successfully treated,32.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Morocco,MAR,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Morocco,MAR,Died,17.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Morocco,MAR,Lost to follow-up,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Morocco,MAR,Not evaluated,27.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Morocco,MAR,Successfully treated,41.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Morocco,MAR,Treatment failed,6.15384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Morocco,MAR,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Morocco,MAR,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Morocco,MAR,Not evaluated,16.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Morocco,MAR,Successfully treated,59.6774193548387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Morocco,MAR,Treatment failed,8.87096774193548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Morocco,MAR,Died,13.7096774193548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Morocco,MAR,Lost to follow-up,14.5161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Morocco,MAR,Not evaluated,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Morocco,MAR,Successfully treated,56.0240963855422 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Morocco,MAR,Treatment failed,13.2530120481928 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Morocco,MAR,Died,10.8433734939759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Morocco,MAR,Lost to follow-up,19.2771084337349 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Morocco,MAR,Not evaluated,0.602409638554217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Morocco,MAR,Successfully treated,54.6610169491525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Morocco,MAR,Treatment failed,11.0169491525424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Morocco,MAR,Died,12.2881355932203 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Morocco,MAR,Lost to follow-up,15.2542372881356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Morocco,MAR,Not evaluated,6.77966101694915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Morocco,MAR,Successfully treated,48.2587064676617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Morocco,MAR,Treatment failed,5.97014925373134 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Morocco,MAR,Died,9.9502487562189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Morocco,MAR,Lost to follow-up,12.9353233830846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Morocco,MAR,Not evaluated,22.8855721393035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Morocco,MAR,Successfully treated,43.1095406360424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Morocco,MAR,Treatment failed,8.48056537102474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Morocco,MAR,Died,8.48056537102474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Morocco,MAR,Lost to follow-up,29.6819787985866 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Morocco,MAR,Not evaluated,10.2473498233216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Morocco,MAR,Successfully treated,57.0707070707071 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Morocco,MAR,Treatment failed,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Morocco,MAR,Died,17.6767676767677 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Morocco,MAR,Lost to follow-up,16.1616161616162 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Morocco,MAR,Not evaluated,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Morocco,MAR,Successfully treated,63.265306122449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Morocco,MAR,Treatment failed,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Morocco,MAR,Died,10.2040816326531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Morocco,MAR,Lost to follow-up,16.734693877551 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Morocco,MAR,Not evaluated,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Morocco,MAR,Successfully treated,69.1629955947137 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Morocco,MAR,Treatment failed,5.2863436123348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Morocco,MAR,Died,5.72687224669604 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Morocco,MAR,Lost to follow-up,19.3832599118943 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Morocco,MAR,Not evaluated,0.440528634361233 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Morocco,MAR,Successfully treated,65.9217877094972 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Morocco,MAR,Treatment failed,3.35195530726257 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Morocco,MAR,Died,12.2905027932961 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Morocco,MAR,Lost to follow-up,16.7597765363129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Morocco,MAR,Not evaluated,1.67597765363129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mozambique,MOZ,Successfully treated,40.8163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mozambique,MOZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mozambique,MOZ,Died,20.4081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mozambique,MOZ,Lost to follow-up,18.3673469387755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mozambique,MOZ,Not evaluated,20.4081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mozambique,MOZ,Successfully treated,36.6336633663366 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mozambique,MOZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mozambique,MOZ,Died,21.7821782178218 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mozambique,MOZ,Lost to follow-up,14.8514851485149 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mozambique,MOZ,Not evaluated,26.7326732673267 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mozambique,MOZ,Successfully treated,36.0294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mozambique,MOZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mozambique,MOZ,Died,25.7352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mozambique,MOZ,Lost to follow-up,16.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mozambique,MOZ,Not evaluated,22.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mozambique,MOZ,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mozambique,MOZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mozambique,MOZ,Died,20.4379562043796 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mozambique,MOZ,Lost to follow-up,11.6788321167883 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mozambique,MOZ,Not evaluated,67.8832116788321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mozambique,MOZ,Successfully treated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mozambique,MOZ,Treatment failed,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mozambique,MOZ,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mozambique,MOZ,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mozambique,MOZ,Not evaluated,39.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mozambique,MOZ,Successfully treated,31.2101910828026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mozambique,MOZ,Treatment failed,2.54777070063694 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mozambique,MOZ,Died,21.0191082802548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mozambique,MOZ,Lost to follow-up,15.9235668789809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mozambique,MOZ,Not evaluated,29.2993630573248 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mozambique,MOZ,Successfully treated,28.0373831775701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mozambique,MOZ,Treatment failed,1.86915887850467 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mozambique,MOZ,Died,27.5700934579439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mozambique,MOZ,Lost to follow-up,12.6168224299065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mozambique,MOZ,Not evaluated,29.9065420560748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mozambique,MOZ,Successfully treated,52.0766773162939 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mozambique,MOZ,Treatment failed,0.958466453674122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mozambique,MOZ,Died,24.2811501597444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mozambique,MOZ,Lost to follow-up,18.5303514376997 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mozambique,MOZ,Not evaluated,4.15335463258786 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mozambique,MOZ,Successfully treated,49.6583143507973 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mozambique,MOZ,Treatment failed,1.82232346241458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mozambique,MOZ,Died,21.6400911161731 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mozambique,MOZ,Lost to follow-up,14.3507972665148 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mozambique,MOZ,Not evaluated,12.5284738041002 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mozambique,MOZ,Successfully treated,47.8328173374613 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mozambique,MOZ,Treatment failed,2.47678018575851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mozambique,MOZ,Died,25.8513931888545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mozambique,MOZ,Lost to follow-up,10.8359133126935 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mozambique,MOZ,Not evaluated,13.0030959752322 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mozambique,MOZ,Successfully treated,49.5316159250586 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mozambique,MOZ,Treatment failed,2.34192037470726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mozambique,MOZ,Died,15.5737704918033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mozambique,MOZ,Lost to follow-up,11.4754098360656 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mozambique,MOZ,Not evaluated,21.0772833723653 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mozambique,MOZ,Successfully treated,61.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mozambique,MOZ,Treatment failed,2.3030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mozambique,MOZ,Died,22.7878787878788 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mozambique,MOZ,Lost to follow-up,12.969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mozambique,MOZ,Not evaluated,0.484848484848485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mozambique,MOZ,Successfully treated,65.8379373848987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mozambique,MOZ,Treatment failed,4.41988950276243 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mozambique,MOZ,Died,18.0478821362799 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mozambique,MOZ,Lost to follow-up,11.6942909760589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mozambique,MOZ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mozambique,MOZ,Successfully treated,72.4550898203593 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mozambique,MOZ,Treatment failed,4.79041916167665 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mozambique,MOZ,Died,13.6976047904192 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mozambique,MOZ,Lost to follow-up,8.15868263473054 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mozambique,MOZ,Not evaluated,0.898203592814371 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mozambique,MOZ,Successfully treated,75.361216730038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mozambique,MOZ,Treatment failed,2.28136882129278 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mozambique,MOZ,Died,12.3954372623574 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mozambique,MOZ,Lost to follow-up,8.36501901140684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mozambique,MOZ,Not evaluated,1.59695817490494 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mozambique,MOZ,Successfully treated,76.6467065868264 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mozambique,MOZ,Treatment failed,1.27245508982036 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mozambique,MOZ,Died,10.7035928143713 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mozambique,MOZ,Lost to follow-up,8.23353293413174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mozambique,MOZ,Not evaluated,3.1437125748503 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mozambique,MOZ,Successfully treated,76.7895878524946 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mozambique,MOZ,Treatment failed,1.08459869848156 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mozambique,MOZ,Died,9.18293564714389 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mozambique,MOZ,Lost to follow-up,8.6767895878525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mozambique,MOZ,Not evaluated,4.26608821402748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Myanmar,MMR,Successfully treated,73.4375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Myanmar,MMR,Treatment failed,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Myanmar,MMR,Died,17.1875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Myanmar,MMR,Lost to follow-up,7.8125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Myanmar,MMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Myanmar,MMR,Successfully treated,69.6808510638298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Myanmar,MMR,Treatment failed,1.59574468085106 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Myanmar,MMR,Died,17.5531914893617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Myanmar,MMR,Lost to follow-up,10.6382978723404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Myanmar,MMR,Not evaluated,0.531914893617021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Myanmar,MMR,Successfully treated,71.1656441717791 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Myanmar,MMR,Treatment failed,1.22699386503067 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Myanmar,MMR,Died,16.5644171779141 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Myanmar,MMR,Lost to follow-up,11.0429447852761 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Myanmar,MMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Myanmar,MMR,Successfully treated,79.2325056433409 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Myanmar,MMR,Treatment failed,1.8058690744921 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Myanmar,MMR,Died,15.8013544018059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Myanmar,MMR,Lost to follow-up,2.70880361173815 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Myanmar,MMR,Not evaluated,0.451467268623025 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Myanmar,MMR,Successfully treated,82.7586206896552 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Myanmar,MMR,Treatment failed,1.19940029985008 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Myanmar,MMR,Died,12.743628185907 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Myanmar,MMR,Lost to follow-up,2.99850074962519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Myanmar,MMR,Not evaluated,0.299850074962519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Myanmar,MMR,Successfully treated,80.2271209084836 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Azerbaijan,AZE,Successfully treated,61.4334470989761 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Azerbaijan,AZE,Treatment failed,24.7440273037543 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Azerbaijan,AZE,Died,10.0682593856655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Azerbaijan,AZE,Lost to follow-up,3.7542662116041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Azerbaijan,AZE,Successfully treated,65.0375939849624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Azerbaijan,AZE,Treatment failed,16.5413533834586 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Azerbaijan,AZE,Died,7.01754385964912 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Azerbaijan,AZE,Lost to follow-up,11.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Azerbaijan,AZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Azerbaijan,AZE,Successfully treated,67.3988439306358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Azerbaijan,AZE,Treatment failed,7.51445086705202 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Azerbaijan,AZE,Died,8.90173410404624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Azerbaijan,AZE,Lost to follow-up,15.4913294797688 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Azerbaijan,AZE,Not evaluated,0.69364161849711 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bahamas,BHS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bahamas,BHS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bahamas,BHS,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bahamas,BHS,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bahamas,BHS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bahamas,BHS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bahamas,BHS,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bahamas,BHS,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bahamas,BHS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bahamas,BHS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bahamas,BHS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bahamas,BHS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahamas,BHS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahamas,BHS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahamas,BHS,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahamas,BHS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahamas,BHS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahamas,BHS,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahamas,BHS,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bahrain,BHR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bahrain,BHR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bahrain,BHR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bahrain,BHR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Bahrain,BHR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bahrain,BHR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bahrain,BHR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bahrain,BHR,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bahrain,BHR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bahrain,BHR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bahrain,BHR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bahrain,BHR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bahrain,BHR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bahrain,BHR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bahrain,BHR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bahrain,BHR,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bahrain,BHR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bahrain,BHR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bahrain,BHR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bahrain,BHR,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahrain,BHR,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahrain,BHR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahrain,BHR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahrain,BHR,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bahrain,BHR,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahrain,BHR,Successfully treated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahrain,BHR,Lost to follow-up,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bahrain,BHR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bangladesh,BGD,Successfully treated,82.0754716981132 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bangladesh,BGD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bangladesh,BGD,Died,9.43396226415094 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bangladesh,BGD,Lost to follow-up,8.49056603773585 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Bangladesh,BGD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bangladesh,BGD,Successfully treated,83.0645161290323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bangladesh,BGD,Treatment failed,2.41935483870968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bangladesh,BGD,Died,4.83870967741936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bangladesh,BGD,Lost to follow-up,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Bangladesh,BGD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bangladesh,BGD,Successfully treated,62.874251497006 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bangladesh,BGD,Treatment failed,1.19760479041916 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bangladesh,BGD,Died,11.9760479041916 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bangladesh,BGD,Lost to follow-up,18.562874251497 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Bangladesh,BGD,Not evaluated,5.38922155688623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bangladesh,BGD,Successfully treated,75.0759878419453 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bangladesh,BGD,Treatment failed,0.60790273556231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bangladesh,BGD,Died,10.6382978723404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bangladesh,BGD,Lost to follow-up,12.7659574468085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Bangladesh,BGD,Not evaluated,0.911854103343465 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bangladesh,BGD,Successfully treated,68.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bangladesh,BGD,Treatment failed,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bangladesh,BGD,Died,14.1666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bangladesh,BGD,Lost to follow-up,14.1666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Bangladesh,BGD,Not evaluated,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bangladesh,BGD,Successfully treated,72.0792079207921 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bangladesh,BGD,Treatment failed,0.99009900990099 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bangladesh,BGD,Died,11.4851485148515 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bangladesh,BGD,Lost to follow-up,13.4653465346535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Bangladesh,BGD,Not evaluated,1.98019801980198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bangladesh,BGD,Successfully treated,74.7813411078717 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bangladesh,BGD,Treatment failed,0.728862973760933 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bangladesh,BGD,Died,11.9533527696793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bangladesh,BGD,Lost to follow-up,8.60058309037901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Bangladesh,BGD,Not evaluated,3.93586005830904 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bangladesh,BGD,Successfully treated,74.1014799154334 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bangladesh,BGD,Treatment failed,0.739957716701903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bangladesh,BGD,Died,12.5792811839323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bangladesh,BGD,Lost to follow-up,9.40803382663848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Bangladesh,BGD,Not evaluated,3.17124735729387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bangladesh,BGD,Successfully treated,78.2954545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bangladesh,BGD,Treatment failed,1.02272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bangladesh,BGD,Died,10.2272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bangladesh,BGD,Lost to follow-up,7.84090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Bangladesh,BGD,Not evaluated,2.61363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bangladesh,BGD,Successfully treated,77.8867102396514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bangladesh,BGD,Treatment failed,2.17864923747277 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bangladesh,BGD,Died,11.6557734204793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bangladesh,BGD,Lost to follow-up,6.97167755991285 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Bangladesh,BGD,Not evaluated,1.30718954248366 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bangladesh,BGD,Successfully treated,73.0141458106638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bangladesh,BGD,Treatment failed,4.24374319912949 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bangladesh,BGD,Died,9.14036996735582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bangladesh,BGD,Lost to follow-up,10.6637649619151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Bangladesh,BGD,Not evaluated,2.9379760609358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bangladesh,BGD,Successfully treated,74.1063644289451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bangladesh,BGD,Treatment failed,3.5745422842197 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bangladesh,BGD,Died,7.67218831734961 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bangladesh,BGD,Lost to follow-up,11.8570183086312 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Bangladesh,BGD,Not evaluated,2.7898866608544 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bangladesh,BGD,Successfully treated,73.6032388663968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bangladesh,BGD,Treatment failed,3.7246963562753 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bangladesh,BGD,Died,8.25910931174089 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bangladesh,BGD,Lost to follow-up,11.0931174089069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Bangladesh,BGD,Not evaluated,3.31983805668016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bangladesh,BGD,Successfully treated,72.6239669421488 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bangladesh,BGD,Treatment failed,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bangladesh,BGD,Died,10.4338842975207 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bangladesh,BGD,Lost to follow-up,12.2933884297521 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Bangladesh,BGD,Not evaluated,2.37603305785124 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bangladesh,BGD,Successfully treated,76.8063583815029 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bangladesh,BGD,Treatment failed,2.3121387283237 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bangladesh,BGD,Died,8.67052023121387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bangladesh,BGD,Lost to follow-up,8.52601156069364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Bangladesh,BGD,Not evaluated,3.6849710982659 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bangladesh,BGD,Successfully treated,78.4267912772586 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bangladesh,BGD,Treatment failed,1.79127725856698 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bangladesh,BGD,Died,8.64485981308411 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bangladesh,BGD,Lost to follow-up,5.45171339563863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Bangladesh,BGD,Not evaluated,5.68535825545171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belarus,BLR,Successfully treated,40.225035161744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belarus,BLR,Treatment failed,10.9704641350211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belarus,BLR,Died,15.0492264416315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belarus,BLR,Lost to follow-up,12.3066104078762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Belarus,BLR,Not evaluated,21.4486638537271 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belarus,BLR,Successfully treated,31.3453536754508 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belarus,BLR,Treatment failed,17.4063800277393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belarus,BLR,Died,10.3328710124827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belarus,BLR,Lost to follow-up,12.1359223300971 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Belarus,BLR,Not evaluated,28.7794729542302 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belarus,BLR,Successfully treated,50.4375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belarus,BLR,Treatment failed,23.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belarus,BLR,Died,10.875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belarus,BLR,Lost to follow-up,9.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Belarus,BLR,Not evaluated,5.6875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belarus,BLR,Successfully treated,54.4440015942607 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belarus,BLR,Treatment failed,21.7218015145476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belarus,BLR,Died,10.6815464328418 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belarus,BLR,Lost to follow-up,9.88441610203268 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Belarus,BLR,Not evaluated,3.26823435631726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belarus,BLR,Successfully treated,53.9325842696629 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belarus,BLR,Treatment failed,22.5187265917603 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belarus,BLR,Died,10.2059925093633 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belarus,BLR,Lost to follow-up,11.9850187265918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Belarus,BLR,Not evaluated,1.35767790262172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belarus,BLR,Successfully treated,59.2391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belarus,BLR,Treatment failed,19.633152173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belarus,BLR,Died,8.55978260869565 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belarus,BLR,Lost to follow-up,12.2961956521739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Belarus,BLR,Not evaluated,0.271739130434783 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Belarus,BLR,Successfully treated,64.2142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Côte d'Ivoire,CIV,Treatment failed,27.027027027027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Côte d'Ivoire,CIV,Died,29.7297297297297 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Côte d'Ivoire,CIV,Lost to follow-up,37.8378378378378 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Côte d'Ivoire,CIV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Côte d'Ivoire,CIV,Successfully treated,85.2090032154341 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Côte d'Ivoire,CIV,Treatment failed,4.18006430868167 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Côte d'Ivoire,CIV,Died,7.39549839228296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Côte d'Ivoire,CIV,Lost to follow-up,3.21543408360129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Côte d'Ivoire,CIV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Côte d'Ivoire,CIV,Successfully treated,85.2090032154341 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Côte d'Ivoire,CIV,Treatment failed,4.18006430868167 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Côte d'Ivoire,CIV,Died,7.39549839228296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Côte d'Ivoire,CIV,Lost to follow-up,3.21543408360129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Côte d'Ivoire,CIV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Côte d'Ivoire,CIV,Successfully treated,76.3819095477387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Côte d'Ivoire,CIV,Treatment failed,2.76381909547739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Côte d'Ivoire,CIV,Died,14.321608040201 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Côte d'Ivoire,CIV,Lost to follow-up,6.03015075376885 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Côte d'Ivoire,CIV,Not evaluated,0.50251256281407 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Côte d'Ivoire,CIV,Successfully treated,74.5283018867925 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Côte d'Ivoire,CIV,Treatment failed,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Côte d'Ivoire,CIV,Died,14.4654088050314 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Côte d'Ivoire,CIV,Lost to follow-up,6.91823899371069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Côte d'Ivoire,CIV,Not evaluated,0.314465408805031 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Côte d'Ivoire,CIV,Successfully treated,74.5283018867925 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Côte d'Ivoire,CIV,Treatment failed,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Côte d'Ivoire,CIV,Died,14.4654088050314 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Côte d'Ivoire,CIV,Lost to follow-up,6.91823899371069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Côte d'Ivoire,CIV,Not evaluated,0.314465408805031 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Côte d'Ivoire,CIV,Successfully treated,74.1935483870968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Côte d'Ivoire,CIV,Treatment failed,4.3010752688172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Côte d'Ivoire,CIV,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Côte d'Ivoire,CIV,Lost to follow-up,4.3010752688172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Côte d'Ivoire,CIV,Not evaluated,0.537634408602151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Côte d'Ivoire,CIV,Successfully treated,72.3350253807107 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Côte d'Ivoire,CIV,Treatment failed,4.56852791878173 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Côte d'Ivoire,CIV,Died,14.7208121827411 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Côte d'Ivoire,CIV,Lost to follow-up,8.3756345177665 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Côte d'Ivoire,CIV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Côte d'Ivoire,CIV,Successfully treated,77.8645833333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Côte d'Ivoire,CIV,Treatment failed,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Côte d'Ivoire,CIV,Died,11.9791666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Côte d'Ivoire,CIV,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Côte d'Ivoire,CIV,Not evaluated,0.78125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Côte d'Ivoire,CIV,Successfully treated,75.1121076233184 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Côte d'Ivoire,CIV,Treatment failed,5.38116591928251 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Côte d'Ivoire,CIV,Died,11.4349775784753 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Côte d'Ivoire,CIV,Lost to follow-up,7.847533632287 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Côte d'Ivoire,CIV,Not evaluated,0.224215246636771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Côte d'Ivoire,CIV,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Côte d'Ivoire,CIV,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Côte d'Ivoire,CIV,Died,11.1363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Côte d'Ivoire,CIV,Lost to follow-up,10.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Côte d'Ivoire,CIV,Not evaluated,1.13636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Croatia,HRV,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Croatia,HRV,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Croatia,HRV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Croatia,HRV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Croatia,HRV,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Croatia,HRV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Croatia,HRV,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Croatia,HRV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Croatia,HRV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Croatia,HRV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Croatia,HRV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Croatia,HRV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Croatia,HRV,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Croatia,HRV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Croatia,HRV,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Croatia,HRV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Croatia,HRV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cuba,CUB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cuba,CUB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cuba,CUB,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cuba,CUB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cuba,CUB,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cuba,CUB,Successfully treated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cuba,CUB,Died,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cuba,CUB,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cuba,CUB,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cuba,CUB,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cuba,CUB,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cuba,CUB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cuba,CUB,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cuba,CUB,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cuba,CUB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cuba,CUB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cuba,CUB,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cuba,CUB,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cuba,CUB,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cuba,CUB,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cuba,CUB,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cuba,CUB,Died,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cuba,CUB,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cuba,CUB,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cuba,CUB,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cuba,CUB,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cuba,CUB,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cuba,CUB,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cuba,CUB,Successfully treated,34.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cuba,CUB,Treatment failed,34.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cuba,CUB,Died,30.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cuba,CUB,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cuba,CUB,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cuba,CUB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cuba,CUB,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cuba,CUB,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cuba,CUB,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cuba,CUB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cuba,CUB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cuba,CUB,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cuba,CUB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cuba,CUB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cuba,CUB,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cuba,CUB,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cuba,CUB,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cuba,CUB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Cyprus,CYP,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Cyprus,CYP,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Cyprus,CYP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Cyprus,CYP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Cyprus,CYP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cyprus,CYP,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cyprus,CYP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cyprus,CYP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cyprus,CYP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cyprus,CYP,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cyprus,CYP,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cyprus,CYP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cyprus,CYP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cyprus,CYP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cyprus,CYP,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cyprus,CYP,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cyprus,CYP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cyprus,CYP,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cyprus,CYP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cyprus,CYP,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Czechia,CZE,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Czechia,CZE,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Czechia,CZE,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Czechia,CZE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Czechia,CZE,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Czechia,CZE,Treatment failed,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Czechia,CZE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Czechia,CZE,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Czechia,CZE,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Czechia,CZE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Czechia,CZE,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Czechia,CZE,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Czechia,CZE,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Czechia,CZE,Successfully treated,44.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Czechia,CZE,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Czechia,CZE,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Czechia,CZE,Not evaluated,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Czechia,CZE,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Czechia,CZE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Czechia,CZE,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Czechia,CZE,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Czechia,CZE,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Czechia,CZE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Czechia,CZE,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Czechia,CZE,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Czechia,CZE,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Czechia,CZE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Czechia,CZE,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Czechia,CZE,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guam,GUM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guam,GUM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guam,GUM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guam,GUM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guam,GUM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guam,GUM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guatemala,GTM,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guatemala,GTM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guatemala,GTM,Died,5.35714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guatemala,GTM,Lost to follow-up,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guatemala,GTM,Not evaluated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guatemala,GTM,Successfully treated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guatemala,GTM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guatemala,GTM,Died,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guatemala,GTM,Lost to follow-up,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guatemala,GTM,Not evaluated,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guatemala,GTM,Successfully treated,59.2592592592593 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guatemala,GTM,Treatment failed,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guatemala,GTM,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guatemala,GTM,Lost to follow-up,29.6296296296296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guatemala,GTM,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guatemala,GTM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guatemala,GTM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guatemala,GTM,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guatemala,GTM,Successfully treated,70.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guatemala,GTM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guatemala,GTM,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guatemala,GTM,Lost to follow-up,18.5185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guatemala,GTM,Not evaluated,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guatemala,GTM,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guatemala,GTM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guatemala,GTM,Died,12.8205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guatemala,GTM,Lost to follow-up,17.948717948718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guatemala,GTM,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guatemala,GTM,Treatment failed,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guatemala,GTM,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guatemala,GTM,Lost to follow-up,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guatemala,GTM,Successfully treated,58.5365853658537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guatemala,GTM,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guatemala,GTM,Died,9.75609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guatemala,GTM,Lost to follow-up,26.8292682926829 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guatemala,GTM,Not evaluated,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guatemala,GTM,Successfully treated,51.1627906976744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guatemala,GTM,Treatment failed,6.97674418604651 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guatemala,GTM,Died,13.953488372093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guatemala,GTM,Lost to follow-up,27.906976744186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guatemala,GTM,Successfully treated,51.8518518518519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guatemala,GTM,Treatment failed,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guatemala,GTM,Died,12.962962962963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guatemala,GTM,Lost to follow-up,31.4814814814815 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guatemala,GTM,Successfully treated,41.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guatemala,GTM,Treatment failed,1.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guatemala,GTM,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guatemala,GTM,Lost to follow-up,34.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guatemala,GTM,Not evaluated,2.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guatemala,GTM,Successfully treated,40.3508771929825 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guatemala,GTM,Treatment failed,3.50877192982456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guatemala,GTM,Died,19.2982456140351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guatemala,GTM,Lost to follow-up,36.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guatemala,GTM,Successfully treated,57.2815533980583 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guatemala,GTM,Treatment failed,1.94174757281553 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guatemala,GTM,Died,17.4757281553398 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guatemala,GTM,Lost to follow-up,23.3009708737864 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guatemala,GTM,Successfully treated,55.8441558441558 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guatemala,GTM,Treatment failed,6.49350649350649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guatemala,GTM,Died,10.3896103896104 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guatemala,GTM,Lost to follow-up,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guatemala,GTM,Successfully treated,64.0625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guatemala,GTM,Treatment failed,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guatemala,GTM,Died,10.9375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guatemala,GTM,Lost to follow-up,15.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guatemala,GTM,Successfully treated,69.6969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guatemala,GTM,Treatment failed,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guatemala,GTM,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guatemala,GTM,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guatemala,GTM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guinea,GIN,Successfully treated,70.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guinea,GIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guinea,GIN,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guinea,GIN,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guinea,GIN,Not evaluated,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guinea,GIN,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guinea,GIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guinea,GIN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guinea,GIN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Guinea,GIN,Not evaluated,58.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guinea,GIN,Successfully treated,58.0645161290323 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guinea,GIN,Treatment failed,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guinea,GIN,Died,19.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guinea,GIN,Lost to follow-up,16.1290322580645 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Guinea,GIN,Not evaluated,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guinea,GIN,Successfully treated,81.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guinea,GIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guinea,GIN,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guinea,GIN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea,GIN,Successfully treated,7.2289156626506 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea,GIN,Treatment failed,2.40963855421687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea,GIN,Died,18.0722891566265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea,GIN,Lost to follow-up,2.40963855421687 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea,GIN,Not evaluated,69.8795180722892 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea,GIN,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea,GIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea,GIN,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea,GIN,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea,GIN,Successfully treated,58.4905660377359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea,GIN,Treatment failed,1.88679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea,GIN,Died,18.8679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea,GIN,Lost to follow-up,15.0943396226415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea,GIN,Not evaluated,5.66037735849057 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea,GIN,Successfully treated,74.7967479674797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea,GIN,Treatment failed,1.6260162601626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea,GIN,Died,16.260162601626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea,GIN,Lost to follow-up,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea,GIN,Successfully treated,78.8461538461538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea,GIN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea,GIN,Died,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea,GIN,Lost to follow-up,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea,GIN,Successfully treated,70.0729927007299 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea,GIN,Treatment failed,5.10948905109489 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea,GIN,Died,12.4087591240876 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea,GIN,Lost to follow-up,12.4087591240876 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea,GIN,Successfully treated,76.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea,GIN,Treatment failed,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea,GIN,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea,GIN,Lost to follow-up,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea,GIN,Not evaluated,8.92857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea,GIN,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea,GIN,Treatment failed,1.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea,GIN,Died,19.5238095238095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea,GIN,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea,GIN,Not evaluated,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea,GIN,Successfully treated,75.3246753246753 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea,GIN,Treatment failed,1.73160173160173 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea,GIN,Died,13.8528138528139 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea,GIN,Lost to follow-up,8.22510822510823 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea,GIN,Not evaluated,0.865800865800866 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea,GIN,Successfully treated,74.9063670411985 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea,GIN,Treatment failed,2.62172284644195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea,GIN,Died,17.6029962546817 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea,GIN,Lost to follow-up,4.8689138576779 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea,GIN,Successfully treated,73.968253968254 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea,GIN,Treatment failed,2.53968253968254 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea,GIN,Died,16.8253968253968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea,GIN,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea,GIN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea,GIN,Successfully treated,76.0479041916168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea,GIN,Treatment failed,2.09580838323353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea,GIN,Died,10.7784431137725 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea,GIN,Lost to follow-up,8.98203592814371 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea,GIN,Not evaluated,2.09580838323353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea-Bissau,GNB,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea-Bissau,GNB,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea-Bissau,GNB,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea-Bissau,GNB,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea-Bissau,GNB,Died,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea-Bissau,GNB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea-Bissau,GNB,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea-Bissau,GNB,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea-Bissau,GNB,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Guinea-Bissau,GNB,Not evaluated,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea-Bissau,GNB,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea-Bissau,GNB,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea-Bissau,GNB,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Guinea-Bissau,GNB,Not evaluated,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea-Bissau,GNB,Successfully treated,46.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Israel,ISR,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Israel,ISR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Israel,ISR,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Israel,ISR,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Israel,ISR,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Israel,ISR,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Israel,ISR,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Israel,ISR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Israel,ISR,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Israel,ISR,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Israel,ISR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Israel,ISR,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Israel,ISR,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Israel,ISR,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Israel,ISR,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Israel,ISR,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Israel,ISR,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Israel,ISR,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Israel,ISR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Israel,ISR,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Israel,ISR,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Israel,ISR,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Israel,ISR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Israel,ISR,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Israel,ISR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Israel,ISR,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Israel,ISR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Israel,ISR,Not evaluated,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jamaica,JAM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jamaica,JAM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jamaica,JAM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jamaica,JAM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jamaica,JAM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Japan,JPN,Successfully treated,51.7857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Japan,JPN,Died,19.6428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Japan,JPN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Japan,JPN,Not evaluated,16.0714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Japan,JPN,Successfully treated,52.3809523809524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Japan,JPN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Japan,JPN,Lost to follow-up,1.58730158730159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Japan,JPN,Not evaluated,31.7460317460318 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Japan,JPN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Japan,JPN,Died,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Japan,JPN,Lost to follow-up,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Japan,JPN,Not evaluated,22.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Japan,JPN,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Japan,JPN,Died,20.4081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Japan,JPN,Lost to follow-up,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Japan,JPN,Not evaluated,18.3673469387755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Japan,JPN,Successfully treated,70.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Japan,JPN,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Japan,JPN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Japan,JPN,Not evaluated,10.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Japan,JPN,Successfully treated,62.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Japan,JPN,Died,16.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Japan,JPN,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Japan,JPN,Not evaluated,18.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Japan,JPN,Successfully treated,59.4594594594595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Japan,JPN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Japan,JPN,Died,16.2162162162162 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Japan,JPN,Lost to follow-up,2.7027027027027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Japan,JPN,Not evaluated,21.6216216216216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Jordan,JOR,Successfully treated,61.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Jordan,JOR,Treatment failed,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Jordan,JOR,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Jordan,JOR,Lost to follow-up,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Jordan,JOR,Not evaluated,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Jordan,JOR,Successfully treated,56.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Jordan,JOR,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Jordan,JOR,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Jordan,JOR,Not evaluated,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Jordan,JOR,Successfully treated,57.8947368421053 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Jordan,JOR,Died,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Jordan,JOR,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Jordan,JOR,Not evaluated,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Jordan,JOR,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Jordan,JOR,Not evaluated,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Jordan,JOR,Successfully treated,44.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Jordan,JOR,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Jordan,JOR,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Jordan,JOR,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Jordan,JOR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Jordan,JOR,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Jordan,JOR,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Jordan,JOR,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Jordan,JOR,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Jordan,JOR,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jordan,JOR,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jordan,JOR,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Jordan,JOR,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Jordan,JOR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Jordan,JOR,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Jordan,JOR,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Jordan,JOR,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Jordan,JOR,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Jordan,JOR,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Jordan,JOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Jordan,JOR,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Jordan,JOR,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Jordan,JOR,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Jordan,JOR,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Jordan,JOR,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Jordan,JOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Jordan,JOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Jordan,JOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Jordan,JOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Jordan,JOR,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Jordan,JOR,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Jordan,JOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Jordan,JOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Jordan,JOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Jordan,JOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Jordan,JOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kazakhstan,KAZ,Successfully treated,80.8602150537634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kazakhstan,KAZ,Treatment failed,3.97849462365591 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kazakhstan,KAZ,Died,4.3010752688172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kazakhstan,KAZ,Lost to follow-up,5.48387096774194 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Kazakhstan,KAZ,Not evaluated,5.37634408602151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kazakhstan,KAZ,Successfully treated,76.8800497203232 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kazakhstan,KAZ,Treatment failed,3.97762585456805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kazakhstan,KAZ,Died,4.47482908638906 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kazakhstan,KAZ,Lost to follow-up,3.54257302672467 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Kazakhstan,KAZ,Not evaluated,11.124922311995 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kazakhstan,KAZ,Successfully treated,74.0740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kazakhstan,KAZ,Treatment failed,4.93827160493827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kazakhstan,KAZ,Died,5.29100529100529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kazakhstan,KAZ,Lost to follow-up,3.92416225749559 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Kazakhstan,KAZ,Not evaluated,11.7724867724868 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kazakhstan,KAZ,Successfully treated,73.158840133436 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kazakhstan,KAZ,Treatment failed,7.15935334872979 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kazakhstan,KAZ,Died,6.5178342314601 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kazakhstan,KAZ,Lost to follow-up,5.31177829099307 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Kazakhstan,KAZ,Not evaluated,7.85219399538106 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kazakhstan,KAZ,Successfully treated,72.6501644452138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Kazakhstan,KAZ,Treatment failed,7.14903929375108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mexico,MEX,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mexico,MEX,Lost to follow-up,20.7792207792208 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mexico,MEX,Successfully treated,63.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mexico,MEX,Treatment failed,4.90196078431373 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mexico,MEX,Died,9.31372549019608 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mexico,MEX,Lost to follow-up,22.5490196078431 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mexico,MEX,Successfully treated,57.7358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mexico,MEX,Treatment failed,4.90566037735849 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mexico,MEX,Died,8.30188679245283 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mexico,MEX,Lost to follow-up,29.0566037735849 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mexico,MEX,Successfully treated,54.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mexico,MEX,Treatment failed,9.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mexico,MEX,Died,15.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mexico,MEX,Lost to follow-up,18.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mexico,MEX,Not evaluated,1.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mexico,MEX,Successfully treated,67.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mexico,MEX,Treatment failed,8.71794871794872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mexico,MEX,Died,11.2820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mexico,MEX,Lost to follow-up,11.2820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mexico,MEX,Not evaluated,1.02564102564103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mexico,MEX,Successfully treated,63.3440514469453 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mexico,MEX,Treatment failed,8.68167202572347 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mexico,MEX,Died,15.112540192926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mexico,MEX,Lost to follow-up,8.68167202572347 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mexico,MEX,Not evaluated,4.18006430868167 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mexico,MEX,Successfully treated,75.3246753246753 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mexico,MEX,Treatment failed,7.35930735930736 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mexico,MEX,Died,5.62770562770563 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mexico,MEX,Lost to follow-up,11.6883116883117 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mexico,MEX,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Micronesia (Federated States of),FSM,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Micronesia (Federated States of),FSM,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Micronesia (Federated States of),FSM,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Micronesia (Federated States of),FSM,Died,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Micronesia (Federated States of),FSM,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Micronesia (Federated States of),FSM,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Micronesia (Federated States of),FSM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Micronesia (Federated States of),FSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Micronesia (Federated States of),FSM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Micronesia (Federated States of),FSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Micronesia (Federated States of),FSM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Micronesia (Federated States of),FSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Micronesia (Federated States of),FSM,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Micronesia (Federated States of),FSM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Micronesia (Federated States of),FSM,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Micronesia (Federated States of),FSM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Micronesia (Federated States of),FSM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mongolia,MNG,Successfully treated,66.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mongolia,MNG,Treatment failed,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mongolia,MNG,Died,14.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mongolia,MNG,Lost to follow-up,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Mongolia,MNG,Not evaluated,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mongolia,MNG,Successfully treated,78.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mongolia,MNG,Treatment failed,4.6875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mongolia,MNG,Died,7.8125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mongolia,MNG,Lost to follow-up,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mongolia,MNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mongolia,MNG,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mongolia,MNG,Treatment failed,4.61538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mongolia,MNG,Died,9.23076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mongolia,MNG,Lost to follow-up,9.23076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mongolia,MNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mongolia,MNG,Successfully treated,73.8636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mongolia,MNG,Treatment failed,10.2272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mongolia,MNG,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mongolia,MNG,Lost to follow-up,6.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mongolia,MNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mongolia,MNG,Successfully treated,74.3589743589744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mongolia,MNG,Treatment failed,5.12820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mongolia,MNG,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mongolia,MNG,Lost to follow-up,8.97435897435897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mongolia,MNG,Not evaluated,3.20512820512821 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mongolia,MNG,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mongolia,MNG,Treatment failed,7.93650793650794 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mongolia,MNG,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mongolia,MNG,Lost to follow-up,11.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mongolia,MNG,Not evaluated,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mongolia,MNG,Successfully treated,61.4525139664805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mongolia,MNG,Treatment failed,6.70391061452514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mongolia,MNG,Died,10.0558659217877 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mongolia,MNG,Lost to follow-up,18.9944134078212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mongolia,MNG,Not evaluated,2.79329608938548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mongolia,MNG,Successfully treated,55.8011049723757 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mongolia,MNG,Treatment failed,7.18232044198895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mongolia,MNG,Died,18.7845303867403 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mongolia,MNG,Lost to follow-up,17.1270718232044 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mongolia,MNG,Not evaluated,1.10497237569061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mongolia,MNG,Successfully treated,66.3265306122449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mongolia,MNG,Treatment failed,3.74149659863946 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mongolia,MNG,Died,11.2244897959184 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mongolia,MNG,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mongolia,MNG,Not evaluated,4.42176870748299 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mongolia,MNG,Successfully treated,59.6078431372549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mongolia,MNG,Treatment failed,3.13725490196078 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mongolia,MNG,Died,19.6078431372549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mongolia,MNG,Lost to follow-up,14.9019607843137 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mongolia,MNG,Not evaluated,2.74509803921569 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mongolia,MNG,Successfully treated,61.8257261410788 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mongolia,MNG,Treatment failed,6.63900414937759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mongolia,MNG,Died,15.7676348547718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mongolia,MNG,Lost to follow-up,15.7676348547718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mongolia,MNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mongolia,MNG,Successfully treated,56.4814814814815 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mongolia,MNG,Treatment failed,5.09259259259259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mongolia,MNG,Died,11.5740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mongolia,MNG,Lost to follow-up,26.3888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mongolia,MNG,Not evaluated,0.462962962962963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mongolia,MNG,Successfully treated,66.4921465968586 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mongolia,MNG,Treatment failed,7.32984293193717 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mongolia,MNG,Died,13.0890052356021 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mongolia,MNG,Lost to follow-up,11.5183246073298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mongolia,MNG,Not evaluated,1.57068062827225 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mongolia,MNG,Successfully treated,70.391061452514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mongolia,MNG,Treatment failed,3.91061452513967 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mongolia,MNG,Died,11.1731843575419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mongolia,MNG,Lost to follow-up,10.0558659217877 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mongolia,MNG,Not evaluated,4.46927374301676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mongolia,MNG,Successfully treated,78.5276073619632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mongolia,MNG,Treatment failed,1.22699386503067 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mongolia,MNG,Died,9.20245398773006 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mongolia,MNG,Lost to follow-up,11.0429447852761 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mongolia,MNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mongolia,MNG,Successfully treated,72.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mongolia,MNG,Treatment failed,1.85185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mongolia,MNG,Died,14.8148148148148 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mongolia,MNG,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mongolia,MNG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mongolia,MNG,Successfully treated,65.3543307086614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mongolia,MNG,Treatment failed,5.51181102362205 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mongolia,MNG,Died,10.2362204724409 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mongolia,MNG,Lost to follow-up,18.1102362204724 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mongolia,MNG,Not evaluated,0.78740157480315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Montenegro,MNE,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Montenegro,MNE,Treatment failed,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Montenegro,MNE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Montenegro,MNE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Montenegro,MNE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Montenegro,MNE,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Montenegro,MNE,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Montenegro,MNE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Montenegro,MNE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Montenegro,MNE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Montenegro,MNE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Montenegro,MNE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Montenegro,MNE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Montenegro,MNE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Montenegro,MNE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Montenegro,MNE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Montenegro,MNE,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Montenegro,MNE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Montenegro,MNE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Montenegro,MNE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Montenegro,MNE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Montenegro,MNE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Montenegro,MNE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Montenegro,MNE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Montenegro,MNE,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Montenegro,MNE,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Montenegro,MNE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Montenegro,MNE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Montenegro,MNE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Montenegro,MNE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Montenegro,MNE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Montenegro,MNE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Montenegro,MNE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Montenegro,MNE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Morocco,MAR,Successfully treated,25.1461988304094 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Morocco,MAR,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Morocco,MAR,Died,5.84795321637427 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Morocco,MAR,Lost to follow-up,12.8654970760234 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Treatment failed,2.20264317180617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Died,10.1321585903084 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Lost to follow-up,15.4185022026432 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Angola,AGO,Successfully treated,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Angola,AGO,Treatment failed,1.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Angola,AGO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Angola,AGO,Lost to follow-up,6.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Angola,AGO,Not evaluated,88.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Angola,AGO,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Angola,AGO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Angola,AGO,Died,4.11985018726592 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Angola,AGO,Lost to follow-up,18.1647940074906 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Angola,AGO,Not evaluated,77.7153558052435 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Argentina,ARG,Successfully treated,28.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Argentina,ARG,Treatment failed,0.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Argentina,ARG,Died,7.2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Argentina,ARG,Lost to follow-up,19.2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Argentina,ARG,Not evaluated,44.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Argentina,ARG,Successfully treated,33.7078651685393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Argentina,ARG,Treatment failed,1.12359550561798 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Argentina,ARG,Died,3.37078651685393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Argentina,ARG,Lost to follow-up,19.1011235955056 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Argentina,ARG,Not evaluated,42.6966292134832 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Argentina,ARG,Successfully treated,14.7727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Argentina,ARG,Treatment failed,1.13636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Argentina,ARG,Died,7.95454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Argentina,ARG,Lost to follow-up,10.2272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Argentina,ARG,Not evaluated,65.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Argentina,ARG,Successfully treated,25.6198347107438 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Argentina,ARG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Argentina,ARG,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Argentina,ARG,Lost to follow-up,10.7438016528926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Argentina,ARG,Not evaluated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Argentina,ARG,Successfully treated,20.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Argentina,ARG,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Argentina,ARG,Died,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Argentina,ARG,Lost to follow-up,15.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Argentina,ARG,Not evaluated,57.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Argentina,ARG,Successfully treated,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Argentina,ARG,Treatment failed,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Argentina,ARG,Died,9.64912280701754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Argentina,ARG,Lost to follow-up,11.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Argentina,ARG,Not evaluated,46.4912280701754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Argentina,ARG,Successfully treated,38.9312977099237 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Argentina,ARG,Treatment failed,0.763358778625954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Argentina,ARG,Died,11.4503816793893 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Argentina,ARG,Lost to follow-up,17.5572519083969 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Argentina,ARG,Not evaluated,31.2977099236641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Argentina,ARG,Successfully treated,30.4635761589404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Argentina,ARG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Argentina,ARG,Died,11.2582781456954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Argentina,ARG,Lost to follow-up,11.9205298013245 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Argentina,ARG,Not evaluated,46.3576158940397 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Argentina,ARG,Successfully treated,30.1020408163265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Argentina,ARG,Treatment failed,1.02040816326531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Argentina,ARG,Died,13.265306122449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Argentina,ARG,Lost to follow-up,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Argentina,ARG,Not evaluated,34.1836734693878 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Argentina,ARG,Successfully treated,34.1463414634146 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Argentina,ARG,Treatment failed,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Argentina,ARG,Died,21.9512195121951 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Argentina,ARG,Lost to follow-up,13.8211382113821 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Argentina,ARG,Not evaluated,27.6422764227642 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Argentina,ARG,Successfully treated,41.566265060241 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Argentina,ARG,Treatment failed,1.80722891566265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Argentina,ARG,Died,9.63855421686747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Argentina,ARG,Lost to follow-up,16.8674698795181 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Argentina,ARG,Not evaluated,30.1204819277108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Argentina,ARG,Successfully treated,44.7115384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Argentina,ARG,Treatment failed,0.961538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Argentina,ARG,Died,12.9807692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Argentina,ARG,Lost to follow-up,14.4230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Argentina,ARG,Not evaluated,26.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Armenia,ARM,Successfully treated,40.7407407407407 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Armenia,ARM,Treatment failed,18.5185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Armenia,ARM,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Armenia,ARM,Lost to follow-up,29.6296296296296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Armenia,ARM,Successfully treated,52.6315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Armenia,ARM,Treatment failed,8.7719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Armenia,ARM,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Armenia,ARM,Lost to follow-up,24.5614035087719 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Armenia,ARM,Not evaluated,3.50877192982456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Armenia,ARM,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Armenia,ARM,Treatment failed,10.3896103896104 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Armenia,ARM,Died,2.5974025974026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Armenia,ARM,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Armenia,ARM,Not evaluated,3.8961038961039 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Armenia,ARM,Successfully treated,51.4925373134328 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Armenia,ARM,Treatment failed,14.1791044776119 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Armenia,ARM,Died,7.46268656716418 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Armenia,ARM,Lost to follow-up,23.134328358209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Armenia,ARM,Not evaluated,3.73134328358209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Armenia,ARM,Successfully treated,44.6969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Armenia,ARM,Treatment failed,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Armenia,ARM,Died,10.6060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Armenia,ARM,Lost to follow-up,31.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Armenia,ARM,Not evaluated,9.84848484848485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Armenia,ARM,Successfully treated,50.4132231404959 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Armenia,ARM,Treatment failed,0.826446280991736 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Armenia,ARM,Died,4.95867768595041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Armenia,ARM,Lost to follow-up,26.4462809917355 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Armenia,ARM,Not evaluated,17.3553719008264 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Armenia,ARM,Successfully treated,44.3478260869565 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Armenia,ARM,Treatment failed,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Armenia,ARM,Died,6.95652173913044 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Armenia,ARM,Lost to follow-up,29.5652173913044 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Armenia,ARM,Not evaluated,14.7826086956522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Armenia,ARM,Successfully treated,43.2692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Armenia,ARM,Treatment failed,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Armenia,ARM,Died,5.76923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Armenia,ARM,Lost to follow-up,28.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Armenia,ARM,Not evaluated,10.5769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Armenia,ARM,Successfully treated,57.6271186440678 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Armenia,ARM,Treatment failed,16.1016949152542 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Armenia,ARM,Died,6.77966101694915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Armenia,ARM,Lost to follow-up,19.4915254237288 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Armenia,ARM,Successfully treated,42.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Armenia,ARM,Treatment failed,16.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Armenia,ARM,Died,7.36842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Armenia,ARM,Lost to follow-up,32.6315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Armenia,ARM,Not evaluated,1.05263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Armenia,ARM,Successfully treated,49.1525423728814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Armenia,ARM,Treatment failed,11.864406779661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Armenia,ARM,Died,11.0169491525424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Armenia,ARM,Lost to follow-up,27.9661016949153 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Armenia,ARM,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Armenia,ARM,Treatment failed,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Armenia,ARM,Died,10.5769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Armenia,ARM,Lost to follow-up,29.8076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Armenia,ARM,Successfully treated,45.8823529411765 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Armenia,ARM,Treatment failed,12.9411764705882 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Armenia,ARM,Died,15.2941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Armenia,ARM,Lost to follow-up,25.8823529411765 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Armenia,ARM,Successfully treated,54.7169811320755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Armenia,ARM,Treatment failed,11.3207547169811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Armenia,ARM,Died,15.0943396226415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Armenia,ARM,Lost to follow-up,18.8679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Armenia,ARM,Successfully treated,62.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Armenia,ARM,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Armenia,ARM,Died,4.44444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Armenia,ARM,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Armenia,ARM,Successfully treated,72.3404255319149 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Armenia,ARM,Treatment failed,4.25531914893617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Armenia,ARM,Died,6.38297872340426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Armenia,ARM,Lost to follow-up,17.0212765957447 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Armenia,ARM,Successfully treated,67.9245283018868 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Armenia,ARM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Armenia,ARM,Died,13.2075471698113 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Armenia,ARM,Lost to follow-up,18.8679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Armenia,ARM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Australia,AUS,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Australia,AUS,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Australia,AUS,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Australia,AUS,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Australia,AUS,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Australia,AUS,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Australia,AUS,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Australia,AUS,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Australia,AUS,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Australia,AUS,Successfully treated,73.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Australia,AUS,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Australia,AUS,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Australia,AUS,Not evaluated,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Australia,AUS,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Australia,AUS,Died,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Australia,AUS,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Australia,AUS,Not evaluated,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Australia,AUS,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Australia,AUS,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Australia,AUS,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Australia,AUS,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Australia,AUS,Successfully treated,55.8823529411765 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Australia,AUS,Died,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Australia,AUS,Lost to follow-up,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Australia,AUS,Not evaluated,26.4705882352941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Australia,AUS,Successfully treated,42.3076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Australia,AUS,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Australia,AUS,Died,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Lost to follow-up,17.5393154486587 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Not evaluated,17.631822386679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,China,CHN,Successfully treated,54.4169611307421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,China,CHN,Treatment failed,7.03348477200067 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,China,CHN,Died,6.39407706545516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,China,CHN,Lost to follow-up,29.1771832407875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,China,CHN,Not evaluated,2.97829379101464 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,China,CHN,Successfully treated,54.021193530396 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,China,CHN,Treatment failed,5.35415504740658 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,China,CHN,Died,6.81539319576129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,China,CHN,Lost to follow-up,31.8683770217513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,China,CHN,Not evaluated,1.94088120468489 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,China,CHN,Successfully treated,53.1016635859519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,China,CHN,Treatment failed,4.36229205175601 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,China,CHN,Died,0.310536044362292 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,China,CHN,Lost to follow-up,42.2255083179298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,China,CHN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,China,CHN,Successfully treated,50.705311030602 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,China,CHN,Treatment failed,3.00624373699222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,China,CHN,Died,6.34394511678101 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,China,CHN,Lost to follow-up,11.5933091806059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,China,CHN,Not evaluated,28.3511909350189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,China,CHN,Successfully treated,65.8908068421464 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,China,CHN,Treatment failed,3.29610247598219 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,China,CHN,Died,8.07623213309381 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,China,CHN,Lost to follow-up,8.81043505428415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,China,CHN,Not evaluated,13.9264234944935 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,China,CHN,Successfully treated,68.3288002417649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,China,CHN,Treatment failed,3.4250025183842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,China,CHN,Died,9.26765387327491 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,China,CHN,Lost to follow-up,12.4508915080085 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,China,CHN,Not evaluated,6.52765185856754 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,"China, Hong Kong SAR",HKG,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,"China, Hong Kong SAR",HKG,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,"China, Hong Kong SAR",HKG,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,"China, Hong Kong SAR",HKG,Not evaluated,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"China, Hong Kong SAR",HKG,Successfully treated,70.9677419354839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"China, Hong Kong SAR",HKG,Treatment failed,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"China, Hong Kong SAR",HKG,Died,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"China, Hong Kong SAR",HKG,Lost to follow-up,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"China, Hong Kong SAR",HKG,Not evaluated,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Hong Kong SAR",HKG,Successfully treated,53.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Hong Kong SAR",HKG,Treatment failed,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Hong Kong SAR",HKG,Died,15.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Hong Kong SAR",HKG,Lost to follow-up,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Hong Kong SAR",HKG,Not evaluated,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Hong Kong SAR",HKG,Successfully treated,55.8823529411765 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Hong Kong SAR",HKG,Died,17.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Hong Kong SAR",HKG,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Hong Kong SAR",HKG,Not evaluated,20.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Hong Kong SAR",HKG,Successfully treated,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Hong Kong SAR",HKG,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Hong Kong SAR",HKG,Lost to follow-up,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Hong Kong SAR",HKG,Not evaluated,34.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Hong Kong SAR",HKG,Successfully treated,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Hong Kong SAR",HKG,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Hong Kong SAR",HKG,Lost to follow-up,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Hong Kong SAR",HKG,Not evaluated,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Hong Kong SAR",HKG,Successfully treated,52.9411764705882 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Hong Kong SAR",HKG,Died,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Hong Kong SAR",HKG,Lost to follow-up,20.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Hong Kong SAR",HKG,Not evaluated,17.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Hong Kong SAR",HKG,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Hong Kong SAR",HKG,Died,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Hong Kong SAR",HKG,Lost to follow-up,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Hong Kong SAR",HKG,Not evaluated,21.2121212121212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Hong Kong SAR",HKG,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Hong Kong SAR",HKG,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Hong Kong SAR",HKG,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Hong Kong SAR",HKG,Not evaluated,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Hong Kong SAR",HKG,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Hong Kong SAR",HKG,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Hong Kong SAR",HKG,Lost to follow-up,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Hong Kong SAR",HKG,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Hong Kong SAR",HKG,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Hong Kong SAR",HKG,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Hong Kong SAR",HKG,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Hong Kong SAR",HKG,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Hong Kong SAR",HKG,Successfully treated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Hong Kong SAR",HKG,Died,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Hong Kong SAR",HKG,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Hong Kong SAR",HKG,Not evaluated,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Hong Kong SAR",HKG,Successfully treated,70.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Hong Kong SAR",HKG,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Hong Kong SAR",HKG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Hong Kong SAR",HKG,Not evaluated,20.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Hong Kong SAR",HKG,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Hong Kong SAR",HKG,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Hong Kong SAR",HKG,Lost to follow-up,19.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Hong Kong SAR",HKG,Not evaluated,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Hong Kong SAR",HKG,Successfully treated,85.1851851851852 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Hong Kong SAR",HKG,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Hong Kong SAR",HKG,Lost to follow-up,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,"China, Hong Kong SAR",HKG,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Hong Kong SAR",HKG,Successfully treated,59.5744680851064 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Hong Kong SAR",HKG,Died,10.6382978723404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Hong Kong SAR",HKG,Lost to follow-up,4.25531914893617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,"China, Hong Kong SAR",HKG,Not evaluated,25.531914893617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Hong Kong SAR",HKG,Successfully treated,78.9473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Hong Kong SAR",HKG,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Hong Kong SAR",HKG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,"China, Hong Kong SAR",HKG,Not evaluated,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Hong Kong SAR",HKG,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Hong Kong SAR",HKG,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Hong Kong SAR",HKG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,"China, Hong Kong SAR",HKG,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Hong Kong SAR",HKG,Successfully treated,92.5925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Hong Kong SAR",HKG,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Hong Kong SAR",HKG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,"China, Hong Kong SAR",HKG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Hong Kong SAR",HKG,Successfully treated,72.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Hong Kong SAR",HKG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Hong Kong SAR",HKG,Died,16.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Hong Kong SAR",HKG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,"China, Hong Kong SAR",HKG,Not evaluated,12.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Macao SAR",MAC,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Macao SAR",MAC,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Macao SAR",MAC,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Macao SAR",MAC,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Macao SAR",MAC,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Macao SAR",MAC,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Macao SAR",MAC,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Macao SAR",MAC,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Macao SAR",MAC,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Macao SAR",MAC,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Macao SAR",MAC,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Macao SAR",MAC,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Macao SAR",MAC,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Macao SAR",MAC,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Macao SAR",MAC,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Macao SAR",MAC,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Macao SAR",MAC,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Macao SAR",MAC,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,"China, Macao SAR",MAC,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Macao SAR",MAC,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Macao SAR",MAC,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Macao SAR",MAC,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,"China, Macao SAR",MAC,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Macao SAR",MAC,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Macao SAR",MAC,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Macao SAR",MAC,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,"China, Macao SAR",MAC,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Macao SAR",MAC,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,"China, Macao SAR",MAC,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,France,FRA,Successfully treated,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,France,FRA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,France,FRA,Died,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,France,FRA,Lost to follow-up,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,France,FRA,Not evaluated,91.3793103448276 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,French Polynesia,PYF,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,French Polynesia,PYF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,French Polynesia,PYF,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,French Polynesia,PYF,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,French Polynesia,PYF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,French Polynesia,PYF,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,French Polynesia,PYF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,French Polynesia,PYF,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,French Polynesia,PYF,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,French Polynesia,PYF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,French Polynesia,PYF,Successfully treated,77.3584905660377 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,French Polynesia,PYF,Treatment failed,7.54716981132076 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,French Polynesia,PYF,Died,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,French Polynesia,PYF,Lost to follow-up,9.43396226415094 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,French Polynesia,PYF,Not evaluated,1.88679245283019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,French Polynesia,PYF,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,French Polynesia,PYF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,French Polynesia,PYF,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,French Polynesia,PYF,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,French Polynesia,PYF,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,French Polynesia,PYF,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,French Polynesia,PYF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gabon,GAB,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gabon,GAB,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gabon,GAB,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gabon,GAB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gabon,GAB,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gabon,GAB,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gabon,GAB,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gabon,GAB,Died,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gabon,GAB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gabon,GAB,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gabon,GAB,Successfully treated,53.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gabon,GAB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gabon,GAB,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gabon,GAB,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gabon,GAB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gabon,GAB,Successfully treated,27.9411764705882 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gabon,GAB,Treatment failed,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gabon,GAB,Died,16.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gabon,GAB,Lost to follow-up,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gabon,GAB,Not evaluated,38.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gabon,GAB,Successfully treated,53.448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gabon,GAB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gabon,GAB,Died,12.0689655172414 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gabon,GAB,Lost to follow-up,13.7931034482759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gabon,GAB,Not evaluated,20.6896551724138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gabon,GAB,Successfully treated,52.1739130434783 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gabon,GAB,Treatment failed,2.89855072463768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gabon,GAB,Died,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gabon,GAB,Lost to follow-up,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gabon,GAB,Not evaluated,18.8405797101449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gabon,GAB,Successfully treated,52.3809523809524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gabon,GAB,Treatment failed,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gabon,GAB,Died,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gabon,GAB,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gabon,GAB,Not evaluated,7.93650793650794 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gabon,GAB,Successfully treated,53.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gabon,GAB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gabon,GAB,Died,12.6315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gabon,GAB,Lost to follow-up,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gabon,GAB,Not evaluated,12.6315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Gambia,GMB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Gambia,GMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Gambia,GMB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Gambia,GMB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gambia,GMB,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gambia,GMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gambia,GMB,Died,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gambia,GMB,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gambia,GMB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gambia,GMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gambia,GMB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gambia,GMB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gambia,GMB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gambia,GMB,Treatment failed,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gambia,GMB,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gambia,GMB,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gambia,GMB,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gambia,GMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gambia,GMB,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gambia,GMB,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gambia,GMB,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gambia,GMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gambia,GMB,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gambia,GMB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gambia,GMB,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gambia,GMB,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gambia,GMB,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gambia,GMB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gambia,GMB,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gambia,GMB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gambia,GMB,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gambia,GMB,Treatment failed,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gambia,GMB,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gambia,GMB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Gambia,GMB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Georgia,GEO,Successfully treated,37.7049180327869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Georgia,GEO,Treatment failed,3.27868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Georgia,GEO,Died,19.672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Georgia,GEO,Lost to follow-up,24.5901639344262 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Georgia,GEO,Not evaluated,14.7540983606557 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Georgia,GEO,Successfully treated,56.3549160671463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Georgia,GEO,Treatment failed,6.23501199040767 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Georgia,GEO,Died,11.5107913669065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Georgia,GEO,Lost to follow-up,20.863309352518 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Georgia,GEO,Not evaluated,5.03597122302158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Georgia,GEO,Successfully treated,53.6779324055666 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Georgia,GEO,Treatment failed,5.96421471172962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Georgia,GEO,Died,7.55467196819086 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Georgia,GEO,Lost to follow-up,28.0318091451292 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Georgia,GEO,Not evaluated,4.7713717693837 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Georgia,GEO,Successfully treated,53.7698412698413 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Georgia,GEO,Treatment failed,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Georgia,GEO,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Georgia,GEO,Lost to follow-up,26.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Georgia,GEO,Not evaluated,6.94444444444445 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Georgia,GEO,Successfully treated,49.9181669394435 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Georgia,GEO,Treatment failed,2.94599018003273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Georgia,GEO,Died,5.07364975450082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Georgia,GEO,Lost to follow-up,36.1702127659575 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Georgia,GEO,Not evaluated,5.89198036006547 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Georgia,GEO,Successfully treated,47.5120385232745 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Georgia,GEO,Treatment failed,2.56821829855538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Georgia,GEO,Died,5.7784911717496 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Georgia,GEO,Lost to follow-up,32.2632423756019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Georgia,GEO,Not evaluated,11.8780096308186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Georgia,GEO,Successfully treated,42.8223844282238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Georgia,GEO,Treatment failed,4.13625304136253 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Georgia,GEO,Died,6.56934306569343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Georgia,GEO,Lost to follow-up,34.3065693430657 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Georgia,GEO,Not evaluated,12.1654501216545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Georgia,GEO,Successfully treated,48.9051094890511 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Georgia,GEO,Treatment failed,6.56934306569343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Georgia,GEO,Died,7.78588807785888 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Georgia,GEO,Lost to follow-up,28.7104622871046 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Georgia,GEO,Not evaluated,8.02919708029197 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Georgia,GEO,Successfully treated,56.0679611650486 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Georgia,GEO,Treatment failed,10.1941747572816 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Georgia,GEO,Died,6.31067961165049 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Georgia,GEO,Lost to follow-up,24.5145631067961 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Georgia,GEO,Not evaluated,2.9126213592233 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Georgia,GEO,Successfully treated,65.4867256637168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Georgia,GEO,Treatment failed,5.30973451327434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Georgia,GEO,Died,5.89970501474926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Georgia,GEO,Lost to follow-up,19.1740412979351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Georgia,GEO,Not evaluated,4.12979351032448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Georgia,GEO,Successfully treated,64.2405063291139 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Georgia,GEO,Treatment failed,6.32911392405063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Georgia,GEO,Died,2.84810126582279 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Georgia,GEO,Lost to follow-up,20.253164556962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Georgia,GEO,Not evaluated,6.32911392405063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Georgia,GEO,Successfully treated,67.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Georgia,GEO,Treatment failed,5.65217391304348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Georgia,GEO,Died,5.65217391304348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Georgia,GEO,Lost to follow-up,14.7826086956522 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Georgia,GEO,Not evaluated,6.52173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Georgia,GEO,Successfully treated,78.4403669724771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Georgia,GEO,Treatment failed,1.8348623853211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Georgia,GEO,Died,5.96330275229358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Georgia,GEO,Lost to follow-up,12.8440366972477 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Georgia,GEO,Not evaluated,0.91743119266055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Georgia,GEO,Successfully treated,75.8389261744967 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Georgia,GEO,Treatment failed,1.34228187919463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Georgia,GEO,Died,2.68456375838926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Georgia,GEO,Lost to follow-up,15.4362416107383 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Georgia,GEO,Not evaluated,4.69798657718121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Georgia,GEO,Successfully treated,76.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Georgia,GEO,Treatment failed,0.714285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Georgia,GEO,Died,6.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Georgia,GEO,Lost to follow-up,12.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Georgia,GEO,Not evaluated,4.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Georgia,GEO,Successfully treated,80.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Georgia,GEO,Treatment failed,2.72727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Georgia,GEO,Died,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Georgia,GEO,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Georgia,GEO,Not evaluated,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Germany,DEU,Successfully treated,62.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Germany,DEU,Treatment failed,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Germany,DEU,Died,17.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,India,IND,Treatment failed,15.2157481350028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,India,IND,Died,13.1207072200861 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,India,IND,Lost to follow-up,13.2291563968583 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,India,IND,Not evaluated,1.10256663051694 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,India,IND,Successfully treated,68.5471021708823 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,India,IND,Treatment failed,4.99651463851822 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,India,IND,Died,13.411173073093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,India,IND,Lost to follow-up,10.7249551882095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,India,IND,Not evaluated,2.32025492929695 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,India,IND,Successfully treated,72.9765758903066 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,India,IND,Treatment failed,2.17736304196026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,India,IND,Died,13.8068939249667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,India,IND,Lost to follow-up,10.207579508665 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,India,IND,Not evaluated,0.831587634101441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,India,IND,Successfully treated,76.8070692194404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,India,IND,Treatment failed,1.3019145802651 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,India,IND,Died,11.9351988217968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,India,IND,Lost to follow-up,8.55375552282769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,India,IND,Not evaluated,1.4020618556701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Indonesia,IDN,Successfully treated,73.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Indonesia,IDN,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Indonesia,IDN,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Indonesia,IDN,Lost to follow-up,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Indonesia,IDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Indonesia,IDN,Successfully treated,72.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Indonesia,IDN,Treatment failed,4.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Indonesia,IDN,Died,12.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Indonesia,IDN,Lost to follow-up,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Indonesia,IDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Indonesia,IDN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Indonesia,IDN,Treatment failed,1.15384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Indonesia,IDN,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Indonesia,IDN,Lost to follow-up,23.8461538461538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Indonesia,IDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Indonesia,IDN,Successfully treated,54.3981481481482 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Indonesia,IDN,Treatment failed,3.24074074074074 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Indonesia,IDN,Died,15.2777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Indonesia,IDN,Lost to follow-up,26.6203703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Indonesia,IDN,Not evaluated,0.462962962962963 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Indonesia,IDN,Successfully treated,50.9270704573548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Indonesia,IDN,Treatment failed,2.84301606922126 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Indonesia,IDN,Died,15.8220024721879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Indonesia,IDN,Lost to follow-up,30.4079110012361 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Indonesia,IDN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Indonesia,IDN,Successfully treated,50.5114083398899 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Indonesia,IDN,Treatment failed,2.6750590086546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Indonesia,IDN,Died,17.5452399685287 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Indonesia,IDN,Lost to follow-up,27.8520849724626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Indonesia,IDN,Not evaluated,1.4162077104642 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Indonesia,IDN,Successfully treated,47.2843450479233 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Indonesia,IDN,Treatment failed,3.70607028753994 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Indonesia,IDN,Died,16.1661341853035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Indonesia,IDN,Lost to follow-up,31.1182108626198 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Indonesia,IDN,Not evaluated,1.72523961661342 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Indonesia,IDN,Successfully treated,47.9265091863517 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Indonesia,IDN,Treatment failed,2.78215223097113 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Indonesia,IDN,Died,16.745406824147 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Indonesia,IDN,Lost to follow-up,25.6167979002625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Indonesia,IDN,Not evaluated,6.92913385826772 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Indonesia,IDN,Successfully treated,45.4454454454455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Indonesia,IDN,Treatment failed,2.7027027027027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Indonesia,IDN,Died,18.4851518184852 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Indonesia,IDN,Lost to follow-up,26.292959626293 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Indonesia,IDN,Not evaluated,7.07374040707374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Indonesia,IDN,Successfully treated,46.9871205151794 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Indonesia,IDN,Treatment failed,3.86384544618215 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Indonesia,IDN,Died,17.3183072677093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Indonesia,IDN,Lost to follow-up,27.2999080036799 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Indonesia,IDN,Not evaluated,4.53081876724931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Indonesia,IDN,Successfully treated,46.7399545109932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Indonesia,IDN,Treatment failed,4.30250189537528 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Indonesia,IDN,Died,17.3995451099318 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Indonesia,IDN,Lost to follow-up,21.4746019711903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Indonesia,IDN,Not evaluated,10.0833965125095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Indonesia,IDN,Successfully treated,51.6317016317016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Indonesia,IDN,Treatment failed,3.82284382284382 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Indonesia,IDN,Died,19.7902097902098 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Indonesia,IDN,Lost to follow-up,18.997668997669 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Indonesia,IDN,Not evaluated,5.75757575757576 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Indonesia,IDN,Successfully treated,57.2266443234185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Indonesia,IDN,Treatment failed,8.81860075408463 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Indonesia,IDN,Died,16.6108085462924 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Indonesia,IDN,Lost to follow-up,17.2392124005027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Indonesia,IDN,Not evaluated,0.104733975701718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Indonesia,IDN,Successfully treated,58.9963598543942 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Indonesia,IDN,Treatment failed,8.29433177327093 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Indonesia,IDN,Died,15.9126365054602 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Indonesia,IDN,Lost to follow-up,15.990639625585 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Indonesia,IDN,Not evaluated,0.806032241289652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Iran (Islamic Republic of),IRN,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Iran (Islamic Republic of),IRN,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Iran (Islamic Republic of),IRN,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Iran (Islamic Republic of),IRN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iran (Islamic Republic of),IRN,Successfully treated,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iran (Islamic Republic of),IRN,Died,8.97435897435897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iran (Islamic Republic of),IRN,Lost to follow-up,10.2564102564103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iran (Islamic Republic of),IRN,Not evaluated,57.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iran (Islamic Republic of),IRN,Successfully treated,51.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iran (Islamic Republic of),IRN,Died,17.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iran (Islamic Republic of),IRN,Lost to follow-up,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iran (Islamic Republic of),IRN,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iran (Islamic Republic of),IRN,Successfully treated,35.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iran (Islamic Republic of),IRN,Died,15.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iran (Islamic Republic of),IRN,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Iran (Islamic Republic of),IRN,Not evaluated,42.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iran (Islamic Republic of),IRN,Successfully treated,42.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iran (Islamic Republic of),IRN,Died,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iran (Islamic Republic of),IRN,Lost to follow-up,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Iran (Islamic Republic of),IRN,Not evaluated,31.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iran (Islamic Republic of),IRN,Successfully treated,40.5797101449275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iran (Islamic Republic of),IRN,Died,11.5942028985507 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iran (Islamic Republic of),IRN,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Iran (Islamic Republic of),IRN,Not evaluated,14.4927536231884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iran (Islamic Republic of),IRN,Successfully treated,68.4684684684685 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iran (Islamic Republic of),IRN,Treatment failed,0.900900900900901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iran (Islamic Republic of),IRN,Died,9.00900900900901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iran (Islamic Republic of),IRN,Lost to follow-up,11.7117117117117 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Iran (Islamic Republic of),IRN,Not evaluated,9.90990990990991 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iran (Islamic Republic of),IRN,Successfully treated,48.3870967741936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iran (Islamic Republic of),IRN,Treatment failed,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iran (Islamic Republic of),IRN,Died,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iran (Islamic Republic of),IRN,Lost to follow-up,11.2903225806452 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Iran (Islamic Republic of),IRN,Not evaluated,24.1935483870968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iran (Islamic Republic of),IRN,Successfully treated,74.0740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iran (Islamic Republic of),IRN,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iran (Islamic Republic of),IRN,Lost to follow-up,9.25925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Iran (Islamic Republic of),IRN,Not evaluated,9.25925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iran (Islamic Republic of),IRN,Successfully treated,58.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iran (Islamic Republic of),IRN,Died,14.5833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iran (Islamic Republic of),IRN,Lost to follow-up,14.5833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Iran (Islamic Republic of),IRN,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iran (Islamic Republic of),IRN,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iran (Islamic Republic of),IRN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iran (Islamic Republic of),IRN,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Iran (Islamic Republic of),IRN,Not evaluated,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iran (Islamic Republic of),IRN,Successfully treated,55.1020408163265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iran (Islamic Republic of),IRN,Died,12.2448979591837 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iran (Islamic Republic of),IRN,Lost to follow-up,20.4081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Iran (Islamic Republic of),IRN,Not evaluated,12.2448979591837 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iran (Islamic Republic of),IRN,Successfully treated,58.6956521739131 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iran (Islamic Republic of),IRN,Died,21.7391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iran (Islamic Republic of),IRN,Lost to follow-up,10.8695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Iran (Islamic Republic of),IRN,Not evaluated,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iran (Islamic Republic of),IRN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iran (Islamic Republic of),IRN,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iran (Islamic Republic of),IRN,Lost to follow-up,17.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Iran (Islamic Republic of),IRN,Not evaluated,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iran (Islamic Republic of),IRN,Successfully treated,53.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iran (Islamic Republic of),IRN,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iran (Islamic Republic of),IRN,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Iran (Islamic Republic of),IRN,Not evaluated,3.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iran (Islamic Republic of),IRN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iran (Islamic Republic of),IRN,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iran (Islamic Republic of),IRN,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Iran (Islamic Republic of),IRN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iran (Islamic Republic of),IRN,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iran (Islamic Republic of),IRN,Died,21.2121212121212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iran (Islamic Republic of),IRN,Lost to follow-up,6.06060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Iran (Islamic Republic of),IRN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iran (Islamic Republic of),IRN,Successfully treated,72.4137931034483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iran (Islamic Republic of),IRN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iran (Islamic Republic of),IRN,Died,20.6896551724138 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iran (Islamic Republic of),IRN,Lost to follow-up,6.89655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Iran (Islamic Republic of),IRN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iraq,IRQ,Successfully treated,45.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iraq,IRQ,Treatment failed,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iraq,IRQ,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iraq,IRQ,Lost to follow-up,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Iraq,IRQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iraq,IRQ,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iraq,IRQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iraq,IRQ,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iraq,IRQ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Iraq,IRQ,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malaysia,MYS,Not evaluated,9.03225806451613 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malaysia,MYS,Successfully treated,63.855421686747 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malaysia,MYS,Treatment failed,1.20481927710843 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malaysia,MYS,Died,20.4819277108434 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malaysia,MYS,Lost to follow-up,8.43373493975904 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Malaysia,MYS,Not evaluated,6.02409638554217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malaysia,MYS,Successfully treated,70.5521472392638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malaysia,MYS,Treatment failed,0.613496932515337 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malaysia,MYS,Died,14.1104294478528 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malaysia,MYS,Lost to follow-up,8.58895705521472 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Malaysia,MYS,Not evaluated,6.13496932515337 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Maldives,MDV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Maldives,MDV,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Maldives,MDV,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Maldives,MDV,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Maldives,MDV,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Maldives,MDV,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Maldives,MDV,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Maldives,MDV,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Maldives,MDV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Maldives,MDV,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Maldives,MDV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Maldives,MDV,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Maldives,MDV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Maldives,MDV,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Maldives,MDV,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Maldives,MDV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Maldives,MDV,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Maldives,MDV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Maldives,MDV,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Maldives,MDV,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Maldives,MDV,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Maldives,MDV,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Maldives,MDV,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Maldives,MDV,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Maldives,MDV,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mali,MLI,Successfully treated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mali,MLI,Died,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mali,MLI,Lost to follow-up,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mali,MLI,Successfully treated,31.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mali,MLI,Treatment failed,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mali,MLI,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mali,MLI,Lost to follow-up,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mali,MLI,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mali,MLI,Died,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mali,MLI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mali,MLI,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mali,MLI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mali,MLI,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mali,MLI,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mali,MLI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Mali,MLI,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mali,MLI,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mali,MLI,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mali,MLI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mali,MLI,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mali,MLI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mali,MLI,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Mali,MLI,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mali,MLI,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mali,MLI,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mali,MLI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mali,MLI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mali,MLI,Successfully treated,61.2903225806452 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mali,MLI,Died,35.4838709677419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mali,MLI,Lost to follow-up,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mali,MLI,Successfully treated,70.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mali,MLI,Died,29.6296296296296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mali,MLI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mali,MLI,Successfully treated,67.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mali,MLI,Died,20.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mali,MLI,Lost to follow-up,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mali,MLI,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mali,MLI,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mali,MLI,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mali,MLI,Lost to follow-up,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mali,MLI,Successfully treated,76.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mali,MLI,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mali,MLI,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Mali,MLI,Not evaluated,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mali,MLI,Successfully treated,70.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mali,MLI,Died,14.8148148148148 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mali,MLI,Lost to follow-up,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Mali,MLI,Not evaluated,9.25925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mali,MLI,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mali,MLI,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mali,MLI,Lost to follow-up,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Mali,MLI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mali,MLI,Successfully treated,80.4347826086957 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mali,MLI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mali,MLI,Died,10.8695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mali,MLI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Mali,MLI,Not evaluated,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malta,MLT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malta,MLT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malta,MLT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malta,MLT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Malta,MLT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malta,MLT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malta,MLT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malta,MLT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malta,MLT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Malta,MLT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malta,MLT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malta,MLT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malta,MLT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malta,MLT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Malta,MLT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Marshall Islands,MHL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Marshall Islands,MHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Marshall Islands,MHL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Marshall Islands,MHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Marshall Islands,MHL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Marshall Islands,MHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Marshall Islands,MHL,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Marshall Islands,MHL,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Marshall Islands,MHL,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Marshall Islands,MHL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Marshall Islands,MHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Marshall Islands,MHL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Marshall Islands,MHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Marshall Islands,MHL,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Marshall Islands,MHL,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Marshall Islands,MHL,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Marshall Islands,MHL,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Marshall Islands,MHL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Marshall Islands,MHL,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Marshall Islands,MHL,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Moldova,MDA,Successfully treated,74.2627345844504 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Moldova,MDA,Treatment failed,2.41286863270777 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Moldova,MDA,Died,12.3324396782842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Moldova,MDA,Lost to follow-up,10.9919571045576 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Republic of Moldova,MDA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Romania,ROU,Successfully treated,61.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Romania,ROU,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Romania,ROU,Died,13.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Romania,ROU,Lost to follow-up,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Romania,ROU,Not evaluated,17.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Romania,ROU,Successfully treated,38.0421313506815 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Romania,ROU,Treatment failed,23.1722428748451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Romania,ROU,Died,16.1090458488228 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Romania,ROU,Lost to follow-up,14.002478314746 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Romania,ROU,Not evaluated,8.67410161090458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Romania,ROU,Successfully treated,23.5015772870662 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Romania,ROU,Treatment failed,30.4416403785489 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Romania,ROU,Died,18.4542586750789 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Romania,ROU,Lost to follow-up,18.1388012618297 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Romania,ROU,Not evaluated,9.46372239747634 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Romania,ROU,Successfully treated,18.5735512630015 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Romania,ROU,Treatment failed,33.7295690936107 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Romania,ROU,Died,16.0475482912333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Romania,ROU,Lost to follow-up,20.5052005943536 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Romania,ROU,Not evaluated,11.1441307578009 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Romania,ROU,Successfully treated,16.2878787878788 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Romania,ROU,Treatment failed,32.7020202020202 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Romania,ROU,Died,19.0656565656566 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Romania,ROU,Lost to follow-up,20.959595959596 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Romania,ROU,Not evaluated,10.9848484848485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Romania,ROU,Successfully treated,16.3461538461538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Romania,ROU,Treatment failed,36.698717948718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Romania,ROU,Died,17.1474358974359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Romania,ROU,Lost to follow-up,20.1923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Romania,ROU,Not evaluated,9.61538461538461 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Romania,ROU,Successfully treated,20.0348432055749 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Romania,ROU,Treatment failed,40.2439024390244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Romania,ROU,Died,15.3310104529617 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Romania,ROU,Lost to follow-up,18.4668989547038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Romania,ROU,Not evaluated,5.92334494773519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Romania,ROU,Successfully treated,26.171875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Romania,ROU,Treatment failed,34.765625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Romania,ROU,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Romania,ROU,Lost to follow-up,16.6015625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Romania,ROU,Not evaluated,3.7109375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Romania,ROU,Successfully treated,33.8557993730408 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Romania,ROU,Treatment failed,26.9592476489028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Romania,ROU,Died,17.3981191222571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Romania,ROU,Lost to follow-up,19.1222570532915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Romania,ROU,Not evaluated,2.66457680250784 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Romania,ROU,Successfully treated,41.4309484193012 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Romania,ROU,Treatment failed,23.1281198003328 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Romania,ROU,Died,16.9717138103161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Romania,ROU,Lost to follow-up,16.6389351081531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Romania,ROU,Not evaluated,1.83028286189684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Romania,ROU,Successfully treated,43.7847866419295 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Romania,ROU,Treatment failed,25.0463821892393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Romania,ROU,Died,15.5844155844156 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Romania,ROU,Lost to follow-up,14.8423005565863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Romania,ROU,Not evaluated,0.742115027829314 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Romania,ROU,Successfully treated,44.6808510638298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Romania,ROU,Treatment failed,26.1121856866538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Romania,ROU,Died,16.4410058027079 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Romania,ROU,Lost to follow-up,12.1856866537718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Romania,ROU,Not evaluated,0.580270793036751 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Romania,ROU,Successfully treated,51.7745302713988 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Romania,ROU,Treatment failed,19.2066805845511 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Romania,ROU,Died,17.3277661795407 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Romania,ROU,Lost to follow-up,11.2734864300626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Romania,ROU,Not evaluated,0.417536534446764 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Romania,ROU,Successfully treated,45.9798994974874 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Romania,ROU,Treatment failed,18.8442211055276 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Romania,ROU,Died,19.3467336683417 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Romania,ROU,Lost to follow-up,14.321608040201 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Romania,ROU,Not evaluated,1.50753768844221 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Romania,ROU,Successfully treated,47.8371501272265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Romania,ROU,Treatment failed,16.030534351145 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Romania,ROU,Died,16.5394402035623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Romania,ROU,Lost to follow-up,18.0661577608143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Romania,ROU,Not evaluated,1.52671755725191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Romania,ROU,Successfully treated,52.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Romania,ROU,Treatment failed,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Romania,ROU,Died,17.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Romania,ROU,Lost to follow-up,14.4117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Romania,ROU,Not evaluated,1.76470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Romania,ROU,Successfully treated,51.8828451882845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Romania,ROU,Treatment failed,15.8995815899582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Romania,ROU,Died,20.9205020920502 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Romania,ROU,Lost to follow-up,9.6234309623431 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Romania,ROU,Not evaluated,1.67364016736402 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Romania,ROU,Successfully treated,48.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Romania,ROU,Treatment failed,16.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Romania,ROU,Died,21.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Romania,ROU,Lost to follow-up,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Romania,ROU,Not evaluated,1.92307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Romania,ROU,Successfully treated,55.0359712230216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Romania,ROU,Treatment failed,14.3884892086331 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Romania,ROU,Died,19.4244604316547 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Romania,ROU,Lost to follow-up,10.0719424460432 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Romania,ROU,Not evaluated,1.07913669064748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Russian Federation,RUS,Successfully treated,50.9433962264151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Russian Federation,RUS,Treatment failed,14.053350683149 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Russian Federation,RUS,Died,8.1327260897853 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Russian Federation,RUS,Lost to follow-up,17.3064411190631 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Russian Federation,RUS,Not evaluated,9.56408588158751 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Russian Federation,RUS,Successfully treated,43.473616748558 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Russian Federation,RUS,Treatment failed,14.3559068575091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Russian Federation,RUS,Died,15.0822473830378 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Russian Federation,RUS,Lost to follow-up,17.581713309122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Russian Federation,RUS,Not evaluated,9.50651570177313 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Russian Federation,RUS,Successfully treated,37.084801207851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Russian Federation,RUS,Treatment failed,18.3442375440362 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Russian Federation,RUS,Died,19.1054353296427 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Russian Federation,RUS,Lost to follow-up,14.7458480120785 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Russian Federation,RUS,Not evaluated,10.7196779063915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Russian Federation,RUS,Successfully treated,40.1160976218713 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Russian Federation,RUS,Treatment failed,14.924162037326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Russian Federation,RUS,Died,18.5381686536421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Russian Federation,RUS,Lost to follow-up,13.1577304787466 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Russian Federation,RUS,Not evaluated,13.263841208414 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Russian Federation,RUS,Successfully treated,48.3281172788668 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Russian Federation,RUS,Treatment failed,13.7978367100423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Russian Federation,RUS,Died,15.7799374073464 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Russian Federation,RUS,Lost to follow-up,10.2564102564103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Russian Federation,RUS,Not evaluated,11.8376983473343 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Russian Federation,RUS,Successfully treated,50.6247199960177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Russian Federation,RUS,Treatment failed,13.2161879635622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Russian Federation,RUS,Died,16.9694857882423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Russian Federation,RUS,Lost to follow-up,9.10946289013888 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Russian Federation,RUS,Not evaluated,10.0801433620389 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Russian Federation,RUS,Successfully treated,53.5984429601451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Russian Federation,RUS,Treatment failed,12.2882293095059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Russian Federation,RUS,Died,15.7207944441987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Russian Federation,RUS,Lost to follow-up,8.44428716769142 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Russian Federation,RUS,Not evaluated,9.94824611845888 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Russian Federation,RUS,Successfully treated,53.7378834152171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Russian Federation,RUS,Treatment failed,12.0302748638959 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Russian Federation,RUS,Died,15.0312043553313 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Russian Federation,RUS,Lost to follow-up,9.05590227061479 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Russian Federation,RUS,Not evaluated,10.1447350949409 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Russian Federation,RUS,Successfully treated,55.1460634906773 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Russian Federation,RUS,Treatment failed,11.7549451988996 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Russian Federation,RUS,Died,15.2307759486485 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Russian Federation,RUS,Lost to follow-up,9.45373564473167 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Russian Federation,RUS,Not evaluated,8.41447971704293 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Russian Federation,RUS,Successfully treated,51.4073712812652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Russian Federation,RUS,Treatment failed,14.3976868947258 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Russian Federation,RUS,Died,15.6343621542535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Russian Federation,RUS,Lost to follow-up,10.7329478157876 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Russian Federation,RUS,Not evaluated,7.82763185396781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Russian Federation,RUS,Successfully treated,51.4038389160708 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Russian Federation,RUS,Treatment failed,14.9040270982311 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Russian Federation,RUS,Died,15.2691004892736 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Russian Federation,RUS,Lost to follow-up,11.1742566804667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Russian Federation,RUS,Not evaluated,7.24877681595785 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Russian Federation,RUS,Successfully treated,50.9936223310842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Russian Federation,RUS,Treatment failed,12.7276088363065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Russian Federation,RUS,Died,16.0643312690637 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Russian Federation,RUS,Lost to follow-up,13.0280062852389 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Russian Federation,RUS,Not evaluated,7.18643127830668 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Russian Federation,RUS,Successfully treated,54.0453860731814 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Russian Federation,RUS,Treatment failed,11.4631420379999 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Russian Federation,RUS,Died,16.0017493561398 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Russian Federation,RUS,Lost to follow-up,11.5992030710919 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Russian Federation,RUS,Not evaluated,6.89051946158706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cambodia,KHM,Lost to follow-up,5.92592592592593 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cambodia,KHM,Not evaluated,0.740740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cambodia,KHM,Successfully treated,80.46875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cambodia,KHM,Treatment failed,1.5625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cambodia,KHM,Died,13.28125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cambodia,KHM,Lost to follow-up,3.90625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cambodia,KHM,Not evaluated,0.78125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cambodia,KHM,Successfully treated,85.0877192982456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cambodia,KHM,Treatment failed,1.75438596491228 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cambodia,KHM,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cambodia,KHM,Lost to follow-up,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cambodia,KHM,Successfully treated,85.0467289719626 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cambodia,KHM,Treatment failed,1.86915887850467 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cambodia,KHM,Died,12.1495327102804 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cambodia,KHM,Lost to follow-up,0.934579439252336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cambodia,KHM,Successfully treated,83.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cambodia,KHM,Treatment failed,4.61538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cambodia,KHM,Died,12.3076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cambodia,KHM,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cambodia,KHM,Successfully treated,85.0877192982456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cambodia,KHM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cambodia,KHM,Died,14.0350877192982 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cambodia,KHM,Lost to follow-up,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cambodia,KHM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cameroon,CMR,Successfully treated,82.3529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cameroon,CMR,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cameroon,CMR,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cameroon,CMR,Successfully treated,95.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cameroon,CMR,Died,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cameroon,CMR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cameroon,CMR,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cameroon,CMR,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cameroon,CMR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cameroon,CMR,Successfully treated,88.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cameroon,CMR,Died,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cameroon,CMR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Cameroon,CMR,Not evaluated,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cameroon,CMR,Successfully treated,12.6984126984127 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cameroon,CMR,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cameroon,CMR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Cameroon,CMR,Not evaluated,82.5396825396826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cameroon,CMR,Successfully treated,92.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cameroon,CMR,Died,6.57894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cameroon,CMR,Lost to follow-up,1.31578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cameroon,CMR,Successfully treated,92.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cameroon,CMR,Died,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cameroon,CMR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cameroon,CMR,Successfully treated,81.3186813186813 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cameroon,CMR,Treatment failed,3.2967032967033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cameroon,CMR,Died,10.989010989011 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cameroon,CMR,Lost to follow-up,4.3956043956044 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cameroon,CMR,Successfully treated,85.8267716535433 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cameroon,CMR,Died,13.3858267716535 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cameroon,CMR,Lost to follow-up,0.78740157480315 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cameroon,CMR,Successfully treated,83.0882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cameroon,CMR,Treatment failed,2.20588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cameroon,CMR,Died,10.2941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cameroon,CMR,Lost to follow-up,4.41176470588235 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cameroon,CMR,Successfully treated,78.8321167883212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cameroon,CMR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cameroon,CMR,Died,13.1386861313869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cameroon,CMR,Lost to follow-up,8.02919708029197 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cameroon,CMR,Successfully treated,82.7814569536424 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cameroon,CMR,Treatment failed,1.98675496688742 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cameroon,CMR,Died,10.5960264900662 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cameroon,CMR,Lost to follow-up,4.63576158940397 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cameroon,CMR,Successfully treated,82.9411764705882 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cameroon,CMR,Treatment failed,1.76470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cameroon,CMR,Died,7.64705882352941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cameroon,CMR,Lost to follow-up,7.64705882352941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cameroon,CMR,Successfully treated,75.974025974026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cameroon,CMR,Treatment failed,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cameroon,CMR,Died,15.5844155844156 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cameroon,CMR,Lost to follow-up,3.8961038961039 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Cameroon,CMR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cameroon,CMR,Successfully treated,81.3084112149533 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cameroon,CMR,Treatment failed,0.934579439252336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cameroon,CMR,Died,11.214953271028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cameroon,CMR,Lost to follow-up,5.60747663551402 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Cameroon,CMR,Not evaluated,0.934579439252336 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cameroon,CMR,Successfully treated,82.1192052980132 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cameroon,CMR,Treatment failed,3.97350993377483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cameroon,CMR,Died,8.60927152317881 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cameroon,CMR,Lost to follow-up,2.64900662251656 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Cameroon,CMR,Not evaluated,2.64900662251656 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Canada,CAN,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Canada,CAN,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Canada,CAN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Canada,CAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Canada,CAN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Canada,CAN,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Canada,CAN,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Canada,CAN,Successfully treated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Canada,CAN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Canada,CAN,Not evaluated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Canada,CAN,Successfully treated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Canada,CAN,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Canada,CAN,Not evaluated,46.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Canada,CAN,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Canada,CAN,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Canada,CAN,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Canada,CAN,Successfully treated,92.3076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Canada,CAN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Canada,CAN,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Canada,CAN,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Canada,CAN,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Canada,CAN,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Canada,CAN,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Canada,CAN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Canada,CAN,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Canada,CAN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Canada,CAN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Canada,CAN,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Canada,CAN,Successfully treated,86.9565217391305 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Canada,CAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Canada,CAN,Died,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Canada,CAN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Canada,CAN,Not evaluated,8.69565217391304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Central African Republic,CAF,Successfully treated,81.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Central African Republic,CAF,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Central African Republic,CAF,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Central African Republic,CAF,Successfully treated,81.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Central African Republic,CAF,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Central African Republic,CAF,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Central African Republic,CAF,Successfully treated,76.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Central African Republic,CAF,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Central African Republic,CAF,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Central African Republic,CAF,Successfully treated,87.8048780487805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Central African Republic,CAF,Died,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Central African Republic,CAF,Lost to follow-up,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Central African Republic,CAF,Successfully treated,58.5365853658537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Central African Republic,CAF,Treatment failed,29.2682926829268 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Central African Republic,CAF,Died,7.31707317073171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Central African Republic,CAF,Lost to follow-up,4.87804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Central African Republic,CAF,Successfully treated,80.2469135802469 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Central African Republic,CAF,Treatment failed,1.23456790123457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Central African Republic,CAF,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Central African Republic,CAF,Lost to follow-up,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Central African Republic,CAF,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Central African Republic,CAF,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Central African Republic,CAF,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Central African Republic,CAF,Died,11.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Central African Republic,CAF,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Central African Republic,CAF,Not evaluated,1.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Successfully treated,62.1621621621622 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Equatorial Guinea,GNQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Equatorial Guinea,GNQ,Died,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Equatorial Guinea,GNQ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Equatorial Guinea,GNQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Equatorial Guinea,GNQ,Successfully treated,86.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Equatorial Guinea,GNQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Equatorial Guinea,GNQ,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Equatorial Guinea,GNQ,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Equatorial Guinea,GNQ,Not evaluated,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Equatorial Guinea,GNQ,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Equatorial Guinea,GNQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Equatorial Guinea,GNQ,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Equatorial Guinea,GNQ,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Equatorial Guinea,GNQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Equatorial Guinea,GNQ,Successfully treated,76.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Equatorial Guinea,GNQ,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Equatorial Guinea,GNQ,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Equatorial Guinea,GNQ,Lost to follow-up,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Equatorial Guinea,GNQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Equatorial Guinea,GNQ,Successfully treated,70.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Equatorial Guinea,GNQ,Treatment failed,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Equatorial Guinea,GNQ,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Equatorial Guinea,GNQ,Lost to follow-up,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Equatorial Guinea,GNQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Equatorial Guinea,GNQ,Successfully treated,51.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Equatorial Guinea,GNQ,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Equatorial Guinea,GNQ,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Equatorial Guinea,GNQ,Lost to follow-up,17.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Equatorial Guinea,GNQ,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Equatorial Guinea,GNQ,Successfully treated,63.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Equatorial Guinea,GNQ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Equatorial Guinea,GNQ,Died,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Equatorial Guinea,GNQ,Lost to follow-up,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Equatorial Guinea,GNQ,Not evaluated,19.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Equatorial Guinea,GNQ,Successfully treated,54.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Equatorial Guinea,GNQ,Treatment failed,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Equatorial Guinea,GNQ,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Equatorial Guinea,GNQ,Lost to follow-up,36.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Equatorial Guinea,GNQ,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eritrea,ERI,Successfully treated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eritrea,ERI,Treatment failed,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eritrea,ERI,Died,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Eritrea,ERI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eritrea,ERI,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eritrea,ERI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eritrea,ERI,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eritrea,ERI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eritrea,ERI,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eritrea,ERI,Successfully treated,90.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eritrea,ERI,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eritrea,ERI,Not evaluated,3.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eritrea,ERI,Successfully treated,79.1666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eritrea,ERI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eritrea,ERI,Not evaluated,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eritrea,ERI,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eritrea,ERI,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eritrea,ERI,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eritrea,ERI,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eritrea,ERI,Successfully treated,88.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eritrea,ERI,Died,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eritrea,ERI,Successfully treated,89.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eritrea,ERI,Died,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eritrea,ERI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eritrea,ERI,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eritrea,ERI,Died,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eritrea,ERI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eritrea,ERI,Not evaluated,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eritrea,ERI,Successfully treated,80.7692307692308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eritrea,ERI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eritrea,ERI,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eritrea,ERI,Lost to follow-up,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eritrea,ERI,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Estonia,EST,Successfully treated,48.7804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Estonia,EST,Treatment failed,6.09756097560976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Estonia,EST,Died,13.4146341463415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Estonia,EST,Lost to follow-up,25.609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Estonia,EST,Not evaluated,6.09756097560976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Estonia,EST,Successfully treated,47.9452054794521 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Estonia,EST,Treatment failed,12.3287671232877 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Estonia,EST,Died,10.958904109589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Estonia,EST,Lost to follow-up,15.0684931506849 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Estonia,EST,Not evaluated,13.6986301369863 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Estonia,EST,Successfully treated,41.1764705882353 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Estonia,EST,Treatment failed,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Estonia,EST,Died,17.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Estonia,EST,Lost to follow-up,10.5882352941176 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Estonia,EST,Not evaluated,24.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Estonia,EST,Successfully treated,46.875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Estonia,EST,Treatment failed,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Estonia,EST,Died,10.9375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Estonia,EST,Lost to follow-up,17.1875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Estonia,EST,Not evaluated,15.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Estonia,EST,Successfully treated,61.4035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Estonia,EST,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Estonia,EST,Died,12.280701754386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Estonia,EST,Lost to follow-up,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Estonia,EST,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Estonia,EST,Successfully treated,76.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Estonia,EST,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Estonia,EST,Lost to follow-up,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Estonia,EST,Not evaluated,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Estonia,EST,Successfully treated,70.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Estonia,EST,Treatment failed,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Estonia,EST,Died,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Estonia,EST,Lost to follow-up,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Estonia,EST,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Estonia,EST,Successfully treated,73.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Estonia,EST,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Estonia,EST,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Estonia,EST,Not evaluated,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Estonia,EST,Successfully treated,70.9677419354839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Estonia,EST,Treatment failed,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Estonia,EST,Died,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Estonia,EST,Lost to follow-up,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Estonia,EST,Not evaluated,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Estonia,EST,Successfully treated,78.9473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Estonia,EST,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Estonia,EST,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Estonia,EST,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Estonia,EST,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Estonia,EST,Successfully treated,88.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Estonia,EST,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Estonia,EST,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Estonia,EST,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Estonia,EST,Successfully treated,68.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Estonia,EST,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Estonia,EST,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Estonia,EST,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Estonia,EST,Successfully treated,81.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Estonia,EST,Treatment failed,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Estonia,EST,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Estonia,EST,Lost to follow-up,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Estonia,EST,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Estonia,EST,Successfully treated,78.9473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Estonia,EST,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Estonia,EST,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Estonia,EST,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Estonia,EST,Successfully treated,89.4736842105263 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Estonia,EST,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Estonia,EST,Lost to follow-up,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Estonia,EST,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Estonia,EST,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Estonia,EST,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Estonia,EST,Died,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Estonia,EST,Lost to follow-up,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Estonia,EST,Not evaluated,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Eswatini,SWZ,Successfully treated,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Eswatini,SWZ,Treatment failed,13.0434782608696 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Eswatini,SWZ,Died,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Eswatini,SWZ,Lost to follow-up,39.1304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Eswatini,SWZ,Not evaluated,26.0869565217391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Eswatini,SWZ,Successfully treated,65.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Eswatini,SWZ,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Eswatini,SWZ,Died,24.1666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Eswatini,SWZ,Lost to follow-up,0.833333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Eswatini,SWZ,Not evaluated,9.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Eswatini,SWZ,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Eswatini,SWZ,Treatment failed,1.42857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Eswatini,SWZ,Died,27.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Eswatini,SWZ,Lost to follow-up,4.28571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Eswatini,SWZ,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Successfully treated,57.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Treatment failed,1.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Died,15.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea-Bissau,GNB,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea-Bissau,GNB,Lost to follow-up,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guinea-Bissau,GNB,Not evaluated,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea-Bissau,GNB,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea-Bissau,GNB,Treatment failed,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea-Bissau,GNB,Died,27.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea-Bissau,GNB,Lost to follow-up,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea-Bissau,GNB,Successfully treated,44.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea-Bissau,GNB,Died,32.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea-Bissau,GNB,Lost to follow-up,24.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea-Bissau,GNB,Successfully treated,39.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea-Bissau,GNB,Died,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea-Bissau,GNB,Lost to follow-up,23.2142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea-Bissau,GNB,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea-Bissau,GNB,Treatment failed,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea-Bissau,GNB,Died,26.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea-Bissau,GNB,Lost to follow-up,19.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea-Bissau,GNB,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea-Bissau,GNB,Treatment failed,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea-Bissau,GNB,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea-Bissau,GNB,Lost to follow-up,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea-Bissau,GNB,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea-Bissau,GNB,Treatment failed,58.974358974359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea-Bissau,GNB,Died,25.6410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea-Bissau,GNB,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea-Bissau,GNB,Successfully treated,70.5882352941177 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea-Bissau,GNB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea-Bissau,GNB,Died,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea-Bissau,GNB,Lost to follow-up,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guinea-Bissau,GNB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guyana,GUY,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guyana,GUY,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guyana,GUY,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Guyana,GUY,Not evaluated,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guyana,GUY,Successfully treated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guyana,GUY,Died,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guyana,GUY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guyana,GUY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guyana,GUY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guyana,GUY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guyana,GUY,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guyana,GUY,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guyana,GUY,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guyana,GUY,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guyana,GUY,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guyana,GUY,Lost to follow-up,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guyana,GUY,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guyana,GUY,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guyana,GUY,Died,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guyana,GUY,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guyana,GUY,Successfully treated,29.4117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guyana,GUY,Treatment failed,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guyana,GUY,Died,29.4117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guyana,GUY,Lost to follow-up,29.4117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guyana,GUY,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guyana,GUY,Died,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guyana,GUY,Lost to follow-up,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guyana,GUY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guyana,GUY,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guyana,GUY,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guyana,GUY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guyana,GUY,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guyana,GUY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guyana,GUY,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guyana,GUY,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Guyana,GUY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Haiti,HTI,Successfully treated,85.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Haiti,HTI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Haiti,HTI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Haiti,HTI,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Haiti,HTI,Successfully treated,57.6923076923077 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Haiti,HTI,Died,26.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Haiti,HTI,Lost to follow-up,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Haiti,HTI,Not evaluated,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Haiti,HTI,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Haiti,HTI,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Haiti,HTI,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Haiti,HTI,Not evaluated,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Haiti,HTI,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Haiti,HTI,Died,10.2564102564103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Haiti,HTI,Lost to follow-up,12.8205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Haiti,HTI,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Haiti,HTI,Successfully treated,68.8524590163934 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Haiti,HTI,Died,9.83606557377049 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Haiti,HTI,Lost to follow-up,4.91803278688525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Haiti,HTI,Not evaluated,16.3934426229508 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Haiti,HTI,Successfully treated,75.8064516129032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Haiti,HTI,Died,14.5161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Haiti,HTI,Lost to follow-up,4.83870967741936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Haiti,HTI,Not evaluated,4.83870967741936 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Haiti,HTI,Successfully treated,82.7160493827161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Haiti,HTI,Treatment failed,1.23456790123457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Haiti,HTI,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Haiti,HTI,Lost to follow-up,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Haiti,HTI,Not evaluated,1.23456790123457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Haiti,HTI,Successfully treated,78.6516853932584 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Haiti,HTI,Died,17.9775280898876 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Haiti,HTI,Lost to follow-up,3.37078651685393 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Haiti,HTI,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Haiti,HTI,Treatment failed,1.11111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Haiti,HTI,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Haiti,HTI,Lost to follow-up,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Haiti,HTI,Successfully treated,81.6793893129771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Haiti,HTI,Died,8.3969465648855 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Haiti,HTI,Lost to follow-up,9.16030534351145 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Haiti,HTI,Not evaluated,0.763358778625954 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Haiti,HTI,Successfully treated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Haiti,HTI,Treatment failed,0.854700854700855 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Haiti,HTI,Died,6.83760683760684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Haiti,HTI,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Haiti,HTI,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Haiti,HTI,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Haiti,HTI,Lost to follow-up,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Haiti,HTI,Successfully treated,92.7083333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Haiti,HTI,Treatment failed,1.04166666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Haiti,HTI,Died,2.08333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Haiti,HTI,Lost to follow-up,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Haiti,HTI,Successfully treated,83.6956521739131 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Haiti,HTI,Died,10.8695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Haiti,HTI,Lost to follow-up,5.43478260869565 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Haiti,HTI,Successfully treated,86.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Haiti,HTI,Died,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Haiti,HTI,Lost to follow-up,1.51515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Haiti,HTI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Haiti,HTI,Successfully treated,84.8484848484848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Haiti,HTI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Haiti,HTI,Died,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Haiti,HTI,Lost to follow-up,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Haiti,HTI,Not evaluated,4.54545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Honduras,HND,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Honduras,HND,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Honduras,HND,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Honduras,HND,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Honduras,HND,Successfully treated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Honduras,HND,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Honduras,HND,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Honduras,HND,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Honduras,HND,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Honduras,HND,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Honduras,HND,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Honduras,HND,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Honduras,HND,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Honduras,HND,Died,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Honduras,HND,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Honduras,HND,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Honduras,HND,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Honduras,HND,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Honduras,HND,Died,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Honduras,HND,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Honduras,HND,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Honduras,HND,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lesotho,LSO,Not evaluated,5.23809523809524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lesotho,LSO,Successfully treated,77.027027027027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lesotho,LSO,Treatment failed,0.900900900900901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lesotho,LSO,Died,17.1171171171171 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lesotho,LSO,Lost to follow-up,1.35135135135135 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lesotho,LSO,Not evaluated,3.6036036036036 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lesotho,LSO,Successfully treated,74.1496598639456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lesotho,LSO,Died,21.7687074829932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lesotho,LSO,Lost to follow-up,0.680272108843537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lesotho,LSO,Not evaluated,3.40136054421769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lesotho,LSO,Successfully treated,72.9281767955801 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lesotho,LSO,Died,18.232044198895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lesotho,LSO,Lost to follow-up,0.552486187845304 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lesotho,LSO,Not evaluated,8.28729281767956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lesotho,LSO,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lesotho,LSO,Treatment failed,0.555555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lesotho,LSO,Died,14.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lesotho,LSO,Lost to follow-up,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lesotho,LSO,Not evaluated,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lesotho,LSO,Successfully treated,73.8738738738739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lesotho,LSO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lesotho,LSO,Died,18.9189189189189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lesotho,LSO,Lost to follow-up,1.8018018018018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lesotho,LSO,Not evaluated,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lesotho,LSO,Successfully treated,73.8738738738739 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lesotho,LSO,Treatment failed,1.8018018018018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lesotho,LSO,Died,15.3153153153153 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lesotho,LSO,Lost to follow-up,4.50450450450451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lesotho,LSO,Not evaluated,4.50450450450451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lesotho,LSO,Successfully treated,83.7209302325582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lesotho,LSO,Treatment failed,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lesotho,LSO,Died,11.6279069767442 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lesotho,LSO,Lost to follow-up,0.775193798449612 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lesotho,LSO,Not evaluated,1.55038759689923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Liberia,LBR,Successfully treated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Liberia,LBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Liberia,LBR,Died,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Liberia,LBR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Liberia,LBR,Successfully treated,72.972972972973 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Liberia,LBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Liberia,LBR,Died,22.972972972973 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Liberia,LBR,Lost to follow-up,4.05405405405405 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Liberia,LBR,Successfully treated,78.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Liberia,LBR,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Liberia,LBR,Died,16.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Liberia,LBR,Lost to follow-up,3.63636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Liberia,LBR,Successfully treated,70.1754385964912 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Liberia,LBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Liberia,LBR,Died,28.0701754385965 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Liberia,LBR,Lost to follow-up,1.75438596491228 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Liberia,LBR,Successfully treated,78.3132530120482 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Liberia,LBR,Treatment failed,1.20481927710843 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Liberia,LBR,Died,14.4578313253012 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Liberia,LBR,Lost to follow-up,6.02409638554217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Liberia,LBR,Successfully treated,84.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Liberia,LBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Liberia,LBR,Died,15.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Liberia,LBR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Liberia,LBR,Successfully treated,84.6153846153846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Liberia,LBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Liberia,LBR,Died,5.4945054945055 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Liberia,LBR,Lost to follow-up,9.89010989010989 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Liberia,LBR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Liberia,LBR,Successfully treated,59.1666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Liberia,LBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Liberia,LBR,Died,11.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Liberia,LBR,Lost to follow-up,11.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Liberia,LBR,Not evaluated,17.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Libya,LBY,Successfully treated,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Libya,LBY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Libya,LBY,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Libya,LBY,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Libya,LBY,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Libya,LBY,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Libya,LBY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Libya,LBY,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Libya,LBY,Lost to follow-up,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Libya,LBY,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Libya,LBY,Successfully treated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Libya,LBY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Libya,LBY,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Libya,LBY,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Libya,LBY,Not evaluated,68.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Libya,LBY,Successfully treated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Libya,LBY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Libya,LBY,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Libya,LBY,Lost to follow-up,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Libya,LBY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Lithuania,LTU,Successfully treated,39.3305439330544 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Lithuania,LTU,Treatment failed,14.2259414225941 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Lithuania,LTU,Died,5.85774058577406 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Lithuania,LTU,Lost to follow-up,40.5857740585774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Lithuania,LTU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Lithuania,LTU,Successfully treated,36.4516129032258 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Lithuania,LTU,Treatment failed,6.45161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Lithuania,LTU,Died,25.4838709677419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Lithuania,LTU,Lost to follow-up,30.3225806451613 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Lithuania,LTU,Not evaluated,1.29032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lithuania,LTU,Successfully treated,3.18471337579618 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lithuania,LTU,Treatment failed,4.45859872611465 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lithuania,LTU,Died,33.4394904458599 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lithuania,LTU,Lost to follow-up,17.515923566879 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Lithuania,LTU,Not evaluated,41.4012738853503 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lithuania,LTU,Successfully treated,26.0869565217391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lithuania,LTU,Treatment failed,11.231884057971 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lithuania,LTU,Died,27.8985507246377 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lithuania,LTU,Lost to follow-up,30.0724637681159 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Lithuania,LTU,Not evaluated,4.71014492753623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lithuania,LTU,Successfully treated,30.1242236024845 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lithuania,LTU,Treatment failed,9.62732919254658 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lithuania,LTU,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lithuania,LTU,Lost to follow-up,30.4347826086957 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Lithuania,LTU,Not evaluated,1.24223602484472 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lithuania,LTU,Successfully treated,29.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lithuania,LTU,Treatment failed,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lithuania,LTU,Died,23.5483870967742 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lithuania,LTU,Lost to follow-up,32.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Lithuania,LTU,Not evaluated,4.51612903225807 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lithuania,LTU,Successfully treated,42.6229508196721 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lithuania,LTU,Treatment failed,7.78688524590164 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lithuania,LTU,Died,20.9016393442623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lithuania,LTU,Lost to follow-up,28.2786885245902 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Lithuania,LTU,Not evaluated,0.409836065573771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lithuania,LTU,Successfully treated,41.0958904109589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lithuania,LTU,Treatment failed,4.5662100456621 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lithuania,LTU,Died,25.1141552511416 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lithuania,LTU,Lost to follow-up,26.027397260274 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Lithuania,LTU,Not evaluated,3.19634703196347 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lithuania,LTU,Successfully treated,39.647577092511 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lithuania,LTU,Treatment failed,5.72687224669604 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lithuania,LTU,Died,22.4669603524229 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lithuania,LTU,Lost to follow-up,24.2290748898678 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Lithuania,LTU,Not evaluated,7.9295154185022 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lithuania,LTU,Successfully treated,16.0550458715596 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lithuania,LTU,Treatment failed,1.8348623853211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lithuania,LTU,Died,20.6422018348624 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lithuania,LTU,Lost to follow-up,16.5137614678899 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Lithuania,LTU,Not evaluated,44.954128440367 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lithuania,LTU,Successfully treated,52.3809523809524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lithuania,LTU,Treatment failed,7.93650793650794 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lithuania,LTU,Died,17.4603174603175 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lithuania,LTU,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Lithuania,LTU,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lithuania,LTU,Successfully treated,55.8375634517767 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lithuania,LTU,Treatment failed,3.55329949238579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lithuania,LTU,Died,18.2741116751269 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lithuania,LTU,Lost to follow-up,20.8121827411168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Lithuania,LTU,Not evaluated,1.52284263959391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lithuania,LTU,Successfully treated,62.7118644067797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lithuania,LTU,Treatment failed,3.38983050847458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lithuania,LTU,Died,17.5141242937853 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lithuania,LTU,Lost to follow-up,15.819209039548 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Lithuania,LTU,Not evaluated,0.564971751412429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lithuania,LTU,Successfully treated,68.7022900763359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lithuania,LTU,Treatment failed,2.29007633587786 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lithuania,LTU,Died,16.030534351145 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lithuania,LTU,Lost to follow-up,11.4503816793893 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Lithuania,LTU,Not evaluated,1.52671755725191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lithuania,LTU,Successfully treated,67.8260869565217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lithuania,LTU,Treatment failed,1.73913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lithuania,LTU,Died,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lithuania,LTU,Lost to follow-up,6.08695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Lithuania,LTU,Not evaluated,6.95652173913044 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lithuania,LTU,Successfully treated,65.4320987654321 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lithuania,LTU,Treatment failed,1.23456790123457 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lithuania,LTU,Died,17.283950617284 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lithuania,LTU,Lost to follow-up,4.93827160493827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Lithuania,LTU,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lithuania,LTU,Successfully treated,70.4761904761905 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lithuania,LTU,Treatment failed,0.952380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lithuania,LTU,Died,22.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lithuania,LTU,Lost to follow-up,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Lithuania,LTU,Not evaluated,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lithuania,LTU,Successfully treated,69.6428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lithuania,LTU,Treatment failed,0.892857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lithuania,LTU,Died,16.9642857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lithuania,LTU,Lost to follow-up,9.82142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Lithuania,LTU,Not evaluated,2.67857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Madagascar,MDG,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Madagascar,MDG,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Madagascar,MDG,Died,35.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Madagascar,MDG,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Madagascar,MDG,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Madagascar,MDG,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Madagascar,MDG,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Philippines,PHL,Treatment failed,2.76195408251338 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Philippines,PHL,Died,10.3745900224409 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Philippines,PHL,Lost to follow-up,7.6126359399275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Philippines,PHL,Not evaluated,0.155359917141378 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Philippines,PHL,Successfully treated,75.6493506493507 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Philippines,PHL,Treatment failed,3.50649350649351 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Philippines,PHL,Died,9.35064935064935 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Philippines,PHL,Lost to follow-up,11.3766233766234 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Philippines,PHL,Not evaluated,0.116883116883117 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Poland,POL,Successfully treated,43.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Poland,POL,Died,28.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Poland,POL,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Poland,POL,Not evaluated,15.625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Poland,POL,Successfully treated,59.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Poland,POL,Died,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Poland,POL,Lost to follow-up,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Poland,POL,Not evaluated,13.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Poland,POL,Successfully treated,47.3684210526316 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Poland,POL,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Poland,POL,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Poland,POL,Lost to follow-up,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Poland,POL,Not evaluated,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Poland,POL,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Poland,POL,Treatment failed,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Poland,POL,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Poland,POL,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Poland,POL,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Poland,POL,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Poland,POL,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Poland,POL,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Poland,POL,Not evaluated,23.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Poland,POL,Successfully treated,35.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Poland,POL,Died,22.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Poland,POL,Lost to follow-up,17.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Poland,POL,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Poland,POL,Successfully treated,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Poland,POL,Treatment failed,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Poland,POL,Died,29.0322580645161 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Poland,POL,Lost to follow-up,19.3548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Poland,POL,Not evaluated,35.4838709677419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Poland,POL,Successfully treated,21.7391304347826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Poland,POL,Died,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Poland,POL,Lost to follow-up,15.2173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Poland,POL,Not evaluated,45.6521739130435 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Poland,POL,Successfully treated,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Poland,POL,Died,29.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Poland,POL,Lost to follow-up,11.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Poland,POL,Not evaluated,40.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Poland,POL,Successfully treated,31.7073170731707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Poland,POL,Died,17.0731707317073 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Poland,POL,Lost to follow-up,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Poland,POL,Not evaluated,48.7804878048781 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Poland,POL,Successfully treated,22.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Poland,POL,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Poland,POL,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Poland,POL,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Poland,POL,Not evaluated,59.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Portugal,PRT,Successfully treated,48.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Portugal,PRT,Treatment failed,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Portugal,PRT,Died,25.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Portugal,PRT,Lost to follow-up,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Portugal,PRT,Not evaluated,17.1428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Portugal,PRT,Successfully treated,55.1020408163265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Portugal,PRT,Treatment failed,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Portugal,PRT,Died,22.4489795918367 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Portugal,PRT,Lost to follow-up,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Portugal,PRT,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Portugal,PRT,Successfully treated,32.3529411764706 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Portugal,PRT,Died,23.5294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Portugal,PRT,Lost to follow-up,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Portugal,PRT,Not evaluated,35.2941176470588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Portugal,PRT,Successfully treated,20.8333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Portugal,PRT,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Portugal,PRT,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Portugal,PRT,Successfully treated,34.4827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Portugal,PRT,Died,10.3448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Portugal,PRT,Lost to follow-up,6.89655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Portugal,PRT,Not evaluated,48.2758620689655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Portugal,PRT,Successfully treated,51.8518518518519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Portugal,PRT,Died,7.40740740740741 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Portugal,PRT,Lost to follow-up,14.8148148148148 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Portugal,PRT,Not evaluated,25.9259259259259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Portugal,PRT,Successfully treated,47.3684210526316 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Portugal,PRT,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Portugal,PRT,Not evaluated,42.1052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Portugal,PRT,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Portugal,PRT,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Portugal,PRT,Not evaluated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Portugal,PRT,Successfully treated,52.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Portugal,PRT,Died,24.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Portugal,PRT,Not evaluated,24.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Portugal,PRT,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Portugal,PRT,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Portugal,PRT,Not evaluated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Portugal,PRT,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Portugal,PRT,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Portugal,PRT,Not evaluated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Portugal,PRT,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Portugal,PRT,Not evaluated,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Portugal,PRT,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Portugal,PRT,Not evaluated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Portugal,PRT,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Portugal,PRT,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Portugal,PRT,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Portugal,PRT,Successfully treated,81.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Portugal,PRT,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Portugal,PRT,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Portugal,PRT,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Portugal,PRT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Portugal,PRT,Not evaluated,36.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Portugal,PRT,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Portugal,PRT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Portugal,PRT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Portugal,PRT,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Portugal,PRT,Not evaluated,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Puerto Rico,PRI,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Puerto Rico,PRI,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Puerto Rico,PRI,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Puerto Rico,PRI,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Puerto Rico,PRI,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Puerto Rico,PRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Puerto Rico,PRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Puerto Rico,PRI,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Puerto Rico,PRI,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Puerto Rico,PRI,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Puerto Rico,PRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Puerto Rico,PRI,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Puerto Rico,PRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Puerto Rico,PRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Puerto Rico,PRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Puerto Rico,PRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Puerto Rico,PRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Puerto Rico,PRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Puerto Rico,PRI,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Puerto Rico,PRI,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Puerto Rico,PRI,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Puerto Rico,PRI,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Puerto Rico,PRI,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Qatar,QAT,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Switzerland,CHE,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Switzerland,CHE,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Switzerland,CHE,Successfully treated,47.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Switzerland,CHE,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Switzerland,CHE,Not evaluated,47.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Switzerland,CHE,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Switzerland,CHE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Switzerland,CHE,Not evaluated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Switzerland,CHE,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Switzerland,CHE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Switzerland,CHE,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Switzerland,CHE,Successfully treated,91.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Switzerland,CHE,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Switzerland,CHE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Switzerland,CHE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Switzerland,CHE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Switzerland,CHE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Switzerland,CHE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Switzerland,CHE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Switzerland,CHE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Switzerland,CHE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Switzerland,CHE,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Switzerland,CHE,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Switzerland,CHE,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Switzerland,CHE,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Switzerland,CHE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Switzerland,CHE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Syrian Arab Republic,SYR,Successfully treated,53.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Syrian Arab Republic,SYR,Treatment failed,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Syrian Arab Republic,SYR,Died,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Syrian Arab Republic,SYR,Lost to follow-up,31.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Syrian Arab Republic,SYR,Successfully treated,59.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Syrian Arab Republic,SYR,Died,22.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Syrian Arab Republic,SYR,Lost to follow-up,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Syrian Arab Republic,SYR,Successfully treated,52.1739130434783 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Syrian Arab Republic,SYR,Died,17.3913043478261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Syrian Arab Republic,SYR,Lost to follow-up,30.4347826086957 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Syrian Arab Republic,SYR,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Syrian Arab Republic,SYR,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Syrian Arab Republic,SYR,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Syrian Arab Republic,SYR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Syrian Arab Republic,SYR,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Syrian Arab Republic,SYR,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Syrian Arab Republic,SYR,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Syrian Arab Republic,SYR,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Syrian Arab Republic,SYR,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Syrian Arab Republic,SYR,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Syrian Arab Republic,SYR,Lost to follow-up,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Syrian Arab Republic,SYR,Successfully treated,53.125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Syrian Arab Republic,SYR,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Syrian Arab Republic,SYR,Lost to follow-up,21.875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Syrian Arab Republic,SYR,Successfully treated,58.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Syrian Arab Republic,SYR,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Syrian Arab Republic,SYR,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Syrian Arab Republic,SYR,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Syrian Arab Republic,SYR,Treatment failed,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Syrian Arab Republic,SYR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Syrian Arab Republic,SYR,Lost to follow-up,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Syrian Arab Republic,SYR,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Syrian Arab Republic,SYR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Syrian Arab Republic,SYR,Successfully treated,41.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Syrian Arab Republic,SYR,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Syrian Arab Republic,SYR,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Syrian Arab Republic,SYR,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Syrian Arab Republic,SYR,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Syrian Arab Republic,SYR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Syrian Arab Republic,SYR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Syrian Arab Republic,SYR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Syrian Arab Republic,SYR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Syrian Arab Republic,SYR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Syrian Arab Republic,SYR,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Syrian Arab Republic,SYR,Successfully treated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Syrian Arab Republic,SYR,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Syrian Arab Republic,SYR,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Syrian Arab Republic,SYR,Not evaluated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Syrian Arab Republic,SYR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Syrian Arab Republic,SYR,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Syrian Arab Republic,SYR,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Syrian Arab Republic,SYR,Lost to follow-up,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Syrian Arab Republic,SYR,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Syrian Arab Republic,SYR,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Syrian Arab Republic,SYR,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Syrian Arab Republic,SYR,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Syrian Arab Republic,SYR,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Syrian Arab Republic,SYR,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Syrian Arab Republic,SYR,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Syrian Arab Republic,SYR,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Syrian Arab Republic,SYR,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Syrian Arab Republic,SYR,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Syrian Arab Republic,SYR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Syrian Arab Republic,SYR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Syrian Arab Republic,SYR,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Syrian Arab Republic,SYR,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Syrian Arab Republic,SYR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tajikistan,TJK,Successfully treated,71.1538461538462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tajikistan,TJK,Treatment failed,11.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tajikistan,TJK,Died,13.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tajikistan,TJK,Lost to follow-up,3.84615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tajikistan,TJK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tajikistan,TJK,Successfully treated,61.6326530612245 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tajikistan,TJK,Treatment failed,13.469387755102 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tajikistan,TJK,Died,13.8775510204082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tajikistan,TJK,Lost to follow-up,10.2040816326531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tajikistan,TJK,Not evaluated,0.816326530612245 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tajikistan,TJK,Successfully treated,63.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tajikistan,TJK,Treatment failed,9.73684210526316 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tajikistan,TJK,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tajikistan,TJK,Lost to follow-up,9.21052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tajikistan,TJK,Not evaluated,2.36842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tajikistan,TJK,Successfully treated,65.607476635514 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tajikistan,TJK,Treatment failed,6.35514018691589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tajikistan,TJK,Died,12.7102803738318 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tajikistan,TJK,Lost to follow-up,14.5794392523365 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tajikistan,TJK,Not evaluated,0.747663551401869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tajikistan,TJK,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tajikistan,TJK,Treatment failed,5.12 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tajikistan,TJK,Died,19.36 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tajikistan,TJK,Lost to follow-up,14.08 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tajikistan,TJK,Not evaluated,1.44 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tajikistan,TJK,Successfully treated,49.5024875621891 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tajikistan,TJK,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tajikistan,TJK,Died,21.1442786069652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tajikistan,TJK,Lost to follow-up,19.7761194029851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tajikistan,TJK,Not evaluated,1.24378109452736 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tajikistan,TJK,Successfully treated,58.3577712609971 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tajikistan,TJK,Treatment failed,7.91788856304985 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tajikistan,TJK,Died,17.8885630498534 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tajikistan,TJK,Lost to follow-up,14.6627565982405 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tajikistan,TJK,Not evaluated,1.17302052785924 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tajikistan,TJK,Successfully treated,64.6108663729809 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tajikistan,TJK,Treatment failed,9.10425844346549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tajikistan,TJK,Died,16.8869309838473 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tajikistan,TJK,Lost to follow-up,8.51688693098385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tajikistan,TJK,Not evaluated,0.881057268722467 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Tajikistan,TJK,Successfully treated,64.4688644688645 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Tajikistan,TJK,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Tajikistan,TJK,Died,14.8351648351648 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Tajikistan,TJK,Lost to follow-up,12.2710622710623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Tajikistan,TJK,Not evaluated,1.28205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tajikistan,TJK,Successfully treated,70.1513067400275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tajikistan,TJK,Treatment failed,3.1636863823934 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tajikistan,TJK,Died,13.0674002751032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tajikistan,TJK,Lost to follow-up,12.1045392022008 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tajikistan,TJK,Not evaluated,1.5130674002751 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tajikistan,TJK,Successfully treated,77.2108843537415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tajikistan,TJK,Treatment failed,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tajikistan,TJK,Died,11.2244897959184 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tajikistan,TJK,Lost to follow-up,9.18367346938776 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tajikistan,TJK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tajikistan,TJK,Successfully treated,80.6179775280899 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tajikistan,TJK,Treatment failed,0.842696629213483 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,South Africa,ZAF,Not evaluated,8.1679215149441 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,South Africa,ZAF,Successfully treated,42.2217447357112 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,South Africa,ZAF,Treatment failed,6.72539750752041 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,South Africa,ZAF,Died,18.4572410829394 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,South Africa,ZAF,Lost to follow-up,17.8985818650623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,South Africa,ZAF,Not evaluated,14.6970348087667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,South Africa,ZAF,Successfully treated,40.3727980335928 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,South Africa,ZAF,Treatment failed,5.85825481360098 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,South Africa,ZAF,Died,17.2879967226547 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,South Africa,ZAF,Lost to follow-up,16.9192953707497 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,South Africa,ZAF,Not evaluated,19.5616550594019 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,South Africa,ZAF,Successfully treated,44.7800091982217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,South Africa,ZAF,Treatment failed,4.85972711942358 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,South Africa,ZAF,Died,17.737237467423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,South Africa,ZAF,Lost to follow-up,19.8374980837038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,South Africa,ZAF,Not evaluated,12.785528131228 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,South Africa,ZAF,Successfully treated,48.936170212766 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,South Africa,ZAF,Treatment failed,3.95843641761504 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,South Africa,ZAF,Died,19.2602671944582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,South Africa,ZAF,Lost to follow-up,24.1835724888669 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,South Africa,ZAF,Not evaluated,3.66155368629391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,South Africa,ZAF,Successfully treated,48.2570190314679 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,South Africa,ZAF,Treatment failed,3.60844168079895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,South Africa,ZAF,Died,22.3289994347089 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,South Africa,ZAF,Lost to follow-up,22.1499905784813 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,South Africa,ZAF,Not evaluated,3.65554927454306 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,South Africa,ZAF,Successfully treated,54.3785437854379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,South Africa,ZAF,Treatment failed,3.0240302403024 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,South Africa,ZAF,Died,21.690216902169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,South Africa,ZAF,Lost to follow-up,18.9451894518945 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,South Africa,ZAF,Not evaluated,1.9620196201962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,South Africa,ZAF,Successfully treated,55.2512820512821 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,South Africa,ZAF,Treatment failed,3.65128205128205 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,South Africa,ZAF,Died,21.6 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,South Africa,ZAF,Lost to follow-up,16.8615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,South Africa,ZAF,Not evaluated,2.63589743589744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,South Africa,ZAF,Successfully treated,53.8309884398244 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,South Africa,ZAF,Treatment failed,3.19025002240344 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,South Africa,ZAF,Died,20.835200286764 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,South Africa,ZAF,Lost to follow-up,19.6164530871942 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,South Africa,ZAF,Not evaluated,2.52710816381396 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Africa,ZAF,Successfully treated,59.8474341192788 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Africa,ZAF,Treatment failed,2.08044382801664 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Africa,ZAF,Died,18.7239944521498 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Africa,ZAF,Lost to follow-up,16.9605706360214 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Africa,ZAF,Not evaluated,2.38755696453339 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Africa,ZAF,Successfully treated,64.8909586551568 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Africa,ZAF,Treatment failed,1.86278964107224 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Africa,ZAF,Died,16.7196728759655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Africa,ZAF,Lost to follow-up,15.0613357564743 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Africa,ZAF,Not evaluated,1.46524307133121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Africa,ZAF,Successfully treated,65.7328363592642 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Africa,ZAF,Treatment failed,1.44282794276783 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Africa,ZAF,Died,16.3400264518456 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Africa,ZAF,Lost to follow-up,15.3781411566671 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Africa,ZAF,Not evaluated,1.10616808945533 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Africa,ZAF,Successfully treated,61.7481956696071 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Africa,ZAF,Treatment failed,2.16519647153168 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Africa,ZAF,Died,17.5300721732157 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Africa,ZAF,Lost to follow-up,16.7602245388933 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Africa,ZAF,Not evaluated,1.79631114675221 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Africa,ZAF,Successfully treated,62.1939432989691 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Africa,ZAF,Treatment failed,2.23904639175258 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Africa,ZAF,Died,16.7364690721649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Africa,ZAF,Lost to follow-up,17.4130154639175 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Africa,ZAF,Not evaluated,1.41752577319588 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Africa,ZAF,Successfully treated,63.0563157136684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Africa,ZAF,Treatment failed,2.16044937346968 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Africa,ZAF,Died,15.8576984012675 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Africa,ZAF,Lost to follow-up,17.8165058332133 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Africa,ZAF,Not evaluated,1.1090306783811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Sudan,SSD,Successfully treated,88.2352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Sudan,SSD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Sudan,SSD,Died,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Sudan,SSD,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,South Sudan,SSD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Sudan,SSD,Successfully treated,85.2459016393443 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Sudan,SSD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Sudan,SSD,Died,4.91803278688525 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Sudan,SSD,Lost to follow-up,9.83606557377049 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,South Sudan,SSD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Sudan,SSD,Successfully treated,90.3225806451613 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Sudan,SSD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Sudan,SSD,Died,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Sudan,SSD,Lost to follow-up,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,South Sudan,SSD,Not evaluated,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Sudan,SSD,Successfully treated,90.4761904761905 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Sudan,SSD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Sudan,SSD,Died,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Sudan,SSD,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,South Sudan,SSD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Sudan,SSD,Successfully treated,95.2755905511811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Sudan,SSD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Sudan,SSD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Sudan,SSD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,South Sudan,SSD,Not evaluated,4.7244094488189 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Sudan,SSD,Successfully treated,93.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Sudan,SSD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Sudan,SSD,Died,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Sudan,SSD,Lost to follow-up,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,South Sudan,SSD,Not evaluated,1.70454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Spain,ESP,Successfully treated,40.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Spain,ESP,Died,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Spain,ESP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Spain,ESP,Not evaluated,40.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Spain,ESP,Successfully treated,43.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Spain,ESP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Spain,ESP,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Spain,ESP,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Spain,ESP,Successfully treated,32.4324324324324 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Spain,ESP,Died,8.10810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Spain,ESP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Spain,ESP,Not evaluated,59.4594594594595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Spain,ESP,Successfully treated,22.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Spain,ESP,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Spain,ESP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Spain,ESP,Not evaluated,68.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Spain,ESP,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Spain,ESP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Spain,ESP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Spain,ESP,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Spain,ESP,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Spain,ESP,Died,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Spain,ESP,Lost to follow-up,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Spain,ESP,Not evaluated,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Spain,ESP,Successfully treated,47.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Spain,ESP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Spain,ESP,Died,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Spain,ESP,Lost to follow-up,2.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Spain,ESP,Not evaluated,47.0588235294118 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Spain,ESP,Successfully treated,70.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Spain,ESP,Treatment failed,1.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Spain,ESP,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Spain,ESP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Spain,ESP,Not evaluated,18.1818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sri Lanka,LKA,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sri Lanka,LKA,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sri Lanka,LKA,Lost to follow-up,43.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sri Lanka,LKA,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sri Lanka,LKA,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sri Lanka,LKA,Lost to follow-up,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Sri Lanka,LKA,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sri Lanka,LKA,Successfully treated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sri Lanka,LKA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sri Lanka,LKA,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Sri Lanka,LKA,Not evaluated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sri Lanka,LKA,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sri Lanka,LKA,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sri Lanka,LKA,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sri Lanka,LKA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sri Lanka,LKA,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sri Lanka,LKA,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sri Lanka,LKA,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sri Lanka,LKA,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sri Lanka,LKA,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sri Lanka,LKA,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sri Lanka,LKA,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sri Lanka,LKA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Sri Lanka,LKA,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sri Lanka,LKA,Successfully treated,69.2307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sri Lanka,LKA,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sri Lanka,LKA,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sri Lanka,LKA,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sri Lanka,LKA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sri Lanka,LKA,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sri Lanka,LKA,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Sri Lanka,LKA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sri Lanka,LKA,Successfully treated,64.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sri Lanka,LKA,Treatment failed,11.7647058823529 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Sri Lanka,LKA,Died,23.5294117647059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uruguay,URY,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uruguay,URY,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uzbekistan,UZB,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uzbekistan,UZB,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uzbekistan,UZB,Died,9.6969696969697 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uzbekistan,UZB,Lost to follow-up,23.030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uzbekistan,UZB,Not evaluated,2.72727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uzbekistan,UZB,Successfully treated,65.6462585034014 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uzbekistan,UZB,Treatment failed,6.12244897959184 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uzbekistan,UZB,Died,5.10204081632653 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uzbekistan,UZB,Lost to follow-up,21.7687074829932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Uzbekistan,UZB,Not evaluated,1.36054421768707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uzbekistan,UZB,Successfully treated,61.4224137931035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uzbekistan,UZB,Treatment failed,10.7758620689655 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uzbekistan,UZB,Died,9.26724137931035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uzbekistan,UZB,Lost to follow-up,16.3793103448276 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uzbekistan,UZB,Not evaluated,2.1551724137931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uzbekistan,UZB,Successfully treated,58.2802547770701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uzbekistan,UZB,Treatment failed,14.171974522293 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uzbekistan,UZB,Died,9.55414012738854 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uzbekistan,UZB,Lost to follow-up,15.1273885350318 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uzbekistan,UZB,Not evaluated,2.86624203821656 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uzbekistan,UZB,Successfully treated,53.2163742690059 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uzbekistan,UZB,Treatment failed,9.47368421052632 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uzbekistan,UZB,Died,13.0994152046784 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uzbekistan,UZB,Lost to follow-up,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uzbekistan,UZB,Not evaluated,1.98830409356725 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uzbekistan,UZB,Successfully treated,49.4299128101945 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uzbekistan,UZB,Treatment failed,10.6639839034205 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uzbekistan,UZB,Died,16.8343393695506 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uzbekistan,UZB,Lost to follow-up,17.4379610999329 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uzbekistan,UZB,Not evaluated,5.63380281690141 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uzbekistan,UZB,Successfully treated,52.5122780506234 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uzbekistan,UZB,Treatment failed,6.91348696637703 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uzbekistan,UZB,Died,19.3426520589346 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uzbekistan,UZB,Lost to follow-up,12.5425009444654 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uzbekistan,UZB,Not evaluated,8.68908197959955 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uzbekistan,UZB,Successfully treated,61.5213770127707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uzbekistan,UZB,Treatment failed,6.13548028872848 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uzbekistan,UZB,Died,16.2965019433648 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uzbekistan,UZB,Lost to follow-up,6.10771793448084 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uzbekistan,UZB,Not evaluated,9.93892282065519 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uzbekistan,UZB,Successfully treated,58.5853885528153 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uzbekistan,UZB,Treatment failed,7.11959050721266 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uzbekistan,UZB,Died,16.6123778501629 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uzbekistan,UZB,Lost to follow-up,7.77105630525826 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uzbekistan,UZB,Not evaluated,9.91158678455095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uzbekistan,UZB,Successfully treated,57.4018126888218 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uzbekistan,UZB,Treatment failed,5.48841893252769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uzbekistan,UZB,Died,15.6596173212487 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uzbekistan,UZB,Lost to follow-up,12.2860020140987 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uzbekistan,UZB,Not evaluated,9.16414904330312 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uzbekistan,UZB,Successfully treated,60.5739514348786 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uzbekistan,UZB,Treatment failed,5.07726269315673 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uzbekistan,UZB,Died,13.598233995585 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uzbekistan,UZB,Lost to follow-up,8.2560706401766 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uzbekistan,UZB,Not evaluated,12.4944812362031 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uzbekistan,UZB,Successfully treated,67.4350171652771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uzbekistan,UZB,Treatment failed,5.88523786169691 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uzbekistan,UZB,Died,13.6341343795978 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uzbekistan,UZB,Lost to follow-up,8.48455125061305 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uzbekistan,UZB,Not evaluated,4.56105934281511 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uzbekistan,UZB,Successfully treated,69.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uzbekistan,UZB,Treatment failed,5.53921568627451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uzbekistan,UZB,Died,10.9313725490196 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uzbekistan,UZB,Lost to follow-up,7.94117647058824 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uzbekistan,UZB,Not evaluated,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uzbekistan,UZB,Successfully treated,71.8115942028986 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uzbekistan,UZB,Treatment failed,5.72463768115942 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uzbekistan,UZB,Died,12.7536231884058 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uzbekistan,UZB,Lost to follow-up,5.65217391304348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uzbekistan,UZB,Not evaluated,4.05797101449275 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uzbekistan,UZB,Successfully treated,73.2458642327439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uzbekistan,UZB,Treatment failed,3.65088419851683 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uzbekistan,UZB,Died,10.1540216771249 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uzbekistan,UZB,Lost to follow-up,7.98630918425556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Uzbekistan,UZB,Not evaluated,4.96292070735881 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Vanuatu,VUT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Vanuatu,VUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Vanuatu,VUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Vanuatu,VUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Vanuatu,VUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Vanuatu,VUT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Vanuatu,VUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Vanuatu,VUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Vanuatu,VUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Vanuatu,VUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Vanuatu,VUT,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Vanuatu,VUT,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Vanuatu,VUT,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Vanuatu,VUT,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Vanuatu,VUT,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Venezuela (Bolivarian Republic of),VEN,Successfully treated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Venezuela (Bolivarian Republic of),VEN,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Venezuela (Bolivarian Republic of),VEN,Died,31.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Venezuela (Bolivarian Republic of),VEN,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Venezuela (Bolivarian Republic of),VEN,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Venezuela (Bolivarian Republic of),VEN,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Venezuela (Bolivarian Republic of),VEN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Venezuela (Bolivarian Republic of),VEN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Venezuela (Bolivarian Republic of),VEN,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Venezuela (Bolivarian Republic of),VEN,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Venezuela (Bolivarian Republic of),VEN,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Venezuela (Bolivarian Republic of),VEN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Venezuela (Bolivarian Republic of),VEN,Died,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Venezuela (Bolivarian Republic of),VEN,Successfully treated,52.3809523809524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Venezuela (Bolivarian Republic of),VEN,Died,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Venezuela (Bolivarian Republic of),VEN,Successfully treated,47.6190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Venezuela (Bolivarian Republic of),VEN,Died,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Venezuela (Bolivarian Republic of),VEN,Not evaluated,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Venezuela (Bolivarian Republic of),VEN,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Venezuela (Bolivarian Republic of),VEN,Treatment failed,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Venezuela (Bolivarian Republic of),VEN,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Venezuela (Bolivarian Republic of),VEN,Successfully treated,52.3809523809524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Venezuela (Bolivarian Republic of),VEN,Treatment failed,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Venezuela (Bolivarian Republic of),VEN,Died,19.0476190476191 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,23.8095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Venezuela (Bolivarian Republic of),VEN,Successfully treated,52.6315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Venezuela (Bolivarian Republic of),VEN,Died,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,21.0526315789474 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Venezuela (Bolivarian Republic of),VEN,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Venezuela (Bolivarian Republic of),VEN,Treatment failed,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Venezuela (Bolivarian Republic of),VEN,Died,15.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Venezuela (Bolivarian Republic of),VEN,Not evaluated,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Venezuela (Bolivarian Republic of),VEN,Successfully treated,70.9677419354839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Venezuela (Bolivarian Republic of),VEN,Treatment failed,3.2258064516129 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Venezuela (Bolivarian Republic of),VEN,Died,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Venezuela (Bolivarian Republic of),VEN,Successfully treated,71.9298245614035 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Venezuela (Bolivarian Republic of),VEN,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Venezuela (Bolivarian Republic of),VEN,Not evaluated,7.01754385964912 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Venezuela (Bolivarian Republic of),VEN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Venezuela (Bolivarian Republic of),VEN,Died,15.2777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,9.72222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Venezuela (Bolivarian Republic of),VEN,Successfully treated,60.9756097560976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Venezuela (Bolivarian Republic of),VEN,Died,9.75609756097561 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,29.2682926829268 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Venezuela (Bolivarian Republic of),VEN,Successfully treated,67.6470588235294 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Venezuela (Bolivarian Republic of),VEN,Died,14.7058823529412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Venezuela (Bolivarian Republic of),VEN,Not evaluated,8.82352941176471 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Venezuela (Bolivarian Republic of),VEN,Successfully treated,63.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Venezuela (Bolivarian Republic of),VEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Venezuela (Bolivarian Republic of),VEN,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Venezuela (Bolivarian Republic of),VEN,Lost to follow-up,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Venezuela (Bolivarian Republic of),VEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Norway,NOR,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Norway,NOR,Treatment failed,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Norway,NOR,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Norway,NOR,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Norway,NOR,Not evaluated,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Norway,NOR,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Norway,NOR,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"occupied Palestinian territory, including east Jerusalem",PSE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"occupied Palestinian territory, including east Jerusalem",PSE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"occupied Palestinian territory, including east Jerusalem",PSE,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"occupied Palestinian territory, including east Jerusalem",PSE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,"occupied Palestinian territory, including east Jerusalem",PSE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"occupied Palestinian territory, including east Jerusalem",PSE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"occupied Palestinian territory, including east Jerusalem",PSE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"occupied Palestinian territory, including east Jerusalem",PSE,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"occupied Palestinian territory, including east Jerusalem",PSE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,"occupied Palestinian territory, including east Jerusalem",PSE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Oman,OMN,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Oman,OMN,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Oman,OMN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Oman,OMN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Oman,OMN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Oman,OMN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Oman,OMN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Oman,OMN,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Oman,OMN,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Oman,OMN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Oman,OMN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Oman,OMN,Successfully treated,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Oman,OMN,Not evaluated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Oman,OMN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Oman,OMN,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Oman,OMN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Oman,OMN,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Oman,OMN,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Oman,OMN,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Oman,OMN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Oman,OMN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Oman,OMN,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Oman,OMN,Not evaluated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Oman,OMN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Oman,OMN,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Oman,OMN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Oman,OMN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Oman,OMN,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Oman,OMN,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Oman,OMN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Oman,OMN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Oman,OMN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Oman,OMN,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Pakistan,PAK,Successfully treated,60.8108108108108 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Pakistan,PAK,Treatment failed,8.10810810810811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Pakistan,PAK,Died,21.6216216216216 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Pakistan,PAK,Lost to follow-up,6.75675675675676 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Pakistan,PAK,Not evaluated,2.7027027027027 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Pakistan,PAK,Successfully treated,70.2564102564103 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Pakistan,PAK,Treatment failed,2.05128205128205 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Pakistan,PAK,Died,14.3589743589744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Pakistan,PAK,Lost to follow-up,9.23076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Pakistan,PAK,Not evaluated,4.1025641025641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Pakistan,PAK,Successfully treated,70.4918032786885 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Pakistan,PAK,Treatment failed,1.63934426229508 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Pakistan,PAK,Died,11.4754098360656 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Pakistan,PAK,Lost to follow-up,5.62060889929742 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Pakistan,PAK,Not evaluated,10.7728337236534 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Pakistan,PAK,Successfully treated,71.0955710955711 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Pakistan,PAK,Treatment failed,2.68065268065268 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Pakistan,PAK,Died,15.1515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Pakistan,PAK,Lost to follow-up,4.66200466200466 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Pakistan,PAK,Not evaluated,6.41025641025641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Pakistan,PAK,Successfully treated,69.0700808625337 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Pakistan,PAK,Treatment failed,3.70619946091644 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Pakistan,PAK,Died,16.9811320754717 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Pakistan,PAK,Lost to follow-up,5.59299191374663 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Pakistan,PAK,Not evaluated,4.64959568733154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Pakistan,PAK,Successfully treated,65.4191033138402 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Pakistan,PAK,Treatment failed,3.31384015594542 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Pakistan,PAK,Died,17.6998050682261 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Pakistan,PAK,Lost to follow-up,9.8635477582846 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Pakistan,PAK,Not evaluated,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Pakistan,PAK,Successfully treated,64.0723270440252 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Pakistan,PAK,Treatment failed,5.26729559748428 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Pakistan,PAK,Died,17.5707547169811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Pakistan,PAK,Lost to follow-up,10.6918238993711 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Pakistan,PAK,Not evaluated,2.39779874213837 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Pakistan,PAK,Successfully treated,63.5520684736091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Pakistan,PAK,Treatment failed,4.38659058487874 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Pakistan,PAK,Died,17.5106990014265 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Pakistan,PAK,Lost to follow-up,9.59343794579173 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Pakistan,PAK,Not evaluated,4.95720399429387 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Pakistan,PAK,Successfully treated,63.597582651973 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Pakistan,PAK,Treatment failed,4.23035904728048 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Pakistan,PAK,Died,18.1301102026306 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Pakistan,PAK,Lost to follow-up,10.5225737646641 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Pakistan,PAK,Not evaluated,3.51937433345183 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Pakistan,PAK,Successfully treated,70.3836150845254 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Pakistan,PAK,Treatment failed,4.29128738621587 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Pakistan,PAK,Died,14.1742522756827 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Pakistan,PAK,Lost to follow-up,9.52535760728219 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Pakistan,PAK,Not evaluated,1.62548764629389 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Pakistan,PAK,Successfully treated,72.5761772853186 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Pakistan,PAK,Treatment failed,3.5219628017412 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Pakistan,PAK,Died,16.0269093787099 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Pakistan,PAK,Lost to follow-up,6.05461020973486 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Pakistan,PAK,Not evaluated,1.82034032449545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Pakistan,PAK,Successfully treated,73.5380980507974 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Pakistan,PAK,Treatment failed,2.30360307147076 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Pakistan,PAK,Died,14.7076196101595 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Pakistan,PAK,Lost to follow-up,7.26520968694625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Pakistan,PAK,Not evaluated,2.18546958062611 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Pakistan,PAK,Successfully treated,73.5017335314512 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Pakistan,PAK,Treatment failed,1.33729569093611 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Pakistan,PAK,Died,15.9980188211986 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Pakistan,PAK,Lost to follow-up,6.19118375433383 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Pakistan,PAK,Not evaluated,2.97176820208024 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Pakistan,PAK,Successfully treated,75.6126021003501 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Pakistan,PAK,Treatment failed,1.32244262932711 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Pakistan,PAK,Died,14.4301828082458 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Pakistan,PAK,Lost to follow-up,7.19564371839751 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Pakistan,PAK,Not evaluated,1.4391287436795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Palau,PLW,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Palau,PLW,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Palau,PLW,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Palau,PLW,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Palau,PLW,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Panama,PAN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Panama,PAN,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Panama,PAN,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Panama,PAN,Successfully treated,72.7272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Panama,PAN,Died,27.2727272727273 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Panama,PAN,Successfully treated,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Panama,PAN,Died,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Panama,PAN,Lost to follow-up,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Panama,PAN,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Panama,PAN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Panama,PAN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Panama,PAN,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Panama,PAN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Panama,PAN,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Singapore,SGP,Successfully treated,59.0909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Singapore,SGP,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Singapore,SGP,Not evaluated,31.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Singapore,SGP,Successfully treated,46.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Singapore,SGP,Died,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Singapore,SGP,Not evaluated,46.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Singapore,SGP,Successfully treated,44.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Singapore,SGP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Singapore,SGP,Not evaluated,55.5555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Singapore,SGP,Successfully treated,37.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Singapore,SGP,Died,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Singapore,SGP,Not evaluated,56.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Singapore,SGP,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Singapore,SGP,Died,9.52380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Singapore,SGP,Not evaluated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Singapore,SGP,Successfully treated,39.1304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Singapore,SGP,Died,4.34782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Singapore,SGP,Not evaluated,56.5217391304348 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Slovakia,SVK,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Slovakia,SVK,Treatment failed,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Slovakia,SVK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Slovakia,SVK,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Slovakia,SVK,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Slovakia,SVK,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Slovakia,SVK,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Slovakia,SVK,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Slovakia,SVK,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Slovakia,SVK,Successfully treated,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Slovakia,SVK,Died,28.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Slovakia,SVK,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovakia,SVK,Successfully treated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovakia,SVK,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovakia,SVK,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Slovakia,SVK,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Slovakia,SVK,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Slovakia,SVK,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Slovakia,SVK,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Slovakia,SVK,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Slovakia,SVK,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Slovakia,SVK,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Slovakia,SVK,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Slovakia,SVK,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Slovakia,SVK,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Slovakia,SVK,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Slovakia,SVK,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Slovakia,SVK,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Slovakia,SVK,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Slovakia,SVK,Died,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Slovakia,SVK,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Slovakia,SVK,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Slovakia,SVK,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Slovakia,SVK,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovakia,SVK,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovakia,SVK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Slovakia,SVK,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Slovakia,SVK,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Slovakia,SVK,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovakia,SVK,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovakia,SVK,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovakia,SVK,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovakia,SVK,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovakia,SVK,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Slovenia,SVN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Slovenia,SVN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovenia,SVN,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovenia,SVN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovenia,SVN,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovenia,SVN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Slovenia,SVN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovenia,SVN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovenia,SVN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovenia,SVN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovenia,SVN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Slovenia,SVN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovenia,SVN,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovenia,SVN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovenia,SVN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovenia,SVN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Slovenia,SVN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Somalia,SOM,Successfully treated,76.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Somalia,SOM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Somalia,SOM,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Somalia,SOM,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Somalia,SOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Somalia,SOM,Successfully treated,76.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Somalia,SOM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Somalia,SOM,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Somalia,SOM,Lost to follow-up,13.1578947368421 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Somalia,SOM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Somalia,SOM,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Somalia,SOM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Somalia,SOM,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Somalia,SOM,Lost to follow-up,9.72222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Somalia,SOM,Not evaluated,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Somalia,SOM,Successfully treated,78.6885245901639 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Somalia,SOM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Somalia,SOM,Died,6.14754098360656 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Somalia,SOM,Lost to follow-up,8.60655737704918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Somalia,SOM,Not evaluated,6.55737704918033 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Somalia,SOM,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Somalia,SOM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Somalia,SOM,Died,7.60869565217391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Somalia,SOM,Lost to follow-up,2.53623188405797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Somalia,SOM,Not evaluated,14.8550724637681 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Somalia,SOM,Successfully treated,70.8708708708709 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Somalia,SOM,Treatment failed,0.3003003003003 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Somalia,SOM,Died,9.00900900900901 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Somalia,SOM,Lost to follow-up,9.30930930930931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Somalia,SOM,Not evaluated,10.5105105105105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Somalia,SOM,Successfully treated,76.7164179104478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Somalia,SOM,Treatment failed,0.298507462686567 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Somalia,SOM,Died,4.47761194029851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Somalia,SOM,Lost to follow-up,8.35820895522388 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Somalia,SOM,Not evaluated,10.1492537313433 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Somalia,SOM,Successfully treated,83.2684824902724 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Somalia,SOM,Treatment failed,0.389105058365759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Somalia,SOM,Died,6.6147859922179 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Somalia,SOM,Lost to follow-up,7.00389105058366 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Somalia,SOM,Not evaluated,2.72373540856031 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Somalia,SOM,Successfully treated,85.5799373040752 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Somalia,SOM,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Somalia,SOM,Died,3.13479623824451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Somalia,SOM,Lost to follow-up,4.38871473354232 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Somalia,SOM,Not evaluated,6.89655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Somalia,SOM,Successfully treated,85.8064516129032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Somalia,SOM,Treatment failed,0.967741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Somalia,SOM,Died,1.93548387096774 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Somalia,SOM,Lost to follow-up,5.16129032258065 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Somalia,SOM,Not evaluated,6.12903225806452 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,South Africa,ZAF,Successfully treated,48.531684698609 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,South Africa,ZAF,Treatment failed,6.02782071097373 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,South Africa,ZAF,Died,21.7928902627512 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,South Africa,ZAF,Lost to follow-up,22.8748068006182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,South Africa,ZAF,Not evaluated,0.772797527047914 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,South Africa,ZAF,Successfully treated,41.9659239842726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,South Africa,ZAF,Treatment failed,4.77064220183486 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,South Africa,ZAF,Died,20.3931847968545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,South Africa,ZAF,Lost to follow-up,9.56749672346003 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,South Africa,ZAF,Not evaluated,23.302752293578 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,South Africa,ZAF,Successfully treated,47.8211270819074 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,South Africa,ZAF,Treatment failed,7.00433493041296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,South Africa,ZAF,Died,19.5300022815423 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,South Africa,ZAF,Lost to follow-up,17.4766141911932 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Republic of Tanzania,TZA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Republic of Tanzania,TZA,Successfully treated,73.9495798319328 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Republic of Tanzania,TZA,Treatment failed,0.840336134453782 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Republic of Tanzania,TZA,Died,18.4873949579832 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Republic of Tanzania,TZA,Lost to follow-up,5.88235294117647 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Republic of Tanzania,TZA,Not evaluated,0.840336134453782 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Republic of Tanzania,TZA,Successfully treated,80.379746835443 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Republic of Tanzania,TZA,Treatment failed,0.632911392405063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Republic of Tanzania,TZA,Died,15.8227848101266 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Republic of Tanzania,TZA,Lost to follow-up,3.16455696202532 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Republic of Tanzania,TZA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Republic of Tanzania,TZA,Successfully treated,82.6589595375723 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Republic of Tanzania,TZA,Treatment failed,1.73410404624277 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Republic of Tanzania,TZA,Died,12.1387283236994 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Republic of Tanzania,TZA,Lost to follow-up,2.89017341040462 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Republic of Tanzania,TZA,Not evaluated,0.578034682080925 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Republic of Tanzania,TZA,Successfully treated,74.5721271393643 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Republic of Tanzania,TZA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Republic of Tanzania,TZA,Died,15.158924205379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Republic of Tanzania,TZA,Lost to follow-up,3.66748166259169 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Republic of Tanzania,TZA,Not evaluated,6.60146699266504 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Republic of Tanzania,TZA,Successfully treated,73.1660231660232 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Republic of Tanzania,TZA,Treatment failed,0.193050193050193 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Republic of Tanzania,TZA,Died,19.3050193050193 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Republic of Tanzania,TZA,Lost to follow-up,5.5984555984556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Republic of Tanzania,TZA,Not evaluated,1.73745173745174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Republic of Tanzania,TZA,Successfully treated,78.3582089552239 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Republic of Tanzania,TZA,Treatment failed,0.248756218905473 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Republic of Tanzania,TZA,Died,13.681592039801 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Republic of Tanzania,TZA,Lost to follow-up,6.21890547263682 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Republic of Tanzania,TZA,Not evaluated,1.49253731343284 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Republic of Tanzania,TZA,Successfully treated,70.6818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Republic of Tanzania,TZA,Treatment failed,0.454545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Republic of Tanzania,TZA,Died,19.5454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Republic of Tanzania,TZA,Lost to follow-up,5.45454545454545 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Republic of Tanzania,TZA,Not evaluated,3.86363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Republic of Tanzania,TZA,Successfully treated,74.0223463687151 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Republic of Tanzania,TZA,Treatment failed,0.558659217877095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Republic of Tanzania,TZA,Died,15.0837988826816 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Republic of Tanzania,TZA,Lost to follow-up,4.18994413407821 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Republic of Tanzania,TZA,Not evaluated,6.14525139664805 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United States of America,USA,Successfully treated,60.9375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United States of America,USA,Treatment failed,5.46875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United States of America,USA,Died,11.71875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United States of America,USA,Not evaluated,21.875 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United States of America,USA,Successfully treated,72.4770642201835 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United States of America,USA,Died,11.9266055045872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United States of America,USA,Lost to follow-up,3.6697247706422 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United States of America,USA,Not evaluated,11.9266055045872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United States of America,USA,Successfully treated,85.3211009174312 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United States of America,USA,Died,5.5045871559633 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United States of America,USA,Lost to follow-up,1.8348623853211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United States of America,USA,Not evaluated,7.3394495412844 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United States of America,USA,Successfully treated,67.0886075949367 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United States of America,USA,Died,13.9240506329114 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United States of America,USA,Lost to follow-up,6.32911392405063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United States of America,USA,Not evaluated,12.6582278481013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United States of America,USA,Successfully treated,62.8318584070797 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United States of America,USA,Died,3.53982300884956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United States of America,USA,Lost to follow-up,3.53982300884956 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United States of America,USA,Not evaluated,30.0884955752212 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United States of America,USA,Successfully treated,69.9029126213592 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United States of America,USA,Died,9.70873786407767 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United States of America,USA,Lost to follow-up,2.9126213592233 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United States of America,USA,Not evaluated,17.4757281553398 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United States of America,USA,Successfully treated,78.9473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United States of America,USA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United States of America,USA,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United States of America,USA,Lost to follow-up,0.87719298245614 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United States of America,USA,Not evaluated,14.9122807017544 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United States of America,USA,Successfully treated,59.2592592592593 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United States of America,USA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United States of America,USA,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United States of America,USA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United States of America,USA,Not evaluated,29.6296296296296 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United States of America,USA,Successfully treated,79.4871794871795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United States of America,USA,Treatment failed,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United States of America,USA,Died,5.12820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United States of America,USA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United States of America,USA,Not evaluated,12.8205128205128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United States of America,USA,Successfully treated,77.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United States of America,USA,Treatment failed,0.925925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United States of America,USA,Died,6.48148148148148 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United States of America,USA,Lost to follow-up,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United States of America,USA,Not evaluated,12.037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United States of America,USA,Successfully treated,68.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United States of America,USA,Treatment failed,0.952380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United States of America,USA,Died,8.57142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United States of America,USA,Lost to follow-up,5.71428571428571 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United States of America,USA,Not evaluated,16.1904761904762 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United States of America,USA,Successfully treated,69.3693693693694 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United States of America,USA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United States of America,USA,Died,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United States of America,USA,Lost to follow-up,4.50450450450451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United States of America,USA,Not evaluated,20.7207207207207 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United States of America,USA,Successfully treated,77.3972602739726 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United States of America,USA,Treatment failed,2.05479452054795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United States of America,USA,Died,10.958904109589 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United States of America,USA,Lost to follow-up,2.05479452054795 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United States of America,USA,Not evaluated,7.53424657534247 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United States of America,USA,Successfully treated,85.3448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United States of America,USA,Treatment failed,0.862068965517241 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United States of America,USA,Died,6.03448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United States of America,USA,Lost to follow-up,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United States of America,USA,Not evaluated,6.03448275862069 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United States of America,USA,Successfully treated,83.7209302325582 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United States of America,USA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United States of America,USA,Died,10.4651162790698 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United States of America,USA,Lost to follow-up,3.48837209302326 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United States of America,USA,Not evaluated,2.32558139534884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United States of America,USA,Successfully treated,80.3030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United States of America,USA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United States of America,USA,Died,7.57575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United States of America,USA,Lost to follow-up,1.51515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United States of America,USA,Not evaluated,10.6060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United States of America,USA,Successfully treated,86.9158878504673 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United States of America,USA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United States of America,USA,Died,7.47663551401869 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United States of America,USA,Lost to follow-up,3.73831775700935 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United States of America,USA,Not evaluated,1.86915887850467 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uruguay,URY,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uruguay,URY,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uruguay,URY,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uruguay,URY,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uruguay,URY,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uruguay,URY,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uruguay,URY,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uruguay,URY,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uruguay,URY,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uruguay,URY,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uruguay,URY,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uruguay,URY,Lost to follow-up,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uruguay,URY,Successfully treated,58.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uruguay,URY,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uruguay,URY,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uruguay,URY,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Uruguay,URY,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,North Macedonia,MKD,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,North Macedonia,MKD,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,North Macedonia,MKD,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,North Macedonia,MKD,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,North Macedonia,MKD,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,North Macedonia,MKD,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,North Macedonia,MKD,Successfully treated,22.2222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,North Macedonia,MKD,Died,44.4444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,North Macedonia,MKD,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,North Macedonia,MKD,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,North Macedonia,MKD,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,North Macedonia,MKD,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,North Macedonia,MKD,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,North Macedonia,MKD,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,North Macedonia,MKD,Successfully treated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,North Macedonia,MKD,Died,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,North Macedonia,MKD,Lost to follow-up,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,North Macedonia,MKD,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,North Macedonia,MKD,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,North Macedonia,MKD,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,North Macedonia,MKD,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,North Macedonia,MKD,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,North Macedonia,MKD,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,North Macedonia,MKD,Lost to follow-up,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,North Macedonia,MKD,Successfully treated,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,North Macedonia,MKD,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,North Macedonia,MKD,Lost to follow-up,40.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,North Macedonia,MKD,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,North Macedonia,MKD,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,North Macedonia,MKD,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,North Macedonia,MKD,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,North Macedonia,MKD,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,North Macedonia,MKD,Lost to follow-up,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,North Macedonia,MKD,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,North Macedonia,MKD,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,North Macedonia,MKD,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,North Macedonia,MKD,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,North Macedonia,MKD,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,North Macedonia,MKD,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,North Macedonia,MKD,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,North Macedonia,MKD,Lost to follow-up,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,North Macedonia,MKD,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Northern Mariana Islands,MNP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Northern Mariana Islands,MNP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Northern Mariana Islands,MNP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Northern Mariana Islands,MNP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Northern Mariana Islands,MNP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Norway,NOR,Successfully treated,71.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Norway,NOR,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Norway,NOR,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Norway,NOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Norway,NOR,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Norway,NOR,Not evaluated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Norway,NOR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Norway,NOR,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Norway,NOR,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Norway,NOR,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Norway,NOR,Treatment failed,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Norway,NOR,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Norway,NOR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Norway,NOR,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Norway,NOR,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Norway,NOR,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Norway,NOR,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Norway,NOR,Treatment failed,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Norway,NOR,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Norway,NOR,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Norway,NOR,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Norway,NOR,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Norway,NOR,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Norway,NOR,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Norway,NOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Norway,NOR,Successfully treated,90.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Norway,NOR,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Norway,NOR,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Norway,NOR,Lost to follow-up,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Norway,NOR,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Norway,NOR,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Norway,NOR,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Norway,NOR,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Norway,NOR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Norway,NOR,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Norway,NOR,Not evaluated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Norway,NOR,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Norway,NOR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Senegal,SEN,Successfully treated,90.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Senegal,SEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Senegal,SEN,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Senegal,SEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Senegal,SEN,Successfully treated,70.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Senegal,SEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Senegal,SEN,Died,25.9259259259259 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Senegal,SEN,Lost to follow-up,3.7037037037037 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Senegal,SEN,Successfully treated,75.8620689655172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Senegal,SEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Senegal,SEN,Died,17.2413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Senegal,SEN,Lost to follow-up,6.89655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Senegal,SEN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Senegal,SEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Senegal,SEN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Senegal,SEN,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Senegal,SEN,Successfully treated,70.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Senegal,SEN,Treatment failed,1.85185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Senegal,SEN,Died,20.3703703703704 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Senegal,SEN,Lost to follow-up,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Senegal,SEN,Not evaluated,1.85185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Senegal,SEN,Successfully treated,92.5925925925926 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Senegal,SEN,Treatment failed,1.85185185185185 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Senegal,SEN,Died,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Senegal,SEN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Senegal,SEN,Successfully treated,80.3571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Senegal,SEN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Senegal,SEN,Died,8.92857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Senegal,SEN,Lost to follow-up,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Senegal,SEN,Successfully treated,86.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Senegal,SEN,Treatment failed,3.40909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Senegal,SEN,Died,6.81818181818182 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Senegal,SEN,Lost to follow-up,2.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Senegal,SEN,Not evaluated,1.13636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Senegal,SEN,Successfully treated,83.6734693877551 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Senegal,SEN,Treatment failed,4.08163265306122 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Senegal,SEN,Died,10.2040816326531 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Senegal,SEN,Lost to follow-up,2.04081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Senegal,SEN,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Senegal,SEN,Treatment failed,3.03030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Senegal,SEN,Died,12.1212121212121 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Senegal,SEN,Lost to follow-up,1.51515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Senegal,SEN,Successfully treated,84.7222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Senegal,SEN,Treatment failed,4.16666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Senegal,SEN,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Senegal,SEN,Lost to follow-up,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Senegal,SEN,Successfully treated,84.1463414634146 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Senegal,SEN,Treatment failed,1.21951219512195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Senegal,SEN,Died,2.4390243902439 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Senegal,SEN,Lost to follow-up,12.1951219512195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Senegal,SEN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Serbia,SRB,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Serbia,SRB,Treatment failed,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Serbia,SRB,Died,30.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Serbia,SRB,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Serbia,SRB,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Serbia,SRB,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Serbia,SRB,Successfully treated,64.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Serbia,SRB,Died,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Serbia,SRB,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Serbia,SRB,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Serbia,SRB,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Serbia,SRB,Lost to follow-up,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Serbia,SRB,Successfully treated,76.9230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Serbia,SRB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Serbia,SRB,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Serbia,SRB,Successfully treated,53.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Serbia,SRB,Treatment failed,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Serbia,SRB,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Serbia,SRB,Lost to follow-up,23.0769230769231 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Serbia,SRB,Successfully treated,80.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Serbia,SRB,Treatment failed,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Serbia,SRB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Serbia,SRB,Successfully treated,70.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Serbia,SRB,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Serbia,SRB,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Serbia,SRB,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Serbia,SRB,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Serbia,SRB,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Serbia,SRB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Serbia,SRB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Serbia,SRB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Serbia,SRB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Serbia,SRB,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Serbia,SRB,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Serbia,SRB,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Serbia,SRB,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Serbia,SRB,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sierra Leone,SLE,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sierra Leone,SLE,Treatment failed,1.92307692307692 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sierra Leone,SLE,Died,16.3461538461538 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sierra Leone,SLE,Lost to follow-up,6.73076923076923 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Sierra Leone,SLE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sierra Leone,SLE,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sierra Leone,SLE,Treatment failed,5.83333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sierra Leone,SLE,Died,17.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sierra Leone,SLE,Lost to follow-up,3.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Sierra Leone,SLE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sierra Leone,SLE,Successfully treated,80.2721088435374 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sierra Leone,SLE,Treatment failed,1.36054421768707 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sierra Leone,SLE,Died,16.3265306122449 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sierra Leone,SLE,Lost to follow-up,2.04081632653061 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Sierra Leone,SLE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sierra Leone,SLE,Successfully treated,72.9885057471264 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sierra Leone,SLE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sierra Leone,SLE,Died,25.2873563218391 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sierra Leone,SLE,Lost to follow-up,1.72413793103448 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Sierra Leone,SLE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sierra Leone,SLE,Successfully treated,74.7474747474748 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sierra Leone,SLE,Treatment failed,1.51515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sierra Leone,SLE,Died,17.1717171717172 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sierra Leone,SLE,Lost to follow-up,5.05050505050505 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Sierra Leone,SLE,Not evaluated,1.51515151515152 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Singapore,SGP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Singapore,SGP,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Singapore,SGP,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,Singapore,SGP,Not evaluated,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Singapore,SGP,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Singapore,SGP,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Singapore,SGP,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Singapore,SGP,Treatment failed,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Singapore,SGP,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Singapore,SGP,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Singapore,SGP,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Singapore,SGP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Singapore,SGP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Singapore,SGP,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Singapore,SGP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Singapore,SGP,Successfully treated,83.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Singapore,SGP,Died,16.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Singapore,SGP,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Singapore,SGP,Successfully treated,54.5454545454546 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Singapore,SGP,Not evaluated,45.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Singapore,SGP,Successfully treated,26.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Singapore,SGP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Singapore,SGP,Not evaluated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Singapore,SGP,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Singapore,SGP,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Singapore,SGP,Not evaluated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Singapore,SGP,Successfully treated,38.4615384615385 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Singapore,SGP,Died,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Singapore,SGP,Not evaluated,53.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Singapore,SGP,Successfully treated,26.3157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Singapore,SGP,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Singapore,SGP,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Singapore,SGP,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Singapore,SGP,Not evaluated,73.6842105263158 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Arab Emirates,ARE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Arab Emirates,ARE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Arab Emirates,ARE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Arab Emirates,ARE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Arab Emirates,ARE,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Arab Emirates,ARE,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Arab Emirates,ARE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Arab Emirates,ARE,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Arab Emirates,ARE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Arab Emirates,ARE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Arab Emirates,ARE,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Arab Emirates,ARE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Arab Emirates,ARE,Treatment failed,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Arab Emirates,ARE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Arab Emirates,ARE,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Arab Emirates,ARE,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Arab Emirates,ARE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Arab Emirates,ARE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Arab Emirates,ARE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Arab Emirates,ARE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Arab Emirates,ARE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,United Kingdom of Great Britain and Northern Ireland,GBR,Died,13.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,15.0943396226415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,United Kingdom of Great Britain and Northern Ireland,GBR,Died,5.66037735849057 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2003,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,75.4716981132076 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,48.9795918367347 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United Kingdom of Great Britain and Northern Ireland,GBR,Died,6.12244897959184 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,22.4489795918367 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,22.4489795918367 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,58.1395348837209 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,United Kingdom of Great Britain and Northern Ireland,GBR,Died,4.65116279069768 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,18.6046511627907 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2005,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,18.6046511627907 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,46.551724137931 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United Kingdom of Great Britain and Northern Ireland,GBR,Died,3.44827586206897 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,13.7931034482759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,36.2068965517241 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,35.4838709677419 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Kingdom of Great Britain and Northern Ireland,GBR,Died,9.67741935483871 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,41.9354838709678 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,50.9090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United Kingdom of Great Britain and Northern Ireland,GBR,Died,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,16.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,25.4545454545455 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,40.9836065573771 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Kingdom of Great Britain and Northern Ireland,GBR,Died,3.27868852459016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,19.672131147541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,36.0655737704918 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,44.7761194029851 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Kingdom of Great Britain and Northern Ireland,GBR,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,16.4179104477612 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,38.8059701492537 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,51.2820512820513 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Kingdom of Great Britain and Northern Ireland,GBR,Died,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,21.7948717948718 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,24.3589743589744 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,53.8461538461539 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Kingdom of Great Britain and Northern Ireland,GBR,Died,2.56410256410256 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,28.2051282051282 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,64.9350649350649 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Kingdom of Great Britain and Northern Ireland,GBR,Died,1.2987012987013 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,19.4805194805195 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,60.377358490566 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Kingdom of Great Britain and Northern Ireland,GBR,Died,3.77358490566038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,11.3207547169811 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,24.5283018867925 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,71.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Kingdom of Great Britain and Northern Ireland,GBR,Died,2.22222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,17.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,66.1016949152543 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Kingdom of Great Britain and Northern Ireland,GBR,Died,6.77966101694915 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,11.864406779661 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,15.2542372881356 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Kingdom of Great Britain and Northern Ireland,GBR,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,23.2142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Kingdom of Great Britain and Northern Ireland,GBR,Died,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,65.9574468085106 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,6.38297872340426 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Kingdom of Great Britain and Northern Ireland,GBR,Died,8.51063829787234 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,10.6382978723404 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,8.51063829787234 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,78.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Kingdom of Great Britain and Northern Ireland,GBR,Died,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,81.5789473684211 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Kingdom of Great Britain and Northern Ireland,GBR,Died,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,2.63157894736842 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,7.89473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Kingdom of Great Britain and Northern Ireland,GBR,Successfully treated,82.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Kingdom of Great Britain and Northern Ireland,GBR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Kingdom of Great Britain and Northern Ireland,GBR,Died,2.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Kingdom of Great Britain and Northern Ireland,GBR,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,United Kingdom of Great Britain and Northern Ireland,GBR,Not evaluated,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Republic of Tanzania,TZA,Successfully treated,62.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Republic of Tanzania,TZA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Republic of Tanzania,TZA,Died,18.75 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Republic of Tanzania,TZA,Lost to follow-up,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,United Republic of Tanzania,TZA,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Republic of Tanzania,TZA,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Republic of Tanzania,TZA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Republic of Tanzania,TZA,Died,15.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Republic of Tanzania,TZA,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,United Republic of Tanzania,TZA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Republic of Tanzania,TZA,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Republic of Tanzania,TZA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Republic of Tanzania,TZA,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Republic of Tanzania,TZA,Lost to follow-up,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,United Republic of Tanzania,TZA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Republic of Tanzania,TZA,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Republic of Tanzania,TZA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Republic of Tanzania,TZA,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Republic of Tanzania,TZA,Lost to follow-up,8.88888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,United Republic of Tanzania,TZA,Not evaluated,4.44444444444444 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Republic of Tanzania,TZA,Successfully treated,68.4782608695652 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Republic of Tanzania,TZA,Treatment failed,1.08695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Republic of Tanzania,TZA,Died,19.5652173913043 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Republic of Tanzania,TZA,Lost to follow-up,10.8695652173913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,United Republic of Tanzania,TZA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Republic of Tanzania,TZA,Successfully treated,75.5244755244755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Republic of Tanzania,TZA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Republic of Tanzania,TZA,Died,17.4825174825175 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,United Republic of Tanzania,TZA,Lost to follow-up,6.99300699300699 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Russian Federation,RUS,Successfully treated,65.0010497585555 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Russian Federation,RUS,Treatment failed,5.00209951711106 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Russian Federation,RUS,Died,15.5994121352089 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Russian Federation,RUS,Lost to follow-up,11.40037791308 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Russian Federation,RUS,Not evaluated,2.99706067604451 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Rwanda,RWA,Successfully treated,86.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Rwanda,RWA,Treatment failed,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Rwanda,RWA,Died,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Rwanda,RWA,Not evaluated,2.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Rwanda,RWA,Successfully treated,86.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Rwanda,RWA,Died,10.7142857142857 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Rwanda,RWA,Lost to follow-up,2.38095238095238 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Rwanda,RWA,Successfully treated,90.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Rwanda,RWA,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Rwanda,RWA,Died,5.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Rwanda,RWA,Lost to follow-up,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Rwanda,RWA,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Rwanda,RWA,Successfully treated,87.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Rwanda,RWA,Treatment failed,1.38888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Rwanda,RWA,Died,9.72222222222222 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Rwanda,RWA,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Trinidad and Tobago,TTO,Not evaluated,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Trinidad and Tobago,TTO,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Trinidad and Tobago,TTO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Trinidad and Tobago,TTO,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Trinidad and Tobago,TTO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Trinidad and Tobago,TTO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Trinidad and Tobago,TTO,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Trinidad and Tobago,TTO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Trinidad and Tobago,TTO,Died,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Trinidad and Tobago,TTO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Trinidad and Tobago,TTO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Trinidad and Tobago,TTO,Successfully treated,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Trinidad and Tobago,TTO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Trinidad and Tobago,TTO,Died,50.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Trinidad and Tobago,TTO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Trinidad and Tobago,TTO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Trinidad and Tobago,TTO,Successfully treated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Trinidad and Tobago,TTO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Trinidad and Tobago,TTO,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Trinidad and Tobago,TTO,Lost to follow-up,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Trinidad and Tobago,TTO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Trinidad and Tobago,TTO,Successfully treated,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Trinidad and Tobago,TTO,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Trinidad and Tobago,TTO,Died,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Trinidad and Tobago,TTO,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Trinidad and Tobago,TTO,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Tunisia,TUN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Tunisia,TUN,Died,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Tunisia,TUN,Not evaluated,12.5 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tunisia,TUN,Successfully treated,81.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tunisia,TUN,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Tunisia,TUN,Not evaluated,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tunisia,TUN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tunisia,TUN,Died,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Tunisia,TUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tunisia,TUN,Successfully treated,75.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tunisia,TUN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Tunisia,TUN,Not evaluated,25.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tunisia,TUN,Successfully treated,73.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tunisia,TUN,Treatment failed,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tunisia,TUN,Died,13.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Tunisia,TUN,Not evaluated,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tunisia,TUN,Successfully treated,78.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tunisia,TUN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Tunisia,TUN,Not evaluated,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tunisia,TUN,Successfully treated,78.5714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tunisia,TUN,Treatment failed,7.14285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tunisia,TUN,Died,14.2857142857143 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Tunisia,TUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tunisia,TUN,Successfully treated,57.1428571428572 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tunisia,TUN,Died,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Tunisia,TUN,Not evaluated,21.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tunisia,TUN,Successfully treated,61.5384615384615 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tunisia,TUN,Died,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tunisia,TUN,Lost to follow-up,15.3846153846154 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Tunisia,TUN,Not evaluated,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tunisia,TUN,Successfully treated,78.9473684210526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tunisia,TUN,Treatment failed,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tunisia,TUN,Died,10.5263157894737 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Tunisia,TUN,Not evaluated,5.26315789473684 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tunisia,TUN,Successfully treated,84.2105263157895 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tunisia,TUN,Died,15.7894736842105 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Tunisia,TUN,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tunisia,TUN,Successfully treated,88.8888888888889 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tunisia,TUN,Treatment failed,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tunisia,TUN,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tunisia,TUN,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Tunisia,TUN,Not evaluated,5.55555555555556 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tunisia,TUN,Successfully treated,60.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tunisia,TUN,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tunisia,TUN,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tunisia,TUN,Lost to follow-up,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Tunisia,TUN,Not evaluated,10.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Türkiye,TUR,Successfully treated,71.0843373493976 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Türkiye,TUR,Treatment failed,0.803212851405623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Türkiye,TUR,Died,9.23694779116466 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Türkiye,TUR,Lost to follow-up,8.03212851405623 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Türkiye,TUR,Not evaluated,10.8433734939759 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Türkiye,TUR,Successfully treated,64.5833333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Türkiye,TUR,Treatment failed,11.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Türkiye,TUR,Died,8.33333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Türkiye,TUR,Lost to follow-up,9.58333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Türkiye,TUR,Not evaluated,6.25 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Türkiye,TUR,Successfully treated,68.4410646387833 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Türkiye,TUR,Treatment failed,1.14068441064639 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Türkiye,TUR,Died,6.4638783269962 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Türkiye,TUR,Lost to follow-up,6.84410646387833 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Türkiye,TUR,Not evaluated,17.1102661596958 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Türkiye,TUR,Successfully treated,66.2162162162162 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Türkiye,TUR,Treatment failed,1.8018018018018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Türkiye,TUR,Died,8.55855855855856 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Türkiye,TUR,Lost to follow-up,5.40540540540541 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Türkiye,TUR,Not evaluated,18.018018018018 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Türkiye,TUR,Successfully treated,67.2 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Türkiye,TUR,Treatment failed,4.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Türkiye,TUR,Died,8.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Türkiye,TUR,Lost to follow-up,6.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Türkiye,TUR,Not evaluated,14.8 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Türkiye,TUR,Successfully treated,65.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Türkiye,TUR,Treatment failed,2.90909090909091 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Türkiye,TUR,Died,9.09090909090909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Türkiye,TUR,Lost to follow-up,8.36363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Türkiye,TUR,Not evaluated,13.8181818181818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Türkiye,TUR,Successfully treated,66.3230240549828 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Türkiye,TUR,Treatment failed,2.74914089347079 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Türkiye,TUR,Died,6.52920962199313 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Türkiye,TUR,Lost to follow-up,10.9965635738832 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Türkiye,TUR,Not evaluated,13.4020618556701 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Türkiye,TUR,Successfully treated,65.3508771929825 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Türkiye,TUR,Treatment failed,6.14035087719298 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Türkiye,TUR,Died,7.45614035087719 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Türkiye,TUR,Lost to follow-up,11.8421052631579 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Türkiye,TUR,Not evaluated,9.21052631578947 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Türkiye,TUR,Successfully treated,63.4241245136187 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Türkiye,TUR,Treatment failed,5.83657587548638 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Türkiye,TUR,Died,10.5058365758755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Türkiye,TUR,Lost to follow-up,11.6731517509728 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Türkiye,TUR,Not evaluated,8.56031128404669 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Türkiye,TUR,Successfully treated,67.8260869565217 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Türkiye,TUR,Treatment failed,7.82608695652174 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Türkiye,TUR,Died,6.52173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Türkiye,TUR,Lost to follow-up,11.304347826087 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Türkiye,TUR,Not evaluated,6.52173913043478 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Türkiye,TUR,Successfully treated,62.085308056872 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Türkiye,TUR,Treatment failed,7.58293838862559 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Türkiye,TUR,Died,9.00473933649289 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Türkiye,TUR,Lost to follow-up,12.7962085308057 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Türkiye,TUR,Not evaluated,8.53080568720379 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Türkiye,TUR,Successfully treated,68.8118811881188 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Türkiye,TUR,Treatment failed,3.96039603960396 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Türkiye,TUR,Died,10.3960396039604 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Türkiye,TUR,Lost to follow-up,9.9009900990099 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Türkiye,TUR,Not evaluated,6.93069306930693 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Türkiye,TUR,Successfully treated,55.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Türkiye,TUR,Treatment failed,1.11111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Türkiye,TUR,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Türkiye,TUR,Lost to follow-up,5.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Türkiye,TUR,Not evaluated,27.7777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Türkiye,TUR,Successfully treated,45.8064516129032 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Türkiye,TUR,Treatment failed,0.645161290322581 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Türkiye,TUR,Died,12.9032258064516 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Türkiye,TUR,Lost to follow-up,7.09677419354839 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Türkiye,TUR,Not evaluated,33.5483870967742 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Türkiye,TUR,Successfully treated,53.030303030303 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Türkiye,TUR,Treatment failed,0.757575757575758 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Türkiye,TUR,Died,11.3636363636364 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Türkiye,TUR,Lost to follow-up,10.6060606060606 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Türkiye,TUR,Not evaluated,24.2424242424242 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Türkiye,TUR,Successfully treated,44.5544554455446 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Türkiye,TUR,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Türkiye,TUR,Died,10.8910891089109 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Türkiye,TUR,Lost to follow-up,11.8811881188119 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Türkiye,TUR,Not evaluated,32.6732673267327 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Türkiye,TUR,Successfully treated,53.90625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Türkiye,TUR,Treatment failed,0.78125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Türkiye,TUR,Died,10.15625 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Türkiye,TUR,Lost to follow-up,9.375 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Türkiye,TUR,Not evaluated,25.78125 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Turkmenistan,TKM,Not evaluated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Turkmenistan,TKM,Successfully treated,67.1361502347418 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Turkmenistan,TKM,Treatment failed,15.0234741784038 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Turkmenistan,TKM,Died,11.2676056338028 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Turkmenistan,TKM,Lost to follow-up,6.57276995305164 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Turkmenistan,TKM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Turkmenistan,TKM,Successfully treated,67.6190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Turkmenistan,TKM,Treatment failed,14.7619047619048 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Turkmenistan,TKM,Died,10.952380952381 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Turkmenistan,TKM,Lost to follow-up,6.66666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Turkmenistan,TKM,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Turkmenistan,TKM,Successfully treated,54.3985637342909 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Turkmenistan,TKM,Treatment failed,17.7737881508079 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Turkmenistan,TKM,Died,16.6965888689408 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Turkmenistan,TKM,Lost to follow-up,9.33572710951526 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Turkmenistan,TKM,Not evaluated,1.79533213644524 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Turkmenistan,TKM,Successfully treated,65.8892128279884 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Turkmenistan,TKM,Treatment failed,12.536443148688 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Turkmenistan,TKM,Died,9.03790087463557 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zambia,ZMB,Not evaluated,2.77777777777778 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Zimbabwe,ZWE,Successfully treated,100.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Zimbabwe,ZWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Zimbabwe,ZWE,Died,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Zimbabwe,ZWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Zimbabwe,ZWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zimbabwe,ZWE,Successfully treated,66.6666666666667 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zimbabwe,ZWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zimbabwe,ZWE,Died,33.3333333333333 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zimbabwe,ZWE,Lost to follow-up,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Zimbabwe,ZWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zimbabwe,ZWE,Successfully treated,81.4285714285714 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zimbabwe,ZWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zimbabwe,ZWE,Died,12.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zimbabwe,ZWE,Lost to follow-up,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Zimbabwe,ZWE,Not evaluated,2.85714285714286 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zimbabwe,ZWE,Successfully treated,74.7863247863248 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zimbabwe,ZWE,Treatment failed,2.99145299145299 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zimbabwe,ZWE,Died,11.1111111111111 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zimbabwe,ZWE,Lost to follow-up,7.69230769230769 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Zimbabwe,ZWE,Not evaluated,3.41880341880342 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zimbabwe,ZWE,Successfully treated,58.974358974359 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zimbabwe,ZWE,Treatment failed,0.284900284900285 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zimbabwe,ZWE,Died,12.2507122507123 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zimbabwe,ZWE,Lost to follow-up,3.98860398860399 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Zimbabwe,ZWE,Not evaluated,24.5014245014245 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zimbabwe,ZWE,Successfully treated,50.6561679790026 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zimbabwe,ZWE,Treatment failed,1.5748031496063 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zimbabwe,ZWE,Died,17.3228346456693 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zimbabwe,ZWE,Lost to follow-up,5.51181102362205 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Zimbabwe,ZWE,Not evaluated,24.9343832020997 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zimbabwe,ZWE,Successfully treated,43.64896073903 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zimbabwe,ZWE,Treatment failed,1.84757505773672 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zimbabwe,ZWE,Died,17.3210161662818 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zimbabwe,ZWE,Lost to follow-up,5.08083140877598 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Zimbabwe,ZWE,Not evaluated,32.1016166281755 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zimbabwe,ZWE,Successfully treated,56.5573770491803 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zimbabwe,ZWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zimbabwe,ZWE,Died,30.5327868852459 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zimbabwe,ZWE,Lost to follow-up,9.01639344262295 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Zimbabwe,ZWE,Not evaluated,3.89344262295082 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zimbabwe,ZWE,Successfully treated,53.9863325740319 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zimbabwe,ZWE,Treatment failed,0.911161731207289 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zimbabwe,ZWE,Died,19.3621867881549 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zimbabwe,ZWE,Lost to follow-up,8.65603644646925 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Zimbabwe,ZWE,Not evaluated,17.0842824601367 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zimbabwe,ZWE,Successfully treated,50.3937007874016 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zimbabwe,ZWE,Treatment failed,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zimbabwe,ZWE,Died,22.8346456692913 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zimbabwe,ZWE,Lost to follow-up,6.03674540682415 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Zimbabwe,ZWE,Not evaluated,20.7349081364829 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zimbabwe,ZWE,Successfully treated,42.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zimbabwe,ZWE,Treatment failed,0.911854103343465 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zimbabwe,ZWE,Died,19.1489361702128 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zimbabwe,ZWE,Lost to follow-up,3.64741641337386 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Zimbabwe,ZWE,Not evaluated,33.4346504559271 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zimbabwe,ZWE,Successfully treated,41.9047619047619 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zimbabwe,ZWE,Treatment failed,0.952380952380952 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zimbabwe,ZWE,Died,22.8571428571429 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zimbabwe,ZWE,Lost to follow-up,4.76190476190476 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Zimbabwe,ZWE,Not evaluated,29.5238095238095 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zimbabwe,ZWE,Successfully treated,68.1034482758621 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zimbabwe,ZWE,Treatment failed,0.431034482758621 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zimbabwe,ZWE,Died,24.5689655172414 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zimbabwe,ZWE,Lost to follow-up,6.89655172413793 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Zimbabwe,ZWE,Not evaluated,0.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zimbabwe,ZWE,Successfully treated,68.6363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zimbabwe,ZWE,Treatment failed,1.36363636363636 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zimbabwe,ZWE,Died,20.0 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zimbabwe,ZWE,Lost to follow-up,7.27272727272727 +39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Zimbabwe,ZWE,Not evaluated,2.72727272727273 diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/README.md b/statvar_imports/tuberculosis_rifampicin_resistant/README.md index 1c742a0100..77accda5a9 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/README.md +++ b/statvar_imports/tuberculosis_rifampicin_resistant/README.md @@ -1,4 +1,4 @@ -# WHO Tuberculosis: Tuberculosis: Treatment outcomes of people with RR/MDR-TB +# WHO Tuberculosis: Tuberculosis: Treatment outcomes of people with RR/MDR-TB ## Overview This dataset provides the percentage of TB patients who started rifampicin-resistant TB treatment and whose treatment outcome was recorded as treatment success (cured or treatment completed), treatment failed, died, lost to follow-up, or not evaluated, within the reporting period. @@ -11,7 +11,7 @@ https://data.who.int/indicators/i/39E4281/F1912F6 The data comes from the official WHO reporting database and includes comprehensive, country-level health metrics detailing annual Tuberculosis notifications and case classifications. ## How To Download Input Data -To download the data, you'll need to run the provided download script `who_data_download_tuberculosis_rifampicin_resistant.py`. This script automatically queries the WHO API for the indicator, merges it with the WHO geographical master list to append standard `iso3` country codes, and saves the cleaned `Tuberculosis_rr_mdr_tb_outcomes.csv` file inside an "input_files" folder. +To download the data, you'll need to run the provided download script `tuberculosis_rifampicin_resistant_data_download.py`. This script automatically queries the WHO API for the indicator, merges it with the WHO geographical master list to append standard `iso3` country codes, and saves the cleaned `tuberculosis_rifampicin_resistant_input.csv` file inside an "input_files" folder. type of place: Country. @@ -28,13 +28,13 @@ To process the WHO Tuberculosis data and generate statistical variables, use the **Download input file** ```bash -python3 statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tuberculosis_rifampicin_resistant.py +python3 statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_data_download.py ``` **For Test Data Run** ```bash python3 tools/statvar_importer/stat_var_processor.py \ - --input_data="statvar_imports/tuberculosis_rifampicin_resistant/testdata/Tuberculosis_rr_mdr_tb_outcomes.csv" \ + --input_data="statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv" \ --pv_map="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv" \ --output_path="statvar_imports/tuberculosis_rifampicin_resistant/output_files/tuberculosis_rifampicin_resistant" \ --config_file="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv" \ @@ -44,11 +44,11 @@ python3 statvar_imports/tuberculosis_rifampicin_resistant/who_data_download_tube **For Main data run** ```bash python3 tools/statvar_importer/stat_var_processor.py \ - --input_data="statvar_imports/tuberculosis_rifampicin_resistant/input_files/Tuberculosis_rr_mdr_tb_outcomes.csv" \ + --input_data="statvar_imports/tuberculosis_rifampicin_resistant/input_files/tuberculosis_rifampicin_resistant_input.csv" \ --pv_map="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv" \ --output_path="statvar_imports/tuberculosis_rifampicin_resistant/output_files/tuberculosis_rifampicin_resistant" \ --config_file="statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv" \ --existing_statvar_mcf="gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" ``` -#### Refresh type: Fully Autorefresh \ No newline at end of file +#### Refresh type: Fully Autorefresh diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/mainfest.json b/statvar_imports/tuberculosis_rifampicin_resistant/mainfest.json new file mode 100644 index 0000000000..b988c711a9 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/mainfest.json @@ -0,0 +1,26 @@ +{ + "import_specifications": [ + { + "import_name": "WHO_TuberculosisRifampicinResistant", + "curator_emails": [ + "support@datacommons.org" + ], + "provenance_url": "https://data.who.int/indicators/i/39E4281/F1912F6", + "provenance_description": "Treatment outcomes among those who started rifampicin-resistant TB treatment during a specified reporting period.", + "scripts": [ + "tuberculosis_rifampicin_resistant_data_download.py", + "../../../tools/statvar_importer/stat_var_processor.py --input_data=input_files/tuberculosis_rifampicin_resistant_input.csv --pv_map=tuberculosis_rifampicin_resistant_pvmap.csv --config_file=tuberculosis_rifampicin_resistant_metadata.csv --output_path=output/tuberculosis_rifampicin_resistant_output --existing_statvar_mcf=gs://unresolved_mcf/scripts/statvar/stat_vars.mcf" + ], + "import_inputs": [ + { + "template_mcf": "output/tuberculosis_rifampicin_resistant_output.tmcf", + "cleaned_csv": "output/tuberculosis_rifampicin_resistant_output.csv" + } + ], + "source_files": [ + "input_files/tuberculosis_rifampicin_resistant_input.csv" + ], + "cron_schedule": "0 10 10,21 * *" + } + ] +} diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv index 0edca6e2b6..e87f8d6dfb 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_input.csv @@ -108,393 +108,3 @@ IND_ID,INDICATOR_NAME,YEAR,COUNTRY,iso3,DISAGGR_1,VALUE 39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Successfully treated,0 39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Treatment failed,0 39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Angola,AGO,Not evaluated,100 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Successfully treated,77.3480662983426 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Treatment failed,0.552486187845304 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Died,8.28729281767956 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Lost to follow-up,13.8121546961326 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Angola,AGO,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Successfully treated,72.4279835390947 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Treatment failed,0.411522633744856 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Died,8.23045267489712 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Lost to follow-up,18.9300411522634 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Angola,AGO,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Angola,AGO,Successfully treated,72.2466960352423 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Died,6.75675675675676 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Lost to follow-up,12.1621621621622 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Central African Republic,CAF,Not evaluated,18.9189189189189 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Successfully treated,80.4347826086957 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Died,4.34782608695652 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Lost to follow-up,9.78260869565217 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Central African Republic,CAF,Not evaluated,5.43478260869565 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Successfully treated,69 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Died,14 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Lost to follow-up,17 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Central African Republic,CAF,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Successfully treated,56 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Died,8 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Lost to follow-up,12 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chad,TCD,Not evaluated,24 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Successfully treated,72.7272727272727 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Died,9.09090909090909 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Lost to follow-up,12.1212121212121 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chad,TCD,Not evaluated,6.06060606060606 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Successfully treated,48.7804878048781 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Treatment failed,2.4390243902439 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Died,14.6341463414634 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Lost to follow-up,9.75609756097561 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chad,TCD,Not evaluated,24.390243902439 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Successfully treated,56.25 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Treatment failed,2.08333333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Died,14.5833333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Lost to follow-up,22.9166666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chad,TCD,Not evaluated,4.16666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Successfully treated,66 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Treatment failed,2 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Died,22 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Lost to follow-up,10 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chad,TCD,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Successfully treated,26.7857142857143 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Treatment failed,1.78571428571429 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Died,10.7142857142857 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Lost to follow-up,16.0714285714286 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chad,TCD,Not evaluated,44.6428571428571 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Successfully treated,61.71875 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Died,12.5 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Lost to follow-up,24.21875 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chad,TCD,Not evaluated,1.5625 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Successfully treated,61.71875 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Died,12.5 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Lost to follow-up,24.21875 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chad,TCD,Not evaluated,1.5625 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Successfully treated,72.8070175438597 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Died,11.4035087719298 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Lost to follow-up,14.0350877192982 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chad,TCD,Not evaluated,1.75438596491228 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Successfully treated,50 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Died,40 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Lost to follow-up,10 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2002,Chile,CHL,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Successfully treated,42.8571428571429 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Died,28.5714285714286 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Lost to follow-up,14.2857142857143 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2004,Chile,CHL,Not evaluated,14.2857142857143 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Successfully treated,50 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Died,7.14285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Lost to follow-up,7.14285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2006,Chile,CHL,Not evaluated,35.7142857142857 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Successfully treated,36.3636363636364 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Lost to follow-up,18.1818181818182 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2007,Chile,CHL,Not evaluated,45.4545454545455 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Successfully treated,16.6666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Died,16.6666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Lost to follow-up,33.3333333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,Chile,CHL,Not evaluated,33.3333333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Successfully treated,21.0526315789474 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Died,26.3157894736842 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Lost to follow-up,15.7894736842105 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Chile,CHL,Not evaluated,36.8421052631579 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Successfully treated,41.6666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Died,16.6666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Lost to follow-up,25 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Chile,CHL,Not evaluated,16.6666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Successfully treated,50 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Died,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Lost to follow-up,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Chile,CHL,Not evaluated,10 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Successfully treated,55.5555555555556 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Died,22.2222222222222 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Lost to follow-up,11.1111111111111 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Chile,CHL,Not evaluated,11.1111111111111 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Successfully treated,21.4285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Treatment failed,7.14285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Died,28.5714285714286 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Lost to follow-up,42.8571428571429 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Chile,CHL,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Successfully treated,30.7692307692308 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Treatment failed,7.69230769230769 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Died,30.7692307692308 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Lost to follow-up,15.3846153846154 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Chile,CHL,Not evaluated,15.3846153846154 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Successfully treated,36.8421052631579 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Died,10.5263157894737 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Lost to follow-up,26.3157894736842 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Chile,CHL,Not evaluated,26.3157894736842 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Successfully treated,71.4285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Died,7.14285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Lost to follow-up,21.4285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Chile,CHL,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Successfully treated,48 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Died,12 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Lost to follow-up,36 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Chile,CHL,Not evaluated,4 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Successfully treated,46.031746031746 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Treatment failed,1.58730158730159 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Died,14.2857142857143 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Lost to follow-up,34.9206349206349 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Chile,CHL,Not evaluated,3.17460317460317 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Successfully treated,50 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Treatment failed,1.66666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Died,13.3333333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Lost to follow-up,28.3333333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Chile,CHL,Not evaluated,6.66666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Successfully treated,59.4594594594595 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Treatment failed,5.40540540540541 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Died,13.5135135135135 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Lost to follow-up,21.6216216216216 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Chile,CHL,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Successfully treated,54.3859649122807 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Died,19.2982456140351 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Lost to follow-up,22.8070175438597 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Chile,CHL,Not evaluated,3.50877192982456 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Successfully treated,63.6363636363636 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Treatment failed,1.81818181818182 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Died,14.5454545454545 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Lost to follow-up,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Chile,CHL,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Successfully treated,46.1538461538462 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Treatment failed,38.4615384615385 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Lost to follow-up,7.69230769230769 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2008,China,CHN,Not evaluated,7.69230769230769 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Successfully treated,46.1538461538462 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Treatment failed,24.6153846153846 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Died,8.46153846153846 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Lost to follow-up,7.69230769230769 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,China,CHN,Not evaluated,13.0769230769231 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Successfully treated,41.8166939443535 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Treatment failed,16.4484451718494 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Died,7.28314238952537 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Lost to follow-up,8.34697217675941 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,China,CHN,Not evaluated,26.1047463175123 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Successfully treated,49.9065420560748 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Treatment failed,20.4672897196262 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Died,8.41121495327103 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Lost to follow-up,8.22429906542056 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,China,CHN,Not evaluated,12.9906542056075 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Successfully treated,42.2350472193074 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Treatment failed,7.71248688352571 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Died,5.40398740818468 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Lost to follow-up,4.45960125918153 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,China,CHN,Not evaluated,40.1888772298006 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Successfully treated,55.4945054945055 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Treatment failed,8.97435897435897 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Died,7.14285714285714 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Lost to follow-up,7.37179487179487 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,China,CHN,Not evaluated,21.0164835164835 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Successfully treated,40.9697821503865 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Treatment failed,6.39494026704146 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Died,5.86788475052706 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Lost to follow-up,8.9599437807449 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,China,CHN,Not evaluated,37.8074490513001 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Successfully treated,40.9945528026709 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Treatment failed,9.7873835881216 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Died,4.09418379898085 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Lost to follow-up,13.1259884027412 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,China,CHN,Not evaluated,31.9978914074855 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Successfully treated,52.2664199814986 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Treatment failed,6.91951896392229 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,China,CHN,Died,5.64292321924144 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Lost to follow-up,25.1428571428571 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Successfully treated,60.1208459214502 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Died,23.5649546827795 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Lost to follow-up,16.3141993957704 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Successfully treated,69.8198198198198 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Treatment failed,1.8018018018018 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Died,19.8198198198198 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Lost to follow-up,8.55855855855856 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Successfully treated,67.5409836065574 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Treatment failed,1.9672131147541 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Died,22.9508196721311 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Lost to follow-up,4.26229508196721 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Eswatini,SWZ,Not evaluated,3.27868852459016 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Successfully treated,71.864406779661 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Treatment failed,4.74576271186441 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Died,18.6440677966102 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Lost to follow-up,2.71186440677966 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Eswatini,SWZ,Not evaluated,2.03389830508475 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Successfully treated,73.4513274336283 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Treatment failed,3.53982300884956 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Died,19.4690265486726 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Lost to follow-up,3.09734513274336 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Eswatini,SWZ,Not evaluated,0.442477876106195 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Successfully treated,76.2237762237762 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Treatment failed,2.0979020979021 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Died,12.5874125874126 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Lost to follow-up,2.7972027972028 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Eswatini,SWZ,Not evaluated,6.29370629370629 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Successfully treated,81.6793893129771 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Treatment failed,0.763358778625954 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Died,15.2671755725191 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Lost to follow-up,2.29007633587786 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Successfully treated,77.6470588235294 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Treatment failed,2.35294117647059 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Died,11.7647058823529 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Lost to follow-up,8.23529411764706 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Successfully treated,84.4155844155844 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Treatment failed,2.5974025974026 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Died,7.79220779220779 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Lost to follow-up,5.1948051948052 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Successfully treated,85.7142857142857 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Treatment failed,1.42857142857143 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Died,8.57142857142857 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Lost to follow-up,4.28571428571429 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Eswatini,SWZ,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Successfully treated,90.4109589041096 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Died,8.21917808219178 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Lost to follow-up,1.36986301369863 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2009,Ethiopia,ETH,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Successfully treated,84.2105263157895 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Treatment failed,0.87719298245614 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Died,13.1578947368421 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Lost to follow-up,0.87719298245614 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2010,Ethiopia,ETH,Not evaluated,0.87719298245614 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Successfully treated,72.4137931034483 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Died,18.1034482758621 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Lost to follow-up,7.75862068965517 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2011,Ethiopia,ETH,Not evaluated,1.72413793103448 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Successfully treated,82.6568265682657 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Treatment failed,3.690036900369 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Died,11.8081180811808 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Lost to follow-up,1.8450184501845 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2012,Ethiopia,ETH,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Successfully treated,68.0100755667506 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Treatment failed,2.51889168765743 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Died,12.3425692695214 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Lost to follow-up,8.06045340050378 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2013,Ethiopia,ETH,Not evaluated,9.06801007556675 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Successfully treated,69.6588868940754 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Treatment failed,0.538599640933573 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Died,15.2603231597846 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Lost to follow-up,8.79712746858169 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Ethiopia,ETH,Not evaluated,5.74506283662478 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Successfully treated,75.1515151515152 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Treatment failed,0.757575757575758 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Died,11.969696969697 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Lost to follow-up,10.4545454545455 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Ethiopia,ETH,Not evaluated,1.66666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Successfully treated,72.4039829302987 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Treatment failed,2.13371266002845 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Died,12.0910384068279 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Lost to follow-up,7.96586059743955 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Ethiopia,ETH,Not evaluated,5.40540540540541 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Successfully treated,75.2824858757062 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Treatment failed,1.69491525423729 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Died,10.7344632768362 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Lost to follow-up,7.20338983050848 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Ethiopia,ETH,Not evaluated,5.08474576271186 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Successfully treated,70.1388888888889 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Treatment failed,1.52777777777778 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Died,10.4166666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Lost to follow-up,6.80555555555556 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,Ethiopia,ETH,Not evaluated,11.1111111111111 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Successfully treated,68.266253869969 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Treatment failed,3.09597523219814 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Died,8.97832817337461 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Lost to follow-up,5.57275541795666 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Ethiopia,ETH,Not evaluated,14.0866873065015 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Successfully treated,60.6164383561644 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Treatment failed,1.1986301369863 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Died,5.82191780821918 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Lost to follow-up,2.73972602739726 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2020,Ethiopia,ETH,Not evaluated,29.6232876712329 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Successfully treated,78.0155642023346 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Treatment failed,2.91828793774319 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Died,8.94941634241245 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Lost to follow-up,4.08560311284047 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Ethiopia,ETH,Not evaluated,6.03112840466926 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Successfully treated,81.9178082191781 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Treatment failed,0.273972602739726 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Died,6.84931506849315 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Lost to follow-up,6.71232876712329 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Ethiopia,ETH,Not evaluated,4.24657534246575 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Successfully treated,100 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2014,Fiji,FJI,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Successfully treated,100 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Fiji,FJI,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Successfully treated,100 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Fiji,FJI,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Successfully treated,100 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Fiji,FJI,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Successfully treated,75 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Died,25 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2021,Fiji,FJI,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Successfully treated,60 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Treatment failed,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Died,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Fiji,FJI,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Successfully treated,50 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2015,Finland,FIN,Not evaluated,50 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Successfully treated,80 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Lost to follow-up,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2016,Finland,FIN,Not evaluated,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Successfully treated,40 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Died,20 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2017,Finland,FIN,Not evaluated,40 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Successfully treated,66.6666666666667 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,Finland,FIN,Not evaluated,33.3333333333333 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Successfully treated,62.5 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Died,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Lost to follow-up,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2022,Finland,FIN,Not evaluated,37.5 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Successfully treated,4.05405405405405 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Treatment failed,0 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Died,1.35135135135135 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Lost to follow-up,1.35135135135135 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2018,France,FRA,Not evaluated,93.2432432432432 -39E4281F1912F6,Treatment outcomes of people with RR/MDR-TB,2019,France,FRA,Successfully treated,8.13953488372093 diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.csv b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.csv index 9ee1054e0e..b2c73b411b 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.csv +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.csv @@ -1,500 +1,100 @@ -observationDate,observationAbout,value,variableMeasured -2011,country/AFG,66.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2011,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2011,country/AFG,9.52381,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2011,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2011,country/AFG,23.80952,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2012,country/AFG,71.05263,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2012,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2012,country/AFG,15.78947,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2012,country/AFG,7.89474,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2012,country/AFG,5.26316,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2013,country/AFG,63.04348,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2013,country/AFG,2.17391,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2013,country/AFG,13.04348,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2013,country/AFG,19.56522,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2013,country/AFG,2.17391,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/AFG,65.11628,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/AFG,11.62791,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/AFG,23.25581,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/AFG,63.85542,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/AFG,16.86747,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/AFG,19.27711,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/AFG,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/AFG,62.0915,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/AFG,2.61438,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/AFG,13.72549,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/AFG,20.91503,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/AFG,0.65359,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/AFG,63.91753,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/AFG,1.03093,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/AFG,12.37113,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/AFG,22.16495,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/AFG,0.51546,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/AFG,68.80734,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/AFG,2.75229,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/AFG,10.09174,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/AFG,16.81957,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/AFG,1.52905,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/AFG,71.21212,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/AFG,2.0202,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/AFG,8.58586,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/AFG,14.39394,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/AFG,3.78788,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/AFG,74.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/AFG,0.95238,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/AFG,9.84127,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/AFG,13.01587,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/AFG,1.90476,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/AFG,68.44784,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/AFG,2.79898,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/AFG,11.19593,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/AFG,16.79389,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/AFG,0.76336,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/AFG,72.31544,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/AFG,2.18121,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/AFG,11.07383,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/AFG,13.42282,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/AFG,1.00671,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2006,country/ALB,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2006,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/ALB,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/ALB,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/ALB,75,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/ALB,25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/ALB,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/ALB,60,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/ALB,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/ALB,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/ALB,66.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/ALB,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/ALB,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/ASM,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/ASM,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/ASM,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2009,country/AGO,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2009,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2011,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2011,country/AGO,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2013,country/AGO,77.34807,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2013,country/AGO,0.55249,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2013,country/AGO,8.28729,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2013,country/AGO,13.81215,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2013,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/AGO,72.42798,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/AGO,0.41152,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/AGO,8.23045,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/AGO,18.93004,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/AGO,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/AGO,72.2467,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/CAF,6.75676,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/CAF,12.16216,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/CAF,18.91892,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/CAF,80.43478,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/CAF,4.34783,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/CAF,9.78261,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/CAF,5.43478,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/CAF,69,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/CAF,14,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/CAF,17,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/CAF,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/TCD,56,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/TCD,8,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/TCD,12,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/TCD,24,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/TCD,72.72727,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/TCD,9.09091,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/TCD,12.12121,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/TCD,6.06061,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/TCD,48.78049,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/TCD,2.43902,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/TCD,14.63415,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/TCD,9.7561,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/TCD,24.39024,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/TCD,56.25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/TCD,2.08333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/TCD,14.58333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/TCD,22.91667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/TCD,4.16667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/TCD,66,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/TCD,2,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/TCD,22,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/TCD,10,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/TCD,26.78571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/TCD,1.78571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/TCD,10.71429,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/TCD,16.07143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/TCD,44.64286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/TCD,61.71875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/TCD,12.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/TCD,24.21875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/TCD,1.5625,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/TCD,61.71875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/TCD,12.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/TCD,24.21875,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/TCD,1.5625,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/TCD,72.80702,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/TCD,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/TCD,11.40351,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/TCD,14.03509,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/TCD,1.75439,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2002,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2002,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2002,country/CHL,40,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2002,country/CHL,10,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2002,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2004,country/CHL,42.85714,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2004,country/CHL,28.57143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2004,country/CHL,14.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2004,country/CHL,14.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2006,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2006,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2006,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2006,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2006,country/CHL,35.71429,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2007,country/CHL,36.36364,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2007,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2007,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2007,country/CHL,18.18182,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2007,country/CHL,45.45455,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2008,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2008,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2008,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2008,country/CHL,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2008,country/CHL,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2009,country/CHL,21.05263,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2009,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2009,country/CHL,26.31579,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2009,country/CHL,15.78947,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2009,country/CHL,36.84211,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2010,country/CHL,41.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2010,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2010,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2010,country/CHL,25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2010,country/CHL,16.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2011,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2011,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2011,country/CHL,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2011,country/CHL,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2011,country/CHL,10,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2012,country/CHL,55.55556,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2012,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2012,country/CHL,22.22222,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2012,country/CHL,11.11111,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2012,country/CHL,11.11111,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2013,country/CHL,21.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2013,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2013,country/CHL,28.57143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2013,country/CHL,42.85714,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2013,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/CHL,30.76923,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/CHL,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/CHL,30.76923,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/CHL,15.38462,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/CHL,15.38462,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/CHL,36.84211,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/CHL,10.52632,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/CHL,26.31579,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/CHL,26.31579,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/CHL,71.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/CHL,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/CHL,21.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/CHL,48,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/CHL,12,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/CHL,36,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/CHL,4,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/CHL,46.03175,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/CHL,1.5873,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/CHL,14.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/CHL,34.92063,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/CHL,3.1746,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/CHL,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/CHL,1.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/CHL,13.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/CHL,28.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/CHL,6.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/CHL,59.45946,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/CHL,5.40541,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/CHL,13.51351,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/CHL,21.62162,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/CHL,54.38596,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/CHL,19.29825,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/CHL,22.80702,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/CHL,3.50877,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/CHL,63.63636,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/CHL,1.81818,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/CHL,14.54545,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/CHL,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/CHL,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2008,country/CHN,46.15385,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2008,country/CHN,38.46154,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2008,country/CHN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2008,country/CHN,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2008,country/CHN,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2009,country/CHN,46.15385,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2009,country/CHN,24.61538,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2009,country/CHN,8.46154,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2009,country/CHN,7.69231,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2009,country/CHN,13.07692,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2010,country/CHN,41.81669,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2010,country/CHN,16.44845,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2010,country/CHN,7.28314,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2010,country/CHN,8.34697,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2010,country/CHN,26.10475,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2011,country/CHN,49.90654,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2011,country/CHN,20.46729,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2011,country/CHN,8.41121,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2011,country/CHN,8.2243,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2011,country/CHN,12.99065,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2012,country/CHN,42.23505,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2012,country/CHN,7.71249,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2012,country/CHN,5.40399,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2012,country/CHN,4.4596,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2012,country/CHN,40.18888,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2013,country/CHN,55.49451,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2013,country/CHN,8.97436,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2013,country/CHN,7.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2013,country/CHN,7.37179,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2013,country/CHN,21.01648,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/CHN,40.96978,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/CHN,6.39494,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/CHN,5.86788,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/CHN,8.95994,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/CHN,37.80745,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/CHN,40.99455,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/CHN,9.78738,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/CHN,4.09418,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/CHN,13.12599,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/CHN,31.99789,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/CHN,52.26642,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/CHN,6.91952,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/CHN,5.64292,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2011,country/SWZ,25.14286,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2011,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2013,country/SWZ,60.12085,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2013,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2013,country/SWZ,23.56495,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2013,country/SWZ,16.3142,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2013,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/SWZ,69.81982,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/SWZ,1.8018,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/SWZ,19.81982,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/SWZ,8.55856,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/SWZ,67.54098,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/SWZ,1.96721,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/SWZ,22.95082,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/SWZ,4.2623,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/SWZ,3.27869,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/SWZ,71.86441,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/SWZ,4.74576,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/SWZ,18.64407,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/SWZ,2.71186,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/SWZ,2.0339,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/SWZ,73.45133,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/SWZ,3.53982,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/SWZ,19.46903,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/SWZ,3.09735,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/SWZ,0.44248,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/SWZ,76.22378,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/SWZ,2.0979,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/SWZ,12.58741,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/SWZ,2.7972,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/SWZ,6.29371,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/SWZ,81.67939,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/SWZ,0.76336,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/SWZ,15.26718,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/SWZ,2.29008,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/SWZ,77.64706,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/SWZ,2.35294,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/SWZ,11.76471,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/SWZ,8.23529,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/SWZ,84.41558,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/SWZ,2.5974,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/SWZ,7.79221,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/SWZ,5.19481,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/SWZ,85.71429,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/SWZ,1.42857,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/SWZ,8.57143,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/SWZ,4.28571,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/SWZ,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2009,country/ETH,90.41096,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2009,country/ETH,8.21918,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2009,country/ETH,1.36986,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2009,country/ETH,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2010,country/ETH,84.21053,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2010,country/ETH,0.87719,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2010,country/ETH,13.15789,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2010,country/ETH,0.87719,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2010,country/ETH,0.87719,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2011,country/ETH,72.41379,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2011,country/ETH,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2011,country/ETH,18.10345,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2011,country/ETH,7.75862,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2011,country/ETH,1.72414,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2012,country/ETH,82.65683,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2012,country/ETH,3.69004,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2012,country/ETH,11.80812,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2012,country/ETH,1.84502,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2012,country/ETH,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2013,country/ETH,68.01008,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2013,country/ETH,2.51889,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2013,country/ETH,12.34257,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2013,country/ETH,8.06045,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2013,country/ETH,9.06801,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/ETH,69.65889,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/ETH,0.5386,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/ETH,15.26032,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/ETH,8.79713,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/ETH,5.74506,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/ETH,75.15152,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/ETH,0.75758,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/ETH,11.9697,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/ETH,10.45455,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/ETH,1.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/ETH,72.40398,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/ETH,2.13371,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/ETH,12.09104,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/ETH,7.96586,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/ETH,5.40541,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/ETH,75.28249,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/ETH,1.69492,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/ETH,10.73446,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/ETH,7.20339,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/ETH,5.08475,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/ETH,70.13889,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/ETH,1.52778,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/ETH,10.41667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/ETH,6.80556,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/ETH,11.11111,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/ETH,68.26625,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/ETH,3.09598,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/ETH,8.97833,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/ETH,5.57276,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/ETH,14.08669,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2020,country/ETH,60.61644,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2020,country/ETH,1.19863,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2020,country/ETH,5.82192,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2020,country/ETH,2.73973,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2020,country/ETH,29.62329,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/ETH,78.01556,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/ETH,2.91829,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/ETH,8.94942,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/ETH,4.0856,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/ETH,6.03113,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/ETH,81.91781,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/ETH,0.27397,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/ETH,6.84932,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/ETH,6.71233,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/ETH,4.24658,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2014,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2014,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/FJI,100,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2021,country/FJI,75,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2021,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2021,country/FJI,25,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2021,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2021,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/FJI,60,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/FJI,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/FJI,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/FJI,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2015,country/FIN,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2015,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2015,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2015,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2015,country/FIN,50,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2016,country/FIN,80,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2016,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2016,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2016,country/FIN,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2016,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2017,country/FIN,40,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2017,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2017,country/FIN,20,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2017,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2017,country/FIN,40,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/FIN,66.66667,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2019,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2019,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2019,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2019,country/FIN,33.33333,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2022,country/FIN,62.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2022,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2022,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2022,country/FIN,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2022,country/FIN,37.5,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2018,country/FRA,4.05405,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated -2018,country/FRA,0,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed -2018,country/FRA,1.35135,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment -2018,country/FRA,1.35135,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp -2018,country/FRA,93.24324,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated -2019,country/FRA,8.13953,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated +observationDate,observationAbout,variableMeasured,value,unit,scalingFactor +2011,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,66.66667,dcs:Percent,100 +2011,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2011,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,9.52381,dcs:Percent,100 +2011,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2011,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,23.80952,dcs:Percent,100 +2012,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,71.05263,dcs:Percent,100 +2012,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2012,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,15.78947,dcs:Percent,100 +2012,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,7.89474,dcs:Percent,100 +2012,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,5.26316,dcs:Percent,100 +2013,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,63.04348,dcs:Percent,100 +2013,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.17391,dcs:Percent,100 +2013,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,13.04348,dcs:Percent,100 +2013,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,19.56522,dcs:Percent,100 +2013,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.17391,dcs:Percent,100 +2014,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,65.11628,dcs:Percent,100 +2014,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2014,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,11.62791,dcs:Percent,100 +2014,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,23.25581,dcs:Percent,100 +2014,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2015,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,63.85542,dcs:Percent,100 +2015,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2015,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,16.86747,dcs:Percent,100 +2015,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,19.27711,dcs:Percent,100 +2015,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2016,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,62.0915,dcs:Percent,100 +2016,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.61438,dcs:Percent,100 +2016,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,13.72549,dcs:Percent,100 +2016,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,20.91503,dcs:Percent,100 +2016,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0.65359,dcs:Percent,100 +2017,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,63.91753,dcs:Percent,100 +2017,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,1.03093,dcs:Percent,100 +2017,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,12.37113,dcs:Percent,100 +2017,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,22.16495,dcs:Percent,100 +2017,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0.51546,dcs:Percent,100 +2018,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,68.80734,dcs:Percent,100 +2018,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.75229,dcs:Percent,100 +2018,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,10.09174,dcs:Percent,100 +2018,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,16.81957,dcs:Percent,100 +2018,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,1.52905,dcs:Percent,100 +2019,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,71.21212,dcs:Percent,100 +2019,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.0202,dcs:Percent,100 +2019,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,8.58586,dcs:Percent,100 +2019,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,14.39394,dcs:Percent,100 +2019,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,3.78788,dcs:Percent,100 +2020,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,74.28571,dcs:Percent,100 +2020,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0.95238,dcs:Percent,100 +2020,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,9.84127,dcs:Percent,100 +2020,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,13.01587,dcs:Percent,100 +2020,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,1.90476,dcs:Percent,100 +2021,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,68.44784,dcs:Percent,100 +2021,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.79898,dcs:Percent,100 +2021,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,11.19593,dcs:Percent,100 +2021,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,16.79389,dcs:Percent,100 +2021,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0.76336,dcs:Percent,100 +2022,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,72.31544,dcs:Percent,100 +2022,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,2.18121,dcs:Percent,100 +2022,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,11.07383,dcs:Percent,100 +2022,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,13.42282,dcs:Percent,100 +2022,country/AFG,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,1.00671,dcs:Percent,100 +2006,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2006,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,100,dcs:Percent,100 +2006,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2006,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2006,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2015,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,100,dcs:Percent,100 +2015,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2016,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,100,dcs:Percent,100 +2016,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2016,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2016,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2016,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2018,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,75,dcs:Percent,100 +2018,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2018,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,25,dcs:Percent,100 +2018,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2018,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2019,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,50,dcs:Percent,100 +2019,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2019,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,50,dcs:Percent,100 +2019,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2020,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,50,dcs:Percent,100 +2020,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2020,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,50,dcs:Percent,100 +2020,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2020,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2021,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,60,dcs:Percent,100 +2021,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,20,dcs:Percent,100 +2021,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,20,dcs:Percent,100 +2022,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,66.66667,dcs:Percent,100 +2022,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2022,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,33.33333,dcs:Percent,100 +2022,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2022,country/ALB,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2017,country/ASM,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_SuccessfullyTreated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,100,dcs:Percent,100 +2017,country/ASM,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentFailed_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2017,country/ASM,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_DiedDuringTreatment_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2017,country/ASM,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_LostToFollowUp_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 +2017,country/ASM,dcid:Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis_TreatmentNotEvaluated_AsAFractionOf_Count_Person_ConditionMultidrugOrRifampicinResistantTuberculosis,0,dcs:Percent,100 diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.tmcf b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.tmcf index f3640586bf..ea0cfca3cf 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.tmcf +++ b/statvar_imports/tuberculosis_rifampicin_resistant/testdata/tuberculosis_rifampicin_resistant_output.tmcf @@ -1,8 +1,8 @@ -Node: E:TB_output->E0 -observationDate: C:TB_output->observationDate -observationAbout: C:TB_output->observationAbout -value: C:TB_output->value -variableMeasured: C:TB_output->variableMeasured -scalingFactor: 100 +Node: E:tuberculosis_rifampicin_resistant->E0 +observationDate: C:tuberculosis_rifampicin_resistant->observationDate +observationAbout: C:tuberculosis_rifampicin_resistant->observationAbout +variableMeasured: C:tuberculosis_rifampicin_resistant->variableMeasured +value: C:tuberculosis_rifampicin_resistant->value +unit: C:tuberculosis_rifampicin_resistant->unit +scalingFactor: C:tuberculosis_rifampicin_resistant->scalingFactor typeOf: dcs:StatVarObservation -unit: dcs:Percent diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_data_download.py b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_data_download.py new file mode 100644 index 0000000000..9a2d783562 --- /dev/null +++ b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_data_download.py @@ -0,0 +1,66 @@ +import os +import requests +import io +import pandas as pd +import logging + +# Configure logging +logging.basicConfig(level=logging.INFO, format='%(asctime)s - %(levelname)s - %(message)s') + +def download_tb_rr_mdr_data(): + # 1. Get the Clean Data from the API using the new Indicator ID + api_url = "https://xmart-api-public.who.int/DATA_/RELAY_TB_DATA" + params = { + "$filter": "IND_ID eq '39E4281F1912F6'", + "$select": "IND_ID,INDICATOR_NAME,YEAR,COUNTRY,DISAGGR_1,VALUE", + "$format": "csv" + } + + logging.info("1. Fetching clean percentage data from WHO API...") + api_response = requests.get(api_url, params=params, timeout=30) + + if api_response.status_code != 200: + logging.error(f"Failed to fetch API data. HTTP {api_response.status_code}") + return + + # Load the clean API data into a pandas table + api_df = pd.read_csv(io.StringIO(api_response.text)) + + # 2. Get ONLY the iso3 code from the master database + logging.info("2. Fetching country iso3 codes from WHO master database...") + master_url = "https://extranet.who.int/tme/generateCSV.asp?ds=notifications" + master_response = requests.get(master_url, timeout=60) + if master_response.status_code != 200: + logging.error(f"Failed to fetch master data. HTTP {master_response.status_code}") + return + + # We only pull the 'country' (for matching) and 'iso3' columns + geo_columns = ['country', 'iso3'] + master_df = pd.read_csv(io.StringIO(master_response.text), usecols=geo_columns).drop_duplicates() + + # 3. Merge the two datasets together based on the country name + logging.info("3. Merging data and formatting...") + # The API uses uppercase 'COUNTRY', the master uses lowercase 'country' + merged_df = pd.merge(api_df, master_df, left_on='COUNTRY', right_on='country', how='left') + + # Drop the duplicate lowercase 'country' column used for joining + merged_df = merged_df.drop(columns=['country']) + + # Reorder columns so the iso3 code sits right next to the Country name + final_columns = [ + 'IND_ID', 'INDICATOR_NAME', 'YEAR', 'COUNTRY', 'iso3','DISAGGR_1', 'VALUE' + ] + merged_df = merged_df[final_columns] + + # 4. Save to CSV in a new folder + output_dir = "input_files" + filename = os.path.join(output_dir, "tuberculosis_rifampicin_resistant_input.csv") + + os.makedirs(output_dir, exist_ok=True) + + # Save without the pandas index column + merged_df.to_csv(filename, index=False) + logging.info(f"Success! Data saved locally as '{filename}'") + +if __name__ == "__main__": + download_tb_rr_mdr_data() diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv index b56a8d7547..3b627bc672 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv +++ b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_metadata.csv @@ -11,4 +11,4 @@ populationType,Person measuredProperty,count header_rows,1 mapped_columns,6 -dc_api_root,https://api.datacommons.org \ No newline at end of file +dc_api_root,https://api.datacommons.org diff --git a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv index 7a483d0c5e..97b910b903 100644 --- a/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv +++ b/statvar_imports/tuberculosis_rifampicin_resistant/tuberculosis_rifampicin_resistant_pvmap.csv @@ -6,4 +6,4 @@ DISAGGR_1:Lost to follow-up,treatmentOutcome,dcs:LostToFollowUp,,,,,, DISAGGR_1:Not evaluated,treatmentOutcome,dcs:TreatmentNotEvaluated,,,,,, DISAGGR_1:Successfully treated,treatmentOutcome,dcs:SuccessfullyTreated,,,,,, DISAGGR_1:Treatment failed,treatmentOutcome,dcs:TreatmentFailed,,,,,, -VALUE,value,{Number},populationType,dcs:Person,measuredProperty,dcs:count,medicalCondition,dcs:MultidrugOrRifampicinResistantTuberculosis,unit,dcs:Percent,scalingFactor,100,, \ No newline at end of file +VALUE,value,{Number},populationType,dcs:Person,measuredProperty,dcs:count,medicalCondition,dcs:MultidrugOrRifampicinResistantTuberculosis,unit,dcs:Percent,scalingFactor,100,measurementDenominator,-treatmentOutcome diff --git a/temp.csv b/temp.csv new file mode 100644 index 0000000000..e69de29bb2